Query 020221
Match_columns 329
No_of_seqs 218 out of 2554
Neff 9.9
Searched_HMMs 46136
Date Fri Mar 29 08:00:26 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/020221.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/020221hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0581 Mitogen-activated prot 100.0 1.6E-55 3.4E-60 375.8 17.3 248 58-308 80-334 (364)
2 KOG0615 Serine/threonine prote 100.0 1.6E-55 3.5E-60 378.9 14.5 255 56-329 171-443 (475)
3 KOG1187 Serine/threonine prote 100.0 2.3E-53 5E-58 380.8 28.4 274 40-316 61-355 (361)
4 KOG0192 Tyrosine kinase specif 100.0 7.6E-53 1.7E-57 375.1 22.2 250 63-317 47-307 (362)
5 KOG0575 Polo-like serine/threo 100.0 9E-53 1.9E-57 378.5 20.1 243 57-308 18-268 (592)
6 KOG0197 Tyrosine kinases [Sign 100.0 1.4E-52 3.1E-57 373.2 17.5 252 59-317 208-465 (468)
7 KOG0595 Serine/threonine-prote 100.0 5.2E-52 1.1E-56 357.5 18.5 246 56-307 9-266 (429)
8 KOG0591 NIMA (never in mitosis 100.0 3E-52 6.6E-57 342.7 10.4 250 57-312 19-284 (375)
9 KOG0598 Ribosomal protein S6 k 100.0 5E-51 1.1E-55 348.1 16.1 239 56-302 24-270 (357)
10 KOG0593 Predicted protein kina 100.0 1.4E-50 3.1E-55 335.9 14.5 248 57-308 2-283 (396)
11 KOG0578 p21-activated serine/t 100.0 4E-50 8.6E-55 358.7 15.9 248 54-308 270-522 (550)
12 KOG0198 MEKK and related serin 100.0 1.1E-49 2.4E-54 344.8 16.8 251 59-314 19-281 (313)
13 KOG0659 Cdk activating kinase 100.0 4.9E-49 1.1E-53 321.3 17.6 248 58-309 3-281 (318)
14 KOG0616 cAMP-dependent protein 100.0 1.9E-49 4.1E-54 328.3 14.9 253 57-327 44-301 (355)
15 KOG0600 Cdc2-related protein k 100.0 2.2E-49 4.7E-54 348.9 15.6 248 57-308 117-399 (560)
16 KOG0661 MAPK related serine/th 100.0 1.9E-49 4.2E-54 347.0 13.2 247 57-308 10-290 (538)
17 KOG0583 Serine/threonine prote 100.0 5.2E-48 1.1E-52 347.0 21.0 244 56-308 16-274 (370)
18 KOG0592 3-phosphoinositide-dep 100.0 1.1E-48 2.3E-53 347.2 15.8 241 59-308 75-337 (604)
19 KOG0582 Ste20-like serine/thre 100.0 1.1E-47 2.3E-52 333.7 19.7 253 55-308 24-292 (516)
20 KOG0605 NDR and related serine 100.0 9.8E-48 2.1E-52 341.1 18.5 248 55-308 139-444 (550)
21 KOG0193 Serine/threonine prote 100.0 6.6E-48 1.4E-52 346.1 17.1 262 60-327 395-670 (678)
22 KOG0588 Serine/threonine prote 100.0 1.2E-47 2.6E-52 347.4 17.5 246 54-308 9-262 (786)
23 KOG0597 Serine-threonine prote 100.0 8.5E-48 1.8E-52 342.6 16.0 241 58-308 3-250 (808)
24 KOG1026 Nerve growth factor re 100.0 1.5E-47 3.4E-52 356.9 14.2 257 59-321 488-770 (774)
25 cd05102 PTKc_VEGFR3 Catalytic 100.0 2.3E-46 5.1E-51 337.2 20.4 254 58-316 8-337 (338)
26 KOG0663 Protein kinase PITSLRE 100.0 4.5E-47 9.8E-52 318.9 14.3 254 52-308 71-360 (419)
27 KOG0585 Ca2+/calmodulin-depend 100.0 1.6E-46 3.4E-51 328.5 18.1 244 57-308 97-371 (576)
28 cd05631 STKc_GRK4 Catalytic do 100.0 2.7E-46 5.9E-51 328.9 19.5 247 59-308 2-260 (285)
29 PHA02988 hypothetical protein; 100.0 1.3E-45 2.8E-50 324.2 23.6 245 64-315 27-281 (283)
30 cd05612 STKc_PRKX_like Catalyt 100.0 2.1E-46 4.5E-51 330.6 18.6 242 58-308 2-253 (291)
31 cd05571 STKc_PKB Catalytic dom 100.0 2.8E-46 6E-51 334.6 19.5 236 64-308 2-250 (323)
32 PTZ00263 protein kinase A cata 100.0 3.4E-46 7.3E-51 334.8 19.0 244 56-308 17-270 (329)
33 cd06649 PKc_MEK2 Catalytic dom 100.0 2.8E-45 6E-50 329.2 22.8 251 57-309 5-301 (331)
34 KOG0201 Serine/threonine prote 100.0 3.9E-47 8.3E-52 329.8 10.2 242 59-308 15-262 (467)
35 KOG0580 Serine/threonine prote 100.0 2.6E-46 5.6E-51 301.1 13.2 243 59-308 24-272 (281)
36 cd05585 STKc_YPK1_like Catalyt 100.0 1.9E-45 4.2E-50 327.6 20.3 235 65-308 1-246 (312)
37 PTZ00426 cAMP-dependent protei 100.0 1.7E-45 3.6E-50 331.3 19.1 244 56-308 29-283 (340)
38 KOG0694 Serine/threonine prote 100.0 1.4E-45 3.1E-50 335.8 18.6 239 55-303 366-613 (694)
39 KOG0033 Ca2+/calmodulin-depend 100.0 1.4E-47 3E-52 309.6 4.8 245 59-308 13-266 (355)
40 cd05593 STKc_PKB_gamma Catalyt 100.0 3.2E-45 6.9E-50 328.3 20.6 237 64-309 2-251 (328)
41 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 3.7E-45 7.9E-50 328.8 20.6 249 58-309 2-257 (333)
42 cd05595 STKc_PKB_beta Catalyti 100.0 2.9E-45 6.4E-50 327.9 19.5 236 64-308 2-250 (323)
43 KOG0589 Serine/threonine prote 100.0 7.5E-46 1.6E-50 329.0 15.4 247 57-309 4-258 (426)
44 KOG0194 Protein tyrosine kinas 100.0 1.5E-45 3.3E-50 332.9 17.2 252 61-318 161-425 (474)
45 cd07848 STKc_CDKL5 Catalytic d 100.0 7.2E-45 1.6E-49 320.0 20.7 248 58-308 2-283 (287)
46 KOG4721 Serine/threonine prote 100.0 3.9E-46 8.4E-51 332.2 12.2 246 56-316 123-371 (904)
47 cd07871 STKc_PCTAIRE3 Catalyti 100.0 8E-45 1.7E-49 320.0 20.1 250 56-308 4-284 (288)
48 KOG1095 Protein tyrosine kinas 100.0 2.7E-45 5.9E-50 353.2 17.8 252 59-316 694-964 (1025)
49 KOG0660 Mitogen-activated prot 100.0 1.7E-45 3.7E-50 313.2 14.5 244 61-308 26-309 (359)
50 cd06650 PKc_MEK1 Catalytic dom 100.0 2.2E-44 4.8E-49 323.5 21.9 250 57-308 5-298 (333)
51 cd05064 PTKc_EphR_A10 Catalyti 100.0 2.6E-44 5.7E-49 313.1 21.4 249 58-313 6-265 (266)
52 cd05072 PTKc_Lyn Catalytic dom 100.0 2.7E-44 5.9E-49 312.0 21.4 250 57-313 6-261 (261)
53 PLN00034 mitogen-activated pro 100.0 9.8E-45 2.1E-49 328.5 19.2 245 55-308 72-327 (353)
54 cd05584 STKc_p70S6K Catalytic 100.0 2.1E-44 4.5E-49 322.4 21.0 237 63-308 2-255 (323)
55 cd05599 STKc_NDR_like Catalyti 100.0 7.4E-45 1.6E-49 330.7 18.3 245 58-308 2-295 (364)
56 cd05573 STKc_ROCK_NDR_like Cat 100.0 8.7E-45 1.9E-49 328.5 18.6 246 58-309 2-285 (350)
57 cd05096 PTKc_DDR1 Catalytic do 100.0 3.8E-44 8.2E-49 318.1 22.3 253 58-311 6-303 (304)
58 cd05626 STKc_LATS2 Catalytic d 100.0 1.6E-44 3.5E-49 330.3 20.4 246 58-308 2-304 (381)
59 cd07869 STKc_PFTAIRE1 Catalyti 100.0 2.5E-44 5.3E-49 319.2 20.9 249 57-308 5-287 (303)
60 cd05594 STKc_PKB_alpha Catalyt 100.0 7.7E-45 1.7E-49 325.6 17.7 237 64-309 2-252 (325)
61 cd05148 PTKc_Srm_Brk Catalytic 100.0 3.5E-44 7.6E-49 311.2 21.1 249 59-313 8-261 (261)
62 cd05052 PTKc_Abl Catalytic dom 100.0 5.8E-44 1.3E-48 310.4 22.5 249 58-313 7-262 (263)
63 KOG0611 Predicted serine/threo 100.0 3.4E-45 7.5E-50 314.7 14.4 243 57-309 53-303 (668)
64 cd05106 PTKc_CSF-1R Catalytic 100.0 1.5E-44 3.2E-49 329.3 19.4 252 58-314 39-373 (374)
65 cd05628 STKc_NDR1 Catalytic do 100.0 1.9E-44 4.1E-49 327.8 20.0 247 58-309 2-293 (363)
66 cd05590 STKc_nPKC_eta Catalyti 100.0 1.8E-44 3.9E-49 322.4 19.4 231 64-303 2-241 (320)
67 cd05048 PTKc_Ror Catalytic Dom 100.0 4.6E-44 1E-48 314.2 21.5 251 57-313 5-283 (283)
68 cd05104 PTKc_Kit Catalytic dom 100.0 2.3E-44 5E-49 328.3 20.2 251 58-313 36-374 (375)
69 KOG0032 Ca2+/calmodulin-depend 100.0 3E-44 6.5E-49 322.6 20.6 246 57-308 35-292 (382)
70 cd05608 STKc_GRK1 Catalytic do 100.0 2.7E-44 5.8E-49 315.4 19.9 241 65-308 1-256 (280)
71 cd05605 STKc_GRK4_like Catalyt 100.0 2.8E-44 6E-49 316.1 20.0 248 59-309 2-261 (285)
72 cd05589 STKc_PKN Catalytic dom 100.0 3E-44 6.5E-49 321.6 20.4 240 59-308 1-256 (324)
73 cd05114 PTKc_Tec_Rlk Catalytic 100.0 7.5E-44 1.6E-48 308.4 22.2 246 57-310 4-255 (256)
74 KOG2345 Serine/threonine prote 100.0 1E-44 2.2E-49 293.4 15.5 255 56-314 20-301 (302)
75 cd05607 STKc_GRK7 Catalytic do 100.0 3.4E-44 7.5E-49 314.3 20.2 245 65-311 1-252 (277)
76 KOG0599 Phosphorylase kinase g 100.0 2.3E-45 4.9E-50 301.1 11.7 246 58-308 18-282 (411)
77 PF07714 Pkinase_Tyr: Protein 100.0 3E-45 6.5E-50 317.9 13.1 244 61-310 3-259 (259)
78 cd05591 STKc_nPKC_epsilon Cata 100.0 3.2E-44 6.9E-49 321.0 20.0 236 64-308 2-253 (321)
79 KOG0658 Glycogen synthase kina 100.0 1.6E-45 3.6E-50 313.8 11.0 241 62-308 29-305 (364)
80 cd07862 STKc_CDK6 Catalytic do 100.0 5.3E-44 1.1E-48 315.0 21.0 249 58-308 2-286 (290)
81 cd05587 STKc_cPKC Catalytic do 100.0 3.4E-44 7.3E-49 321.2 19.4 236 59-303 2-246 (324)
82 cd05620 STKc_nPKC_delta Cataly 100.0 3.7E-44 8E-49 319.8 19.2 236 64-308 2-247 (316)
83 cd05625 STKc_LATS1 Catalytic d 100.0 3.6E-44 7.9E-49 328.1 19.6 245 58-308 2-304 (382)
84 cd05614 STKc_MSK2_N N-terminal 100.0 3.3E-44 7.2E-49 322.4 18.8 245 59-308 2-266 (332)
85 cd05629 STKc_NDR_like_fungal C 100.0 3.6E-44 7.8E-49 327.6 19.1 245 58-308 2-304 (377)
86 PTZ00267 NIMA-related protein 100.0 6.1E-44 1.3E-48 334.9 20.9 245 58-308 68-322 (478)
87 cd05592 STKc_nPKC_theta_delta 100.0 6.4E-44 1.4E-48 318.3 20.0 236 64-308 2-247 (316)
88 cd05596 STKc_ROCK Catalytic do 100.0 5.3E-44 1.2E-48 325.3 19.9 246 55-308 41-303 (370)
89 cd05619 STKc_nPKC_theta Cataly 100.0 5.6E-44 1.2E-48 318.6 19.6 236 64-308 2-247 (316)
90 cd07859 STKc_TDY_MAPK_plant Ca 100.0 5.3E-44 1.2E-48 321.7 19.6 246 59-308 2-289 (338)
91 cd05598 STKc_LATS Catalytic do 100.0 2.6E-44 5.5E-49 328.5 17.7 245 58-308 2-300 (376)
92 cd05570 STKc_PKC Catalytic dom 100.0 6.1E-44 1.3E-48 318.7 19.4 236 64-308 2-251 (318)
93 cd05049 PTKc_Trk Catalytic dom 100.0 1.4E-43 2.9E-48 310.7 21.3 249 58-312 6-280 (280)
94 cd05588 STKc_aPKC Catalytic do 100.0 7.8E-44 1.7E-48 319.5 20.2 240 64-308 2-261 (329)
95 cd05068 PTKc_Frk_like Catalyti 100.0 2E-43 4.4E-48 306.6 22.1 249 58-313 7-261 (261)
96 cd05094 PTKc_TrkC Catalytic do 100.0 1.9E-43 4.2E-48 311.7 22.2 257 58-320 6-289 (291)
97 cd05618 STKc_aPKC_iota Catalyt 100.0 1E-43 2.2E-48 318.6 20.3 235 64-303 2-250 (329)
98 cd05093 PTKc_TrkB Catalytic do 100.0 2.1E-43 4.6E-48 311.0 21.9 256 58-319 6-285 (288)
99 cd05575 STKc_SGK Catalytic dom 100.0 8.5E-44 1.8E-48 318.5 19.6 232 64-304 2-242 (323)
100 cd05616 STKc_cPKC_beta Catalyt 100.0 8.9E-44 1.9E-48 318.4 19.6 236 59-303 2-246 (323)
101 KOG0594 Protein kinase PCTAIRE 100.0 6.5E-44 1.4E-48 304.2 17.4 251 57-309 11-302 (323)
102 cd05601 STKc_CRIK Catalytic do 100.0 3.3E-44 7.1E-49 322.2 16.5 246 58-308 2-262 (330)
103 cd06654 STKc_PAK1 Catalytic do 100.0 2.2E-43 4.7E-48 312.1 21.5 249 53-308 16-269 (296)
104 cd05113 PTKc_Btk_Bmx Catalytic 100.0 2.2E-43 4.8E-48 305.6 20.8 247 57-311 4-256 (256)
105 cd05582 STKc_RSK_N N-terminal 100.0 3.5E-44 7.7E-49 320.3 16.2 234 63-305 2-245 (318)
106 KOG0579 Ste20-like serine/thre 100.0 6.8E-45 1.5E-49 327.7 11.4 250 54-308 29-288 (1187)
107 PHA03212 serine/threonine kina 100.0 3.4E-43 7.4E-48 321.6 22.9 242 57-308 92-375 (391)
108 cd05621 STKc_ROCK2 Catalytic d 100.0 1.4E-43 3E-48 322.3 20.1 245 56-308 42-303 (370)
109 cd08529 STKc_FA2-like Catalyti 100.0 4.9E-43 1.1E-47 303.0 22.5 244 59-308 2-252 (256)
110 cd05090 PTKc_Ror1 Catalytic do 100.0 4.2E-43 9.1E-48 308.2 21.9 251 56-312 4-282 (283)
111 cd08228 STKc_Nek6 Catalytic do 100.0 5.9E-43 1.3E-47 304.5 22.6 255 57-314 2-266 (267)
112 cd05108 PTKc_EGFR Catalytic do 100.0 3.6E-43 7.8E-48 313.5 21.7 252 58-317 8-272 (316)
113 cd05604 STKc_SGK3 Catalytic do 100.0 8.1E-44 1.8E-48 318.9 17.5 237 64-309 2-247 (325)
114 KOG0610 Putative serine/threon 100.0 1.6E-43 3.4E-48 305.3 18.5 249 55-308 75-391 (459)
115 cd05105 PTKc_PDGFR_alpha Catal 100.0 2.9E-43 6.4E-48 322.4 21.4 253 58-315 38-399 (400)
116 cd06655 STKc_PAK2 Catalytic do 100.0 5.5E-43 1.2E-47 309.5 22.2 252 50-308 12-268 (296)
117 cd05627 STKc_NDR2 Catalytic do 100.0 9.9E-44 2.1E-48 322.7 17.7 245 58-308 2-292 (360)
118 cd06643 STKc_SLK Catalytic dom 100.0 7E-43 1.5E-47 306.6 22.3 245 59-308 7-261 (282)
119 cd05091 PTKc_Ror2 Catalytic do 100.0 3.8E-43 8.2E-48 308.5 20.6 250 57-312 5-282 (283)
120 cd05054 PTKc_VEGFR Catalytic d 100.0 3.8E-43 8.3E-48 315.8 21.0 253 58-315 8-335 (337)
121 cd05067 PTKc_Lck_Blk Catalytic 100.0 6.6E-43 1.4E-47 303.2 21.8 247 58-312 7-259 (260)
122 cd05033 PTKc_EphR Catalytic do 100.0 1.1E-42 2.3E-47 302.9 23.0 248 59-313 6-265 (266)
123 cd06644 STKc_STK10_LOK Catalyt 100.0 7.6E-43 1.6E-47 308.0 22.2 255 49-308 4-268 (292)
124 cd05089 PTKc_Tie1 Catalytic do 100.0 9.8E-43 2.1E-47 308.1 22.8 259 57-321 2-283 (297)
125 PTZ00283 serine/threonine prot 100.0 2.5E-43 5.5E-48 331.2 20.0 247 57-309 32-297 (496)
126 PTZ00036 glycogen synthase kin 100.0 1.6E-43 3.4E-48 328.6 18.3 246 57-308 66-350 (440)
127 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 8.9E-43 1.9E-47 302.4 21.9 247 58-312 7-259 (260)
128 cd05071 PTKc_Src Catalytic dom 100.0 1.2E-42 2.7E-47 301.9 22.7 248 58-313 7-260 (262)
129 KOG1989 ARK protein kinase fam 100.0 2E-43 4.3E-48 330.7 19.0 250 59-316 39-314 (738)
130 cd05084 PTKc_Fes Catalytic dom 100.0 1.2E-42 2.5E-47 300.2 22.3 241 64-311 2-251 (252)
131 KOG0667 Dual-specificity tyros 100.0 2E-43 4.3E-48 321.3 18.0 195 58-255 187-391 (586)
132 cd05602 STKc_SGK1 Catalytic do 100.0 3E-43 6.5E-48 315.2 18.8 236 64-308 2-246 (325)
133 cd08229 STKc_Nek7 Catalytic do 100.0 1.1E-42 2.5E-47 302.7 21.9 255 57-314 2-266 (267)
134 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 9.5E-43 2.1E-47 306.1 21.6 254 58-313 5-283 (284)
135 cd07863 STKc_CDK4 Catalytic do 100.0 5.8E-43 1.3E-47 308.0 20.2 248 59-308 2-284 (288)
136 cd05059 PTKc_Tec_like Catalyti 100.0 8.6E-43 1.9E-47 301.8 20.9 245 58-310 5-255 (256)
137 cd06646 STKc_MAP4K5 Catalytic 100.0 6E-43 1.3E-47 304.6 20.0 249 56-309 8-265 (267)
138 cd05082 PTKc_Csk Catalytic dom 100.0 1.1E-42 2.5E-47 301.0 21.5 248 57-313 6-256 (256)
139 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 9.6E-43 2.1E-47 302.7 21.0 239 64-311 2-262 (262)
140 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 2.5E-43 5.5E-48 305.5 17.2 240 64-311 2-258 (258)
141 cd05088 PTKc_Tie2 Catalytic do 100.0 9.1E-43 2E-47 309.1 21.1 259 56-320 6-287 (303)
142 cd05615 STKc_cPKC_alpha Cataly 100.0 5.1E-43 1.1E-47 313.4 19.6 235 60-303 3-246 (323)
143 cd05092 PTKc_TrkA Catalytic do 100.0 8.8E-43 1.9E-47 305.8 20.7 249 57-311 5-279 (280)
144 KOG0577 Serine/threonine prote 100.0 7E-44 1.5E-48 319.0 13.8 244 60-310 29-279 (948)
145 cd05116 PTKc_Syk Catalytic dom 100.0 1.3E-42 2.7E-47 301.0 21.3 241 64-313 2-255 (257)
146 cd07853 STKc_NLK Catalytic dom 100.0 5E-43 1.1E-47 319.5 19.6 246 59-308 2-287 (372)
147 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 1.2E-42 2.7E-47 305.2 21.3 251 60-314 7-282 (283)
148 cd05630 STKc_GRK6 Catalytic do 100.0 5E-43 1.1E-47 308.2 18.8 246 60-308 3-260 (285)
149 cd05111 PTK_HER3 Pseudokinase 100.0 2.3E-42 4.9E-47 303.0 23.0 252 58-317 8-272 (279)
150 cd05597 STKc_DMPK_like Catalyt 100.0 7.9E-43 1.7E-47 313.2 20.5 249 58-309 2-266 (331)
151 cd06611 STKc_SLK_like Catalyti 100.0 8.4E-43 1.8E-47 305.8 20.2 249 55-308 3-261 (280)
152 cd07872 STKc_PCTAIRE2 Catalyti 100.0 7.5E-43 1.6E-47 310.5 20.0 250 56-308 5-285 (309)
153 cd05603 STKc_SGK2 Catalytic do 100.0 4.5E-43 9.6E-48 313.6 18.6 232 64-304 2-242 (321)
154 cd05069 PTKc_Yes Catalytic dom 100.0 2E-42 4.3E-47 300.2 22.1 247 58-312 7-259 (260)
155 cd06656 STKc_PAK3 Catalytic do 100.0 7.8E-43 1.7E-47 308.7 19.9 252 50-308 12-268 (297)
156 cd06625 STKc_MEKK3_like Cataly 100.0 2E-42 4.3E-47 300.5 22.0 243 59-308 4-259 (263)
157 cd06615 PKc_MEK Catalytic doma 100.0 1.9E-42 4.2E-47 307.7 22.3 250 58-309 2-287 (308)
158 cd07876 STKc_JNK2 Catalytic do 100.0 1.6E-42 3.5E-47 314.7 22.0 246 57-308 21-314 (359)
159 cd05039 PTKc_Csk_like Catalyti 100.0 2.3E-42 5E-47 299.0 21.9 248 58-313 7-256 (256)
160 cd05034 PTKc_Src_like Catalyti 100.0 2.5E-42 5.4E-47 299.6 22.2 248 58-312 7-260 (261)
161 cd06645 STKc_MAP4K3 Catalytic 100.0 1.3E-42 2.9E-47 302.4 20.5 246 58-308 10-264 (267)
162 cd06637 STKc_TNIK Catalytic do 100.0 1.5E-42 3.2E-47 302.8 20.8 244 59-308 8-268 (272)
163 cd05617 STKc_aPKC_zeta Catalyt 100.0 8.3E-43 1.8E-47 312.6 19.6 236 64-304 2-249 (327)
164 cd06624 STKc_ASK Catalytic dom 100.0 1.7E-42 3.7E-47 301.9 21.1 250 51-308 5-264 (268)
165 cd05622 STKc_ROCK1 Catalytic d 100.0 9.2E-43 2E-47 317.2 20.2 251 54-310 40-305 (371)
166 cd05632 STKc_GRK5 Catalytic do 100.0 1.5E-42 3.3E-47 305.1 20.8 247 60-309 3-261 (285)
167 cd07874 STKc_JNK3 Catalytic do 100.0 1E-42 2.2E-47 315.6 20.2 247 56-308 16-310 (355)
168 cd08227 PK_STRAD_alpha Pseudok 100.0 1.3E-42 2.9E-47 311.3 20.7 247 61-308 2-306 (327)
169 cd05062 PTKc_IGF-1R Catalytic 100.0 1.6E-42 3.5E-47 303.6 20.7 248 59-312 8-277 (277)
170 cd08219 STKc_Nek3 Catalytic do 100.0 2E-42 4.3E-47 299.2 20.6 245 59-309 2-252 (255)
171 cd05109 PTKc_HER2 Catalytic do 100.0 4.4E-42 9.5E-47 301.1 23.0 252 58-317 8-272 (279)
172 cd05053 PTKc_FGFR Catalytic do 100.0 2.4E-42 5.2E-47 304.9 21.3 250 59-314 14-292 (293)
173 cd06619 PKc_MKK5 Catalytic dom 100.0 3.1E-42 6.7E-47 302.2 21.7 243 59-308 3-252 (279)
174 cd05098 PTKc_FGFR1 Catalytic d 100.0 2.8E-42 6E-47 306.6 21.5 254 58-317 19-303 (307)
175 KOG0574 STE20-like serine/thre 100.0 1.3E-44 2.8E-49 300.6 6.0 244 59-309 35-283 (502)
176 cd05115 PTKc_Zap-70 Catalytic 100.0 3.9E-42 8.4E-47 298.0 21.7 242 64-313 2-255 (257)
177 cd08223 STKc_Nek4 Catalytic do 100.0 3.9E-42 8.4E-47 297.6 21.7 244 59-308 2-253 (257)
178 KOG0196 Tyrosine kinase, EPH ( 100.0 3.6E-44 7.7E-49 329.6 9.3 251 60-317 632-895 (996)
179 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 2.4E-42 5.1E-47 302.1 20.4 238 64-310 2-273 (274)
180 cd05035 PTKc_Axl_like Catalyti 100.0 6.1E-42 1.3E-46 298.9 22.9 248 60-313 2-272 (273)
181 cd05101 PTKc_FGFR2 Catalytic d 100.0 3.5E-42 7.6E-47 305.5 21.7 252 58-315 16-298 (304)
182 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 3.9E-42 8.5E-47 302.3 21.7 253 59-313 6-283 (284)
183 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 3.5E-42 7.6E-47 302.8 21.4 249 58-308 2-261 (286)
184 cd07875 STKc_JNK1 Catalytic do 100.0 2.5E-42 5.5E-47 314.0 21.1 246 57-308 24-317 (364)
185 cd00192 PTKc Catalytic domain 100.0 6.6E-42 1.4E-46 296.4 22.7 242 64-311 2-262 (262)
186 cd05085 PTKc_Fer Catalytic dom 100.0 7.3E-42 1.6E-46 294.8 22.5 241 64-311 2-249 (250)
187 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 7.6E-42 1.6E-46 297.4 22.8 253 58-314 3-266 (267)
188 cd05055 PTKc_PDGFR Catalytic d 100.0 4.2E-42 9.1E-47 304.7 21.2 250 59-313 37-301 (302)
189 cd06610 STKc_OSR1_SPAK Catalyt 100.0 6.1E-42 1.3E-46 297.8 21.8 250 58-308 2-263 (267)
190 cd06613 STKc_MAP4K3_like Catal 100.0 1.1E-41 2.4E-46 295.5 23.3 248 58-308 4-259 (262)
191 cd06612 STKc_MST1_2 Catalytic 100.0 5E-42 1.1E-46 296.6 21.1 244 58-308 4-252 (256)
192 PF00069 Pkinase: Protein kina 100.0 4.2E-43 9E-48 304.0 14.4 247 59-308 1-256 (260)
193 cd05065 PTKc_EphR_B Catalytic 100.0 5.2E-42 1.1E-46 299.0 21.3 249 58-313 5-268 (269)
194 cd07878 STKc_p38beta_MAPK11 Ca 100.0 3.1E-42 6.7E-47 311.0 20.5 247 57-308 15-297 (343)
195 cd05075 PTKc_Axl Catalytic dom 100.0 8.5E-42 1.8E-46 298.0 22.5 247 61-313 3-271 (272)
196 cd06609 STKc_MST3_like Catalyt 100.0 6E-42 1.3E-46 299.4 21.5 242 58-308 2-250 (274)
197 cd08218 STKc_Nek1 Catalytic do 100.0 5.3E-42 1.2E-46 296.7 20.9 244 59-308 2-252 (256)
198 cd05045 PTKc_RET Catalytic dom 100.0 7.5E-42 1.6E-46 301.4 22.2 251 59-315 2-288 (290)
199 PHA03209 serine/threonine kina 100.0 1.5E-41 3.3E-46 307.9 24.8 242 58-308 67-350 (357)
200 cd05586 STKc_Sck1_like Catalyt 100.0 8.4E-43 1.8E-47 313.0 16.2 235 65-308 1-252 (330)
201 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 1E-41 2.2E-46 297.2 22.6 246 64-311 2-268 (269)
202 cd05041 PTKc_Fes_like Catalyti 100.0 9.2E-42 2E-46 294.3 22.0 241 64-311 2-250 (251)
203 cd06628 STKc_MAPKKK_Byr2_like 100.0 8.1E-42 1.8E-46 297.4 21.9 241 60-308 3-263 (267)
204 KOG4257 Focal adhesion tyrosin 100.0 2E-42 4.3E-47 311.3 18.2 245 63-315 395-651 (974)
205 cd05107 PTKc_PDGFR_beta Cataly 100.0 4.1E-42 8.9E-47 314.7 20.8 250 59-313 39-399 (401)
206 cd05040 PTKc_Ack_like Catalyti 100.0 9.9E-42 2.1E-46 295.2 22.1 242 64-311 2-256 (257)
207 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 4.7E-42 1E-46 301.4 20.3 255 57-313 4-283 (284)
208 cd05042 PTKc_Aatyk Catalytic d 100.0 8.4E-42 1.8E-46 297.7 21.6 245 64-310 2-267 (269)
209 cd07873 STKc_PCTAIRE1 Catalyti 100.0 5.4E-42 1.2E-46 303.9 20.7 251 55-308 4-285 (301)
210 cd05043 PTK_Ryk Pseudokinase d 100.0 9.5E-42 2.1E-46 299.1 21.9 252 59-316 8-279 (280)
211 cd06658 STKc_PAK5 Catalytic do 100.0 3.1E-42 6.7E-47 304.1 18.8 239 63-308 28-271 (292)
212 cd05623 STKc_MRCK_alpha Cataly 100.0 3.9E-42 8.4E-47 308.9 19.7 249 58-309 2-266 (332)
213 cd05073 PTKc_Hck Catalytic dom 100.0 1.3E-41 2.9E-46 295.0 22.4 248 58-313 7-260 (260)
214 cd08221 STKc_Nek9 Catalytic do 100.0 1.5E-41 3.2E-46 293.9 22.5 245 59-309 2-253 (256)
215 cd05036 PTKc_ALK_LTK Catalytic 100.0 7.6E-42 1.6E-46 299.4 20.9 248 59-312 8-277 (277)
216 KOG4717 Serine/threonine prote 100.0 1.8E-42 4E-47 305.7 16.9 251 59-317 20-280 (864)
217 cd05063 PTKc_EphR_A2 Catalytic 100.0 1.1E-41 2.3E-46 296.8 21.7 247 60-313 8-267 (268)
218 cd05058 PTKc_Met_Ron Catalytic 100.0 1.1E-41 2.4E-46 295.6 21.7 245 64-315 2-261 (262)
219 cd07861 STKc_CDK1_euk Catalyti 100.0 6.6E-42 1.4E-46 300.7 20.3 248 59-308 2-281 (285)
220 cd05032 PTKc_InsR_like Catalyt 100.0 9.1E-42 2E-46 298.6 21.1 248 58-311 7-276 (277)
221 KOG4278 Protein tyrosine kinas 100.0 8.6E-43 1.9E-47 313.6 14.8 249 61-316 271-526 (1157)
222 cd06631 STKc_YSK4 Catalytic do 100.0 9.2E-42 2E-46 296.8 20.9 244 59-308 2-261 (265)
223 KOG1094 Discoidin domain recep 100.0 1.2E-42 2.7E-47 310.6 15.6 252 60-313 541-804 (807)
224 cd05099 PTKc_FGFR4 Catalytic d 100.0 1.5E-41 3.2E-46 302.9 22.5 253 58-316 13-296 (314)
225 cd05624 STKc_MRCK_beta Catalyt 100.0 4.2E-42 9E-47 308.5 19.1 248 58-308 2-265 (331)
226 PHA03211 serine/threonine kina 100.0 5.9E-42 1.3E-46 317.6 20.7 242 58-308 170-454 (461)
227 cd05051 PTKc_DDR Catalytic dom 100.0 1.2E-41 2.6E-46 300.8 21.5 255 57-312 5-296 (296)
228 cd08220 STKc_Nek8 Catalytic do 100.0 1.6E-41 3.4E-46 293.6 21.7 244 59-308 2-252 (256)
229 cd05112 PTKc_Itk Catalytic dom 100.0 1.4E-41 3.1E-46 294.0 21.4 246 57-310 4-255 (256)
230 cd05097 PTKc_DDR_like Catalyti 100.0 1.2E-41 2.6E-46 300.8 21.4 254 58-312 6-295 (295)
231 cd05060 PTKc_Syk_like Catalyti 100.0 1.7E-41 3.8E-46 293.8 21.9 242 64-314 2-256 (257)
232 cd05103 PTKc_VEGFR2 Catalytic 100.0 1.1E-41 2.4E-46 307.3 21.2 254 58-316 8-342 (343)
233 cd07868 STKc_CDK8 Catalytic do 100.0 1.7E-41 3.7E-46 302.8 22.2 242 63-308 7-313 (317)
234 cd06607 STKc_TAO Catalytic dom 100.0 2.1E-41 4.5E-46 301.0 22.6 246 57-309 15-267 (307)
235 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 9.2E-42 2E-46 299.9 20.1 255 57-314 5-271 (284)
236 cd05066 PTKc_EphR_A Catalytic 100.0 1.6E-41 3.5E-46 295.7 21.5 249 58-313 5-266 (267)
237 cd05050 PTKc_Musk Catalytic do 100.0 1.3E-41 2.8E-46 299.5 20.9 249 58-312 6-288 (288)
238 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 1E-41 2.2E-46 295.3 19.8 237 64-311 2-259 (259)
239 cd05574 STKc_phototropin_like 100.0 1.6E-41 3.6E-46 302.8 21.8 246 58-308 2-288 (316)
240 cd05083 PTKc_Chk Catalytic dom 100.0 1.3E-41 2.8E-46 294.1 20.4 246 57-312 6-253 (254)
241 PRK13184 pknD serine/threonine 100.0 1.2E-41 2.7E-46 329.8 22.3 256 57-316 2-293 (932)
242 cd06636 STKc_MAP4K4_6 Catalyti 100.0 1.2E-41 2.5E-46 298.9 20.3 245 58-308 17-278 (282)
243 cd06629 STKc_MAPKKK_Bck1_like 100.0 1.6E-41 3.5E-46 296.4 21.0 247 59-308 3-268 (272)
244 cd05061 PTKc_InsR Catalytic do 100.0 1.7E-41 3.7E-46 298.8 21.4 251 58-314 7-279 (288)
245 PTZ00284 protein kinase; Provi 100.0 1E-41 2.2E-46 319.6 20.8 248 57-308 129-437 (467)
246 cd06642 STKc_STK25-YSK1 Cataly 100.0 1.1E-41 2.4E-46 298.2 19.8 241 59-308 6-252 (277)
247 cd05057 PTKc_EGFR_like Catalyt 100.0 3E-41 6.6E-46 295.8 22.5 253 58-318 8-273 (279)
248 cd06659 STKc_PAK6 Catalytic do 100.0 1.1E-41 2.4E-46 301.3 19.9 240 63-309 27-271 (297)
249 cd06640 STKc_MST4 Catalytic do 100.0 2.9E-41 6.2E-46 295.7 22.1 243 58-309 5-253 (277)
250 cd05047 PTKc_Tie Catalytic dom 100.0 2.8E-41 6.1E-46 294.7 22.0 245 64-314 2-269 (270)
251 cd07847 STKc_CDKL1_4 Catalytic 100.0 1.6E-41 3.5E-46 298.4 20.6 248 58-308 2-282 (286)
252 PHA03207 serine/threonine kina 100.0 8.5E-42 1.8E-46 313.2 19.3 242 58-308 93-374 (392)
253 cd07839 STKc_CDK5 Catalytic do 100.0 6.2E-42 1.4E-46 300.8 17.5 247 59-308 2-280 (284)
254 cd05095 PTKc_DDR2 Catalytic do 100.0 2.9E-41 6.3E-46 298.5 21.7 254 58-312 6-296 (296)
255 KOG0986 G protein-coupled rece 100.0 4.9E-43 1.1E-47 305.0 10.1 244 54-304 185-436 (591)
256 cd05056 PTKc_FAK Catalytic dom 100.0 3.2E-41 6.9E-46 294.2 21.5 250 59-316 8-268 (270)
257 KOG4279 Serine/threonine prote 100.0 1.3E-42 2.8E-47 315.8 13.0 240 64-308 582-831 (1226)
258 cd05100 PTKc_FGFR3 Catalytic d 100.0 3.5E-41 7.5E-46 303.0 22.3 253 59-317 14-297 (334)
259 cd06605 PKc_MAPKK Catalytic do 100.0 1.4E-41 3E-46 295.5 18.9 246 59-308 3-256 (265)
260 cd07832 STKc_CCRK Catalytic do 100.0 2.8E-41 6.1E-46 296.8 20.9 247 59-308 2-281 (286)
261 KOG3653 Transforming growth fa 100.0 1.1E-41 2.4E-46 298.1 17.9 248 59-317 212-507 (534)
262 cd05580 STKc_PKA Catalytic dom 100.0 2.8E-41 6.1E-46 297.7 20.9 242 58-308 2-253 (290)
263 cd05086 PTKc_Aatyk2 Catalytic 100.0 5.5E-41 1.2E-45 292.6 22.2 246 64-311 2-267 (268)
264 cd06630 STKc_MEKK1 Catalytic d 100.0 3.3E-41 7.2E-46 293.6 20.8 244 61-308 4-263 (268)
265 PHA03390 pk1 serine/threonine- 100.0 3.8E-41 8.2E-46 293.4 20.9 251 47-308 7-261 (267)
266 cd06647 STKc_PAK_I Catalytic d 100.0 1.9E-41 4.2E-46 299.2 19.1 247 55-308 17-268 (293)
267 cd06608 STKc_myosinIII_like Ca 100.0 4.8E-41 1E-45 293.3 21.4 247 57-308 6-271 (275)
268 cd06626 STKc_MEKK4 Catalytic d 100.0 8.9E-41 1.9E-45 290.1 22.7 243 59-308 2-260 (264)
269 cd05110 PTKc_HER4 Catalytic do 100.0 5.2E-41 1.1E-45 297.9 21.5 251 59-317 9-272 (303)
270 KOG0604 MAP kinase-activated p 100.0 3.5E-42 7.5E-47 285.6 12.7 240 63-308 68-321 (400)
271 cd07860 STKc_CDK2_3 Catalytic 100.0 3.4E-41 7.3E-46 296.2 19.7 248 59-308 2-280 (284)
272 cd06651 STKc_MEKK3 Catalytic d 100.0 6.1E-41 1.3E-45 291.9 21.1 241 60-308 5-260 (266)
273 cd06632 STKc_MEKK1_plant Catal 100.0 5.9E-41 1.3E-45 290.2 20.8 242 60-308 3-254 (258)
274 KOG0983 Mitogen-activated prot 100.0 2E-42 4.3E-47 283.9 10.4 245 60-308 95-348 (391)
275 cd06648 STKc_PAK_II Catalytic 100.0 4.8E-41 1E-45 295.6 19.9 239 63-308 25-268 (285)
276 cd08225 STKc_Nek5 Catalytic do 100.0 6.6E-41 1.4E-45 289.8 20.5 244 59-308 2-253 (257)
277 cd05578 STKc_Yank1 Catalytic d 100.0 3.2E-41 6.9E-46 292.2 18.5 244 59-308 2-254 (258)
278 cd06652 STKc_MEKK2 Catalytic d 100.0 1.1E-40 2.4E-45 290.1 21.9 242 59-308 4-260 (265)
279 cd05046 PTK_CCK4 Pseudokinase 100.0 7.1E-41 1.5E-45 292.8 20.7 249 58-311 6-274 (275)
280 cd05609 STKc_MAST Catalytic do 100.0 8.9E-41 1.9E-45 296.7 21.5 248 58-311 2-272 (305)
281 cd07846 STKc_CDKL2_3 Catalytic 100.0 3.4E-41 7.5E-46 296.3 18.6 248 58-308 2-282 (286)
282 cd06638 STKc_myosinIIIA Cataly 100.0 1E-40 2.2E-45 293.4 21.5 247 57-308 18-282 (286)
283 PTZ00266 NIMA-related protein 100.0 2.7E-41 5.8E-46 328.8 19.3 248 56-308 12-294 (1021)
284 cd07867 STKc_CDC2L6 Catalytic 100.0 6.5E-41 1.4E-45 299.0 20.2 241 64-308 8-313 (317)
285 cd05044 PTKc_c-ros Catalytic d 100.0 6.8E-41 1.5E-45 291.8 19.8 243 64-312 2-269 (269)
286 cd08217 STKc_Nek2 Catalytic do 100.0 1.3E-40 2.8E-45 288.9 21.3 244 59-308 2-261 (265)
287 cd06639 STKc_myosinIIIB Cataly 100.0 8.7E-41 1.9E-45 294.7 20.4 247 57-308 22-286 (291)
288 smart00219 TyrKc Tyrosine kina 100.0 1.4E-40 3E-45 287.7 20.9 244 61-310 3-258 (258)
289 cd07844 STKc_PCTAIRE_like Cata 100.0 1.2E-40 2.6E-45 293.7 20.8 250 56-308 4-287 (291)
290 cd06616 PKc_MKK4 Catalytic dom 100.0 5.3E-41 1.1E-45 295.6 18.5 249 59-308 6-266 (288)
291 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 2.5E-40 5.4E-45 291.3 22.8 248 59-308 3-265 (287)
292 cd07843 STKc_CDC2L1 Catalytic 100.0 7.5E-41 1.6E-45 295.4 19.2 250 56-308 4-289 (293)
293 cd07833 STKc_CDKL Catalytic do 100.0 9.1E-41 2E-45 293.9 19.6 248 58-308 2-284 (288)
294 cd05611 STKc_Rim15_like Cataly 100.0 1.5E-40 3.3E-45 288.3 20.6 241 63-308 2-247 (260)
295 cd06614 STKc_PAK Catalytic dom 100.0 2.2E-40 4.7E-45 291.4 21.8 247 56-308 18-269 (286)
296 cd05572 STKc_cGK_PKG Catalytic 100.0 1.5E-40 3.3E-45 288.6 20.5 239 65-308 1-251 (262)
297 cd05577 STKc_GRK Catalytic dom 100.0 1.2E-40 2.6E-45 291.8 19.9 241 65-308 1-253 (277)
298 cd06623 PKc_MAPKK_plant_like C 100.0 2.4E-40 5.2E-45 287.4 21.4 242 59-308 3-255 (264)
299 KOG0596 Dual specificity; seri 100.0 3.4E-41 7.4E-46 299.9 15.9 245 57-308 361-626 (677)
300 PHA03210 serine/threonine kina 100.0 5E-41 1.1E-45 316.4 18.1 249 57-308 148-453 (501)
301 cd06657 STKc_PAK4 Catalytic do 100.0 2.3E-40 5.1E-45 292.1 21.2 239 63-308 26-269 (292)
302 cd05122 PKc_STE Catalytic doma 100.0 3.7E-40 8E-45 283.7 22.0 245 59-308 2-250 (253)
303 cd07841 STKc_CDK7 Catalytic do 100.0 1.8E-40 3.8E-45 293.7 20.4 247 59-308 2-281 (298)
304 cd08215 STKc_Nek Catalytic dom 100.0 3.1E-40 6.6E-45 285.3 21.2 244 59-308 2-254 (258)
305 cd06917 STKc_NAK1_like Catalyt 100.0 2.9E-40 6.3E-45 289.2 21.3 241 59-308 3-254 (277)
306 cd06641 STKc_MST3 Catalytic do 100.0 3E-40 6.5E-45 289.2 21.3 242 59-309 6-253 (277)
307 cd06635 STKc_TAO1 Catalytic do 100.0 6E-40 1.3E-44 292.9 23.5 250 59-315 27-283 (317)
308 cd08528 STKc_Nek10 Catalytic d 100.0 3.7E-40 8.1E-45 287.3 21.4 249 59-311 2-268 (269)
309 cd06617 PKc_MKK3_6 Catalytic d 100.0 2.4E-40 5.1E-45 290.6 20.3 244 58-308 2-260 (283)
310 cd05633 STKc_GRK3 Catalytic do 100.0 2.4E-40 5.3E-45 290.2 20.1 238 65-308 2-254 (279)
311 cd07870 STKc_PFTAIRE2 Catalyti 100.0 4.7E-40 1E-44 290.0 21.4 249 57-308 5-287 (291)
312 cd08226 PK_STRAD_beta Pseudoki 100.0 3.7E-40 8.1E-45 295.6 21.1 242 66-308 9-307 (328)
313 cd06634 STKc_TAO2 Catalytic do 100.0 5.6E-40 1.2E-44 291.9 21.9 244 59-309 17-267 (308)
314 cd07835 STKc_CDK1_like Catalyt 100.0 4.1E-40 8.9E-45 289.1 20.5 247 60-308 2-279 (283)
315 cd06606 STKc_MAPKKK Catalytic 100.0 6.3E-40 1.4E-44 283.3 21.3 244 59-308 2-256 (260)
316 KOG0586 Serine/threonine prote 100.0 6.2E-41 1.3E-45 302.4 15.3 247 53-308 52-305 (596)
317 KOG0199 ACK and related non-re 100.0 4E-41 8.7E-46 306.2 14.1 244 61-310 114-369 (1039)
318 cd07831 STKc_MOK Catalytic dom 100.0 5.7E-40 1.2E-44 287.9 21.0 246 59-308 1-278 (282)
319 cd05074 PTKc_Tyro3 Catalytic d 100.0 7.6E-40 1.6E-44 285.9 21.3 248 60-313 2-272 (273)
320 cd06633 STKc_TAO3 Catalytic do 100.0 1.4E-39 3.1E-44 290.0 22.9 242 60-308 24-272 (313)
321 cd07850 STKc_JNK Catalytic dom 100.0 7.3E-40 1.6E-44 296.6 21.1 246 57-308 16-310 (353)
322 cd05118 STKc_CMGC Catalytic do 100.0 5.5E-40 1.2E-44 288.1 19.6 247 59-308 1-279 (283)
323 cd06627 STKc_Cdc7_like Catalyt 100.0 1.4E-39 3.1E-44 280.8 21.6 242 59-308 2-250 (254)
324 cd07840 STKc_CDK9_like Catalyt 100.0 8.9E-40 1.9E-44 287.2 20.6 247 59-308 1-283 (287)
325 cd05579 STKc_MAST_like Catalyt 100.0 7.6E-40 1.6E-44 284.1 19.7 235 65-308 1-256 (265)
326 PLN00009 cyclin-dependent kina 100.0 8.5E-40 1.8E-44 288.8 20.2 250 57-308 2-283 (294)
327 cd07837 STKc_CdkB_plant Cataly 100.0 6.6E-40 1.4E-44 289.5 19.2 248 59-308 3-290 (295)
328 cd07845 STKc_CDK10 Catalytic d 100.0 8.2E-40 1.8E-44 291.0 19.6 251 55-308 5-289 (309)
329 cd07865 STKc_CDK9 Catalytic do 100.0 1.1E-39 2.5E-44 289.8 20.3 250 55-308 10-306 (310)
330 cd05606 STKc_beta_ARK Catalyti 100.0 2.5E-39 5.3E-44 283.7 22.0 238 65-308 2-254 (278)
331 cd08216 PK_STRAD Pseudokinase 100.0 1.8E-39 4E-44 289.3 21.5 239 69-308 12-294 (314)
332 cd06653 STKc_MEKK3_like_1 Cata 100.0 2.4E-39 5.3E-44 281.5 21.7 242 59-308 4-260 (264)
333 KOG0607 MAP kinase-interacting 100.0 4.5E-40 9.7E-45 275.3 16.1 240 64-308 85-360 (463)
334 cd07836 STKc_Pho85 Catalytic d 100.0 9.9E-40 2.2E-44 286.8 19.3 248 59-308 2-280 (284)
335 cd07849 STKc_ERK1_2_like Catal 100.0 7.2E-40 1.6E-44 294.7 18.2 252 58-314 6-299 (336)
336 KOG0612 Rho-associated, coiled 100.0 1.5E-40 3.2E-45 316.4 13.9 247 54-308 72-337 (1317)
337 cd07842 STKc_CDK8_like Catalyt 100.0 1.4E-39 2.9E-44 290.2 19.4 248 59-308 2-312 (316)
338 cd07834 STKc_MAPK Catalytic do 100.0 1.2E-39 2.5E-44 292.6 18.9 254 59-316 2-298 (330)
339 cd07855 STKc_ERK5 Catalytic do 100.0 1.5E-39 3.2E-44 292.5 19.3 247 58-308 6-293 (334)
340 cd05581 STKc_PDK1 Catalytic do 100.0 1.6E-39 3.5E-44 284.5 19.0 242 58-308 2-276 (280)
341 cd07838 STKc_CDK4_6_like Catal 100.0 5E-39 1.1E-43 282.6 21.6 248 59-308 1-283 (287)
342 cd07858 STKc_TEY_MAPK_plant Ca 100.0 1.9E-39 4.1E-44 292.1 19.3 254 58-315 6-299 (337)
343 PHA02882 putative serine/threo 100.0 2.4E-39 5.2E-44 286.0 19.4 250 57-310 12-293 (294)
344 KOG4645 MAPKKK (MAP kinase kin 100.0 1.7E-41 3.7E-46 326.4 6.2 239 64-309 1242-1494(1509)
345 cd06618 PKc_MKK7 Catalytic dom 100.0 4.9E-39 1.1E-43 284.3 21.1 250 55-309 13-273 (296)
346 cd07830 STKc_MAK_like Catalyti 100.0 4E-39 8.8E-44 282.7 20.4 247 60-308 2-279 (283)
347 cd08530 STKc_CNK2-like Catalyt 100.0 5.7E-39 1.2E-43 277.4 20.8 244 59-308 2-252 (256)
348 cd07829 STKc_CDK_like Catalyti 100.0 4.7E-39 1E-43 282.0 20.4 246 60-308 2-278 (282)
349 KOG0690 Serine/threonine prote 100.0 2.8E-40 6.1E-45 277.3 11.9 234 59-301 170-411 (516)
350 KOG0584 Serine/threonine prote 100.0 1.8E-40 3.9E-45 299.9 11.5 237 64-308 47-295 (632)
351 cd05123 STKc_AGC Catalytic dom 100.0 6.7E-39 1.5E-43 276.1 20.6 235 65-308 1-246 (250)
352 cd07854 STKc_MAPK4_6 Catalytic 100.0 2.3E-39 5.1E-44 292.1 18.3 247 57-308 5-299 (342)
353 PLN00113 leucine-rich repeat r 100.0 9.9E-39 2.2E-43 324.0 24.8 244 63-317 696-955 (968)
354 KOG0662 Cyclin-dependent kinas 100.0 1.4E-39 3E-44 252.1 14.0 247 59-308 4-282 (292)
355 cd05613 STKc_MSK1_N N-terminal 100.0 5.9E-39 1.3E-43 282.9 20.0 245 59-308 2-267 (290)
356 cd07864 STKc_CDK12 Catalytic d 100.0 5.5E-39 1.2E-43 284.6 19.8 248 58-308 8-298 (302)
357 cd08222 STKc_Nek11 Catalytic d 100.0 6.8E-39 1.5E-43 277.9 19.9 243 59-308 2-256 (260)
358 cd07852 STKc_MAPK15 Catalytic 100.0 5.3E-39 1.1E-43 289.2 19.6 252 58-314 8-302 (337)
359 KOG2052 Activin A type IB rece 100.0 2.7E-39 5.8E-44 281.2 16.9 249 60-315 214-505 (513)
360 KOG0668 Casein kinase II, alph 100.0 2.9E-40 6.4E-45 264.7 10.0 257 43-308 24-321 (338)
361 cd07879 STKc_p38delta_MAPK13 C 100.0 8.6E-39 1.9E-43 288.4 20.4 253 57-315 15-305 (342)
362 PTZ00024 cyclin-dependent prot 100.0 8.9E-39 1.9E-43 287.5 19.4 242 63-308 15-312 (335)
363 KOG0603 Ribosomal protein S6 k 100.0 1.7E-39 3.7E-44 294.5 14.3 240 54-308 319-562 (612)
364 cd07866 STKc_BUR1 Catalytic do 100.0 1.1E-38 2.5E-43 283.6 18.9 250 56-308 7-307 (311)
365 KOG0666 Cyclin C-dependent kin 100.0 5.2E-40 1.1E-44 274.1 9.3 254 55-310 22-338 (438)
366 cd05583 STKc_MSK_N N-terminal 100.0 1.3E-38 2.9E-43 280.4 18.7 249 59-312 2-266 (288)
367 cd07880 STKc_p38gamma_MAPK12 C 100.0 2.1E-38 4.5E-43 286.0 20.2 253 57-314 15-305 (343)
368 cd07851 STKc_p38 Catalytic dom 100.0 9.2E-39 2E-43 288.3 17.3 247 57-308 15-297 (343)
369 KOG1035 eIF-2alpha kinase GCN2 100.0 7.4E-39 1.6E-43 306.9 17.4 242 59-308 481-870 (1351)
370 cd07877 STKc_p38alpha_MAPK14 C 100.0 2.3E-38 5.1E-43 285.8 19.8 254 47-308 10-299 (345)
371 cd05576 STKc_RPK118_like Catal 100.0 1.6E-38 3.4E-43 272.1 17.7 218 68-303 4-223 (237)
372 cd07857 STKc_MPK1 Catalytic do 100.0 3.6E-38 7.7E-43 283.3 20.2 246 59-308 2-291 (332)
373 KOG1006 Mitogen-activated prot 100.0 1.8E-40 3.8E-45 271.3 4.7 244 62-308 69-326 (361)
374 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 4.1E-38 8.9E-43 282.2 20.2 246 59-309 12-288 (328)
375 KOG4236 Serine/threonine prote 100.0 1.2E-39 2.6E-44 288.6 9.7 238 64-308 571-818 (888)
376 KOG0200 Fibroblast/platelet-de 100.0 7.4E-38 1.6E-42 299.6 19.5 249 63-315 302-581 (609)
377 cd05610 STKc_MASTL Catalytic d 100.0 1E-37 2.2E-42 302.7 20.6 146 56-204 3-152 (669)
378 KOG1025 Epidermal growth facto 100.0 3.1E-38 6.7E-43 291.9 13.4 256 60-323 699-967 (1177)
379 KOG0669 Cyclin T-dependent kin 100.0 2.7E-39 5.9E-44 262.6 5.3 251 57-310 17-316 (376)
380 KOG4250 TANK binding protein k 100.0 1.5E-37 3.3E-42 284.3 14.2 251 63-314 19-311 (732)
381 KOG0587 Traf2- and Nck-interac 100.0 4.8E-37 1E-41 286.2 17.6 247 57-308 19-281 (953)
382 KOG0671 LAMMER dual specificit 100.0 1E-37 2.2E-42 266.9 10.7 249 57-308 89-405 (415)
383 KOG0608 Warts/lats-like serine 100.0 2E-37 4.3E-42 279.6 12.5 247 49-301 621-917 (1034)
384 KOG0696 Serine/threonine prote 100.0 1.9E-37 4.1E-42 267.6 10.4 236 58-302 350-594 (683)
385 smart00220 S_TKc Serine/Threon 100.0 7.3E-36 1.6E-40 255.2 20.2 234 69-308 1-240 (244)
386 PLN03225 Serine/threonine-prot 100.0 1.7E-36 3.7E-41 287.6 17.4 249 55-308 130-449 (566)
387 KOG0614 cGMP-dependent protein 100.0 1.3E-37 2.8E-42 274.5 6.2 241 55-302 418-665 (732)
388 PLN03224 probable serine/threo 100.0 6.9E-35 1.5E-39 270.6 21.4 251 57-308 145-499 (507)
389 KOG1151 Tousled-like protein k 100.0 1.4E-35 3E-40 258.2 11.3 246 59-308 465-740 (775)
390 KOG0984 Mitogen-activated prot 100.0 1.5E-35 3.3E-40 234.2 10.3 197 61-258 50-258 (282)
391 KOG0695 Serine/threonine prote 100.0 5.5E-35 1.2E-39 246.6 10.4 241 57-302 250-503 (593)
392 KOG0664 Nemo-like MAPK-related 100.0 8.4E-36 1.8E-40 245.1 4.1 244 63-310 59-344 (449)
393 KOG1024 Receptor-like protein 100.0 3.2E-34 6.9E-39 246.1 13.6 250 62-316 289-558 (563)
394 KOG1027 Serine/threonine prote 100.0 8.2E-35 1.8E-39 270.2 9.9 238 57-308 512-766 (903)
395 KOG1290 Serine/threonine prote 100.0 1.1E-33 2.3E-38 248.8 16.0 131 57-189 78-221 (590)
396 KOG0576 Mitogen-activated prot 100.0 7E-35 1.5E-39 264.6 7.8 250 54-308 12-270 (829)
397 KOG0670 U4/U6-associated splic 100.0 2.3E-34 4.9E-39 254.7 9.8 248 58-308 433-745 (752)
398 cd00180 PKc Catalytic domain o 100.0 7E-32 1.5E-36 225.2 20.0 206 65-309 1-214 (215)
399 KOG0665 Jun-N-terminal kinase 100.0 2.5E-33 5.4E-38 235.0 9.7 241 61-308 21-309 (369)
400 KOG1152 Signal transduction se 100.0 2.4E-33 5.3E-38 250.9 10.0 200 51-253 555-770 (772)
401 KOG1167 Serine/threonine prote 100.0 4.2E-32 9.2E-37 235.3 10.7 243 58-308 37-380 (418)
402 KOG1345 Serine/threonine kinas 100.0 3.2E-31 7E-36 217.7 11.5 247 58-310 25-285 (378)
403 smart00221 STYKc Protein kinas 100.0 4.8E-30 1E-34 217.0 18.6 191 61-254 3-202 (225)
404 PLN00181 protein SPA1-RELATED; 100.0 5.3E-31 1.1E-35 261.5 10.0 190 109-308 28-264 (793)
405 smart00750 KIND kinase non-cat 100.0 1.9E-29 4E-34 205.9 13.7 168 138-316 1-172 (176)
406 KOG0195 Integrin-linked kinase 100.0 6.7E-30 1.5E-34 210.3 6.3 254 55-314 188-447 (448)
407 KOG1164 Casein kinase (serine/ 100.0 4.1E-27 9E-32 210.1 19.8 257 58-317 19-301 (322)
408 KOG1163 Casein kinase (serine/ 99.9 1.8E-27 4E-32 192.6 12.2 254 58-317 16-288 (341)
409 KOG1165 Casein kinase (serine/ 99.9 9.5E-27 2.1E-31 196.5 14.2 253 59-317 30-303 (449)
410 PRK09188 serine/threonine prot 99.9 1.6E-25 3.5E-30 199.9 14.7 156 59-227 20-195 (365)
411 KOG0590 Checkpoint kinase and 99.9 2.2E-26 4.8E-31 218.2 5.7 242 63-308 324-584 (601)
412 COG0515 SPS1 Serine/threonine 99.9 9.9E-24 2.1E-28 187.7 20.3 247 59-309 2-275 (384)
413 cd05147 RIO1_euk RIO kinase fa 99.9 5.8E-24 1.3E-28 174.9 11.6 140 62-207 2-168 (190)
414 PRK10359 lipopolysaccharide co 99.9 1.2E-23 2.7E-28 175.2 10.0 168 58-246 32-216 (232)
415 cd05145 RIO1_like RIO kinase f 99.9 1.2E-22 2.6E-27 167.6 13.5 141 62-208 2-169 (190)
416 KOG0603 Ribosomal protein S6 k 99.9 4E-24 8.7E-29 194.8 4.7 224 65-303 2-232 (612)
417 KOG1023 Natriuretic peptide re 99.9 4.6E-23 1E-27 187.6 11.2 209 107-317 1-228 (484)
418 KOG1240 Protein kinase contain 99.9 1.9E-23 4.2E-28 199.8 6.9 242 58-312 24-294 (1431)
419 KOG4158 BRPK/PTEN-induced prot 99.9 5.2E-22 1.1E-26 171.8 11.3 194 111-313 274-514 (598)
420 PF14531 Kinase-like: Kinase-l 99.9 1.4E-22 2.9E-27 173.9 7.5 227 62-300 17-288 (288)
421 PRK10345 hypothetical protein; 99.9 5.4E-21 1.2E-25 158.8 12.8 133 63-203 8-156 (210)
422 PRK12274 serine/threonine prot 99.9 7.4E-21 1.6E-25 155.4 12.9 177 63-254 8-209 (218)
423 KOG1166 Mitotic checkpoint ser 99.9 4.7E-21 1E-25 186.1 13.2 240 59-315 700-955 (974)
424 smart00090 RIO RIO-like kinase 99.8 8.9E-20 1.9E-24 155.1 13.3 142 58-207 29-199 (237)
425 PRK14879 serine/threonine prot 99.8 2.6E-19 5.6E-24 150.4 13.7 134 63-205 2-143 (211)
426 KOG1033 eIF-2alpha kinase PEK/ 99.8 1.8E-20 3.9E-25 168.0 6.5 168 127-305 330-508 (516)
427 KOG0606 Microtubule-associated 99.8 4.7E-20 1E-24 176.6 8.0 201 59-302 85-305 (1205)
428 TIGR03724 arch_bud32 Kae1-asso 99.8 3.9E-19 8.4E-24 147.9 10.7 129 65-205 2-138 (199)
429 cd05144 RIO2_C RIO kinase fami 99.8 1.7E-18 3.7E-23 143.9 12.4 137 59-208 17-177 (198)
430 PRK09605 bifunctional UGMP fam 99.8 2E-18 4.4E-23 164.2 13.7 132 61-205 337-476 (535)
431 KOG0590 Checkpoint kinase and 99.7 2.5E-19 5.4E-24 170.4 2.1 248 57-308 20-285 (601)
432 cd05120 APH_ChoK_like Aminogly 99.7 1.2E-17 2.7E-22 132.0 9.6 134 62-207 3-140 (155)
433 cd05119 RIO RIO kinase family, 99.7 6.7E-17 1.4E-21 133.0 11.9 137 63-208 3-166 (187)
434 PRK01723 3-deoxy-D-manno-octul 99.7 1.7E-16 3.7E-21 135.2 13.3 133 65-206 39-192 (239)
435 TIGR01982 UbiB 2-polyprenylphe 99.6 8.1E-15 1.7E-19 135.4 10.6 140 64-208 124-309 (437)
436 KOG0601 Cyclin-dependent kinas 99.6 4.9E-15 1.1E-19 135.6 7.9 239 61-308 118-378 (524)
437 KOG1266 Protein kinase [Signal 99.5 2.4E-14 5.2E-19 121.9 7.8 201 104-313 118-335 (458)
438 PRK04750 ubiB putative ubiquin 99.5 5.2E-14 1.1E-18 131.8 6.9 137 63-208 125-316 (537)
439 KOG0601 Cyclin-dependent kinas 99.5 8.3E-14 1.8E-18 127.6 7.8 243 58-312 266-517 (524)
440 cd05151 ChoK Choline Kinase (C 99.5 2.8E-13 6E-18 109.5 9.9 127 63-205 4-136 (170)
441 KOG1243 Protein kinase [Genera 99.5 1.4E-12 3E-17 121.0 15.0 163 78-249 34-200 (690)
442 cd05146 RIO3_euk RIO kinase fa 99.4 4.7E-12 1E-16 103.5 13.4 136 63-207 3-175 (197)
443 KOG3741 Poly(A) ribonuclease s 99.3 3.3E-11 7.2E-16 108.8 14.6 215 69-309 288-521 (655)
444 cd05154 ACAD10_11_like Acyl-Co 99.3 1.7E-11 3.6E-16 103.5 11.8 139 64-205 5-206 (223)
445 KOG0606 Microtubule-associated 99.3 1.4E-12 2.9E-17 126.1 4.4 240 59-304 806-1084(1205)
446 COG3642 Mn2+-dependent serine/ 99.3 5.9E-11 1.3E-15 94.1 11.9 131 64-206 3-141 (204)
447 KOG3087 Serine/threonine prote 99.3 6E-11 1.3E-15 93.8 10.7 142 62-205 12-165 (229)
448 COG4248 Uncharacterized protei 99.2 1.5E-09 3.3E-14 96.1 16.5 247 63-316 17-303 (637)
449 PRK15123 lipopolysaccharide co 99.2 6E-10 1.3E-14 96.2 13.3 132 72-205 37-194 (268)
450 PF01163 RIO1: RIO1 family; I 99.1 4.8E-10 1E-14 91.4 8.9 126 72-207 1-157 (188)
451 KOG2137 Protein kinase [Signal 99.1 5.1E-11 1.1E-15 111.2 1.9 145 162-308 106-264 (700)
452 COG0478 RIO-like serine/threon 98.9 3.2E-08 6.8E-13 83.4 13.3 137 59-207 93-253 (304)
453 PRK09902 hypothetical protein; 98.9 6.4E-08 1.4E-12 79.6 14.0 137 66-204 27-178 (216)
454 COG1718 RIO1 Serine/threonine 98.9 4.9E-08 1.1E-12 81.4 12.7 160 40-207 31-217 (268)
455 PF06293 Kdo: Lipopolysacchari 98.8 4E-08 8.6E-13 82.0 10.5 106 98-206 56-171 (206)
456 COG0661 AarF Predicted unusual 98.7 5.7E-08 1.2E-12 90.9 10.1 141 64-209 132-318 (517)
457 PF06176 WaaY: Lipopolysacchar 98.6 1.3E-06 2.8E-11 72.2 12.6 130 63-205 37-183 (229)
458 TIGR02172 Fb_sc_TIGR02172 Fibr 98.5 1.9E-06 4E-11 72.9 12.3 135 64-204 8-181 (226)
459 KOG1235 Predicted unusual prot 98.5 9.8E-07 2.1E-11 82.5 11.2 141 64-208 168-357 (538)
460 COG2112 Predicted Ser/Thr prot 98.5 1.6E-06 3.5E-11 68.6 9.9 131 60-206 25-156 (201)
461 cd05150 APH Aminoglycoside 3'- 98.4 3.5E-06 7.5E-11 72.3 11.4 74 66-143 7-82 (244)
462 KOG0576 Mitogen-activated prot 98.4 1.2E-07 2.6E-12 88.3 2.1 176 64-251 249-429 (829)
463 PLN02876 acyl-CoA dehydrogenas 98.3 1.1E-05 2.4E-10 81.0 13.4 80 61-140 42-131 (822)
464 PF01636 APH: Phosphotransfera 98.2 1.2E-05 2.7E-10 68.0 10.8 77 63-142 3-84 (239)
465 PF12260 PIP49_C: Protein-kina 98.2 4.5E-06 9.7E-11 68.4 7.4 100 102-205 8-111 (188)
466 KOG1035 eIF-2alpha kinase GCN2 98.2 6.4E-06 1.4E-10 81.9 9.4 195 100-312 229-437 (1351)
467 PF10707 YrbL-PhoP_reg: PhoP r 98.2 2.9E-05 6.3E-10 63.9 11.8 126 64-199 8-165 (199)
468 PF13095 FTA2: Kinetochore Sim 98.0 7.4E-05 1.6E-09 61.2 10.9 125 57-203 37-206 (207)
469 cd05155 APH_ChoK_like_1 Unchar 97.9 8.3E-05 1.8E-09 63.3 9.9 71 65-141 5-82 (235)
470 TIGR02721 ycfN_thiK thiamine k 97.9 0.00011 2.4E-09 63.4 10.1 134 66-205 5-175 (256)
471 PRK10593 hypothetical protein; 97.8 0.0003 6.5E-09 62.1 12.2 77 61-140 18-100 (297)
472 TIGR00938 thrB_alt homoserine 97.8 0.00055 1.2E-08 60.8 13.8 158 44-204 7-216 (307)
473 cd05157 ETNK_euk Ethanolamine 97.8 0.00023 5.1E-09 60.5 10.2 72 64-140 5-79 (235)
474 cd05153 HomoserineK_II Homoser 97.8 0.00061 1.3E-08 60.1 13.1 139 62-204 19-204 (296)
475 PRK05231 homoserine kinase; Pr 97.7 0.0017 3.6E-08 58.0 14.7 160 42-205 5-217 (319)
476 PRK09550 mtnK methylthioribose 97.6 0.0019 4.2E-08 59.0 14.2 76 62-139 31-117 (401)
477 KOG2270 Serine/threonine prote 97.5 0.0013 2.9E-08 58.4 11.0 140 60-205 147-313 (520)
478 cd05156 ChoK_euk Choline Kinas 97.3 0.0021 4.5E-08 56.9 10.4 72 65-141 6-85 (302)
479 COG3173 Predicted aminoglycosi 97.3 0.0063 1.4E-07 53.8 12.8 155 54-209 22-232 (321)
480 cd05152 MPH2' Macrolide 2'-Pho 97.3 0.0045 9.7E-08 54.0 11.7 30 176-205 186-216 (276)
481 KOG2268 Serine/threonine prote 97.2 0.00066 1.4E-08 59.4 5.7 148 44-204 79-250 (465)
482 KOG1826 Ras GTPase activating 97.1 6.8E-05 1.5E-09 76.9 -1.4 154 99-252 1275-1440(2724)
483 TIGR01767 MTRK 5-methylthiorib 97.1 0.0081 1.8E-07 54.0 11.1 74 64-138 2-85 (370)
484 PLN02756 S-methyl-5-thioribose 97.0 0.014 2.9E-07 53.5 12.5 74 61-137 36-119 (418)
485 PLN02236 choline kinase 97.0 0.0046 1E-07 55.8 9.6 138 63-205 42-231 (344)
486 KOG1093 Predicted protein kina 96.8 0.0037 8.1E-08 58.0 7.1 160 96-307 25-192 (725)
487 TIGR02906 spore_CotS spore coa 96.6 0.024 5.3E-07 50.2 11.1 28 176-204 188-215 (313)
488 PF03881 Fructosamin_kin: Fruc 96.6 0.0096 2.1E-07 52.2 8.1 72 63-138 23-97 (288)
489 KOG1236 Predicted unusual prot 96.5 0.011 2.3E-07 53.6 7.3 60 128-190 320-379 (565)
490 PRK11768 serine/threonine prot 96.3 0.24 5.2E-06 44.4 15.5 97 41-139 8-113 (325)
491 PRK12396 5-methylribose kinase 96.3 0.031 6.8E-07 50.9 9.4 74 62-137 34-117 (409)
492 PF07387 Seadorna_VP7: Seadorn 96.3 0.023 4.9E-07 47.3 7.7 151 68-249 73-225 (308)
493 PLN02421 phosphotransferase, a 96.2 0.028 6.1E-07 50.5 9.0 136 65-205 22-213 (330)
494 TIGR02904 spore_ysxE spore coa 96.2 0.066 1.4E-06 47.6 11.1 31 175-205 196-226 (309)
495 COG2334 Putative homoserine ki 96.1 0.11 2.3E-06 46.6 11.7 145 56-204 25-227 (331)
496 COG5072 ALK1 Serine/threonine 96.0 0.029 6.2E-07 50.2 7.5 75 127-209 300-374 (488)
497 COG3001 Uncharacterized protei 95.6 0.16 3.4E-06 42.7 9.9 68 71-141 27-99 (286)
498 PRK06148 hypothetical protein; 95.6 0.41 9E-06 49.7 15.0 148 54-205 22-236 (1013)
499 PTZ00384 choline kinase; Provi 94.8 0.22 4.8E-06 45.6 9.4 75 62-141 55-137 (383)
500 PRK10271 thiK thiamine kinase; 94.0 0.04 8.6E-07 44.8 2.5 30 176-206 78-107 (188)
No 1
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-55 Score=375.85 Aligned_cols=248 Identities=17% Similarity=0.234 Sum_probs=209.0
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCe-eEEEEec
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE-RLLVAEY 134 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~ 134 (329)
+.+.++.||.|..|+||++. ..+++.+|+|.+..... ...+++.+|+++++..+||+||.++|+|..... +.|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 44566788999999999999 56788999999965533 346689999999999999999999999999884 9999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCc
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~ 212 (329)
|++|||++++. ..+.+++....+++.+|++||.|||+..+||||||||+|||++..|.+||+|||.+....+. .++
T Consensus 160 MDgGSLd~~~k--~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tf 237 (364)
T KOG0581|consen 160 MDGGSLDDILK--RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTF 237 (364)
T ss_pred cCCCCHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccc
Confidence 99999999996 34679999999999999999999997449999999999999999999999999998765443 577
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-HhhhchhhhccccccCCCChH-HHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQFSSD-EGTELVRLAS 290 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~ 290 (329)
.||..|||||-+.+..|+.++||||||++++|+.+|+.|++...... ..-..+..+++. ..+..|.. +|+++++|+.
T Consensus 238 vGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP~~~fS~ef~~FV~ 316 (364)
T KOG0581|consen 238 VGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE-PPPRLPEGEFSPEFRSFVS 316 (364)
T ss_pred cccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC-CCCCCCcccCCHHHHHHHH
Confidence 89999999999999999999999999999999999998876631000 000112222221 22345555 8999999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~ 308 (329)
.||++||.+|||+.++++
T Consensus 317 ~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 317 CCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHhcCCcccCCCHHHHhc
Confidence 999999999999999998
No 2
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.6e-55 Score=378.92 Aligned_cols=255 Identities=18% Similarity=0.245 Sum_probs=214.6
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh-------HHHHHHHHHHHhcCCCccccccceeeeeCCe
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-------ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (329)
++.|.+.+.+|+|+||.|-+|. .++|+.||||++....... ...+.+|+++|++|+|||||++.+++..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3456677889999999999998 7889999999998753221 2235799999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC---CCeeeecccCcc
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMK 204 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~ 204 (329)
.|+||||++||.|.+.+. .++.+.+.....+++||+.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+
T Consensus 251 ~YmVlE~v~GGeLfd~vv--~nk~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV--ANKYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred eEEEEEEecCccHHHHHH--hccccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 999999999999999887 556788888899999999999999999 99999999999999765 679999999999
Q ss_pred cCCCC---CCccCcccccCcccccCCC---CCCcccchhhhHHHHHHHhCCCCCCchhhHH-HhhhchhhhccccccCCC
Q 020221 205 NSRDG---RSYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDL-IRDRNIQTLTDSCLEGQF 277 (329)
Q Consensus 205 ~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 277 (329)
....+ .+.+||+.|.|||++.+.. +..++|+||+||+||.+++|.+||.....+. ..++.......- .+..
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f--~p~~ 405 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF--GPLQ 405 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc--cChh
Confidence 88655 4678999999999998665 4458899999999999999999998765544 444433332221 1123
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCccccccC
Q 020221 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWVMLA 329 (329)
Q Consensus 278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~p~~~~~ 329 (329)
....+++..+||.+||..||+.|||+.++|+ |||+..|
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~--------------hpW~~~~ 443 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALN--------------HPWFKDA 443 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhc--------------Chhhhcc
Confidence 3567899999999999999999999999998 8998643
No 3
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-53 Score=380.83 Aligned_cols=274 Identities=35% Similarity=0.617 Sum_probs=234.3
Q ss_pred cccccCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccc
Q 020221 40 VFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLL 119 (329)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 119 (329)
....|+++++..+|++|+..+++ |+|+||.||+|..+++..||||++.....+...+|.+|+.++..++|||+|+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~i---g~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLI---GEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcce---ecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEE
Confidence 67779999999999999999988 999999999999988889999988776543145699999999999999999999
Q ss_pred eeeeeCC-eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CccccccCCCceeeCCCCCee
Q 020221 120 GCCCEGD-ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE--RALYHDLNAYRIVFDDDVNPR 196 (329)
Q Consensus 120 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~k 196 (329)
|||.+.+ ..+||+||+++|||.+.|.......++|.++.+|+.++|+||+|||... .|+|||||++|||+|+++++|
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9999988 5999999999999999997633328899999999999999999999863 499999999999999999999
Q ss_pred eecccCcccCCC-CCCc----cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCch-------h----hHHH
Q 020221 197 LSCFGLMKNSRD-GRSY----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH-------A----LDLI 260 (329)
Q Consensus 197 l~Dfg~a~~~~~-~~~~----~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~-------~----~~~~ 260 (329)
|+|||+|+.... .... .||.+|+|||+...+..+.++||||||++|+||+||+.+.... . ...+
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999977654 3322 7899999999999999999999999999999999999754321 1 1233
Q ss_pred hhhchhhhcccccc-CCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221 261 RDRNIQTLTDSCLE-GQFSS-DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 261 ~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~ 316 (329)
......+++++.+. ..++. .....+..+...|++.+|..||+|.+|++.|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 34456677777665 45554 5667799999999999999999999999999776544
No 4
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=7.6e-53 Score=375.08 Aligned_cols=250 Identities=27% Similarity=0.397 Sum_probs=214.3
Q ss_pred ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCC-eeEEEEecCCCCC
Q 020221 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGD-ERLLVAEYMPNDT 139 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gs 139 (329)
+.+|+|+||+||+|.+.+...||+|++....... .+.|.+|+.+|.+++|||||+++|+|.++. ...+||||+++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 3469999999999999766559999998764332 458999999999999999999999998877 7999999999999
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-ccccccCCCceeeCCCC-CeeeecccCcccCCC----CCCcc
Q 020221 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER-ALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRD----GRSYS 213 (329)
Q Consensus 140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~----~~~~~ 213 (329)
|.+++.......+++..+..++.||++||.|||++ + ||||||||+|||++.++ ++||+|||+++.... .....
T Consensus 127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~ 205 (362)
T KOG0192|consen 127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVA 205 (362)
T ss_pred HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCC
Confidence 99999754467899999999999999999999999 8 99999999999999997 999999999976443 23367
Q ss_pred CcccccCccccc--CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 214 TNLAFTPPEYLR--TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 214 ~~~~y~aPE~~~--~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
||+.|||||++. ...|+.++||||||+++|||+||+.||...... +....+.....++.++..+++.+..++..
T Consensus 206 GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~ 281 (362)
T KOG0192|consen 206 GTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----QVASAVVVGGLRPPIPKECPPHLSSLMER 281 (362)
T ss_pred CCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcCCCCCCCccCCHHHHHHHHH
Confidence 899999999999 558999999999999999999999888754332 22223333445556677788999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 292 CLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
||..||+.||++.+++..|+.+....
T Consensus 282 CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 282 CWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred hCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 99999999999999999999887643
No 5
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=9e-53 Score=378.55 Aligned_cols=243 Identities=17% Similarity=0.215 Sum_probs=215.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
..|+.-+.||+|+|+.||.++. .+|+.||+|++.+.. ....+.+.+|+++.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4566777779999999999995 899999999998742 233567899999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--- 209 (329)
|+|..++|..+++ ..+.+++.+++.+++||+.||.|||+. +|+|||||..|++++++.++||+|||+|......
T Consensus 98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 9999999999987 567899999999999999999999999 9999999999999999999999999999887644
Q ss_pred -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
.+.+||+.|+|||++.....+..+||||+|||+|.|+.|++||.............. .....|...+.++++|
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------~~Y~~P~~ls~~A~dL 248 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------NEYSMPSHLSAEAKDL 248 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh------cCcccccccCHHHHHH
Confidence 467899999999999988899999999999999999999999887655544433322 1234567889999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 020221 289 ASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~ 308 (329)
|.++|+.||.+|||+++|+.
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999997
No 6
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-52 Score=373.15 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=216.9
Q ss_pred ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.++++.||+|.||.||.|.+++...||+|.++... ...+.|.+|+++|++|+|+|||+++|+|..+..++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 35678899999999999999888899999998764 34578999999999999999999999999888999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc-----c
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY-----S 213 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-----~ 213 (329)
+|.++|+...+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||+|+...+..-. .
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k 365 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK 365 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence 999999876677889999999999999999999999 9999999999999999999999999999954443211 1
Q ss_pred CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCC-CchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIP-PSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
-.+.|.|||.+..+.|+.+||||||||+||||+|.+..+ +......+ ...++...+-+.|..+|+++.++|..|
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-----~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-----LELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-----HHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 247899999999999999999999999999999966544 43333222 333444455566888999999999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 293 LQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 293 l~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
|..+|++|||++.+...|+.+....
T Consensus 441 W~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred hhCCcccCCCHHHHHHHHHHhhhcc
Confidence 9999999999999999998876543
No 7
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=5.2e-52 Score=357.45 Aligned_cols=246 Identities=19% Similarity=0.265 Sum_probs=204.5
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
..+|.+.+.||.|+||+||+|+ .+++..||||.+.... ....+-+..|+.+|+.++|||||.++++++.++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4556777788999999999999 5668899999998773 333555789999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC------CCeeeecccCcccC
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD------VNPRLSCFGLMKNS 206 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~------~~~kl~Dfg~a~~~ 206 (329)
|||.||+|.+|++ ....+++..++.++.|++.||++||++ +||||||||+|||++.. -.+||+|||+|+..
T Consensus 89 EyC~gGDLs~yi~--~~~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR--RRGRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999997 445899999999999999999999999 99999999999999754 45899999999998
Q ss_pred CCCC---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 207 RDGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 207 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
.++. +.+|++-|||||++..++|+.|+|+||+|++||++++|+.||.............. ........+...+.
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k---~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK---GNEIVPVLPAELSN 242 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---cccccCchhhhccC
Confidence 8764 56899999999999999999999999999999999999998876655444332111 11122233444555
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH
Q 020221 284 ELVRLASRCLQYEPRERPNPRSLV 307 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps~~~~l 307 (329)
...+++...+..+|.+|-+..+-.
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhh
Confidence 666788888888888777666554
No 8
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3e-52 Score=342.68 Aligned_cols=250 Identities=19% Similarity=0.242 Sum_probs=211.0
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccce-eeeeCCe-eEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLG-CCCEGDE-RLLV 131 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 131 (329)
..|.++++||+|.||+||++. ..+|..+|.|.++-.... ..++...|+.+|+.|+|||||++++ .+.+... ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 347788889999999999998 788999999999854322 3456889999999999999999998 4555444 8999
Q ss_pred EecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhc--CCC--ccccccCCCceeeCCCCCeeeecccCccc
Q 020221 132 AEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTS--KER--ALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
||||..|+|...++.. ..+.+++..+|+++.|++.||..+|. . + ++||||||.||+++++|.+||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999998753 34678999999999999999999999 4 4 89999999999999999999999999998
Q ss_pred CCCCC----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC-hH
Q 020221 206 SRDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SD 280 (329)
Q Consensus 206 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 280 (329)
+.... +.+|||.||+||.+.+.+|++++||||+||++|||+.-++||.++............-. ++.| ..
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~-----~~~p~~~ 252 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY-----PPLPDEH 252 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC-----CCCcHHH
Confidence 87664 56899999999999999999999999999999999999999988866555444333322 2234 66
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
.|.++..++..|+..||+.||+.-.+++.+..
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 89999999999999999999985555544443
No 9
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=5e-51 Score=348.14 Aligned_cols=239 Identities=20% Similarity=0.245 Sum_probs=207.5
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
.+++++++.||+|+||.|+.++ .++++.+|+|++++... ...+....|..+|..++||.||+++..|+++..+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3456677888999999999998 66789999999987542 2345678999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC---
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD--- 208 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--- 208 (329)
+||+.||.|...|. +...+++..+..++.+|+.||.|||++ |||||||||+|||+|.+|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~--~eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ--REGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHH--hcCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999999996 567899999999999999999999999 999999999999999999999999999985332
Q ss_pred -CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221 209 -GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (329)
Q Consensus 209 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
..+.+||+.|||||++.+..|+..+|+||+|+++|||++|.+||.......+......... ...+.-.+.+.++
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-----~~~p~~ls~~ard 255 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-----PLPPGYLSEEARD 255 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-----CCCCccCCHHHHH
Confidence 2456899999999999999999999999999999999999999988776655554443321 1234447889999
Q ss_pred HHHHhcccCCCCCCC
Q 020221 288 LASRCLQYEPRERPN 302 (329)
Q Consensus 288 li~~cl~~dp~~Rps 302 (329)
++.++|+.||++|..
T Consensus 256 ll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 256 LLKKLLKRDPRQRLG 270 (357)
T ss_pred HHHHHhccCHHHhcC
Confidence 999999999999964
No 10
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=1.4e-50 Score=335.90 Aligned_cols=248 Identities=20% Similarity=0.327 Sum_probs=201.5
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-h-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-D-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
+.|+.++++|+|+||+||+++ .++|+.||||++..+... . .+-.++|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 357788899999999999999 677999999999876532 2 3347899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC-CCC--
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR-DGR-- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~-~~~-- 210 (329)
||+. ++.+.|.+ ....++...+..+++|++.|+.|+|++ +++||||||+|||++.+|.+||+|||+|+... ++.
T Consensus 82 ~~dh-TvL~eLe~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELER-YPNGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHh-ccCCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 9988 55555543 556789999999999999999999999 99999999999999999999999999999876 443
Q ss_pred -CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchh-hHHHh------hh-------------chhhh
Q 020221 211 -SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIR------DR-------------NIQTL 268 (329)
Q Consensus 211 -~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~-~~~~~------~~-------------~~~~~ 268 (329)
.++.|.+|.|||.+.| .+|...+||||+||++.||++|.+.||+.. .+... .. ....+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 4567999999999987 569999999999999999999998887652 11110 00 00000
Q ss_pred cccc------ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 269 TDSC------LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 269 ~~~~------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.-+. +...+ +..+.-+.+++..||..||++|++-++++.
T Consensus 239 ~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0000 00011 235678999999999999999999999985
No 11
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4e-50 Score=358.71 Aligned_cols=248 Identities=18% Similarity=0.280 Sum_probs=213.0
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+.-..|....++|+|+-|.||.+. ..+++.||||.+........+-+.+|+.+|+..+|+|||.+++.|..++.+|+||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 344456666778999999999998 6778899999999888776777899999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--- 209 (329)
||+++|+|.+.+ ....+++.++..|.++++.||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+...
T Consensus 350 Eym~ggsLTDvV---t~~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 350 EYMEGGSLTDVV---TKTRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred eecCCCchhhhh---hcccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999999998 556699999999999999999999999 9999999999999999999999999998776554
Q ss_pred -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
.+.+||+.|||||++....|.+++||||||++++||+-|.+||..+.-- + ............-..+...|+++++|
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--r-AlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--R-ALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--H-HHHHHhhcCCCCcCCccccCHHHHHH
Confidence 3568999999999999999999999999999999999999888653211 0 00000111112223467789999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 020221 289 ASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~ 308 (329)
+.+||..|+++|++|.++|+
T Consensus 503 L~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHhhcchhcCCCHHHHhc
Confidence 99999999999999999998
No 12
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-49 Score=344.82 Aligned_cols=251 Identities=20% Similarity=0.294 Sum_probs=204.3
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCC--eeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD--ERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~ 135 (329)
+...+.||+|+||+||++. .++|...|||.+........+.+.+|+++|..++|||||+.+|...... .+++.|||+
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 4455667999999999999 4558899999998765444677899999999999999999999754444 689999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCcccCCC------
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRD------ 208 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~------ 208 (329)
++|||.+++.+..+ .+++..+..+.+|++.||+|||++ |++||||||+|||++. ++.+||+|||+++....
T Consensus 99 ~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 99999999986444 799999999999999999999999 9999999999999999 79999999999886552
Q ss_pred -CCCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 209 -GRSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 209 -~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
.....||+.|||||++.++. ....+|||||||++.||+||..|+... .... .......... ..+.+|...+.+.+
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~-~~~~~ig~~~-~~P~ip~~ls~~a~ 253 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEA-EALLLIGRED-SLPEIPDSLSDEAK 253 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchH-HHHHHHhccC-CCCCCCcccCHHHH
Confidence 22467899999999999643 445999999999999999998776542 0000 0111111111 22366777899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221 287 RLASRCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
+|+..|+..||++||||.+++++.--..
T Consensus 254 ~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 254 DFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 9999999999999999999998654433
No 13
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=4.9e-49 Score=321.34 Aligned_cols=248 Identities=21% Similarity=0.282 Sum_probs=203.6
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
.|..++.+|+|.||+||+|+ ..+|+.||||+++.....+ .....+|++.|+.++|+||+.++++|...+.+.||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 46677888999999999999 7789999999998764332 34578999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC---
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS--- 211 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--- 211 (329)
++. +|...+++ +...++..++..++.++++||+|||++ .|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 83 m~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 83 MPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred ccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 987 89999976 566789999999999999999999999 999999999999999999999999999998765432
Q ss_pred -ccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-----------------------h
Q 020221 212 -YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-----------------------Q 266 (329)
Q Consensus 212 -~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-----------------------~ 266 (329)
.+.|.+|.|||.+.|.+ |...+||||.|||+.||+.|.+.+++...-.-..... .
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 25689999999998776 9999999999999999999997666542110000000 0
Q ss_pred hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~ 309 (329)
....+.... .-...+.++.+|+..+|.+||.+|+|++|++++
T Consensus 240 ~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 240 QFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 000111111 223456778999999999999999999999973
No 14
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-49 Score=328.33 Aligned_cols=253 Identities=18% Similarity=0.225 Sum_probs=218.2
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhH---HHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDA---RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
++++.++.+|.|+||.|.+++ ..+|..+|+|++.....-.. +...+|..+|+.+.||.++++++.+.+.+++++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 345677888999999999999 56788999999987654333 34678999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CC
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RS 211 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~ 211 (329)
||++||.|.++++ +.+.+++..++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+..... -+
T Consensus 124 eyv~GGElFS~Lr--k~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~T 200 (355)
T KOG0616|consen 124 EYVPGGELFSYLR--KSGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWT 200 (355)
T ss_pred eccCCccHHHHHH--hcCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCCcEEEEeccceEEecCcEEE
Confidence 9999999999997 667899999999999999999999999 9999999999999999999999999999977655 45
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
.+||+.|+|||.+....++.++|.|||||++|||+.|.+||..+....+.+..... .-.+|..++.++++|+..
T Consensus 201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~------~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG------KVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC------cccCCcccCHHHHHHHHH
Confidence 68999999999999999999999999999999999999999876554333333322 124678889999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhhhccccccCccccc
Q 020221 292 CLQYEPRERPNPRSLVTALVTLQKDTELYLSLPWVM 327 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~p~~~ 327 (329)
+|+.|-.+| +-.++.+..-...|||+.
T Consensus 275 LL~vD~t~R---------~gnlknG~~dIk~H~wF~ 301 (355)
T KOG0616|consen 275 LLQVDLTKR---------FGNLKNGVEDIKNHPWFK 301 (355)
T ss_pred HHhhhhHhh---------hcCcCCCccccccCcccc
Confidence 999999988 445555667777788864
No 15
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.2e-49 Score=348.94 Aligned_cols=248 Identities=22% Similarity=0.258 Sum_probs=202.8
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLV 131 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 131 (329)
+.|+.+++||+|.||.||+|+ ..+|+.||+|+++.+. .....-..+||.+|++|.||||+++.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 446778899999999999999 7789999999998765 33355578999999999999999999998876 689999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 210 (329)
+|||+. +|.-++.. ..-.|++.++..+++|++.||+|||++ |++|||||.+|||||++|.+||+|||+|+++....
T Consensus 197 FeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred Eecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 999988 79888854 456899999999999999999999999 99999999999999999999999999999765543
Q ss_pred ----CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh--------cc-------
Q 020221 211 ----SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL--------TD------- 270 (329)
Q Consensus 211 ----~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~--------~~------- 270 (329)
+.+.|++|.|||.+.|.. |+..+|+||.||||.||++|++.+++..-- .+-..+..+ +.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCCChhccccccCCcc
Confidence 345689999999999876 999999999999999999999877654210 000000000 00
Q ss_pred ccccCC--C-------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 271 SCLEGQ--F-------SSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 271 ~~~~~~--~-------~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...+.. + ...+++...+|+..+|..||++|.||.++++
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000000 0 1245788999999999999999999999986
No 16
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-49 Score=346.97 Aligned_cols=247 Identities=19% Similarity=0.299 Sum_probs=205.1
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHH--HHHHHHHHhcCC-CccccccceeeeeCC-eeEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQ--FLEEARAVGQLR-NRRLANLLGCCCEGD-ERLLV 131 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~lv 131 (329)
..|.+++++|.|.||.||+|+ ..++..||||+++..... .++ -++|++.|+++. ||||+++.+++.+.+ .+++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 458889999999999999999 777889999999876533 333 478999999998 999999999998887 99999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-- 209 (329)
||||+. +|.++++.+ ++.+++..+..|+.||++||+|+|.+ |++|||+||+|||+..+..+||+|||+|+.....
T Consensus 89 fE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred HHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccceeEecccccccccccCCC
Confidence 999977 899999875 78999999999999999999999999 9999999999999999999999999999976654
Q ss_pred -CCccCcccccCccccc-CCCCCCcccchhhhHHHHHHHhCCCCCCchh-hHHHhh----------------hchhhhc-
Q 020221 210 -RSYSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRD----------------RNIQTLT- 269 (329)
Q Consensus 210 -~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~~~~~~~-~~~~~~----------------~~~~~~~- 269 (329)
..++.|.+|.|||++. .+.|+.+.|||++|||++|+.+-++.||+.. .+.+.. ..+...+
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 4567899999999875 4569999999999999999999999888642 111100 0000000
Q ss_pred -------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 270 -------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 270 -------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...+....+ ..+.++.+++..|++.||++||||.++++
T Consensus 246 f~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred cCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 000111122 37889999999999999999999999998
No 17
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.2e-48 Score=347.01 Aligned_cols=244 Identities=20% Similarity=0.232 Sum_probs=208.2
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC----CC-hhHHHHHHHHHHHhcCC-CccccccceeeeeCCee
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS----AW-PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDER 128 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 128 (329)
...|.+.+.||+|+||.|+.|. ..++..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 4467788888999999999998 667899999977664 11 22445678999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCC
Q 020221 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSR 207 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~ 207 (329)
++||||+.+|+|.+++.+ ...+.+..+..+++|+++|++|||++ ||+||||||+|||++.+ +++||+|||++....
T Consensus 96 ~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999974 57889999999999999999999999 99999999999999999 999999999998772
Q ss_pred -C---CCCccCcccccCcccccCCC-CC-CcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221 208 -D---GRSYSTNLAFTPPEYLRTGR-VT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (329)
Q Consensus 208 -~---~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (329)
. ..+.+|++.|+|||++.+.. |+ .++||||+||+||.|++|..||.......+...... . ...+|..+
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~----~--~~~~p~~~ 246 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK----G--EFKIPSYL 246 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc----C--CccCCCCc
Confidence 2 24678999999999999877 76 689999999999999999999987544433333111 1 12345555
Q ss_pred -HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 282 -GTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 282 -~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
++++++|+.+||..||.+|+|+.+++.
T Consensus 247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 247 LSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 899999999999999999999999995
No 18
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-48 Score=347.21 Aligned_cols=241 Identities=20% Similarity=0.252 Sum_probs=207.1
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEe
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 133 (329)
+.+.+.+|.|+|++|++|+ ..+++.+|||++.+.. ....+.+..|-.+|..| .||.|++|+-.|++...+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 4445556999999999999 6788999999997653 22234577899999999 79999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---- 209 (329)
|+++|+|.++|. +-+.+++..++.++.||+.||+|||+. |||||||||+|||+|.+++++|+|||.|+...+.
T Consensus 155 ~A~nGdll~~i~--K~Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~ 231 (604)
T KOG0592|consen 155 YAPNGDLLDLIK--KYGSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQ 231 (604)
T ss_pred ecCCCcHHHHHH--HhCcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCCcEEEeeccccccCChhhccc
Confidence 999999999997 457899999999999999999999999 9999999999999999999999999998754321
Q ss_pred -------------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCC
Q 020221 210 -------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (329)
Q Consensus 210 -------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (329)
.+++||-.|.+||++.+...+..+|+|+||||||+|+.|.+||.......+-+..+. +...
T Consensus 232 ~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~------l~y~ 305 (604)
T KOG0592|consen 232 ENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA------LDYE 305 (604)
T ss_pred cCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH------hccc
Confidence 246789999999999999999999999999999999999988876543333332222 3345
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
++..+++.+.+|+.+.|..||.+|+|..+|.+
T Consensus 306 fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 306 FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred CCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 67788899999999999999999999988876
No 19
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-47 Score=333.69 Aligned_cols=253 Identities=17% Similarity=0.228 Sum_probs=208.2
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+-+.|++...||.|.-++||+|. ...++.||||++....-. +.+.+.+|++.++.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 44668888888999999999999 778899999999876533 3578999999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC-CCC--
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS-RDG-- 209 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~-~~~-- 209 (329)
.||.+||+.+.+...-...+.+..+..|.+++++||.|||.+ |.||||||+.|||++.+|.+||+|||.+-.. ..+
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 999999999999765566799999999999999999999999 9999999999999999999999999975332 222
Q ss_pred -----CCccCcccccCcccccCC--CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc----cccCCCC
Q 020221 210 -----RSYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS----CLEGQFS 278 (329)
Q Consensus 210 -----~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 278 (329)
....||+.|||||++... .|+.|+||||||++..||.+|..||.....-.+....+....+. .......
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~ 262 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDED 262 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHh
Confidence 345789999999996543 49999999999999999999998875432222222222222111 1111112
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 279 SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...+..+.+++..||.+||.+|||+++++.
T Consensus 263 k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 263 KKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 335779999999999999999999999996
No 20
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=9.8e-48 Score=341.09 Aligned_cols=248 Identities=16% Similarity=0.151 Sum_probs=205.6
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
..++++++..||+|+||.||+++ .++|+.+|+|++++...-. ..-++.|-.+|....+|+||+++..|++..++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45667788888999999999999 7789999999998864332 4457889999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC---
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--- 207 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~--- 207 (329)
||||++||++..+|. +...+++..+..++.+++.|+..||.. |+|||||||+|+|||..|++||+|||++.-..
T Consensus 219 iMEylPGGD~mTLL~--~~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM--RKDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEecCCccHHHHHH--hcCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999997 567899999999999999999999999 99999999999999999999999999974210
Q ss_pred -----------------------C-----C--------------------CCccCcccccCcccccCCCCCCcccchhhh
Q 020221 208 -----------------------D-----G--------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFG 239 (329)
Q Consensus 208 -----------------------~-----~--------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 239 (329)
. . .+.+|||.|+|||++.+..|+...|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 0 023578999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 020221 240 TLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVT 308 (329)
Q Consensus 240 ~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~~l~ 308 (329)
||+|||+.|-+||..+.....-.....- ...+..+.....+.++.+||.+|+. ||++|.. +.||.+
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 9999999999999876554433332221 1112222334567899999999999 9999975 444443
No 21
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=6.6e-48 Score=346.12 Aligned_cols=262 Identities=21% Similarity=0.324 Sum_probs=214.3
Q ss_pred cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
.+...||+|+||+||+|.|.+ .||||++....... .+.|++|+..+++-+|.||+-+.|+|..+.. .||+.+|+|
T Consensus 395 ~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG 471 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG 471 (678)
T ss_pred hccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence 355677999999999999855 59999998875443 5679999999999999999999999987766 999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC------CCC
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------GRS 211 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~------~~~ 211 (329)
.+|..+++. ....+...+...|++||++|+.|||.+ +|||||||..||++.+++.|||+|||++..-.. ...
T Consensus 472 sSLY~hlHv-~etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~q 549 (678)
T KOG0193|consen 472 SSLYTHLHV-QETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQ 549 (678)
T ss_pred chhhhhccc-hhhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCC
Confidence 999999976 446789999999999999999999999 999999999999999999999999999864221 122
Q ss_pred ccCcccccCcccccC---CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
..+...|||||+++. .+|++.+||||||+++|||++|..|+.....+.+.-..-.....+.+ .....+++.++.+|
T Consensus 550 p~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~-s~~~s~~pk~mk~L 628 (678)
T KOG0193|consen 550 PHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL-SKIRSNCPKAMKRL 628 (678)
T ss_pred CccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc-hhhhccCHHHHHHH
Confidence 356688999999974 35999999999999999999999888754433332222222111111 11235678899999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhhh---ccccccCccccc
Q 020221 289 ASRCLQYEPRERPNPRSLVTALVTLQK---DTELYLSLPWVM 327 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~~L~~~~~---~~~~~~~~p~~~ 327 (329)
+..||+.++++||.+.+|+..|+.+.+ +..-++|+|-++
T Consensus 629 l~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~~~ 670 (678)
T KOG0193|consen 629 LSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPVLL 670 (678)
T ss_pred HHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccchh
Confidence 999999999999999999998888876 347778888765
No 22
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.2e-47 Score=347.44 Aligned_cols=246 Identities=17% Similarity=0.241 Sum_probs=217.0
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-C--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-W--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (329)
+....+++-+.||.|+-|.|..|+ ..+|+.+|||++.... . .....+.+|+-+|+.+.|||++++++++.+..++|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 445667788889999999999999 6789999999998762 1 12345789999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+|.||+++|.|.+++. ..+++++.++.++++||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|....++
T Consensus 89 lvlEyv~gGELFdylv--~kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLV--RKGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEEecCCchhHHHHH--hhCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999999998 567899999999999999999999999 9999999999999999999999999999877666
Q ss_pred C---CccCcccccCcccccCCCCCC-cccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221 210 R---SYSTNLAFTPPEYLRTGRVTP-ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (329)
Q Consensus 210 ~---~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
. +.+|.+.|.|||+++|.+|+- ++||||.|||||.|+||+.||.++....+......... ..|...++++
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f------~MPs~Is~ea 239 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF------EMPSNISSEA 239 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc------cCCCcCCHHH
Confidence 4 568999999999999999764 89999999999999999999988776655444333322 3567889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 020221 286 VRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
++|+.+|+..||++|.|.++|+.
T Consensus 240 QdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 240 QDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHHHHHHhccCccccccHHHHhh
Confidence 99999999999999999999998
No 23
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=8.5e-48 Score=342.58 Aligned_cols=241 Identities=19% Similarity=0.259 Sum_probs=210.5
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
.|.+.+.||+|+||+||||+ ..+.+.||+|.+.+..... .+.+.+|+++++.++||||+.++++|++..++|+|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 35566677999999999999 5678899999998765443 55689999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---- 210 (329)
+.| +|..+|. ....++++.+..++.+++.||.|||+. +|+|||+||.|||++..+++|++|||+|+......
T Consensus 83 a~g-~L~~il~--~d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 83 AVG-DLFTILE--QDGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhh-hHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 987 9999997 567899999999999999999999999 99999999999999999999999999998766553
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
...||+.|||||+..++.|+..+|+||+||++||+.+|++||.....-.....+..+ + ..+|...+..+..|+.
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~---v~~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---P---VKPPSTASSSFVNFLQ 232 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---C---CCCcccccHHHHHHHH
Confidence 457899999999999999999999999999999999999998765543333322221 1 1345678899999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~ 308 (329)
..|.+||.+|.|..+++.
T Consensus 233 gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHhhcChhhcccHHHHhc
Confidence 999999999999999986
No 24
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=1.5e-47 Score=356.92 Aligned_cols=257 Identities=25% Similarity=0.342 Sum_probs=215.1
Q ss_pred ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
....++||+|+||.||+|... +.+.||||.++..... ..++|++|++.+..++|||||+++|+|..++..++|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 345678899999999999842 3467999999988766 466799999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhccC--------CCCC----CCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeec
Q 020221 132 AEYMPNDTLAKHLFHW--------ETQP----MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSC 199 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~--------~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~D 199 (329)
+|||..|+|..+|+.. .+.. ++..+.+.|+.|||.|+.||-+. .+|||||..+|+||.++..|||+|
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccceEEEecc
Confidence 9999999999999743 1223 78899999999999999999998 999999999999999999999999
Q ss_pred ccCcccCCCCCCc------cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCC-CCCCchhhHHHhhhchhhhcccc
Q 020221 200 FGLMKNSRDGRSY------STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSC 272 (329)
Q Consensus 200 fg~a~~~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~ 272 (329)
||+++.....+-+ .-.++|||||.+..++|+.+||||||||+|||+++-. -|+.+...+.+.... ....
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i----~~g~ 722 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI----RAGQ 722 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH----HcCC
Confidence 9999875544322 2358999999999999999999999999999999955 455443333333222 2222
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 020221 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYL 321 (329)
Q Consensus 273 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~ 321 (329)
+ -..|..+|.++..||..||+.+|++||++++|-..|+..-+..+...
T Consensus 723 l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~ 770 (774)
T KOG1026|consen 723 L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYS 770 (774)
T ss_pred c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcccc
Confidence 2 34678899999999999999999999999999999999877655443
No 25
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=2.3e-46 Score=337.20 Aligned_cols=254 Identities=21% Similarity=0.318 Sum_probs=201.8
Q ss_pred cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeC-Cee
Q 020221 58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DER 128 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~~ 128 (329)
.+++.+.||+|+||.||+|.. .++..||+|++...... ....+.+|+.++..+ +||||+++++++... ...
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 466778889999999999973 23467999999765322 345688999999999 899999999988664 458
Q ss_pred EEEEecCCCCCHHhhhccCC------------------------------------------------------------
Q 020221 129 LLVAEYMPNDTLAKHLFHWE------------------------------------------------------------ 148 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 148 (329)
+++|||+++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 89999999999999886421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------CccCcccccCcc
Q 020221 149 TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPE 222 (329)
Q Consensus 149 ~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE 222 (329)
...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...... ...+++.|+|||
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 13477888999999999999999999 99999999999999999999999999997643221 223457899999
Q ss_pred cccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC
Q 020221 223 YLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301 (329)
Q Consensus 223 ~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 301 (329)
++.+..++.++||||||+++|||++ |..||........... ..........+...++++.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ----RLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH----HHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9998889999999999999999997 8877764322111111 1111111223455678899999999999999999
Q ss_pred CHHHHHHHHHhhhhc
Q 020221 302 NPRSLVTALVTLQKD 316 (329)
Q Consensus 302 s~~~~l~~L~~~~~~ 316 (329)
|+.++++.|+++..+
T Consensus 323 s~~el~~~l~~~~~~ 337 (338)
T cd05102 323 TFSALVEILGDLLQE 337 (338)
T ss_pred CHHHHHHHHHHHHhc
Confidence 999999999988653
No 26
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=4.5e-47 Score=318.90 Aligned_cols=254 Identities=18% Similarity=0.238 Sum_probs=205.0
Q ss_pred HhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeC--C
Q 020221 52 ATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG--D 126 (329)
Q Consensus 52 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~ 126 (329)
..+..+.|+++..|++|+||.||+|+ ..+++.||+|+++...... .-..++|+.+|...+|||||.+-.+.... +
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 34556778888999999999999999 6678899999998765322 22468999999999999999998887543 6
Q ss_pred eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (329)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 206 (329)
.+|+|||||+. +|.+++... .+++...++.-++.|+++|++|||.+ .|+|||||++|+|++..|.+||+|||+|+.+
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCCcEEecccchhhhh
Confidence 79999999987 899998653 36899999999999999999999999 9999999999999999999999999999987
Q ss_pred CCC----CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhh------------------
Q 020221 207 RDG----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRD------------------ 262 (329)
Q Consensus 207 ~~~----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~------------------ 262 (329)
... ...+.|.+|.|||.+.+.. |+...||||+|||+.|++++++.|++..- +.+..
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 655 4456799999999998876 99999999999999999999988876421 11100
Q ss_pred ------hchhhhccccccCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 263 ------RNIQTLTDSCLEGQFSSD-EGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 263 ------~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..........++..++.. .++...+|+..+|.+||.+|.||.+.|+
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000000111111222222 5688999999999999999999999997
No 27
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-46 Score=328.50 Aligned_cols=244 Identities=17% Similarity=0.182 Sum_probs=199.5
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--------------hhHHHHHHHHHHHhcCCCcccccccee
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--------------PDARQFLEEARAVGQLRNRRLANLLGC 121 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~~~~~ 121 (329)
-.|++++.||+|.||.|-+|. ..+++.||||++.+... ...+...+|+.+|+++.|||||+++++
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 346788899999999999999 66789999999965321 124578899999999999999999999
Q ss_pred eeeC--CeeEEEEecCCCCCHHhhhccCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeee
Q 020221 122 CCEG--DERLLVAEYMPNDTLAKHLFHWETQP-MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS 198 (329)
Q Consensus 122 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~ 198 (329)
..++ +.+|||+|||..|.+...- .... +++.+++.+++++..||+|||.+ ||+||||||+|+|++++|++||+
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcCCCcEEee
Confidence 8765 6899999999988764432 4445 89999999999999999999999 99999999999999999999999
Q ss_pred cccCcccCCCC---------CCccCcccccCcccccCCC----CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch
Q 020221 199 CFGLMKNSRDG---------RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI 265 (329)
Q Consensus 199 Dfg~a~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~ 265 (329)
|||.+.....+ ....||+.|+|||.+.++. ...+.||||+||+||.|+.|+.||.++..-.......
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99998765332 1357899999999988743 4468999999999999999999998765433333322
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
... +.-+...+..+++++||.++|.+||++|.+..+|..
T Consensus 333 n~p----L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 333 NDP----LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred cCc----ccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 221 221222356889999999999999999999999987
No 28
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=2.7e-46 Score=328.91 Aligned_cols=247 Identities=17% Similarity=0.222 Sum_probs=201.5
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
|++++.||+|+||.||++. ..+++.||+|.+..... .....+.+|+++++.++|+||+++.+++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 3456677999999999998 56789999999875432 2233577899999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CC
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RS 211 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~ 211 (329)
+++|+|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++...... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 9999999888654445789999999999999999999999 9999999999999999999999999998765433 23
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
..|+..|+|||++.+..++.++||||||+++|+|++|..||.................. ....++...++++.+|+.+
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 238 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAKSICRM 238 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHHHHHHH
Confidence 46789999999999889999999999999999999999888653221111111111111 1123445677899999999
Q ss_pred hcccCCCCCCC-----HHHHHH
Q 020221 292 CLQYEPRERPN-----PRSLVT 308 (329)
Q Consensus 292 cl~~dp~~Rps-----~~~~l~ 308 (329)
||+.||++||+ ++++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 239 LLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HhhcCHHHhcCCCCCCHHHHhc
Confidence 99999999997 788887
No 29
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=1.3e-45 Score=324.21 Aligned_cols=245 Identities=16% Similarity=0.243 Sum_probs=203.0
Q ss_pred cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeee----CCeeEEEEecCC
Q 020221 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLVAEYMP 136 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~ 136 (329)
.+|+|++|.||+|.+ +|+.||||.+....... .+.+.+|+.+++.++||||+++++++.+ ....++||||++
T Consensus 27 ~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred EEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 359999999999998 57799999998654333 4567899999999999999999999876 357899999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCccCc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTN 215 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~ 215 (329)
+|+|.+++. ....+++.....++.|++.||.|||+..+++||||||+||++++++.+||+|||++...... ....++
T Consensus 106 ~g~L~~~l~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 183 (283)
T PHA02988 106 RGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183 (283)
T ss_pred CCcHHHHHh--hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCc
Confidence 999999996 34578999999999999999999998448899999999999999999999999998754433 234578
Q ss_pred ccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221 216 LAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (329)
Q Consensus 216 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 293 (329)
..|+|||++.+ ..++.++||||||+++|||++|..||........... +.....+...+...++++.+++.+||
T Consensus 184 ~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~l~~li~~cl 259 (283)
T PHA02988 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL----IINKNNSLKLPLDCPLEIKCIVEACT 259 (283)
T ss_pred ccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence 89999999976 6799999999999999999999998865433222221 11111222344467889999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhhh
Q 020221 294 QYEPRERPNPRSLVTALVTLQK 315 (329)
Q Consensus 294 ~~dp~~Rps~~~~l~~L~~~~~ 315 (329)
+.||++|||+.++++.|+.+..
T Consensus 260 ~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 260 SHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred cCCcccCcCHHHHHHHHHHHHh
Confidence 9999999999999999998764
No 30
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=2.1e-46 Score=330.61 Aligned_cols=242 Identities=18% Similarity=0.184 Sum_probs=202.5
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|++++.||+|+||.||++.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 456777889999999999994 4688999999865422 224557889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCc
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~ 212 (329)
|+++|+|.+++. ....+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (291)
T cd05612 82 YVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158 (291)
T ss_pred CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence 999999999986 345789999999999999999999999 9999999999999999999999999998765443 234
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
.|++.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...++.+.+++.+|
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~ 232 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG------KLEFPRHLDLYAKDLIKKL 232 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CcCCCccCCHHHHHHHHHH
Confidence 6889999999999888999999999999999999999888654332222221111 1123445578899999999
Q ss_pred cccCCCCCCC-----HHHHHH
Q 020221 293 LQYEPRERPN-----PRSLVT 308 (329)
Q Consensus 293 l~~dp~~Rps-----~~~~l~ 308 (329)
|..||.+||+ +.++++
T Consensus 233 l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 233 LVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred cCCCHHHccCCccCCHHHHhc
Confidence 9999999995 888886
No 31
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=2.8e-46 Score=334.58 Aligned_cols=236 Identities=18% Similarity=0.233 Sum_probs=198.7
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
.||+|+||.||++. ..+++.||+|++.... ......+.+|+.+++.++||||+++.+++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 46999999999998 5678899999987542 2234457789999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCc
Q 020221 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTN 215 (329)
Q Consensus 140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~ 215 (329)
|.+++. ....+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++..... ....|+
T Consensus 82 L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 82 LFFHLS--RERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecC
Confidence 999886 446789999999999999999999999 9999999999999999999999999998753221 234689
Q ss_pred ccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhccc
Q 020221 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (329)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 295 (329)
+.|+|||++.+..++.++|||||||++|||++|..||............... ...++...++++.+++.+||..
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred ccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHHccC
Confidence 9999999999888999999999999999999999988655433322221111 1234556778999999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 020221 296 EPRERP-----NPRSLVT 308 (329)
Q Consensus 296 dp~~Rp-----s~~~~l~ 308 (329)
||++|| ++.++++
T Consensus 233 dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 233 DPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHcCCCCCCCHHHHHc
Confidence 999999 7888886
No 32
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=3.4e-46 Score=334.79 Aligned_cols=244 Identities=15% Similarity=0.178 Sum_probs=203.4
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
+..|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 45677888899999999999994 568899999987542 12345688999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-C
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-R 210 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~ 210 (329)
|||+.+|+|.+++. ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...... .
T Consensus 97 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 97 LEFVVGGELFTHLR--KAGRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred EcCCCCChHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 99999999999986 345788999999999999999999999 9999999999999999999999999999765443 2
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
...|++.|+|||++.+..++.++||||||+++|+|++|..||............. .. ...++...+..+.+++.
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~----~~--~~~~p~~~~~~~~~li~ 247 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL----AG--RLKFPNWFDGRARDLVK 247 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh----cC--CcCCCCCCCHHHHHHHH
Confidence 4568899999999998889999999999999999999999886543222221111 11 11234446678999999
Q ss_pred HhcccCCCCCCC-----HHHHHH
Q 020221 291 RCLQYEPRERPN-----PRSLVT 308 (329)
Q Consensus 291 ~cl~~dp~~Rps-----~~~~l~ 308 (329)
+||+.||.+||+ +.+++.
T Consensus 248 ~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 248 GLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhc
Confidence 999999999997 577775
No 33
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=2.8e-45 Score=329.21 Aligned_cols=251 Identities=18% Similarity=0.229 Sum_probs=202.5
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
..|++++.||+|+||.||++. ..++..+|+|.+...... ..+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 456778888999999999999 456888999998765322 345689999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCc
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~ 212 (329)
+++++|.+++. ....+++..+..++.|++.||.|||++++++|+||||+||+++.++.++|+|||++...... ...
T Consensus 85 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 85 MDGGSLDQVLK--EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence 99999999986 34568999999999999999999998646999999999999999999999999998755432 234
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------------------------
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT------------------------- 267 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~------------------------- 267 (329)
.++..|+|||++.+..++.++||||||+++|||++|+.||...............
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG 242 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccc
Confidence 6789999999999888999999999999999999999988643222111100000
Q ss_pred -----------------hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221 268 -----------------LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 268 -----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~ 309 (329)
+.............++++.+|+.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000112356789999999999999999999999983
No 34
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-47 Score=329.82 Aligned_cols=242 Identities=15% Similarity=0.253 Sum_probs=205.5
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
|+.+..||+|.||.||+|. ..+++.||+|++..... ...+++.+|+.+|..++++||.++++.+..+..+|++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 4455677999999999999 56788999999987643 346778999999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY 212 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~ 212 (329)
+|++.+.+. ....+.+..+..++++++.||.|||.. +.+|||||+.|||+..+|.+|++|||.+...... .++
T Consensus 95 gGsv~~lL~--~~~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf 171 (467)
T KOG0201|consen 95 GGSVLDLLK--SGNILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF 171 (467)
T ss_pred Ccchhhhhc--cCCCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence 999999995 334448888899999999999999999 9999999999999999999999999998765433 567
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
.||+.|||||++.+..|+.++||||||++.+||.+|.+|+..... ....-.+.....+.+...+++.+++|+..|
T Consensus 172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----mrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----MRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----ceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 899999999999988899999999999999999999976643211 111122233333344457889999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020221 293 LQYEPRERPNPRSLVT 308 (329)
Q Consensus 293 l~~dp~~Rps~~~~l~ 308 (329)
|++||+.||+|.+++.
T Consensus 247 L~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLK 262 (467)
T ss_pred hhcCcccCcCHHHHhh
Confidence 9999999999999986
No 35
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.6e-46 Score=301.15 Aligned_cols=243 Identities=21% Similarity=0.266 Sum_probs=210.6
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
.++-+.||+|-||.||.|+ .+++..||+|++.+... +...++.+|+++-+.|+||||+++++++.+....||++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 3445556999999999999 66788999999876542 2346789999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC--CCCCc
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--DGRSY 212 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~--~~~~~ 212 (329)
...|+|...|+......+++.....+++|++.||.|+|.+ +++||||||+|+|++..+.+||+|||-+.... ...+.
T Consensus 104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tl 182 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKTL 182 (281)
T ss_pred cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCCCeeccCCCceeecCCCCceee
Confidence 9999999999876777899999999999999999999999 99999999999999999999999999876543 33567
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
+||..|.+||+..+...+..+|+|++|++.||++.|.+||.....+........ .+..+|...+.++.++|.+|
T Consensus 183 cgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k------~~~~~p~~is~~a~dlI~~l 256 (281)
T KOG0580|consen 183 CGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK------VDLKFPSTISGGAADLISRL 256 (281)
T ss_pred ecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH------ccccCCcccChhHHHHHHHH
Confidence 899999999999999999999999999999999999998876553333322221 22335677889999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020221 293 LQYEPRERPNPRSLVT 308 (329)
Q Consensus 293 l~~dp~~Rps~~~~l~ 308 (329)
+.++|.+|.+..++++
T Consensus 257 l~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 257 LVKNPIERLALTEVMD 272 (281)
T ss_pred hccCccccccHHHHhh
Confidence 9999999999999998
No 36
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=1.9e-45 Score=327.59 Aligned_cols=235 Identities=18% Similarity=0.205 Sum_probs=195.9
Q ss_pred CCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (329)
Q Consensus 65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (329)
||+|+||.||++. ..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 5999999999999 4568899999986532 22345678899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCcc
Q 020221 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNL 216 (329)
Q Consensus 141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~ 216 (329)
.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++...... ....||+
T Consensus 81 ~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 81 FHHLQ--REGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence 99986 345689999999999999999999999 9999999999999999999999999998753322 2346889
Q ss_pred cccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 020221 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (329)
Q Consensus 217 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 296 (329)
.|+|||++.+..++.++||||||+++|+|++|..||.............. . ...++...++++.+++.+||..|
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----~--~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----E--PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc----C--CCCCCCcCCHHHHHHHHHHcCCC
Confidence 99999999988899999999999999999999998876543332222111 1 12345567788999999999999
Q ss_pred CCCCCC---HHHHHH
Q 020221 297 PRERPN---PRSLVT 308 (329)
Q Consensus 297 p~~Rps---~~~~l~ 308 (329)
|++||+ +.++++
T Consensus 232 p~~R~~~~~~~e~l~ 246 (312)
T cd05585 232 PTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHcCCCCCHHHHHc
Confidence 999985 555554
No 37
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=1.7e-45 Score=331.30 Aligned_cols=244 Identities=17% Similarity=0.203 Sum_probs=202.5
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-C-CCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 56 FAMENIVSEHGEKAPNVVYKGKLE-N-QFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
+..|.+++.||+|+||.||+|... + +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 445778888899999999999843 3 3689999986432 2234567889999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 209 (329)
||||+++|+|.+++. ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR--RNKRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred EEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 999999999999986 345789999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
....||+.|+|||++.+..++.++|||||||++|||++|..||................ ..++...++.+.+++
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~------~~~p~~~~~~~~~li 259 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI------IYFPKFLDNNCKHLM 259 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC------CCCCCCCCHHHHHHH
Confidence 34568999999999998889999999999999999999999887543322222211111 123455677899999
Q ss_pred HHhcccCCCCCC-----CHHHHHH
Q 020221 290 SRCLQYEPRERP-----NPRSLVT 308 (329)
Q Consensus 290 ~~cl~~dp~~Rp-----s~~~~l~ 308 (329)
.+||+.||++|+ +++++++
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHc
Confidence 999999999995 7888876
No 38
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-45 Score=335.83 Aligned_cols=239 Identities=19% Similarity=0.287 Sum_probs=205.2
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (329)
+....++++.||+|+||+|+++. ..+++.+|||.++++.. .+.+....|.+++... +||.++.++..|++.+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 34556778888999999999999 56688999999998742 3455677788877777 6999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC--
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR-- 207 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~-- 207 (329)
+||||+.||++.... ....+++..+..++..|+.||.|||++ ||||||||.+|||+|.+|++||+|||+++...
T Consensus 446 fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccCcEEecccccccccCCC
Confidence 999999999954444 557899999999999999999999999 99999999999999999999999999998643
Q ss_pred --CCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221 208 --DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (329)
Q Consensus 208 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
...+.+||+.|+|||++.+..|+..+|+|||||+||||+.|..||+++.-+.+-+....+ ...+|..++.+.
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d------~~~yP~~ls~ea 595 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND------EVRYPRFLSKEA 595 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------CCCCCCcccHHH
Confidence 335678999999999999999999999999999999999999999977655444433321 224677889999
Q ss_pred HHHHHHhcccCCCCCCCH
Q 020221 286 VRLASRCLQYEPRERPNP 303 (329)
Q Consensus 286 ~~li~~cl~~dp~~Rps~ 303 (329)
..++.++|..+|++|..+
T Consensus 596 ~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 596 IAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHhccCcccccCC
Confidence 999999999999999865
No 39
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-47 Score=309.62 Aligned_cols=245 Identities=20% Similarity=0.233 Sum_probs=210.0
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|.+...||+|.|+.|+++. ..+|+.+|+|++.... ..+.+++.+|+++.+.|+||||+++.+...+....++|+|++
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 4455566999999999998 6778889998876442 235778999999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC---CCCCeeeecccCcccCCCCCC-
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDGRS- 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~~~- 211 (329)
.|++|..-+.. ..-+++..+..+++||+.+|.|+|.+ +|||||+||+|+|+. ....+||+|||+|....++..
T Consensus 93 ~G~dl~~eIV~--R~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~ 169 (355)
T KOG0033|consen 93 TGGELFEDIVA--REFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW 169 (355)
T ss_pred cchHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence 99999877753 35678999999999999999999999 999999999999995 334599999999998886543
Q ss_pred --ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 212 --YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 212 --~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
..||+.|||||++...+|+..+|||+.||+||-|+.|..||+++....+.++......+- .++.-+..+++.++|+
T Consensus 170 ~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~--~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 170 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDY--PSPEWDTVTPEAKSLI 247 (355)
T ss_pred ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCC--CCcccCcCCHHHHHHH
Confidence 467999999999999999999999999999999999999999877666666655544432 2334456789999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 020221 290 SRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 290 ~~cl~~dp~~Rps~~~~l~ 308 (329)
.+||..||.+|.|+.|+|+
T Consensus 248 rrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHhccChhhhccHHHHhC
Confidence 9999999999999999998
No 40
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=3.2e-45 Score=328.27 Aligned_cols=237 Identities=18% Similarity=0.234 Sum_probs=198.2
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
.||+|+||.||++. ..+++.||+|++.... ......+.+|+++++.++||||+++.+++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 46999999999998 5578899999997542 2234567889999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCc
Q 020221 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTN 215 (329)
Q Consensus 140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~ 215 (329)
|..++. ....+++.++..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++...... ....|+
T Consensus 82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 82 LFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCC
Confidence 998886 345789999999999999999999999 9999999999999999999999999998753221 234688
Q ss_pred ccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhccc
Q 020221 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (329)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 295 (329)
+.|+|||++.+..++.++||||||+++|+|++|..||.............. ....++...++++.+++.+||..
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~------~~~~~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EDIKFPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred cCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc------CCccCCCCCCHHHHHHHHHHcCC
Confidence 999999999988899999999999999999999998865433322221111 11134456678899999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 020221 296 EPRERP-----NPRSLVTA 309 (329)
Q Consensus 296 dp~~Rp-----s~~~~l~~ 309 (329)
||++|| ++.+++++
T Consensus 233 dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHcCCCCCCCHHHHhcC
Confidence 999997 88998863
No 41
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=3.7e-45 Score=328.75 Aligned_cols=249 Identities=17% Similarity=0.155 Sum_probs=203.6
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|++++.||+|+||.||+|.. .+++.||+|++.... ......+.+|++++..++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 466778889999999999994 468899999987542 1234567889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCc
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~ 212 (329)
|+++++|.+++. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... ...
T Consensus 82 ~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~ 158 (333)
T cd05600 82 YVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158 (333)
T ss_pred CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence 999999999996 345689999999999999999999999 9999999999999999999999999998765442 345
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh--hhccccccCCCChHHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--TLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
.|++.|+|||++.+..++.++||||||+++|||++|..||.............. ...............+.++.+++.
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~ 238 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHH
Confidence 689999999999988999999999999999999999998865433222111110 001000000001245788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~~ 309 (329)
+||..+|++||++.+++++
T Consensus 239 ~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 239 KLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHhhChhhhcCCHHHHHhC
Confidence 9999999999999999974
No 42
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=2.9e-45 Score=327.88 Aligned_cols=236 Identities=18% Similarity=0.241 Sum_probs=196.9
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
.||+|+||.||++. ..+|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 46999999999998 4578899999987542 2234457789999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCc
Q 020221 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTN 215 (329)
Q Consensus 140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~ 215 (329)
|..++. ....+++..+..++.||+.||.|||++ |++||||||+|||+++++.+||+|||++...... ....|+
T Consensus 82 L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 82 LFFHLS--RERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred HHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCC
Confidence 998886 345789999999999999999999999 9999999999999999999999999998753221 234688
Q ss_pred ccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhccc
Q 020221 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (329)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 295 (329)
+.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...++++.+++.+||+.
T Consensus 159 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------EIRFPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHccC
Confidence 9999999999889999999999999999999999888654333222211111 1123456678999999999999
Q ss_pred CCCCCC-----CHHHHHH
Q 020221 296 EPRERP-----NPRSLVT 308 (329)
Q Consensus 296 dp~~Rp-----s~~~~l~ 308 (329)
||++|| ++.++++
T Consensus 233 dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 233 DPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHhCCCCCCCHHHHHc
Confidence 999998 7888876
No 43
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=7.5e-46 Score=329.03 Aligned_cols=247 Identities=19% Similarity=0.199 Sum_probs=218.6
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCe-eEEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDE-RLLVA 132 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 132 (329)
+.|..++.+|+|+||.++..+ ..+++.+++|.+....... .+...+|+.++++++|||||.+.+.|...+. .+|+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 467888899999999999998 4567799999998765333 3457899999999999999999999988887 99999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-- 210 (329)
+||+||+|.+.+.+.+...+++..+..++.|++.|+.|||++ +|+|||||+.||+++.++.++|+|||+|+...+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 999999999999876667889999999999999999999988 99999999999999999999999999999876653
Q ss_pred --CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 211 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
+..||+.|++||.+.+.+|+.++|||||||++|||++-+++|.................. +.+...+.+++.+
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~-----Plp~~ys~el~~l 237 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS-----PLPSMYSSELRSL 237 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC-----CCCccccHHHHHH
Confidence 568999999999999999999999999999999999999988877666665555554433 4567788999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 020221 289 ASRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~~ 309 (329)
+..||..+|+.||++.+++..
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999975
No 44
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-45 Score=332.88 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=210.9
Q ss_pred ccccCCCCCCcEEEEEEeC--CC---CEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 61 IVSEHGEKAPNVVYKGKLE--NQ---FRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~--~~---~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+.++||+|+||.||+|.+. ++ ..||+|..+... .....++.+|.++|+.++|||||+++|++.....+++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 3467899999999999843 22 238999988532 344667999999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS- 211 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~- 211 (329)
|+|.||+|.++|+. ....++..+...++.+.++||+|||++ +++||||..+|+|++.++.+||+|||+++.......
T Consensus 241 El~~gGsL~~~L~k-~~~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~ 318 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKK-NKKSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK 318 (474)
T ss_pred EecCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCCeEEeCccccccCCcceeec
Confidence 99999999999975 333699999999999999999999999 999999999999999999999999999876542221
Q ss_pred ---ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221 212 ---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (329)
Q Consensus 212 ---~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
......|+|||.+....|++++|||||||++||+++ |..|++......+..... ....+...+...+.++..
T Consensus 319 ~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~----~~~~r~~~~~~~p~~~~~ 394 (474)
T KOG0194|consen 319 KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV----KNGYRMPIPSKTPKELAK 394 (474)
T ss_pred cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH----hcCccCCCCCCCHHHHHH
Confidence 124588999999999999999999999999999999 677777655444433331 222333455677889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221 288 LASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (329)
Q Consensus 288 li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~ 318 (329)
++.+||..||++||+|.++.+.|+.+.+...
T Consensus 395 ~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 395 VMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 9999999999999999999999999987654
No 45
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=7.2e-45 Score=320.02 Aligned_cols=248 Identities=18% Similarity=0.218 Sum_probs=197.5
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
.|++++.||+|+||+||++.. .+++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 366778889999999999995 4678999999876432 2345678999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----- 209 (329)
++++++..+.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 82 VEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99876665443 345689999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh--------------------hhc
Q 020221 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------------------TLT 269 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~--------------------~~~ 269 (329)
....+++.|+|||++.+..++.++||||||+++|+|++|+.||+............. ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 234578899999999988899999999999999999999988865422111000000 000
Q ss_pred ccccc------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 270 DSCLE------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 270 ~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.+... .......+.++.+|+.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0011235678999999999999999999999998
No 46
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-46 Score=332.16 Aligned_cols=246 Identities=21% Similarity=0.320 Sum_probs=210.2
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|+...-++-+|.|+.|-||+|++.+ +.||||+++.-. ..+|+-|+.|+|+||+.+.|+|.....++||||||
T Consensus 123 Fe~IsELeWlGSGaQGAVF~Grl~n-etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 123 FEEISELEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred HHHhhhhhhhccCcccceeeeeccC-ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 3333345677999999999999854 489999986433 24778899999999999999999888999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCc
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSY 212 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~ 212 (329)
..|-|..+|+ ..+.++......|..+|+.|+.|||.. .|||||||.-||||.-+..+||+|||.++...+. ..+
T Consensus 195 a~GqL~~VLk--a~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLK--AGRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccccHHHHHh--ccCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhh
Confidence 9999999997 567889999999999999999999998 9999999999999999999999999998866554 356
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
.||+.|||||++...+.++|+|||||||+||||+||..|+-+-... .++-.+-...+....|..++..|.-|+++|
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kqc 347 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQC 347 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHHH
Confidence 8999999999999999999999999999999999999876432211 222333344556667888899999999999
Q ss_pred cccCCCCCCCHHHHHHHHHhhhhc
Q 020221 293 LQYEPRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 293 l~~dp~~Rps~~~~l~~L~~~~~~ 316 (329)
|+..|-.||++++++.+|+-...+
T Consensus 348 w~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 348 WNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred HhcCCCCCccHHHHHHHHhhcCHH
Confidence 999999999999999999876543
No 47
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=8e-45 Score=320.03 Aligned_cols=250 Identities=18% Similarity=0.234 Sum_probs=198.4
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.+.|.+++.||.|+||.||+|. ..++..||+|.+...... ....+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 4567888889999999999998 456889999998754322 23467789999999999999999999998899999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---- 209 (329)
|+++ +|.+++.. ....+++..+..++.||+.||+|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 84 YLDS-DLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CCCc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 9975 89988854 334578999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------hcccc---------
Q 020221 210 RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------LTDSC--------- 272 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-------~~~~~--------- 272 (329)
....+++.|+|||++.+ ..++.++||||+|+++|+|++|..||............... .....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 23456889999998875 45889999999999999999999888654332211111000 00000
Q ss_pred ccC--------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 273 LEG--------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 273 ~~~--------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
... ......+.++.+|+.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 001234678899999999999999999999997
No 48
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-45 Score=353.22 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=209.1
Q ss_pred ccccccCCCCCCcEEEEEEeCC--C----CEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLEN--Q----FRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~--~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
-.+.+.||+|+||.||.|...+ + ..||+|.+.... .+...+|.+|..+|+.++|||||+++|++.+....+|+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 3455678999999999998433 3 349999998764 34566799999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221 132 AEYMPNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 206 (329)
+|||++|+|..+|++.+ ...++..+.+.++.|||+|+.||+++ ++|||||..+|+|+++...+||+|||+|+..
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 99999999999998631 45678999999999999999999999 9999999999999999999999999999954
Q ss_pred CCCCC------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-hccccccCCCCh
Q 020221 207 RDGRS------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-LTDSCLEGQFSS 279 (329)
Q Consensus 207 ~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 279 (329)
....- ..-...|||||.+.++.|+.++|||||||+|||++|.+.+|+.+... ..+.. +.... +-..|.
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n----~~v~~~~~~gg-RL~~P~ 927 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN----FEVLLDVLEGG-RLDPPS 927 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----HHHHHHHHhCC-ccCCCC
Confidence 43321 12247899999999999999999999999999999977655433211 11111 22222 445677
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221 280 DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 280 ~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~ 316 (329)
.++..+.++|.+||+.+|++||++..+++.+..+...
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 8889999999999999999999999999988888664
No 49
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-45 Score=313.17 Aligned_cols=244 Identities=20% Similarity=0.309 Sum_probs=196.8
Q ss_pred ccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC--CChhHHHHHHHHHHHhcCCCccccccceeeee-----CCeeEEEE
Q 020221 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCE-----GDERLLVA 132 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~ 132 (329)
.++.+|+|+||.|.++. ..+|+.||+|++... ....++...+|++.|+.++|+||+.+.+.+.. -..+|+|+
T Consensus 26 ~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 26 LIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred ccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 36778999999999998 667899999999843 44457788999999999999999999998855 25689999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--- 209 (329)
|+|+. +|...++ .++.++...+..+++|+++||+|+|+. +++||||||+|+|++.+..+||+|||+|+.....
T Consensus 106 elMet-DL~~iik--~~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 106 ELMET-DLHQIIK--SQQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred hHHhh-HHHHHHH--cCccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 99955 8999986 445599999999999999999999999 9999999999999999999999999999977431
Q ss_pred ---CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhh-------------------HHHhhhchh
Q 020221 210 ---RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-------------------DLIRDRNIQ 266 (329)
Q Consensus 210 ---~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~-------------------~~~~~~~~~ 266 (329)
..+..|.+|.|||.+.. ..|+...||||+|||+.||++|++.|++... ..+......
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 34567999999998764 4599999999999999999999998876421 111100011
Q ss_pred hhcccc---ccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 267 TLTDSC---LEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 267 ~~~~~~---~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..+... .+.. .-+..++.+.+|+.+||..||.+|+|++++++
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111100 0001 11246789999999999999999999999997
No 50
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=2.2e-44 Score=323.48 Aligned_cols=250 Identities=19% Similarity=0.274 Sum_probs=199.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
..|++++.||+|+||.||++.. .++..+|+|.+...... ....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 3467778889999999999994 46888999988765322 345688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCc
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~ 212 (329)
+++++|.+++. ....+++..+..++.|++.||.|||+..+++|+||||+||+++.++.+||+|||++...... ...
T Consensus 85 ~~~~~L~~~l~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 162 (333)
T cd06650 85 MDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (333)
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence 99999999986 34568899999999999999999998547999999999999999999999999998754332 334
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc---hh-----------------------
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---IQ----------------------- 266 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~---~~----------------------- 266 (329)
.++..|+|||++.+..++.++||||||+++|+|++|..||............ ..
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (333)
T cd06650 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242 (333)
T ss_pred CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence 6789999999999888999999999999999999999887643221111000 00
Q ss_pred ----------hhccccc---cCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 267 ----------TLTDSCL---EGQF-SSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 267 ----------~~~~~~~---~~~~-~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
....... .... ....+.++.+|+.+||+.||++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000000 0001 1124578999999999999999999999986
No 51
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=2.6e-44 Score=313.15 Aligned_cols=249 Identities=19% Similarity=0.275 Sum_probs=202.6
Q ss_pred cccccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
.+++.+.||+|+||.||+|.+. .+..||+|.++...... ...+.+|+..++.++||||+++++++..++..++||
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 85 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT 85 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEE
Confidence 4567777899999999999742 35689999998754322 346889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-- 210 (329)
||+++|+|.+++.. ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.......
T Consensus 86 e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 86 EYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EeCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 99999999999864 335789999999999999999999999 99999999999999999999999999876533221
Q ss_pred ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
...++..|+|||.+.+..++.++||||||+++||+++ |..||............. .......+..++..+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-----DGFRLPAPRNCPNLLH 238 (266)
T ss_pred cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-----CCCCCCCCCCCCHHHH
Confidence 1234568999999998899999999999999999775 887775433222211111 1112233456678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 287 RLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
+++.+||+.+|++||++.++++.|.++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999999999998764
No 52
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=2.7e-44 Score=311.99 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=207.5
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
+.+++++.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..++++||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 4577888999999999999998778889999987644 235678999999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~ 211 (329)
+++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence 99999998754556789999999999999999999999 99999999999999999999999999997654432 1
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
..++..|+|||.+.+..++.++||||||+++|+|++ |..|+............... .........+.++.+++.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~ 238 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-----YRMPRMENCPDELYDIMK 238 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-----CCCCCCCCCCHHHHHHHH
Confidence 234567999999988889999999999999999998 88777654322222211111 111222345678999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhh
Q 020221 291 RCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
+||..+|++||++.++.+.|+++
T Consensus 239 ~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 239 TCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHccCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999864
No 53
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=9.8e-45 Score=328.45 Aligned_cols=245 Identities=17% Similarity=0.182 Sum_probs=195.7
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
.+..++.++.||+|+||.||++. ..+++.||+|++...... ....+.+|+++++.++|+||+++++++...+..++||
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 45566778889999999999998 457889999999755432 2456889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--- 209 (329)
||+++++|.... ...+..+..++.||+.||.|||+. +++||||||+|||+++++.+||+|||++......
T Consensus 152 e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 152 EFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 999999986532 346778889999999999999999 9999999999999999999999999998765432
Q ss_pred -CCccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 210 -RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 210 -~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
....|+..|+|||++.. ...+.++|||||||++|||++|+.||........... ..... .......+...+.
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~ 302 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL-MCAIC-MSQPPEAPATASR 302 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH-HHHHh-ccCCCCCCCccCH
Confidence 23468899999998753 2245689999999999999999988863221111100 00000 0111223445678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 284 ELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
++.+|+.+||+.||++|||+.++++
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 8999999999999999999999998
No 54
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=2.1e-44 Score=322.44 Aligned_cols=237 Identities=19% Similarity=0.238 Sum_probs=195.8
Q ss_pred ccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCC----ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 63 SEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4679999999999974 357889999987532 12234567899999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~ 210 (329)
+++++|.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...... .
T Consensus 82 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 82 LSGGELFMHLE--REGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCchHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccc
Confidence 99999999886 345678889999999999999999999 9999999999999999999999999998643222 2
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
...|++.|+|||++.+..++.++||||||+++|||++|..||............ ... ....+...++++.+++.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~----~~~--~~~~~~~~~~~~~~li~ 232 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI----LKG--KLNLPPYLTPEARDLLK 232 (323)
T ss_pred ccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH----HcC--CCCCCCCCCHHHHHHHH
Confidence 345789999999999888999999999999999999999888654332222111 111 11234556788999999
Q ss_pred HhcccCCCCCC-----CHHHHHH
Q 020221 291 RCLQYEPRERP-----NPRSLVT 308 (329)
Q Consensus 291 ~cl~~dp~~Rp-----s~~~~l~ 308 (329)
+||+.||++|| ++.++++
T Consensus 233 ~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 233 KLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHcccCHhHcCCCCCCCHHHHhc
Confidence 99999999999 7888876
No 55
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=7.4e-45 Score=330.70 Aligned_cols=245 Identities=16% Similarity=0.131 Sum_probs=198.1
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|++++.||+|+||+||++. ..+++.||||++.... ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 45677788999999999999 4568899999997532 1234457889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999986 345689999999999999999999999 99999999999999999999999999986432110
Q ss_pred ---------------------------------------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCC
Q 020221 211 ---------------------------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI 251 (329)
Q Consensus 211 ---------------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~ 251 (329)
...||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 13588999999999988899999999999999999999988
Q ss_pred CCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 020221 252 PPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVT 308 (329)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~~l~ 308 (329)
|............... ............++++.+++.+|+. +|.+|++ +.++++
T Consensus 239 f~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 239 FCSDNPQETYRKIINW--KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 8654332221111110 0001111112357789999999996 9999998 888887
No 56
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=8.7e-45 Score=328.47 Aligned_cols=246 Identities=20% Similarity=0.204 Sum_probs=202.3
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|.+++.||+|+||+||++.. .+++.||+|++.... ......+.+|++++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 466778889999999999994 478899999987542 1234568889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+++++|.+++.+ ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIR--KDVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999964 36789999999999999999999999 99999999999999999999999999987654332
Q ss_pred ------------------------------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHH
Q 020221 211 ------------------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI 260 (329)
Q Consensus 211 ------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 260 (329)
...||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 33578999999999999999999999999999999999998865543222
Q ss_pred hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 020221 261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN-PRSLVTA 309 (329)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~~~l~~ 309 (329)
...... .. ...........++++.+++..||. ||++||+ +.+++++
T Consensus 239 ~~~i~~-~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 239 YNKIIN-WK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHhc-cC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211111 00 111111112257889999999997 9999999 9999973
No 57
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=3.8e-44 Score=318.14 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=197.4
Q ss_pred cccccccCCCCCCcEEEEEEeCC-----------------CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccc
Q 020221 58 MENIVSEHGEKAPNVVYKGKLEN-----------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLL 119 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~ 119 (329)
.+.+.+.||+|+||.||++.+.+ +..||+|.+...... ....+.+|++++..++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 46677788999999999997432 346999999865433 345688999999999999999999
Q ss_pred eeeeeCCeeEEEEecCCCCCHHhhhccCC-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccc
Q 020221 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWE-----------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDL 182 (329)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl 182 (329)
+++.+.+..+++|||+.+|+|.+++.... ...+++..+..++.||+.||.|||+. +++||||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~ivH~dl 164 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-NFVHRDL 164 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-CccccCc
Confidence 99999899999999999999999885321 12467889999999999999999999 9999999
Q ss_pred CCCceeeCCCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCC--CCCCc
Q 020221 183 NAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK--HIPPS 254 (329)
Q Consensus 183 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~--~~~~~ 254 (329)
||+|||++.++.+||+|||++....... ...++..|+|||++.++.++.++||||||+++|+|+++. .|+..
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 9999999999999999999987654332 223467899999998888999999999999999999754 34432
Q ss_pred hhhHHHhhhchhhhcc--ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 255 HALDLIRDRNIQTLTD--SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 255 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
................ .......+..++..+.+++.+||+.||++|||+.++.+.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 245 LTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 2221111111100000 00111123456788999999999999999999999998876
No 58
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=1.6e-44 Score=330.25 Aligned_cols=246 Identities=17% Similarity=0.174 Sum_probs=196.9
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.+++++.||+|+||+||+|. ..+++.||+|++..... .....+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 46678888999999999998 56788999999976432 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----- 208 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----- 208 (329)
|+++|+|.+++. ....+++..+..++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~gg~L~~~l~--~~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 999999999986 345689999999999999999999999 999999999999999999999999998753210
Q ss_pred ----------------------------------------------CCCccCcccccCcccccCCCCCCcccchhhhHHH
Q 020221 209 ----------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL 242 (329)
Q Consensus 209 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il 242 (329)
.....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 0123588999999999988899999999999999
Q ss_pred HHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH--hcccCCCCCCCHHHHHH
Q 020221 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR--CLQYEPRERPNPRSLVT 308 (329)
Q Consensus 243 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dp~~Rps~~~~l~ 308 (329)
|||++|..||.............. .............++++.+++.+ |+..+|..||++.++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999998865432222111110 01111111122457889999988 44556667999999997
No 59
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=2.5e-44 Score=319.21 Aligned_cols=249 Identities=18% Similarity=0.190 Sum_probs=193.9
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
+.|++++.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 4577888889999999999994 47889999998754322 234577899999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~ 210 (329)
+. ++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... .
T Consensus 85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 85 VH-TDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred CC-cCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 96 578887754 345688999999999999999999999 9999999999999999999999999998653322 2
Q ss_pred CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhH-HHhhhchh-------h----------hccc
Q 020221 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-LIRDRNIQ-------T----------LTDS 271 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~-~~~~~~~~-------~----------~~~~ 271 (329)
...+++.|+|||++.+. .++.++||||||+++|+|++|..||...... ........ . ....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE 241 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence 34568899999998754 4888999999999999999999988642110 00000000 0 0000
Q ss_pred cccCCCC---------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 272 CLEGQFS---------SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 272 ~~~~~~~---------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
......+ ...+.++.+++.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 012467889999999999999999999997
No 60
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=7.7e-45 Score=325.56 Aligned_cols=237 Identities=19% Similarity=0.245 Sum_probs=196.8
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
.||+|+||.||++. ..+++.||+|++.... ......+.+|+++++.++||||+++.+++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 46999999999998 5678899999987542 2234457789999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST 214 (329)
Q Consensus 140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~ 214 (329)
|..++. ....+++..+..++.||+.||.|||+ . |++||||||+|||++.++.+||+|||++...... ....|
T Consensus 82 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~-~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 82 LFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcC-CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccC
Confidence 998886 34578999999999999999999997 6 9999999999999999999999999998753221 23468
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
++.|+|||++.+..++.++||||||+++|+|++|..||............... ...++...++++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EIRFPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred CcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHhh
Confidence 89999999999888999999999999999999999988654433222211111 112345567889999999999
Q ss_pred cCCCCCC-----CHHHHHHH
Q 020221 295 YEPRERP-----NPRSLVTA 309 (329)
Q Consensus 295 ~dp~~Rp-----s~~~~l~~ 309 (329)
.||++|+ ++.+++++
T Consensus 233 ~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcC
Confidence 9999997 89998863
No 61
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=3.5e-44 Score=311.23 Aligned_cols=249 Identities=22% Similarity=0.373 Sum_probs=209.5
Q ss_pred ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
|.+++.||.|+||.||+|...++..+++|.+..........+.+|+.+++.++|+||+++++++......+++|||++++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence 56677889999999999997778899999998776555678899999999999999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----CccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~~~ 214 (329)
+|.+++.+.....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||.+....... ...+
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 166 (261)
T cd05148 88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI 166 (261)
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCC
Confidence 999999765556789999999999999999999999 99999999999999999999999999987654332 2234
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 293 (329)
+..|+|||.+.+..++.++||||||+++|+|++ |..|+............. ...+...+...++++.+++.+||
T Consensus 167 ~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~l 241 (261)
T cd05148 167 PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-----AGYRMPCPAKCPQEIYKIMLECW 241 (261)
T ss_pred ceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-----hCCcCCCCCCCCHHHHHHHHHHc
Confidence 578999999988889999999999999999998 677665433222211111 11222334566788999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhh
Q 020221 294 QYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 294 ~~dp~~Rps~~~~l~~L~~~ 313 (329)
+.||++|||+.++++.|+.+
T Consensus 242 ~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 242 AAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCchhCcCHHHHHHHHhcC
Confidence 99999999999999999864
No 62
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=5.8e-44 Score=310.37 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=206.7
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
.+.+.+.||+|+||.||+|. .++++.||+|.+.... .....+.+|++.++.++|+||+++++++......+++|||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 35566778999999999999 4558889999987654 335678899999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-----
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----- 211 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----- 211 (329)
+++|.+++.......+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~ 164 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence 99999998754455689999999999999999999999 999999999999999999999999999876544321
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
...+..|+|||.+.+..++.++||||||+++|||++ |..|++........... ........+...+.++.+++.
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKGYRMERPEGCPPKVYELMR 239 (263)
T ss_pred CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----HCCCCCCCCCCCCHHHHHHHH
Confidence 123567999999998889999999999999999998 77777654333222111 111222344556789999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhh
Q 020221 291 RCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
+||+.||++|||+.++++.|+.+
T Consensus 240 ~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 240 ACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHccCCcccCCCHHHHHHHHHhh
Confidence 99999999999999999999875
No 63
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=3.4e-45 Score=314.71 Aligned_cols=243 Identities=17% Similarity=0.245 Sum_probs=210.9
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHH---HHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDAR---QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
-.|++.+.||.|.||.|-++. ...|..||||.++++...+.+ .+.+|+++|..|+||||+.++.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 347788889999999999998 688999999999887654443 4789999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--- 209 (329)
||..+|.|.+|+. +.+.+++..+..+++||.+|+.|+|.+ +++|||||.+|||+|.|+++||+|||++-.+.+.
T Consensus 133 EYaS~GeLYDYiS--er~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYIS--ERGSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EecCCccHHHHHH--HhccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCCCeeeeccchhhhhccccHH
Confidence 9999999999997 567899999999999999999999999 9999999999999999999999999999877766
Q ss_pred CCccCcccccCcccccCCCCC-CcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 210 RSYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
.+++|++-|.+||.++|.+|. +.+|-||||++||.|+.|..||.+.....+..+....... .+..+.+..-|
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-------EP~~PSdA~gL 282 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-------EPETPSDASGL 282 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc-------CCCCCchHHHH
Confidence 467899999999999999876 5799999999999999999999876555444433322221 12234567789
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 020221 289 ASRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~~ 309 (329)
|.+||..||++|-|..+|..+
T Consensus 283 IRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred HHHHHhcCcccchhHHHHhhh
Confidence 999999999999999999864
No 64
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=1.5e-44 Score=329.29 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=201.5
Q ss_pred cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221 58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (329)
.+.+.+.||+|+||.||++.. .+++.||+|.+...... ....+.+|+++++.+ +|+||+++++++......+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 356677789999999999873 22457999999765433 345688999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCC-------------------------------------------------------------
Q 020221 130 LVAEYMPNDTLAKHLFHWE------------------------------------------------------------- 148 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~------------------------------------------------------------- 148 (329)
+||||+++|+|.+++....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 9999999999999885311
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC------ccCc
Q 020221 149 -------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------YSTN 215 (329)
Q Consensus 149 -------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~------~~~~ 215 (329)
...+++..+..++.||+.||.|||++ +++||||||+||++++++.++|+|||++........ ..++
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~ 277 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence 12478889999999999999999999 999999999999999999999999999876443221 2234
Q ss_pred ccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
..|+|||++.+..++.++||||||+++|+|++ |..||+....... .............+...++++.+++.+||+
T Consensus 278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----FYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----HHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 67999999988889999999999999999997 8887765432111 111111112222334457889999999999
Q ss_pred cCCCCCCCHHHHHHHHHhhh
Q 020221 295 YEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 295 ~dp~~Rps~~~~l~~L~~~~ 314 (329)
.||++|||+.++++.|+++.
T Consensus 354 ~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 354 LEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CChhhCcCHHHHHHHHHHHh
Confidence 99999999999999998863
No 65
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=1.9e-44 Score=327.78 Aligned_cols=247 Identities=12% Similarity=0.082 Sum_probs=195.3
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
++++++.||+|+||+||++. ..+++.||+|++..... .....+.+|+.++..++|+||+++++.+.+....++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 45677788999999999998 55688999999975321 223457889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---- 209 (329)
|+++|+|.+++. ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLM--KKDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999986 345789999999999999999999999 9999999999999999999999999998643211
Q ss_pred -----------------------------------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCc
Q 020221 210 -----------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS 254 (329)
Q Consensus 210 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 254 (329)
....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 123688999999999988899999999999999999999998865
Q ss_pred hhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 020221 255 HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ--YEPRERPNPRSLVTA 309 (329)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~dp~~Rps~~~~l~~ 309 (329)
.................... .....++++.+++.+++. .++..||++.+++++
T Consensus 239 ~~~~~~~~~i~~~~~~~~~p--~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 239 ETPQETYKKVMNWKETLIFP--PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCHHHHHHHHHcCcCcccCC--CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 43322222111100000001 112346788889888654 233356899999873
No 66
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=1.8e-44 Score=322.38 Aligned_cols=231 Identities=20% Similarity=0.257 Sum_probs=191.6
Q ss_pred cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||+||++.. .+++.||+|++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 469999999999994 568899999987532 22345567888888876 6999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~ 214 (329)
+|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~i~--~~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 82 DLMFHIQ--KSRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred hHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccccccc
Confidence 9999886 345789999999999999999999999 999999999999999999999999999875322 123467
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
++.|+|||++.+..++.++||||||+++|+|++|+.||............... ....+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~L~ 232 (320)
T cd05590 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------EVVYPTWLSQDAVDILKAFMT 232 (320)
T ss_pred CccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHcc
Confidence 89999999999888999999999999999999999988655433322222111 112344567889999999999
Q ss_pred cCCCCCCCH
Q 020221 295 YEPRERPNP 303 (329)
Q Consensus 295 ~dp~~Rps~ 303 (329)
.||++||++
T Consensus 233 ~dP~~R~~~ 241 (320)
T cd05590 233 KNPTMRLGS 241 (320)
T ss_pred cCHHHCCCC
Confidence 999999998
No 67
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=4.6e-44 Score=314.21 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=204.3
Q ss_pred CcccccccCCCCCCcEEEEEEeCC-C-----CEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLEN-Q-----FRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (329)
.++++++.||+|+||.||+|.... + ..||+|.+...... ....+.+|++.++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 346677888999999999998432 2 57999998765433 2456889999999999999999999998888999
Q ss_pred EEEecCCCCCHHhhhccCCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCe
Q 020221 130 LVAEYMPNDTLAKHLFHWET--------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~ 195 (329)
++|||+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEcCCCcE
Confidence 99999999999999864211 4578899999999999999999999 99999999999999999999
Q ss_pred eeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhh
Q 020221 196 RLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTL 268 (329)
Q Consensus 196 kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~ 268 (329)
+|+|||++....... ...+++.|+|||.+.+..++.++||||||+++|||++ |..||.............
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~--- 240 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR--- 240 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---
Confidence 999999987543321 2244678999999988889999999999999999998 887776433322222111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
.......+..++.++.+|+.+||+.||++||++.++++.|+.+
T Consensus 241 --~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 241 --SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred --cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1112234556788999999999999999999999999999763
No 68
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=2.3e-44 Score=328.26 Aligned_cols=251 Identities=21% Similarity=0.309 Sum_probs=199.3
Q ss_pred cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221 58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (329)
.+++.+.||+|+||.||+|.. .++..||+|+++... ....+.+.+|+++++.+ +||||+++++++..++..+
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 356677789999999999963 345689999997543 23345688999999999 8999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCC-------------------------------------------------------------
Q 020221 130 LVAEYMPNDTLAKHLFHWE------------------------------------------------------------- 148 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~------------------------------------------------------------- 148 (329)
+||||+++|+|.+++....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 9999999999999886421
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-----
Q 020221 149 ------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----- 211 (329)
Q Consensus 149 ------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----- 211 (329)
...+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 12468889999999999999999999 999999999999999999999999999876543321
Q ss_pred -ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 212 -YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 212 -~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
..++..|+|||++.+..++.++||||||+++|||++ |..|+.......... ...........+...+.++.+++
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY----KMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH----HHHHhCccCCCCCCCCHHHHHHH
Confidence 223467999999998899999999999999999998 666654332111111 11111111122334467899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhh
Q 020221 290 SRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 290 ~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
.+||+.||++|||+.++++.|++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHccCChhHCcCHHHHHHHHHhh
Confidence 999999999999999999999863
No 69
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=3e-44 Score=322.59 Aligned_cols=246 Identities=19% Similarity=0.169 Sum_probs=210.2
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 131 (329)
..|++.+.||+|.||.||+++ ..+|+.+|+|.+.+..... ...+.+|+.+|+.++ |||||.+.+++.+...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 346666788999999999999 5559999999998765433 357899999999998 99999999999999999999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC----CCCeeeecccCcccCC
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD----DVNPRLSCFGLMKNSR 207 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~a~~~~ 207 (329)
||++.||.|.+.+... .+++.++..++.|++.+++|||+. |++|||+||+|+|+.. ++.++++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999754 399999999999999999999999 9999999999999963 3579999999999877
Q ss_pred CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 208 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
.+ ....||+.|+|||++....|+..+||||+|+++|.|++|.+||................. .......+..+..
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--DFTSEPWDDISES 268 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC--CCCCCCccccCHH
Confidence 63 345789999999999999999999999999999999999999987654433332222211 1222334566899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+.+++..++..||..|+|+.++++
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhc
Confidence 999999999999999999999999
No 70
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=2.7e-44 Score=315.43 Aligned_cols=241 Identities=19% Similarity=0.242 Sum_probs=195.3
Q ss_pred CCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (329)
Q Consensus 65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (329)
||+|+||+||++. ..+++.+|+|.+...... ..+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 5999999999998 457889999998754322 234567899999999999999999999998999999999999999
Q ss_pred HhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----CccC
Q 020221 141 AKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SYST 214 (329)
Q Consensus 141 ~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~~~ 214 (329)
..++... ....+++..+..++.||+.||.|||+. +++||||||+||++++++.++|+|||++....... ...+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 8877432 335689999999999999999999999 99999999999999999999999999987654332 3467
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
++.|+|||++.+..++.++||||||+++|+|++|+.||................... ....+...++++.+++.+||+
T Consensus 160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHHHHHhc
Confidence 899999999999999999999999999999999998886432111111111111111 112345577899999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 020221 295 YEPRERP-----NPRSLVT 308 (329)
Q Consensus 295 ~dp~~Rp-----s~~~~l~ 308 (329)
.||++|| +++++++
T Consensus 238 ~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHhcCCCCCCHHHHhc
Confidence 9999999 6777776
No 71
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=2.8e-44 Score=316.14 Aligned_cols=248 Identities=17% Similarity=0.207 Sum_probs=202.1
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
|++++.||+|+||+||++. ..+++.||+|++...... ....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 4566777999999999999 456889999998754322 233467899999999999999999999998999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---C
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---S 211 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~ 211 (329)
+++|+|.+.+.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 9999999888654445789999999999999999999999 99999999999999999999999999987654332 2
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
..++..|+|||++.+..++.++||||+|+++|++++|..||...............+.. ....++...+..+.+++..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--DQEEYSEKFSEAARSICRQ 238 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh--cccccCcccCHHHHHHHHH
Confidence 36788999999999888999999999999999999999888654322111111111111 1123345577889999999
Q ss_pred hcccCCCCCC-----CHHHHHHH
Q 020221 292 CLQYEPRERP-----NPRSLVTA 309 (329)
Q Consensus 292 cl~~dp~~Rp-----s~~~~l~~ 309 (329)
||..||++|| ++.+++++
T Consensus 239 ~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 239 LLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HccCCHHHhcCCCCCCHHHHhcC
Confidence 9999999999 88888763
No 72
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=3e-44 Score=321.59 Aligned_cols=240 Identities=19% Similarity=0.279 Sum_probs=194.8
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHH---hcCCCccccccceeeeeCCeeEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAV---GQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
|++++.||+|+||.||++. ..+++.||+|+++... ....+.+.+|++++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 3567788999999999998 4568899999997542 12234566666554 566899999999999999999999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-- 209 (329)
|||+++++|...+. ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......
T Consensus 81 ~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 81 MEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999998884 45799999999999999999999999 9999999999999999999999999998653222
Q ss_pred --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (329)
Q Consensus 210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||............... ....+...++++.+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~~~~p~~~~~~~~~ 230 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------EVRYPRFLSREAIS 230 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CCCCCCCCCHHHHH
Confidence 2346789999999999888999999999999999999999988654333222211111 11234556788999
Q ss_pred HHHHhcccCCCCCC-----CHHHHHH
Q 020221 288 LASRCLQYEPRERP-----NPRSLVT 308 (329)
Q Consensus 288 li~~cl~~dp~~Rp-----s~~~~l~ 308 (329)
++.+||+.||++|| ++.++++
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 99999999999999 4666665
No 73
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=7.5e-44 Score=308.41 Aligned_cols=246 Identities=22% Similarity=0.336 Sum_probs=201.0
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
+++++++.||+|+||.||++.+.++..+|+|.+.... .....+.+|+.+++.++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3466778889999999999998777889999987544 234678899999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~ 211 (329)
+|+|.+++... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||.+....... .
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 83 NGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 99999998642 34689999999999999999999999 99999999999999999999999999987643322 1
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
..++..|+|||++.+..++.++|+||||+++|+|++ |..|+............... .....+...+.++.+++.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-----FRLYRPKLASMTVYEVMY 235 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----CCCCCCCCCCHHHHHHHH
Confidence 223567999999988889999999999999999999 77766543322221111111 111223345678999999
Q ss_pred HhcccCCCCCCCHHHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~~L 310 (329)
+||+.||++||++.++++.|
T Consensus 236 ~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 236 SCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHccCCcccCcCHHHHHHhh
Confidence 99999999999999999876
No 74
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=1e-44 Score=293.38 Aligned_cols=255 Identities=19% Similarity=0.190 Sum_probs=209.6
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCC-----eeE
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERL 129 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~ 129 (329)
-.+|++.+.+|+|+|+-||.++ ..++..+|+|++.-....+.+..++|++..++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3568899999999999999999 7888999999998887777888999999999999999999999875443 489
Q ss_pred EEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCC--ccccccCCCceeeCCCCCeeeecccCccc
Q 020221 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKER--ALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
|+++|...|||.+.+.+. ++..+++.+++.|+.++++||++||+. . ++||||||.|||+.+.+.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999764 344689999999999999999999998 6 99999999999999999999999999875
Q ss_pred CCCC-------------CCccCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-hhh
Q 020221 206 SRDG-------------RSYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-QTL 268 (329)
Q Consensus 206 ~~~~-------------~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-~~~ 268 (329)
..-. .....|..|.|||.+. +...++++|||||||+||+|+.|..||..... ..+.+ ..+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---~GgSlaLAv 255 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---QGGSLALAV 255 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---cCCeEEEee
Confidence 4321 1224578999999986 55688999999999999999999988753211 11111 111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
......-+.....|+.+.+++++|++.||.+||++.+++..++.+.
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1212222223347899999999999999999999999999988753
No 75
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=3.4e-44 Score=314.25 Aligned_cols=245 Identities=16% Similarity=0.197 Sum_probs=195.5
Q ss_pred CCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (329)
Q Consensus 65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (329)
||+|+||.||++. ..+|+.+|+|.+..... .....+..|+++++.++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 5999999999998 45689999999865321 1233456799999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---CccCccc
Q 020221 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---SYSTNLA 217 (329)
Q Consensus 141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~ 217 (329)
.+.+.......+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++....... ...++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence 9888654555689999999999999999999999 99999999999999999999999999987654432 2457889
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 297 (329)
|+|||++.+..++.++||||||+++|+|++|..|+...................... ......++++.+++.+||+.||
T Consensus 160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P 238 (277)
T cd05607 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLFLAKKP 238 (277)
T ss_pred ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHHhccCH
Confidence 999999998889999999999999999999998875432111111111111111111 1113457789999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 020221 298 RERPNPRSLVTALV 311 (329)
Q Consensus 298 ~~Rps~~~~l~~L~ 311 (329)
++||+++++++.+.
T Consensus 239 ~~R~~~~~~~~~~~ 252 (277)
T cd05607 239 EDRLGSREKNDDPR 252 (277)
T ss_pred hhCCCCccchhhhh
Confidence 99999977664443
No 76
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=2.3e-45 Score=301.13 Aligned_cols=246 Identities=19% Similarity=0.210 Sum_probs=203.2
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh----h----HHHHHHHHHHHhcC-CCccccccceeeeeCCe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP----D----ARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~----~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 127 (329)
.|+-.+.+|+|..++|.++. ..+|+.+|+|++...... . .+.-.+|+.+|+++ -||+|+++.++++++..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 33334445999999999988 667889999998653211 1 23356899999999 59999999999999999
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
+++|+|.|+.|.|.++|. ..-.+++....+|++|+..|++|||.+ +||||||||+|||+|++.+++|+|||+++...
T Consensus 98 ~FlVFdl~prGELFDyLt--s~VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLT--SKVTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhh--hheeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999999996 456789999999999999999999999 99999999999999999999999999999988
Q ss_pred CCC---CccCcccccCccccc------CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221 208 DGR---SYSTNLAFTPPEYLR------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (329)
Q Consensus 208 ~~~---~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (329)
++. ..+||++|.|||.+. ...|+..+|+|++|+|+|.|+.|.+||.....-.+.......... ...+.-
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq--F~speW 252 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ--FRSPEW 252 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc--cCCcch
Confidence 875 568999999999875 234888999999999999999999888654332222222222211 222334
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 279 SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.+.+.+..+||.+||+.||.+|.|++++|.
T Consensus 253 adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 253 ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 677899999999999999999999999997
No 77
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=3e-45 Score=317.87 Aligned_cols=244 Identities=27% Similarity=0.455 Sum_probs=194.5
Q ss_pred ccccCCCCCCcEEEEEEeC-----CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 61 IVSEHGEKAPNVVYKGKLE-----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
+.+.||.|+||.||+|.+. .+..|+||.++..... ..+.+.+|++.++.++||||++++|++......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4567899999999999965 3578999999765433 367899999999999999999999999988889999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----- 209 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----- 209 (329)
+++|+|.+++.......+++..+..++.|++.||.|||++ +++|+||+++||+++.++.+||+|||++......
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999875467899999999999999999999999 9999999999999999999999999998776322
Q ss_pred -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (329)
Q Consensus 210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
........|+|||.+.+..++.++||||||+++|||++ |..|+............ ....+...+..++..+.+
T Consensus 162 ~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 236 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-----KQGQRLPIPDNCPKDIYS 236 (259)
T ss_dssp STTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-----HTTEETTSBTTSBHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccceeccchhHHHHH
Confidence 22345678999999998889999999999999999999 56665443222221111 111222344556788999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHH
Q 020221 288 LASRCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 288 li~~cl~~dp~~Rps~~~~l~~L 310 (329)
++..||+.||++|||+.++++.|
T Consensus 237 li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 237 LIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHhcC
Confidence 99999999999999999999876
No 78
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=3.2e-44 Score=321.00 Aligned_cols=236 Identities=17% Similarity=0.238 Sum_probs=194.3
Q ss_pred cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||+|.. .+++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 469999999999984 567899999987542 22344567888888866 7999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~ 214 (329)
+|..++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...... ....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 82 DLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccccccc
Confidence 9999886 445789999999999999999999999 9999999999999999999999999998753222 23457
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
++.|+|||++.+..++.++||||||+++|+|++|..||.............. . ....+...++++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~ll~~~L~ 232 (321)
T cd05591 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH----D--DVLYPVWLSKEAVSILKAFMT 232 (321)
T ss_pred CccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc----C--CCCCCCCCCHHHHHHHHHHhc
Confidence 8999999999988899999999999999999999998865543322222111 1 112334467889999999999
Q ss_pred cCCCCCC-------CHHHHHH
Q 020221 295 YEPRERP-------NPRSLVT 308 (329)
Q Consensus 295 ~dp~~Rp-------s~~~~l~ 308 (329)
.||++|| ++.++++
T Consensus 233 ~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 233 KNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred cCHHHcCCCCCCCCCHHHHhc
Confidence 9999999 7777775
No 79
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=1.6e-45 Score=313.82 Aligned_cols=241 Identities=22% Similarity=0.271 Sum_probs=191.0
Q ss_pred cccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCC-----eeEEEEecC
Q 020221 62 VSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERLLVAEYM 135 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~ 135 (329)
.+.+|.|+||.||+|. ..+++.||||++-.+.. .--+|+++|+.++|||||++..+|.... ...+||||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 3455999999999999 55678999999866542 2236999999999999999998885532 345899999
Q ss_pred CCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCCCCC--
Q 020221 136 PNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRDGR-- 210 (329)
Q Consensus 136 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~~-- 210 (329)
+. +|..+++.. .++.++.-.++-+.+||++||.|||+. ||+||||||.|+|+|.+ |.+||+|||.|+....+.
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 88 899988632 256788888999999999999999998 99999999999999965 899999999999876654
Q ss_pred -CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHh----------------hhc-------h
Q 020221 211 -SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----------------DRN-------I 265 (329)
Q Consensus 211 -~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~----------------~~~-------~ 265 (329)
++..+..|.|||.+.|.. |+.+.||||.||++.||+-|++.|+++...... ... .
T Consensus 183 iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~ 262 (364)
T KOG0658|consen 183 ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKF 262 (364)
T ss_pred eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccC
Confidence 455688999999999876 999999999999999999999988875221110 000 0
Q ss_pred hhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 266 QTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..+....+..-+....++++.+|+.++|.++|.+|.++.+++.
T Consensus 263 p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 263 PQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0000000111133456789999999999999999999999985
No 80
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=5.3e-44 Score=314.98 Aligned_cols=249 Identities=18% Similarity=0.226 Sum_probs=192.6
Q ss_pred cccccccCCCCCCcEEEEEEe--CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcC---CCccccccceeee-----eC
Q 020221 58 MENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQL---RNRRLANLLGCCC-----EG 125 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~~ 125 (329)
.|++++.||+|+||.||++.. .++..||+|.+...... ....+.+|+.+++.+ +||||+++++++. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 467778889999999999984 34678999998754322 233456677776665 6999999999875 24
Q ss_pred CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
...++||||+. ++|.+++.......+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 56899999997 5899998754556689999999999999999999999 999999999999999999999999999876
Q ss_pred CCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc-------------
Q 020221 206 SRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT------------- 269 (329)
Q Consensus 206 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~------------- 269 (329)
.... ....+++.|+|||.+.+..++.++||||||+++|||++|..||.................
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 5432 234578999999999888899999999999999999999988765422111111100000
Q ss_pred -ccccc--C-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 270 -DSCLE--G-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 270 -~~~~~--~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..... . ......++.+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 0 011235678899999999999999999999997
No 81
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=3.4e-44 Score=321.24 Aligned_cols=236 Identities=19% Similarity=0.236 Sum_probs=193.9
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCC-ccccccceeeeeCCeeEEEEe
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRN-RRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 133 (329)
|++++.||+|+||.||+|. ..+++.||+|++.... ....+.+..|.+++..++| ++|+++.+++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 5677888999999999998 4567899999987542 2234567789999999975 568888999988899999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----C
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----G 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~ 209 (329)
|+++|+|.+++. ....+++..+..++.||+.||.|||++ +++||||||+|||++.++.++|+|||++..... .
T Consensus 82 ~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 82 YVNGGDLMYHIQ--QVGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred CCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence 999999999886 345689999999999999999999999 999999999999999999999999999864321 1
Q ss_pred CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
....|++.|+|||++.+..++.++||||||+++|+|++|..||.............. ....++...++++.+++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~li 232 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME------HNVSYPKSLSKEAVSIC 232 (324)
T ss_pred eeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc------CCCCCCCCCCHHHHHHH
Confidence 234578999999999998899999999999999999999988865433222221111 11234455678899999
Q ss_pred HHhcccCCCCCCCH
Q 020221 290 SRCLQYEPRERPNP 303 (329)
Q Consensus 290 ~~cl~~dp~~Rps~ 303 (329)
.+||..||++|++.
T Consensus 233 ~~~l~~~P~~R~~~ 246 (324)
T cd05587 233 KGLLTKHPAKRLGC 246 (324)
T ss_pred HHHhhcCHHHcCCC
Confidence 99999999999976
No 82
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=3.7e-44 Score=319.82 Aligned_cols=236 Identities=19% Similarity=0.216 Sum_probs=193.2
Q ss_pred cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||++.. .+++.||+|.++... .........|..++... +||||+++++++.+.+..++||||+.+|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 469999999999994 568899999997542 12344567788887754 8999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~ 214 (329)
+|..++. ....+++..+..++.|++.||+|||++ |++||||||+||+++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~i~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 82 DLMFHIQ--DKGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCC
Confidence 9999886 345689999999999999999999999 999999999999999999999999999874321 223467
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
++.|+|||++.+..++.++||||||+++|+|++|..||.............. .....+...+.++.+++.+||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05620 159 TPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV------DTPHYPRWITKESKDILEKLFE 232 (316)
T ss_pred CcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCCCCCHHHHHHHHHHcc
Confidence 8999999999988999999999999999999999998865543322221111 1122344567789999999999
Q ss_pred cCCCCCCCHH-HHHH
Q 020221 295 YEPRERPNPR-SLVT 308 (329)
Q Consensus 295 ~dp~~Rps~~-~~l~ 308 (329)
.||++||++. ++++
T Consensus 233 ~dP~~R~~~~~~~~~ 247 (316)
T cd05620 233 RDPTRRLGVVGNIRG 247 (316)
T ss_pred CCHHHcCCChHHHHc
Confidence 9999999984 5553
No 83
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=3.6e-44 Score=328.12 Aligned_cols=245 Identities=17% Similarity=0.164 Sum_probs=195.9
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.+++++.||+|+||+||+|. ..+++.||+|++..... .....+.+|+++++.++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 35677888999999999998 56788999999875421 224467889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----- 208 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----- 208 (329)
|+++|+|.+++.+ ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999863 35688999999999999999999999 999999999999999999999999999742210
Q ss_pred ----------------------------------------------CCCccCcccccCcccccCCCCCCcccchhhhHHH
Q 020221 209 ----------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL 242 (329)
Q Consensus 209 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il 242 (329)
.....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0123578999999999988899999999999999
Q ss_pred HHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 020221 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVT 308 (329)
Q Consensus 243 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~~l~ 308 (329)
|||++|..||.............. .............++++.+++.+++ .+|++|++ +.++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 999999998865432221111111 0111111112345778899998876 59999997 777775
No 84
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=3.3e-44 Score=322.39 Aligned_cols=245 Identities=18% Similarity=0.214 Sum_probs=196.2
Q ss_pred ccccccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCC----ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221 59 ENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSA----WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (329)
|++++.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++..+ +|+||+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 56778889999999999874 357899999986532 12234577899999999 5999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+||||+++|+|.+++. ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 82 lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 82 LILDYVSGGEMFTHLY--QRDNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999986 345689999999999999999999999 9999999999999999999999999998754322
Q ss_pred -----CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 210 -----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 210 -----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
....||+.|+|||++.+.. ++.++||||||+++|||++|..||...............+.. .....+...++
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK--CDPPFPSFIGP 236 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCH
Confidence 2346889999999998654 788999999999999999999887532111000000111111 11234455678
Q ss_pred HHHHHHHHhcccCCCCCC-----CHHHHHH
Q 020221 284 ELVRLASRCLQYEPRERP-----NPRSLVT 308 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rp-----s~~~~l~ 308 (329)
.+.+++.+||+.||++|| ++.++++
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 899999999999999999 6777776
No 85
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=3.6e-44 Score=327.61 Aligned_cols=245 Identities=16% Similarity=0.112 Sum_probs=195.9
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|.+++.||.|+||.||++. ..+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 45677888999999999998 5678899999986532 1224567889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---- 209 (329)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. |++||||||+|||++.++.++|+|||+++.....
T Consensus 82 ~~~gg~L~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLI--KYDTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999986 345789999999999999999999999 9999999999999999999999999998532110
Q ss_pred -----------------------------------------------CCccCcccccCcccccCCCCCCcccchhhhHHH
Q 020221 210 -----------------------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLL 242 (329)
Q Consensus 210 -----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il 242 (329)
....||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 013578999999999988899999999999999
Q ss_pred HHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 020221 243 LDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER---PNPRSLVT 308 (329)
Q Consensus 243 ~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R---ps~~~~l~ 308 (329)
|||++|..||............... ... ..-......+.++.+++.+||. +|.+| +++.++++
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~-~~~-~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIINW-RET-LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHcc-CCc-cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 9999999888654322211111110 000 0101112356789999999997 77765 59999887
No 86
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=6.1e-44 Score=334.91 Aligned_cols=245 Identities=18% Similarity=0.202 Sum_probs=203.2
Q ss_pred cccccccCCCCCCcEEEEEEe-CC-CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-EN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
.|.+.+.+|+|++|.||++.. .+ +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 477888889999999999983 34 6789999876655444556788999999999999999999999999999999999
Q ss_pred CCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221 136 PNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (329)
Q Consensus 136 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---- 209 (329)
++|+|.+++.+. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 999999887532 344688999999999999999999999 9999999999999999999999999999865432
Q ss_pred --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (329)
Q Consensus 210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
....||+.|+|||++.+..++.++||||||+++|+|++|..||................. ...+...+.++.+
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~~ 301 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY-----DPFPCPVSSGMKA 301 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCCCccCCHHHHH
Confidence 234589999999999988899999999999999999999988865433222222111111 1234456788999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 020221 288 LASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 288 li~~cl~~dp~~Rps~~~~l~ 308 (329)
++..||..||++||++.+++.
T Consensus 302 li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 302 LLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHhccChhhCcCHHHHHh
Confidence 999999999999999999875
No 87
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=6.4e-44 Score=318.27 Aligned_cols=236 Identities=19% Similarity=0.263 Sum_probs=192.1
Q ss_pred cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||+|.. .+++.||+|.++... ....+.+..|..++... +||||+++++++......++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 469999999999994 567899999987542 12234456677777654 8999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~ 214 (329)
+|..++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...... ....|
T Consensus 82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 82 DLMFHIQ--SSGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccC
Confidence 9999886 345689999999999999999999999 9999999999999999999999999998754322 23467
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
|+.|+|||++.+..++.++||||||+++|+|++|..||............. . ....++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~----~--~~~~~~~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL----N--DRPHFPRWISKEAKDCLSKLFE 232 (316)
T ss_pred CccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH----c--CCCCCCCCCCHHHHHHHHHHcc
Confidence 899999999998889999999999999999999999886544332222111 1 1123345567889999999999
Q ss_pred cCCCCCCCHH-HHHH
Q 020221 295 YEPRERPNPR-SLVT 308 (329)
Q Consensus 295 ~dp~~Rps~~-~~l~ 308 (329)
.||++||++. ++++
T Consensus 233 ~~P~~R~~~~~~l~~ 247 (316)
T cd05592 233 RDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCHHHcCCChHHHHc
Confidence 9999999875 5544
No 88
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=5.3e-44 Score=325.28 Aligned_cols=246 Identities=16% Similarity=0.143 Sum_probs=200.5
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
....|++++.||+|+||.||++. ..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 44567788889999999999998 4568899999986432 1223457789999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 209 (329)
||||+++|+|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~---~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMS---NYDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999884 34688899999999999999999999 9999999999999999999999999998765432
Q ss_pred ----CCccCcccccCcccccCC----CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC--h
Q 020221 210 ----RSYSTNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS--S 279 (329)
Q Consensus 210 ----~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 279 (329)
....|++.|+|||++.+. .++.++|||||||++|||++|..||............. .......++ .
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~ 272 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM----DHKNSLTFPDDI 272 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH----cCCCcCCCCCcC
Confidence 234688999999998653 37889999999999999999999887654332222111 111011122 2
Q ss_pred HHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 020221 280 DEGTELVRLASRCLQYEPRE--RPNPRSLVT 308 (329)
Q Consensus 280 ~~~~~~~~li~~cl~~dp~~--Rps~~~~l~ 308 (329)
..+.++.+++.+||..+|++ |+++.++++
T Consensus 273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 273 EISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 45789999999999999988 999999987
No 89
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=5.6e-44 Score=318.58 Aligned_cols=236 Identities=19% Similarity=0.229 Sum_probs=192.8
Q ss_pred cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||+|.. .+++.||+|.++... .........|..++... +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 469999999999994 557899999987642 12234566777887764 8999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~ 214 (329)
+|..++. ....+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 82 DLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecC
Confidence 9999986 345689999999999999999999999 999999999999999999999999999875322 123467
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
+..|+|||++.+..++.++||||||+++|+|++|..||.............. ....++...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~li~~~l~ 232 (316)
T cd05619 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM------DNPCYPRWLTREAKDILVKLFV 232 (316)
T ss_pred CccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CCCCCCccCCHHHHHHHHHHhc
Confidence 8999999999988899999999999999999999988865433222221111 1112344567789999999999
Q ss_pred cCCCCCCCHH-HHHH
Q 020221 295 YEPRERPNPR-SLVT 308 (329)
Q Consensus 295 ~dp~~Rps~~-~~l~ 308 (329)
.||++||++. ++++
T Consensus 233 ~~P~~R~~~~~~l~~ 247 (316)
T cd05619 233 REPERRLGVKGDIRQ 247 (316)
T ss_pred cCHhhcCCChHHHHc
Confidence 9999999997 5654
No 90
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=5.3e-44 Score=321.73 Aligned_cols=246 Identities=19% Similarity=0.294 Sum_probs=192.1
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC-----CeeEE
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERLL 130 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l 130 (329)
|++.+.||+|+||.||+|. ..+++.||+|++.... ......+.+|+++++.++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 5677788999999999999 5578899999987532 22345688999999999999999999987543 35799
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 209 (329)
||||+. ++|.+++. ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 82 v~e~~~-~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 82 VFELME-SDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEecCC-CCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 999996 58998886 345689999999999999999999999 9999999999999999999999999998754321
Q ss_pred ------CCccCcccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh-------------------h
Q 020221 210 ------RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-------------------D 262 (329)
Q Consensus 210 ------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~-------------------~ 262 (329)
....++..|+|||++.+ ..++.++||||||+++|+|++|+.||......... .
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 23457899999999875 56899999999999999999999887643211100 0
Q ss_pred hchhhhcc---ccccCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 263 RNIQTLTD---SCLEGQF---SSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 263 ~~~~~~~~---~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
........ ....... ....++++.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000 0000000 0124567899999999999999999999997
No 91
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=2.6e-44 Score=328.50 Aligned_cols=245 Identities=17% Similarity=0.165 Sum_probs=197.9
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|++++.||+|+||.||++. ..+++.||+|++..... .....+.+|+++++.++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 57788889999999999998 55688999999865321 224457889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----- 208 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----- 208 (329)
|+++|+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~~g~L~~~i~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLI--RLGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999986 345688999999999999999999999 999999999999999999999999999742210
Q ss_pred ------------------------------------------CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHH
Q 020221 209 ------------------------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246 (329)
Q Consensus 209 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 246 (329)
.....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 01235889999999999888999999999999999999
Q ss_pred hCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC---CHHHHHH
Q 020221 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP---NPRSLVT 308 (329)
Q Consensus 247 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp---s~~~~l~ 308 (329)
+|+.||.............. .............++++.+++.+|+ .+|++|+ ++.++++
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 239 VGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99998865433222111111 0111111122345778899999977 5999999 8899887
No 92
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=6.1e-44 Score=318.74 Aligned_cols=236 Identities=19% Similarity=0.261 Sum_probs=195.0
Q ss_pred cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||+||++.. .+++.||+|+++... ......+.+|..+++.+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 469999999999984 467899999987542 22345567888888888 6999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~ 214 (329)
+|..++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...... ....+
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 82 DLMFHIQ--RSGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceec
Confidence 9999886 345799999999999999999999999 9999999999999999999999999998643221 23357
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
++.|+|||++.+..++.++|||||||++|+|++|..||.............. . ....+...+.++.+++.+||.
T Consensus 159 ~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~----~--~~~~~~~~~~~~~~li~~~l~ 232 (318)
T cd05570 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE----D--EVRYPRWLSKEAKSILKSFLT 232 (318)
T ss_pred CccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc----C--CCCCCCcCCHHHHHHHHHHcc
Confidence 8999999999998999999999999999999999998865433222221111 1 112344567889999999999
Q ss_pred cCCCCCCCH-----HHHHH
Q 020221 295 YEPRERPNP-----RSLVT 308 (329)
Q Consensus 295 ~dp~~Rps~-----~~~l~ 308 (329)
.||++||++ .++++
T Consensus 233 ~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 233 KNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCHHHcCCCCCCCHHHHhc
Confidence 999999999 77775
No 93
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=1.4e-43 Score=310.67 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=203.7
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
.+.+++.+|+|+||.||+|... ++..||+|.+...... ..+.+.+|+++++.++|+||+++++++......++
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 85 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM 85 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence 4567778899999999999853 2478999999876544 35678999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeee
Q 020221 131 VAEYMPNDTLAKHLFHWE------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS 198 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~ 198 (329)
+|||+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCCCeEEEC
Confidence 999999999999986421 23578899999999999999999999 99999999999999999999999
Q ss_pred cccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccc
Q 020221 199 CFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDS 271 (329)
Q Consensus 199 Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
|||++...... ....+++.|+|||++.+..++.++||||||+++|+|++ |..|+...............
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~---- 240 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG---- 240 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----
Confidence 99998754322 12234678999999999899999999999999999998 88877554333222211111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
.....+...+..+.+++.+||+.||++||++.++++.|++
T Consensus 241 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 241 -RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1112234567889999999999999999999999998863
No 94
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=7.8e-44 Score=319.47 Aligned_cols=240 Identities=15% Similarity=0.217 Sum_probs=193.4
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||++. ..+++.||+|+++... ....+.+.+|..++..+ +||||+++++++.+....++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999998 4568899999997642 22344578899999888 7999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~ 214 (329)
+|..++. ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++..... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccC
Confidence 9998885 346799999999999999999999999 999999999999999999999999999864221 123467
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-----HhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----IRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
|+.|+|||++.+..++.++|+||||+++|+|++|..||....... ........+... ....+...+.++.+++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li 236 (329)
T cd05588 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKASSVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence 899999999999889999999999999999999998874211000 000001111111 1124455678899999
Q ss_pred HHhcccCCCCCCC------HHHHHH
Q 020221 290 SRCLQYEPRERPN------PRSLVT 308 (329)
Q Consensus 290 ~~cl~~dp~~Rps------~~~~l~ 308 (329)
.+||+.||++||+ +.++++
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhc
Confidence 9999999999998 566664
No 95
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=2e-43 Score=306.55 Aligned_cols=249 Identities=21% Similarity=0.317 Sum_probs=205.6
Q ss_pred cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
.+++.+.||+|++|.||+|...+++.||+|.++.... ..+++.+|+++++.++|+||+++++++...+..+++|||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 3566778899999999999977778899999976542 356788999999999999999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC--ccC-
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS--YST- 214 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~- 214 (329)
++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++........ ..+
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05068 86 GSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA 164 (261)
T ss_pred CcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence 9999999754445789999999999999999999999 999999999999999999999999999876543221 112
Q ss_pred --cccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 215 --NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 215 --~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
+..|+|||++.+..++.++||||||+++|+|++ |..|+............. .......+...+..+.+++.+
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-----QGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred cCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-----cCCCCCCCCcCCHHHHHHHHH
Confidence 357999999998889999999999999999999 777765433222221111 111122344567889999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 020221 292 CLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
||+.||++||++.++++.|+.+
T Consensus 240 ~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 240 CWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HhhcCcccCCCHHHHHHHHhcC
Confidence 9999999999999999999863
No 96
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=1.9e-43 Score=311.65 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=208.9
Q ss_pred cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
.+.+.+.||+|+||.||++.. .++..+++|.+........+.+.+|++.++.++|+||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 456667889999999999973 23456999998776655566789999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221 132 AEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl 197 (329)
|||+++++|.+++.... ...+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEE
Confidence 99999999999986421 23478999999999999999999999 9999999999999999999999
Q ss_pred ecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhcc
Q 020221 198 SCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTD 270 (329)
Q Consensus 198 ~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~ 270 (329)
+|||++...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..|+...............
T Consensus 165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~--- 241 (291)
T cd05094 165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG--- 241 (291)
T ss_pred CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC---
Confidence 999998754332 12334678999999998889999999999999999999 88776543322222111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 020221 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELY 320 (329)
Q Consensus 271 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~ 320 (329)
.....+...+..+.+++.+||+.||++|||+.++++.|+++.+.+..+
T Consensus 242 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~~ 289 (291)
T cd05094 242 --RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIY 289 (291)
T ss_pred --CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCcc
Confidence 111223345678999999999999999999999999999998865543
No 97
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=1e-43 Score=318.62 Aligned_cols=235 Identities=17% Similarity=0.221 Sum_probs=189.8
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||++. ..+++.||+|++.... ......+.+|+.++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 46999999999999 4567899999997642 22344577888888776 7999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~ 214 (329)
+|..++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 82 DLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccC
Confidence 9998886 445789999999999999999999999 999999999999999999999999999875322 123467
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhH-----HHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD-----LIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
|+.|+|||++.+..++.++||||||+++|+|++|..||...... .........+... ....+...+..+.+++
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll 236 (329)
T cd05618 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVL 236 (329)
T ss_pred CccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHHHHHH
Confidence 89999999999989999999999999999999999887421000 0000001111111 1234556678899999
Q ss_pred HHhcccCCCCCCCH
Q 020221 290 SRCLQYEPRERPNP 303 (329)
Q Consensus 290 ~~cl~~dp~~Rps~ 303 (329)
.+||+.||++||++
T Consensus 237 ~~~L~~dP~~R~~~ 250 (329)
T cd05618 237 KSFLNKDPKERLGC 250 (329)
T ss_pred HHHhcCCHHHcCCC
Confidence 99999999999984
No 98
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=2.1e-43 Score=310.97 Aligned_cols=256 Identities=23% Similarity=0.321 Sum_probs=206.8
Q ss_pred cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
.+.+.+.+|+|+||.||++.. .++..+|+|.+........+.+.+|+++++.++||||+++++++...+..+++
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 355667789999999999973 23456899998776545566789999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecc
Q 020221 132 AEYMPNDTLAKHLFHWE-----------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Df 200 (329)
+||+++++|.+++.... ...+++..+..++.|++.||+|||+. |++||||||+||++++++.++|+||
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCCcEEeccC
Confidence 99999999999986321 13489999999999999999999999 9999999999999999999999999
Q ss_pred cCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccc
Q 020221 201 GLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCL 273 (329)
Q Consensus 201 g~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (329)
|++....... ...++..|+|||++.+..++.++||||||+++|+|++ |..|+................
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~----- 239 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR----- 239 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 9987543321 2233568999999998889999999999999999999 776665433222221111111
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccc
Q 020221 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTEL 319 (329)
Q Consensus 274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~ 319 (329)
....+...+.++.+++.+||+.||.+|||+.+++..|+.+.+....
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~ 285 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPV 285 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhccc
Confidence 1112334567899999999999999999999999999999876544
No 99
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=8.5e-44 Score=318.54 Aligned_cols=232 Identities=20% Similarity=0.230 Sum_probs=189.5
Q ss_pred cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHH-HHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||+||++.. .+++.||+|++..... .....+..|.. +++.++||||+++++.+...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 469999999999994 5788999999875421 12334555554 567789999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~ 214 (329)
+|..++. ....+++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+|||++...... ....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 82 ELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccC
Confidence 9999886 345789999999999999999999999 9999999999999999999999999998753222 23457
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
++.|+|||++.+..++.++||||||+++|+|++|..||................ ...+...++++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------LRLKPNISVSARHLLEGLLQ 232 (323)
T ss_pred ChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------CCCCCCCCHHHHHHHHHHhh
Confidence 899999999998889999999999999999999999887544332222211111 12233457889999999999
Q ss_pred cCCCCCCCHH
Q 020221 295 YEPRERPNPR 304 (329)
Q Consensus 295 ~dp~~Rps~~ 304 (329)
.||++||++.
T Consensus 233 ~~p~~R~~~~ 242 (323)
T cd05575 233 KDRTKRLGAK 242 (323)
T ss_pred cCHHhCCCCC
Confidence 9999999985
No 100
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=8.9e-44 Score=318.40 Aligned_cols=236 Identities=18% Similarity=0.234 Sum_probs=194.0
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEe
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 133 (329)
|++++.||+|+||.||++. ..+++.||+|++..... ...+.+..|..++..+ +|++|+++.+++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 5567778999999999998 45678999999875421 2234466778888777 58999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----C
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----G 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~ 209 (329)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++..... .
T Consensus 82 ~~~~g~L~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 82 YVNGGDLMYQIQ--QVGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred CCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence 999999999886 345689999999999999999999999 999999999999999999999999999875332 2
Q ss_pred CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
....|++.|+|||++.+..++.++|||||||++|||++|..||.............. . ...++...+.++.+++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~----~--~~~~p~~~s~~~~~li 232 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----H--NVAYPKSMSKEAVAIC 232 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCCCCcCCHHHHHHH
Confidence 234678999999999998999999999999999999999998865443322222111 1 1234556678899999
Q ss_pred HHhcccCCCCCCCH
Q 020221 290 SRCLQYEPRERPNP 303 (329)
Q Consensus 290 ~~cl~~dp~~Rps~ 303 (329)
.+||+.||++|++.
T Consensus 233 ~~~l~~~p~~R~~~ 246 (323)
T cd05616 233 KGLMTKHPGKRLGC 246 (323)
T ss_pred HHHcccCHHhcCCC
Confidence 99999999999985
No 101
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=6.5e-44 Score=304.20 Aligned_cols=251 Identities=18% Similarity=0.196 Sum_probs=199.3
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCcc-ccccceeeeeCC------
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRR-LANLLGCCCEGD------ 126 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------ 126 (329)
..+..++++|+|+||+||+|+ ..+|+.||+|+++..... ......+|+.+++.++|+| |+.+.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 345566678999999999999 677899999999876532 2345789999999999999 999999998776
Q ss_pred eeEEEEecCCCCCHHhhhccCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221 127 ERLLVAEYMPNDTLAKHLFHWET--QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 204 (329)
.+++|+||++. +|..++..... ..++...+..+++||+.||+|||++ +|+||||||.|||+++.|.+||+|||+|+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCCcEeeeccchHH
Confidence 78999999977 89999975332 4678889999999999999999999 99999999999999999999999999998
Q ss_pred cCC-CC---CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-------cccc
Q 020221 205 NSR-DG---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------TDSC 272 (329)
Q Consensus 205 ~~~-~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------~~~~ 272 (329)
... +. ....+|.+|.|||++.+. .|+...||||+|||+.||++++..|+..............+ ++..
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 655 22 344678999999999987 49999999999999999999998887653211111110000 0000
Q ss_pred ---------ccCCC-Ch-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221 273 ---------LEGQF-SS-------DEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 273 ---------~~~~~-~~-------~~~~~~~~li~~cl~~dp~~Rps~~~~l~~ 309 (329)
..... +. ...+...+++.+||+++|.+|.|+..++++
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00000 11 112588999999999999999999999985
No 102
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=3.3e-44 Score=322.18 Aligned_cols=246 Identities=16% Similarity=0.129 Sum_probs=199.2
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|.+.+.||+|+||+||++. ..+++.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 35677788999999999998 55788999999976432 234457889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+++|+|.+++.+ ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~-~~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 82 YQPGGDLLSLLNR-YEDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999964 235789999999999999999999999 99999999999999999999999999997654332
Q ss_pred --CccCcccccCccccc------CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221 211 --SYSTNLAFTPPEYLR------TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (329)
Q Consensus 211 --~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (329)
...+++.|+|||++. ...++.++||||||+++|+|++|..||............... ............+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 237 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPKVS 237 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCCCC
Confidence 235789999999986 455788999999999999999999988654433222211111 0011111122457
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 283 TELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.++.+++..||. ||++|||+.++++
T Consensus 238 ~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 238 SDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 789999999997 9999999999986
No 103
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=2.2e-43 Score=312.09 Aligned_cols=249 Identities=18% Similarity=0.242 Sum_probs=206.7
Q ss_pred hcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 53 TSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 53 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
.+....|.+++.+|+|+||.||++. ..+++.|++|.+........+.+.+|+.+++.+.|+|++++++.+..+...++|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4445667888889999999999998 457889999999876666667788999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 210 (329)
|||+++++|.+++. ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~---~~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 96 MEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred ecccCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999999984 34688999999999999999999999 99999999999999999999999999987543322
Q ss_pred ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (329)
Q Consensus 211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
...+++.|+|||.+.+..++.++||||||+++|+|++|..||............. .........+...++.+.+
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRD 248 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh---cCCCCCCCCccccCHHHHH
Confidence 2357789999999998889999999999999999999998886543211111111 1111111223456778999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 020221 288 LASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 288 li~~cl~~dp~~Rps~~~~l~ 308 (329)
++.+||..||++||++.++++
T Consensus 249 li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhh
Confidence 999999999999999999997
No 104
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=2.2e-43 Score=305.62 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=201.8
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
.++.+++.+|+|+||+||++...++..+|+|.+..... ....+.+|+.+++.++||||+++++++......+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 34677888899999999999977777799999876543 34678999999999999999999999988889999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~ 211 (329)
+++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+....... .
T Consensus 83 ~~~l~~~i~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 83 NGCLLNYLRE-HGKRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999864 234689999999999999999999999 99999999999999999999999999987554332 1
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
..++..|+|||.+.+..++.++||||||+++|+|++ |..|+............... .....+...+..+.+++.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-----LRLYRPHLASEKVYAIMY 235 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-----CCCCCCCCCCHHHHHHHH
Confidence 223567999999988889999999999999999998 77766433222221111111 111223345688999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~~L~ 311 (329)
+||..||++||++.+++..|+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHcCCCcccCCCHHHHHHhhC
Confidence 999999999999999998763
No 105
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=3.5e-44 Score=320.32 Aligned_cols=234 Identities=17% Similarity=0.193 Sum_probs=194.0
Q ss_pred ccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 63 SEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
+.||+|+||.||++.. .+++.+|+|++...... ....+.+|+++++.++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4579999999999873 35789999999754321 23456789999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY 212 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~ 212 (329)
+|+|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++...... ...
T Consensus 82 ~~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 82 GGDLFTRLS--KEVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 999999986 345689999999999999999999999 9999999999999999999999999998764433 234
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
.|++.|+|||.+.+..++.++||||||+++|+|++|+.||.............. . ....+...++++.+++.+|
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li~~~ 232 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK----A--KLGMPQFLSPEAQSLLRAL 232 (318)
T ss_pred cCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc----C--CCCCCCCCCHHHHHHHHHH
Confidence 578999999999988899999999999999999999988865433222221111 1 1123455678899999999
Q ss_pred cccCCCCCCCHHH
Q 020221 293 LQYEPRERPNPRS 305 (329)
Q Consensus 293 l~~dp~~Rps~~~ 305 (329)
|+.||++||++.+
T Consensus 233 l~~~P~~R~~a~~ 245 (318)
T cd05582 233 FKRNPANRLGAGP 245 (318)
T ss_pred hhcCHhHcCCCCC
Confidence 9999999999655
No 106
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.8e-45 Score=327.74 Aligned_cols=250 Identities=18% Similarity=0.220 Sum_probs=207.3
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+.-+.+++++.||.|+||.||++. ...+-..|.|++........++++-|+++|..++||+||++++.|...+.+|++.
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 344557899999999999999999 4445556788887777777889999999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC----CC
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS----RD 208 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~----~~ 208 (329)
|||.||..+..+.. -+..+++.++..+++|++.||.|||++ +|||||||..|||++-+|.++|+|||.+-.. ..
T Consensus 109 EFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred eecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence 99999999888775 457899999999999999999999999 9999999999999999999999999986532 23
Q ss_pred CCCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 209 GRSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 209 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
..++.||++|||||+.. +.+|+.++||||||++|.||..+.+|...- ..++.-.....-++ .....|..++.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel--npMRVllKiaKSeP-PTLlqPS~Ws~ 263 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL--NPMRVLLKIAKSEP-PTLLQPSHWSR 263 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc--chHHHHHHHhhcCC-CcccCcchhhh
Confidence 45789999999999875 567999999999999999999999654322 11111110000011 11124677899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 284 ELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.|.+|+..||..||..||++.++++
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhh
Confidence 9999999999999999999999998
No 107
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=3.4e-43 Score=321.58 Aligned_cols=242 Identities=17% Similarity=0.189 Sum_probs=193.2
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
..|.+++.||+|+||.||++. ..+++.||+|.... ..+.+|+++++.++||||+++++++......++++|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 458888999999999999998 56788999997532 34678999999999999999999999999999999998
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----C
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----R 210 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----~ 210 (329)
. ++|..++. ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++...... .
T Consensus 166 ~-~~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 166 K-TDLYCYLA--AKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred C-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 5 58888886 345689999999999999999999999 9999999999999999999999999998653221 2
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-----------HHHhhh--------------ch
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-----------DLIRDR--------------NI 265 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-----------~~~~~~--------------~~ 265 (329)
...||+.|+|||++.+..++.++||||||+++|||++|..|+..... ..+... ..
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 34689999999999988899999999999999999999977643210 000000 00
Q ss_pred hhhc----c-----ccccCCC--ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 266 QTLT----D-----SCLEGQF--SSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 266 ~~~~----~-----~~~~~~~--~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.... . +..+..+ ....+.++.+|+.+||+.||++|||+.++++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0 0000000 0134678999999999999999999999997
No 108
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=1.4e-43 Score=322.33 Aligned_cols=245 Identities=17% Similarity=0.157 Sum_probs=198.0
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
...|++++.||+|+||.||++. ..+++.+|+|.+.... ......+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 3567788889999999999999 4568899999986422 12234577899999999999999999999999999999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-- 209 (329)
|||+++|+|.+++. ...+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~---~~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 122 MEYMPGGDLVNLMS---NYDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 99999999999984 34688999999999999999999999 9999999999999999999999999998765432
Q ss_pred ---CCccCcccccCcccccCCC----CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC--hH
Q 020221 210 ---RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS--SD 280 (329)
Q Consensus 210 ---~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 280 (329)
....||+.|+|||++.+.. ++.++||||||+++|+|++|..||........... +........++ ..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~p~~~~ 273 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK----IMDHKNSLNFPEDVE 273 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCcccCCCCccc
Confidence 2346899999999987543 77899999999999999999998876543222211 11111111122 24
Q ss_pred HHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 020221 281 EGTELVRLASRCLQYEPRE--RPNPRSLVT 308 (329)
Q Consensus 281 ~~~~~~~li~~cl~~dp~~--Rps~~~~l~ 308 (329)
.+..+.+++..||..++.+ |+++.++++
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred CCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 5788999999999865544 889999988
No 109
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=4.9e-43 Score=303.00 Aligned_cols=244 Identities=20% Similarity=0.266 Sum_probs=203.6
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|.+.+.+|+|++|.||++.. .+++.|++|.+.... ......+.+|+++++.++|||++++++++...+..++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 44566779999999999994 568899999987542 234566889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~ 211 (329)
++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 999999999764456789999999999999999999999 99999999999999999999999999987654432 2
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
..+++.|+|||++.+..++.++|+||||+++++|++|..|+................ ....+...+.++.+++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-----FPPVSQMYSQQLAQLIDQ 235 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----CCCCccccCHHHHHHHHH
Confidence 356788999999998889999999999999999999998886544322222211111 122333567789999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 020221 292 CLQYEPRERPNPRSLVT 308 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~ 308 (329)
||+.+|++||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 236 CLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HccCCcccCcCHHHHhh
Confidence 99999999999999998
No 110
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=4.2e-43 Score=308.23 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=201.6
Q ss_pred CCcccccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221 56 FAMENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (329)
++.+++.+.||+|+||.||+|.. .++..+++|.+...... ....+.+|+.+++.++||||+++++++..+...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 34567788899999999999973 24578999999754432 3456889999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWE---------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~ 194 (329)
++|||+++++|.+++.... ...+++.++..++.|++.||.|||++ +++|+||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEcCCCc
Confidence 9999999999999885211 23478889999999999999999999 9999999999999999999
Q ss_pred eeeecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhh
Q 020221 195 PRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT 267 (329)
Q Consensus 195 ~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~ 267 (329)
+||+|||++...... ....++..|+|||++.+..++.++||||||+++|||++ |..||..............
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~- 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK- 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 999999998764332 12234567999999988889999999999999999999 7766644322211111111
Q ss_pred hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
......+..+++.+.+++.+||+.||++||++.++++.|..
T Consensus 242 ----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 ----RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11112344567889999999999999999999999998864
No 111
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=5.9e-43 Score=304.51 Aligned_cols=255 Identities=16% Similarity=0.195 Sum_probs=205.9
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
..|++.+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 346677788999999999999 5578899999876432 222446888999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
||+++++|.+++... ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999887532 234578999999999999999999999 99999999999999999999999999987654332
Q ss_pred ----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 211 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......... ...+.........+...+..+.
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL--CQKIEQCDYPPLPTEHYSEKLR 238 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH--HHHHhcCCCCCCChhhcCHHHH
Confidence 3457789999999988889999999999999999999998875432211110 0111111111122335667899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221 287 RLASRCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
+++.+||+.+|++||++.++++.+++++
T Consensus 239 ~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 239 ELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 9999999999999999999999998864
No 112
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=3.6e-43 Score=313.55 Aligned_cols=252 Identities=18% Similarity=0.274 Sum_probs=202.2
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCC----EEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
++++++.||+|+||.||+|.+ .+++ .||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ...+++
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~~~~v 86 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLI 86 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CCceee
Confidence 466777789999999999984 3343 389999875432 335678899999999999999999999865 467899
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS 211 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 211 (329)
+||+++|+|.+++.. ....+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 87 ~e~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 87 TQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eecCCCCCHHHHHHh-ccccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999999999864 344688999999999999999999999 999999999999999999999999999986543321
Q ss_pred ------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 212 ------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 212 ------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
...+..|+|||++.+..++.++||||||+++|||++ |..|+.......... ..........+..++.+
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 239 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-----ILEKGERLPQPPICTID 239 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHhCCCCCCCCCCCCHH
Confidence 123567999999998899999999999999999998 787765432222111 11111111223445678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
+.+++.+||..||++||++.+++..|..+.++.
T Consensus 240 ~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 240 VYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999887654
No 113
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=8.1e-44 Score=318.92 Aligned_cols=237 Identities=17% Similarity=0.190 Sum_probs=191.9
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHH-HHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||++. ..+|+.+|+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 46999999999998 5578899999987542 122334555654 467789999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~ 214 (329)
+|..++. ....+++..+..++.||+.||.|||+. |++||||||+|||++.++.+||+|||++..... .....|
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 82 ELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccC
Confidence 9998886 456789999999999999999999999 999999999999999999999999999875322 123458
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
++.|+|||++.+..++.++||||||+++|+|++|..||................ ...+...+..+.+++..||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------LVLRPGASLTAWSILEELLE 232 (325)
T ss_pred ChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------ccCCCCCCHHHHHHHHHHhc
Confidence 899999999999899999999999999999999999887654333322221111 11223456788999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 020221 295 YEPRERPNPRSLVTA 309 (329)
Q Consensus 295 ~dp~~Rps~~~~l~~ 309 (329)
.||.+||++++.++.
T Consensus 233 ~~p~~R~~~~~~~~~ 247 (325)
T cd05604 233 KDRQRRLGAKEDFLE 247 (325)
T ss_pred cCHHhcCCCCCCHHH
Confidence 999999998644433
No 114
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.6e-43 Score=305.30 Aligned_cols=249 Identities=18% Similarity=0.192 Sum_probs=206.6
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
++...++++.||.|.-|+||++.. .++..+|+|++.+..... ......|.++|+.++||.++.+++.++.....++
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 456678889999999999999995 456899999998765433 3346779999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC---
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR--- 207 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~--- 207 (329)
+||||+||+|..++++...+.+++..++.++.+++-||+|||.. |||+|||||+||||-++|++-|+||.++....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml-GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML-GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh-ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999999999999887788899999999999999999999999 99999999999999999999999999853110
Q ss_pred -------------------------------C-C-------------------------CCccCcccccCcccccCCCCC
Q 020221 208 -------------------------------D-G-------------------------RSYSTNLAFTPPEYLRTGRVT 230 (329)
Q Consensus 208 -------------------------------~-~-------------------------~~~~~~~~y~aPE~~~~~~~~ 230 (329)
. . .+++||-.|.|||++.|...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 023567889999999999999
Q ss_pred CcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC----HHHH
Q 020221 231 PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN----PRSL 306 (329)
Q Consensus 231 ~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps----~~~~ 306 (329)
.++|+|+|||++|||+.|.-||-+...+..... ++...+.-.-....+..+++||.++|.+||.+|.. |.+|
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N----Iv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN----IVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH----HhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 999999999999999999999977654433322 22222222222366789999999999999999998 5555
Q ss_pred HH
Q 020221 307 VT 308 (329)
Q Consensus 307 l~ 308 (329)
-+
T Consensus 390 K~ 391 (459)
T KOG0610|consen 390 KR 391 (459)
T ss_pred hc
Confidence 44
No 115
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=2.9e-43 Score=322.39 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=202.5
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCC-CccccccceeeeeCCeeE
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERL 129 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 129 (329)
.+.+.+.||+|+||.||+|... .+..||+|++...... ..+.+.+|+++++.+. ||||+++++++.+....+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 4566778899999999999842 1346999999765433 3456899999999996 999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCC-------------------------------------------------------------
Q 020221 130 LVAEYMPNDTLAKHLFHWE------------------------------------------------------------- 148 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~------------------------------------------------------------- 148 (329)
+||||+++|+|.+++....
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 9999999999998875321
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCe
Q 020221 149 ---------------------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (329)
Q Consensus 149 ---------------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~ 195 (329)
...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEEEeCCCEE
Confidence 12477888899999999999999999 99999999999999999999
Q ss_pred eeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhh
Q 020221 196 RLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTL 268 (329)
Q Consensus 196 kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~ 268 (329)
||+|||++....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|++....+..... .
T Consensus 277 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~----~ 352 (400)
T cd05105 277 KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN----K 352 (400)
T ss_pred EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH----H
Confidence 999999987643322 2234578999999998889999999999999999997 7777764322211111 1
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (329)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~ 315 (329)
.........+...+.++.+++.+||+.||++|||+.++.+.|+++.+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111222345567889999999999999999999999999998754
No 116
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=5.5e-43 Score=309.51 Aligned_cols=252 Identities=17% Similarity=0.242 Sum_probs=207.6
Q ss_pred HHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCee
Q 020221 50 RTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (329)
Q Consensus 50 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (329)
....+....|.+++.+|.|++|.||++. ..+++.|++|.+........+.+.+|+..++.++|||++++++++......
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 12 VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred HhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 3344445568888889999999999998 567889999999776555566788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 208 (329)
++|+||+++++|..++. ...+++.++..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 92 FVVMEYLAGGSLTDVVT---ETCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEEEecCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 99999999999999884 34689999999999999999999999 999999999999999999999999999875443
Q ss_pred CC----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 209 GR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 209 ~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
.. ...++..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ........+...++.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 244 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSPI 244 (296)
T ss_pred ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCcccCCcccCCHH
Confidence 32 23567899999999988899999999999999999999988755322111111100 000111223456778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+.+++.+||..||++||++.++++
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhh
Confidence 999999999999999999999997
No 117
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=9.9e-44 Score=322.74 Aligned_cols=245 Identities=12% Similarity=0.101 Sum_probs=195.3
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.+++++.||+|+||.||++. ..+++.||+|++.... ......+.+|+.++..++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 35667788999999999998 4568899999987532 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---- 209 (329)
|+++|+|.+++. ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLM--KKDTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999986 345689999999999999999999999 9999999999999999999999999998643211
Q ss_pred -----------------------------------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCc
Q 020221 210 -----------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS 254 (329)
Q Consensus 210 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 254 (329)
....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 123588999999999998999999999999999999999998865
Q ss_pred hhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 020221 255 HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN---PRSLVT 308 (329)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~~~l~ 308 (329)
............. ... .........++++.+++.+++ .||++|++ +.++++
T Consensus 239 ~~~~~~~~~i~~~-~~~-~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 239 ETPQETYRKVMNW-KET-LVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCHHHHHHHHHcC-CCc-eecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 4433222211110 000 000011125678999999877 49999985 566665
No 118
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=7e-43 Score=306.65 Aligned_cols=245 Identities=17% Similarity=0.204 Sum_probs=199.3
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
|++++.||+|+||.||++.. .++..+++|.+........+.+.+|+++++.++|||++++++++..+...++++||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 46777889999999999994 45778999998766555566788999999999999999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCcc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYS 213 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~ 213 (329)
++|..++.+ ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ....
T Consensus 87 ~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 87 GAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 999888754 345789999999999999999999999 9999999999999999999999999998654322 2345
Q ss_pred CcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 214 TNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 214 ~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
++..|+|||++. +..++.++||||||+++|+|++|..|+................. .....+...+.++.++
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l 241 (282)
T cd06643 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP---PTLAQPSRWSSEFKDF 241 (282)
T ss_pred ccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC---CCCCCccccCHHHHHH
Confidence 788999999884 34477899999999999999999987754322111111111100 0112234567789999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 020221 289 ASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~ 308 (329)
+.+||+.||++||++.++++
T Consensus 242 i~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHccCChhhCcCHHHHhc
Confidence 99999999999999999987
No 119
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=3.8e-43 Score=308.47 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=201.5
Q ss_pred CcccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (329)
+.+++++.||.|+||.||+|... .++.||+|++....... ...+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 44677788899999999999843 24789999998654332 356888999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCe
Q 020221 130 LVAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNP 195 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~ 195 (329)
+++||+.+++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEecCCCce
Confidence 999999999999988421 123478888999999999999999999 99999999999999999999
Q ss_pred eeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhh
Q 020221 196 RLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTL 268 (329)
Q Consensus 196 kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~ 268 (329)
||+|||+++...... ...+++.|+|||.+.+..++.++||||||+++|||++ |..|+........... +
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~----i 239 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM----I 239 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----H
Confidence 999999987543322 2234678999999988889999999999999999998 6655543322222111 1
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
.. ......+..++..+.+++.+||+.+|++||++.++++.|++
T Consensus 240 ~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 RN-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred Hc-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 11123455678889999999999999999999999999875
No 120
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=3.8e-43 Score=315.84 Aligned_cols=253 Identities=20% Similarity=0.301 Sum_probs=200.8
Q ss_pred cccccccCCCCCCcEEEEEEe-C-----CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeC-Cee
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-E-----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DER 128 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~~ 128 (329)
.+++.+.||+|+||.||+|.. . +++.||+|+++..... ..+.+.+|+.++..+ +|+||+++++++... ...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 467788889999999999963 2 2468999998765422 245678899999999 799999999988654 568
Q ss_pred EEEEecCCCCCHHhhhccCC-----------------------------------------------------------C
Q 020221 129 LLVAEYMPNDTLAKHLFHWE-----------------------------------------------------------T 149 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------~ 149 (329)
++++||+++++|.+++.... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 89999999999999885321 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------CccCcccccCccc
Q 020221 150 QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEY 223 (329)
Q Consensus 150 ~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~ 223 (329)
..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.++|+|||++....... ...++..|+|||+
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 2678999999999999999999999 99999999999999999999999999997653321 2234578999999
Q ss_pred ccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 020221 224 LRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302 (329)
Q Consensus 224 ~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 302 (329)
+.+..++.++|||||||++|||++ |..||......... ............+...++++.+++.+||+.+|++||+
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF----CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH----HHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999999999999999999999998 88776532111110 0111111112233455678999999999999999999
Q ss_pred HHHHHHHHHhhhh
Q 020221 303 PRSLVTALVTLQK 315 (329)
Q Consensus 303 ~~~~l~~L~~~~~ 315 (329)
+.+++++|+++.+
T Consensus 323 ~~ell~~l~~~~~ 335 (337)
T cd05054 323 FSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998765
No 121
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=6.6e-43 Score=303.17 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=204.1
Q ss_pred cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
.+++++.||+|+||.||+|...+++.||+|.+..... ....+.+|+.+++.++|+|++++++++ ..+..++++||+.+
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~ 84 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMEN 84 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCC
Confidence 4677888999999999999987888999999986553 356788999999999999999999886 45678999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----Cc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SY 212 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~ 212 (329)
++|.+++.......+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++....... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05067 85 GSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA 163 (260)
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCC
Confidence 9999998654556789999999999999999999999 99999999999999999999999999987654221 12
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
.++..|+|||++.+..++.++||||||+++|++++ |..|+............ ........+...+.++.+++.+
T Consensus 164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-----ERGYRMPRPDNCPEELYELMRL 238 (260)
T ss_pred cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-----HcCCCCCCCCCCCHHHHHHHHH
Confidence 34568999999998889999999999999999999 88777544322222111 1111122334456789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHh
Q 020221 292 CLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L~~ 312 (329)
||+.+|++||++++++..|+.
T Consensus 239 ~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 239 CWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999875
No 122
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=1.1e-42 Score=302.85 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=202.0
Q ss_pred ccccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
+++.+.||+|+||.||+|.+. +...||+|.+...... ....+.+|+.+++.++||||+++++++......+++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 455667799999999999853 2457999998765433 34568899999999999999999999998899999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 86 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 86 YMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred cCCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 9999999999864 334789999999999999999999999 99999999999999999999999999988764211
Q ss_pred ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
...++..|+|||.+.+..++.++||||||+++|+|++ |..|+.............. ......+...++.+.
T Consensus 164 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~ 238 (266)
T cd05033 164 TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-----GYRLPPPMDCPSALY 238 (266)
T ss_pred eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHH
Confidence 1223567999999998889999999999999999998 8777654332222211111 111123345678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 287 RLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
+++.+||+.+|++||++.++++.|+++
T Consensus 239 ~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 239 QLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999875
No 123
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=7.6e-43 Score=308.00 Aligned_cols=255 Identities=17% Similarity=0.205 Sum_probs=205.1
Q ss_pred HHHHhcCCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCe
Q 020221 49 LRTATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (329)
Q Consensus 49 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (329)
+.+-....+.|++++.+|.|+||.||+|.. .+++.+++|.+........+.+.+|+.+++.++|+|++++++.+.....
T Consensus 4 ~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (292)
T cd06644 4 VRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGK 83 (292)
T ss_pred hhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCe
Confidence 334444556788899999999999999994 5588999999987665556778899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.++||||+++++|..++.+ ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~~lv~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 84 LWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred EEEEEecCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999887754 345689999999999999999999999 99999999999999999999999999876533
Q ss_pred CC----CCccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221 208 DG----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (329)
Q Consensus 208 ~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (329)
.. ....++..|+|||++.+ ..++.++|+||||+++|+|++|..|+............... .. .....+
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~ 238 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EP--PTLSQP 238 (292)
T ss_pred ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC-CC--ccCCCC
Confidence 22 23356789999999853 34778999999999999999999877543221111111110 00 011223
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 279 SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...+.++.+++.+||..||++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 456678999999999999999999999987
No 124
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=9.8e-43 Score=308.08 Aligned_cols=259 Identities=20% Similarity=0.283 Sum_probs=205.9
Q ss_pred CcccccccCCCCCCcEEEEEEeC-CC--CEEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLE-NQ--FRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~-~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 131 (329)
+.+.+.+.||+|+||.||+|... ++ ..+++|.++... ....+.+.+|++++..+ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 45667778899999999999853 33 347888887432 23356788999999999 799999999999988999999
Q ss_pred EecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221 132 AEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl 197 (329)
+||+++++|.+++.... ...+++..+..++.|++.||+|||+. |++|+||||+||++++++.+||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCCCeEEE
Confidence 99999999999986421 13478899999999999999999999 9999999999999999999999
Q ss_pred ecccCcccCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccc
Q 020221 198 SCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCL 273 (329)
Q Consensus 198 ~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (329)
+|||++...... .....+..|+|||++.+..++.++||||||+++|||++ |..||.............. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~-----~~ 235 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-----GY 235 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc-----CC
Confidence 999998643221 11122457999999988889999999999999999998 8877755433322221111 11
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccccc
Q 020221 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELYL 321 (329)
Q Consensus 274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~ 321 (329)
....+..++.++.+++.+||+.||.+||++.++++.|+.+..+.....
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 222334567789999999999999999999999999999987655443
No 125
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=2.5e-43 Score=331.15 Aligned_cols=247 Identities=17% Similarity=0.200 Sum_probs=202.4
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCC-------
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD------- 126 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------- 126 (329)
..|.+.+.||+|+||+||++. ..+++.||||.+..... .....+.+|+..+..++|+|++++...+...+
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 356777788999999999998 56789999999876532 23456788999999999999999887764332
Q ss_pred -eeEEEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221 127 -ERLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (329)
Q Consensus 127 -~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 203 (329)
..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 367999999999999988642 235689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCC
Q 020221 204 KNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (329)
Q Consensus 204 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (329)
+..... ....||+.|+|||++.+..++.++||||||+++|||++|..||................ ....
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~-----~~~~ 265 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR-----YDPL 265 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC-----CCCC
Confidence 754322 23468899999999999889999999999999999999999887654433322222211 1223
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~ 309 (329)
+...++++.+++.+||+.||++||++.+++++
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 45667899999999999999999999999864
No 126
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=1.6e-43 Score=328.62 Aligned_cols=246 Identities=21% Similarity=0.268 Sum_probs=190.0
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeC--------Ce
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG--------DE 127 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~~ 127 (329)
..|.+.+.||+|+||.||+|. ..+++.||||++.... ....+|+.+++.++||||+++.+++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 357788888999999999999 4568899999986543 2345799999999999999998876432 24
Q ss_pred eEEEEecCCCCCHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcc
Q 020221 128 RLLVAEYMPNDTLAKHLFH--WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMK 204 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~ 204 (329)
+++||||+++ +|.+++.. .....+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 6789999986 67776642 1346789999999999999999999999 999999999999999665 69999999998
Q ss_pred cCCCC---CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------------
Q 020221 205 NSRDG---RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT------------- 267 (329)
Q Consensus 205 ~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~------------- 267 (329)
..... ....+++.|+|||++.+. .++.++|||||||++|||++|.+||...............
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 65433 234678999999998764 5899999999999999999999888654221111110000
Q ss_pred ----------hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 268 ----------LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 268 ----------~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+....+...++...++++.+|+.+||..||++|||+.++++
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00000111123345678999999999999999999999996
No 127
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=8.9e-43 Score=302.36 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=203.1
Q ss_pred cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
.+++++.+|+|+||.||++...++..+|+|.+..... ..+.+.+|+.+++.++|+|++++++++. ....+++|||+++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 4667788899999999999987888899999986543 3457899999999999999999999874 4678999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----Cc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SY 212 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~ 212 (329)
++|.+++.......+++.++..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++....... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05070 85 GSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence 9999999754455689999999999999999999999 99999999999999999999999999987654322 12
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
.++..|+|||.+.+..++.++|+||||+++|+|++ |..||........... .........+...+..+.+++.+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ-----VERGYRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-----HHcCCCCCCCCcCCHHHHHHHHH
Confidence 34567999999988889999999999999999999 6766654332221111 11112223455667889999999
Q ss_pred hcccCCCCCCCHHHHHHHHHh
Q 020221 292 CLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L~~ 312 (329)
||..||++|||+.++.+.|+.
T Consensus 239 ~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 239 CWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HcccCcccCcCHHHHHHHHhc
Confidence 999999999999999998875
No 128
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=1.2e-42 Score=301.94 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=201.7
Q ss_pred cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
.|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|+++++.++|+||+++++.+. ....+++|||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 4778888999999999999976666899999986442 3457889999999999999999998874 4568999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----Cc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SY 212 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~ 212 (329)
|+|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+....... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~ 163 (262)
T cd05071 85 GSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163 (262)
T ss_pred CcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence 9999999753445679999999999999999999999 99999999999999999999999999987554332 12
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
.++..|+|||+..+..++.++||||||+++|+|++ |..|+.............. ......+...+..+.+++.+
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----GYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-----CCCCCCccccCHHHHHHHHH
Confidence 34567999999988889999999999999999999 6655544322222111111 11112344567889999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 020221 292 CLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
||+.||++||++.++++.|+..
T Consensus 239 ~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 239 CWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HccCCcccCCCHHHHHHHHHHh
Confidence 9999999999999999998864
No 129
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=2e-43 Score=330.71 Aligned_cols=250 Identities=17% Similarity=0.152 Sum_probs=208.5
Q ss_pred ccccccCCCCCCcEEEEEEeCCC-CEEEEEEeCCCCChhHHHHHHHHHHHhcCC-Cccccccceee-ee------CCeeE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLENQ-FRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCC-CE------GDERL 129 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~-~~------~~~~~ 129 (329)
.++.+.|.+|+|+.||.+....+ ..+|+|++...+....+.+.+|+++|+.|+ |+|||.+++.. .. .-+++
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 45667789999999999995554 999999998888778888999999999997 99999999932 21 13578
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 208 (329)
|.||||.+|+|.+++..+....|++.++++|+.++++|+++||.. ..|||||||.+|||++.+++.||||||.|.-...
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~ 198 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKIL 198 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccC
Confidence 999999999999999876667799999999999999999999986 3499999999999999999999999999864332
Q ss_pred CC-------------CccCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccc
Q 020221 209 GR-------------SYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC 272 (329)
Q Consensus 209 ~~-------------~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 272 (329)
.. ...+|+.|+|||++. +..+++|+|||+|||+||-|+....||..... ..++...
T Consensus 199 ~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--------laIlng~ 270 (738)
T KOG1989|consen 199 SPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--------LAILNGN 270 (738)
T ss_pred CCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------eeEEecc
Confidence 21 124689999999874 67799999999999999999999999865411 2233322
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 273 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~ 316 (329)
..-+-.+..+..+.+||..||+.||++||++.+++..+-++...
T Consensus 271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 22222356789999999999999999999999999999998764
No 130
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=1.2e-42 Score=300.21 Aligned_cols=241 Identities=25% Similarity=0.380 Sum_probs=195.7
Q ss_pred cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (329)
.||+|+||.||+|.. .+++.+|+|.+...... ....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 469999999999984 57889999988754332 3456899999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC------ccCc
Q 020221 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------YSTN 215 (329)
Q Consensus 142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~------~~~~ 215 (329)
+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++........ ...+
T Consensus 82 ~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 82 TFLRT-EGPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99864 334689999999999999999999999 999999999999999999999999999875443211 1123
Q ss_pred ccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
..|+|||.+.+..++.++||||||+++|+|++ |..|+.......... ..........+...+..+.+++.+||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~ 234 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-----AIEQGVRLPCPELCPDAVYRLMERCWE 234 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-----HHHcCCCCCCcccCCHHHHHHHHHHcC
Confidence 56999999998889999999999999999998 665553322111111 111112223445567889999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 020221 295 YEPRERPNPRSLVTALV 311 (329)
Q Consensus 295 ~dp~~Rps~~~~l~~L~ 311 (329)
.||++|||+.++++.|+
T Consensus 235 ~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 235 YDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CChhhCcCHHHHHHHHh
Confidence 99999999999999876
No 131
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=2e-43 Score=321.31 Aligned_cols=195 Identities=18% Similarity=0.191 Sum_probs=173.7
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-C-----ccccccceeeeeCCeeEE
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-N-----RRLANLLGCCCEGDERLL 130 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~l 130 (329)
.|++++.||+|+||.|-+|. ..+++.||||+++... .-..+...|+.+|..|+ | -|+|+++++|...++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 45778999999999999999 6779999999998765 33566778999999996 4 389999999999999999
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC--CCeeeecccCcccCCC
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD--VNPRLSCFGLMKNSRD 208 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~--~~~kl~Dfg~a~~~~~ 208 (329)
|+|.+.. +|.+++++.+-..++...++.++.||+.||.+||+. +|||+||||+|||+.+. ..+||+|||.++....
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 9999966 899999987778899999999999999999999998 99999999999999744 3699999999987665
Q ss_pred C-CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCch
Q 020221 209 G-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH 255 (329)
Q Consensus 209 ~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 255 (329)
. ..+..+..|.|||++.|.+|+.+.||||||||+.||++|.+.|+++
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 4 3556778999999999999999999999999999999999888765
No 132
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=3e-43 Score=315.24 Aligned_cols=236 Identities=19% Similarity=0.212 Sum_probs=190.2
Q ss_pred cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHH-HHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||+||++.. .+++.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 469999999999994 5678899999875321 11233444444 567889999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~ 214 (329)
+|.+++. ....+++..+..++.||+.||.|||+. |++||||||+||+++.++.++|+|||++..... .....|
T Consensus 82 ~L~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 82 ELFYHLQ--RERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccC
Confidence 9999886 345688889999999999999999999 999999999999999999999999999875322 123468
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
++.|+|||++.+..++.++||||||+++|+|++|..||............... ....+...+..+.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------PLQLKPNITNSARHLLEGLLQ 232 (325)
T ss_pred CccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC------CcCCCCCCCHHHHHHHHHHcc
Confidence 89999999999988999999999999999999999988754433222221111 112234567889999999999
Q ss_pred cCCCCCCCHHHHHH
Q 020221 295 YEPRERPNPRSLVT 308 (329)
Q Consensus 295 ~dp~~Rps~~~~l~ 308 (329)
.||.+||++.+.+.
T Consensus 233 ~~p~~R~~~~~~~~ 246 (325)
T cd05602 233 KDRTKRLGAKDDFM 246 (325)
T ss_pred cCHHHCCCCCCCHH
Confidence 99999999875443
No 133
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=1.1e-42 Score=302.75 Aligned_cols=255 Identities=17% Similarity=0.215 Sum_probs=206.5
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
..|++.+.||+|+||.||++. ..++..+++|.+..... .....+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 346677788999999999999 56788999998865332 22456889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999988632 235689999999999999999999999 99999999999999999999999999987654332
Q ss_pred ----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 211 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
...++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....+.... ...+.........+...++++.
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH--hhhhhcCCCCCCCcccccHHHH
Confidence 2357789999999988889999999999999999999998875432211110 0111111111112235678999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221 287 RLASRCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
+++.+||+.||++|||+.+|++.+.++.
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 9999999999999999999999998763
No 134
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=9.5e-43 Score=306.09 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=200.9
Q ss_pred cccccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLL 130 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 130 (329)
.+++++.||+|+||.||++.. .++..||+|.+........+.+.+|+++++.++||||+++.+++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 456778889999999999974 2578899999987665556778999999999999999999998644 346889
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
|+||+++++|.+++.+ ....+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++.......
T Consensus 85 v~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 85 VMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred EEEecCCCCHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999999999864 234689999999999999999999999 99999999999999999999999999988654332
Q ss_pred C-------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh---hh--------chhhhcccc
Q 020221 211 S-------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR---DR--------NIQTLTDSC 272 (329)
Q Consensus 211 ~-------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~---~~--------~~~~~~~~~ 272 (329)
. ..++..|+|||.+.+..++.++||||||++++||++|..++......... .. .........
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05081 163 EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNN 242 (284)
T ss_pred cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcC
Confidence 2 12234699999999888999999999999999999987654322111110 00 000111111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 273 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
.....+...+.++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 243 GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11122345677899999999999999999999999999875
No 135
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=5.8e-43 Score=307.98 Aligned_cols=248 Identities=15% Similarity=0.166 Sum_probs=192.0
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcC---CCccccccceeeee-----CCe
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQL---RNRRLANLLGCCCE-----GDE 127 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~~ 127 (329)
|++++.||+|+||+||++. ..+++.||+|.+...... ....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 5677788999999999998 557889999998754322 223456677776665 69999999998754 245
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.++++||+.+ +|.+++.......+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 7999999975 898888654455689999999999999999999999 99999999999999999999999999987654
Q ss_pred CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-------cc-------
Q 020221 208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------TD------- 270 (329)
Q Consensus 208 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------~~------- 270 (329)
.. ....++..|+|||++.+..++.++||||||+++|+|++|.+||................ ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 33 23456889999999998889999999999999999999998775432211111100000 00
Q ss_pred cccc-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 271 SCLE-------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 271 ~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.... .......+.++.+++.+||+.||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0011235678899999999999999999999997
No 136
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=8.6e-43 Score=301.84 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=199.4
Q ss_pred cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
++.+.+.||+|+||.||++...++..+|+|.+..... ....+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 3556777899999999999977777899999875442 345688899999999999999999999988999999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-----c
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-----Y 212 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-----~ 212 (329)
++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++....+... .
T Consensus 84 ~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 84 GCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 999999864 234689999999999999999999999 999999999999999999999999999876543221 1
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
.++..|+|||.+.+..++.++||||||+++|++++ |..|+............ ........+...+.++.+++.+
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-----SAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH-----HcCCcCCCCCCCCHHHHHHHHH
Confidence 22357999999998889999999999999999999 66665432222111111 1111222344567899999999
Q ss_pred hcccCCCCCCCHHHHHHHH
Q 020221 292 CLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L 310 (329)
||..+|++|||+.++++.|
T Consensus 237 cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HhcCChhhCcCHHHHHHHh
Confidence 9999999999999999876
No 137
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=6e-43 Score=304.57 Aligned_cols=249 Identities=16% Similarity=0.172 Sum_probs=200.6
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
...|++++.||+|+||.||+|. ..+++.||+|++..........+.+|+.+++.++||||+++++++......++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 3467788889999999999999 467889999999766544556688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~ 210 (329)
+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... .
T Consensus 88 ~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 88 CGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred CCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99999999886 345689999999999999999999999 9999999999999999999999999998754322 2
Q ss_pred CccCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc-hhhhccccccCCCChHHHHHHH
Q 020221 211 SYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-IQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
...++..|+|||.+. ...++.++|+||||+++|+|++|+.|+............ ......+.. ......+.++.
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 242 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL--KDKTKWSSTFH 242 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCC--ccccccCHHHH
Confidence 345678999999874 344778999999999999999999876432211110000 000001100 11234567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 020221 287 RLASRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~ 309 (329)
+++.+||+.||++|||++++++.
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcC
Confidence 99999999999999999999974
No 138
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=1.1e-42 Score=301.00 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=203.0
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeee-eCCeeEEEEecC
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERLLVAEYM 135 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 135 (329)
..+.+.+.+|+|+||.||++... +..+|+|.++... ..+.+.+|+.+++.++|+|++++++++. .++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 45667788899999999999864 6689999987543 3457889999999999999999999764 456789999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-CccC
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYST 214 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 214 (329)
++++|.+++.+.....+++..+..++.|++.||+|||++ |++|+||||+||++++++.+||+|||++....... ....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 161 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 161 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCCcEEecCCccceeccccCCCCcc
Confidence 999999999754445689999999999999999999999 99999999999999999999999999987644332 2334
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 293 (329)
+..|+|||++.+..++.++||||||+++|+|++ |..|+.............. ......+...++.+.+++.+||
T Consensus 162 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-----GYKMDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred ceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----CCCCCCCCCCCHHHHHHHHHHh
Confidence 568999999988889999999999999999998 8877654433322211111 1122334556788999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhh
Q 020221 294 QYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 294 ~~dp~~Rps~~~~l~~L~~~ 313 (329)
+.||++|||+.++++.|+++
T Consensus 237 ~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 237 HLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred cCChhhCcCHHHHHHHHhcC
Confidence 99999999999999998864
No 139
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=9.6e-43 Score=302.66 Aligned_cols=239 Identities=19% Similarity=0.338 Sum_probs=191.5
Q ss_pred cCCCCCCcEEEEEEeCC-------------CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 64 EHGEKAPNVVYKGKLEN-------------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
.||+|+||.||+|.+.+ ...|++|.+..........+.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 46999999999998432 23589998876654445578889999999999999999999998889999
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC-------eeeecccCc
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-------PRLSCFGLM 203 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~-------~kl~Dfg~a 203 (329)
+|||+++++|..++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++. ++++|||++
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 82 VEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999999988854 345689999999999999999999999 9999999999999987664 899999998
Q ss_pred ccCCCCCCccCcccccCccccc-CCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221 204 KNSRDGRSYSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (329)
Q Consensus 204 ~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (329)
..........++..|+|||.+. +..++.++||||||+++|||++ |..|+.......... ...... ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-----~~~~~~--~~~~~~ 232 (262)
T cd05077 160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-----FYEGQC--MLVTPS 232 (262)
T ss_pred ccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-----HHhcCc--cCCCCC
Confidence 7766555566788999999887 4568889999999999999985 665554332211111 011100 112223
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 282 GTELVRLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 282 ~~~~~~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
++++.+++.+||+.||++||++.++++.|+
T Consensus 233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 233 CKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 568999999999999999999999998763
No 140
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=2.5e-43 Score=305.53 Aligned_cols=240 Identities=24% Similarity=0.365 Sum_probs=194.4
Q ss_pred cCCCCCCcEEEEEEeC-C-------CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 64 EHGEKAPNVVYKGKLE-N-------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
.||.|+||+||+|... . ...+++|.+........+.+.+|+.+++.++|||++++++++..+...++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 4699999999999843 2 2348888887655445567889999999999999999999999989999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC--------eeeecccCcccCC
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--------PRLSCFGLMKNSR 207 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--------~kl~Dfg~a~~~~ 207 (329)
++|+|.+++.. ....+++..+..++.||+.||+|||++ +++||||||+||+++.++. ++++|||++....
T Consensus 82 ~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 82 KFGSLDTYLKK-NKNLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred CCCcHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99999999864 334689999999999999999999999 9999999999999987765 5999999988776
Q ss_pred CCCCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 208 DGRSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 208 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
......++..|+|||++.+. .++.++||||||+++|+|++|..++........... .... ....+...+.++.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~ 233 (258)
T cd05078 160 PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ----FYED--RHQLPAPKWTELA 233 (258)
T ss_pred CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH----HHHc--cccCCCCCcHHHH
Confidence 66666788899999999864 478899999999999999999654433221111111 1111 1223444567899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 287 RLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
+++.+||+.||++|||++++++.|+
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHhcC
Confidence 9999999999999999999998763
No 141
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=9.1e-43 Score=309.15 Aligned_cols=259 Identities=21% Similarity=0.306 Sum_probs=204.3
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCC--EEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEE
Q 020221 56 FAMENIVSEHGEKAPNVVYKGKL-ENQF--RIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 130 (329)
+..+.+.+.||+|+||.||+|.. .++. .+++|.+..... .....+.+|+.++..+ +|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 44566777789999999999984 3443 467877765332 2345688899999999 89999999999999999999
Q ss_pred EEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCee
Q 020221 131 VAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR 196 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~k 196 (329)
++||+++++|.+++.... ...+++.++..++.|++.||+|||+. |++||||||+||+++.++.++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecCCCcEE
Confidence 999999999999986421 23578999999999999999999999 999999999999999999999
Q ss_pred eecccCcccCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhcccc
Q 020221 197 LSCFGLMKNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSC 272 (329)
Q Consensus 197 l~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~ 272 (329)
|+|||++...... .....+..|+|||.+.+..++.++||||||+++|+|+| |..||............ ...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-----~~~ 239 (303)
T cd05088 165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQG 239 (303)
T ss_pred eCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hcC
Confidence 9999998643221 11123567999999988889999999999999999998 88776543322221111 111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccccc
Q 020221 273 LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDTELY 320 (329)
Q Consensus 273 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~ 320 (329)
.....+...++++.+++.+||+.+|++||++.++++.|+.+.+.....
T Consensus 240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 122233445678999999999999999999999999999987765433
No 142
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=5.1e-43 Score=313.40 Aligned_cols=235 Identities=17% Similarity=0.241 Sum_probs=192.4
Q ss_pred cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEec
Q 020221 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
+..+.||+|+||+||++. ..+++.||+|++.... ....+.+..|..++..+. |++|+++.+++.+.+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 455667999999999998 4568899999987542 223445778888888885 67788899999888999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~ 210 (329)
+++|+|.+++. ....+++.++..++.|++.||.|||++ |++||||||+||+++.++.++|+|||++...... .
T Consensus 83 ~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 83 VNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred CCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 99999999886 345689999999999999999999999 9999999999999999999999999998753322 2
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
...|++.|+|||++.+..++.++||||||+++|+|++|..||.............. . ...++...+.++.+++.
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~----~--~~~~p~~~~~~~~~li~ 233 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME----H--NVSYPKSLSKEAVSICK 233 (323)
T ss_pred CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----C--CCCCCccCCHHHHHHHH
Confidence 34578999999999988899999999999999999999988865433322222111 1 11234556788999999
Q ss_pred HhcccCCCCCCCH
Q 020221 291 RCLQYEPRERPNP 303 (329)
Q Consensus 291 ~cl~~dp~~Rps~ 303 (329)
+||+.||++|++.
T Consensus 234 ~~l~~~p~~R~~~ 246 (323)
T cd05615 234 GLMTKHPSKRLGC 246 (323)
T ss_pred HHcccCHhhCCCC
Confidence 9999999999985
No 143
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=8.8e-43 Score=305.79 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=201.1
Q ss_pred CcccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
..+.+.+.+|+|+||.||++.. .++..+|+|.+..........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4456778889999999999963 2356799999887665556779999999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhccCCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221 131 VAEYMPNDTLAKHLFHWET-------------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl 197 (329)
++||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCCCCEEE
Confidence 9999999999999864321 3478999999999999999999999 9999999999999999999999
Q ss_pred ecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhcc
Q 020221 198 SCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTD 270 (329)
Q Consensus 198 ~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~ 270 (329)
+|||++....... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..|+........... ...
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~ 239 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC----ITQ 239 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH----HHc
Confidence 9999986543221 2234578999999998889999999999999999998 7766543322111111 111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 271 SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 271 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
......+..+++.+.+++.+||+.||++||++.++++.|+
T Consensus 240 -~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 -GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111223456678999999999999999999999999886
No 144
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7e-44 Score=318.96 Aligned_cols=244 Identities=20% Similarity=0.241 Sum_probs=205.8
Q ss_pred cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
.-++.||-|+||-||-+. ..+.+.||||++.-...+. ++++.+|+..|+.+.|||++.+.|+|......|||||||
T Consensus 29 ~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC 108 (948)
T KOG0577|consen 29 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC 108 (948)
T ss_pred HHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH
Confidence 345677999999999999 6778899999998765443 667899999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCc
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN 215 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 215 (329)
-| |-.+++.- ..+++.+..+..|..+.+.||+|||+. +.||||||..|||+++.|.|||+|||.|....+..+++||
T Consensus 109 lG-SAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGT 185 (948)
T KOG0577|consen 109 LG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSFVGT 185 (948)
T ss_pred hc-cHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCCeeeeccccchhhcCchhcccCC
Confidence 65 77777643 456889999999999999999999999 9999999999999999999999999999999999999999
Q ss_pred ccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 216 LAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 216 ~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
+.|||||++. .+.|+-++||||||++..||.-+++|.+....-...-. +-..-.+.....+++..|+.|+..|
T Consensus 186 PywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH----IAQNesPtLqs~eWS~~F~~Fvd~C 261 (948)
T KOG0577|consen 186 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPTLQSNEWSDYFRNFVDSC 261 (948)
T ss_pred ccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH----HHhcCCCCCCCchhHHHHHHHHHHH
Confidence 9999999874 67799999999999999999999977654321111111 1111111122467899999999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 020221 293 LQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 293 l~~dp~~Rps~~~~l~~L 310 (329)
|+.-|++|||..+++.+-
T Consensus 262 LqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 262 LQKIPQERPTSEELLKHR 279 (948)
T ss_pred HhhCcccCCcHHHHhhcc
Confidence 999999999999998743
No 145
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=1.3e-42 Score=300.96 Aligned_cols=241 Identities=20% Similarity=0.268 Sum_probs=196.0
Q ss_pred cCCCCCCcEEEEEEe---CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKL---ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
+||+|+||.||+|.+ .++..+|+|++..... ...+.+.+|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 579999999999964 3578899999875432 23456889999999999999999999875 46778999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-------
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------- 211 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~------- 211 (329)
+|.+++. ....+++..+..++.|++.||.|||++ |++|+||||+||++++++.++|+|||++........
T Consensus 81 ~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999986 345689999999999999999999999 999999999999999999999999999876543321
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
..++..|+|||.+....++.++|+||||+++|||++ |..||.......... .+........+...++++.+++.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-----~i~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-----MIESGERMECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHCCCCCCCCCCCCHHHHHHHH
Confidence 123478999999988889999999999999999998 887775432221111 11111222345567789999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhh
Q 020221 291 RCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
+||+.||++||++.+|...|++.
T Consensus 233 ~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 233 LCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHhccCchhCcCHHHHHHHHhcc
Confidence 99999999999999999998763
No 146
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=5e-43 Score=319.51 Aligned_cols=246 Identities=18% Similarity=0.221 Sum_probs=193.6
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCC-----eeEE
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERLL 130 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 130 (329)
+++++.||+|+||.||++. ..+++.||+|++.... ....+.+.+|+++++.++|+||+++++++.... ..++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 3456777999999999999 4578999999987542 223456889999999999999999999998766 7899
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 209 (329)
|+||+.+ +|.+.+. ....+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 82 v~e~~~~-~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 82 VTELMQS-DLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred Eeecccc-CHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 9999974 7888775 446789999999999999999999999 9999999999999999999999999998754332
Q ss_pred ----CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-------------------
Q 020221 210 ----RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI------------------- 265 (329)
Q Consensus 210 ----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~------------------- 265 (329)
....++..|+|||++.+.. ++.++|||||||++|||++|+.||.............
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 1234678899999988754 7889999999999999999998885432111100000
Q ss_pred hhhcccccc-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 266 QTLTDSCLE-------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 266 ~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..+...... .......++++.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000000000 0112234678999999999999999999999997
No 147
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=1.2e-42 Score=305.25 Aligned_cols=251 Identities=23% Similarity=0.310 Sum_probs=199.5
Q ss_pred cccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEEE
Q 020221 60 NIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLV 131 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 131 (329)
.+++.||+|+||+||++.. .++..||+|.+..... .....+.+|+++++.++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6777889999999988652 3577899999876543 2345688999999999999999999987653 468899
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 210 (329)
|||+++++|.+++. ...+++.++..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++.......
T Consensus 87 ~e~~~~~~l~~~~~---~~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHH---HcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 99999999999985 34699999999999999999999999 99999999999999999999999999987654332
Q ss_pred ------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhH--HHhhh--------chhhhcccccc
Q 020221 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALD--LIRDR--------NIQTLTDSCLE 274 (329)
Q Consensus 211 ------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~--~~~~~--------~~~~~~~~~~~ 274 (329)
...++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ..... ...........
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCC
Confidence 123456799999998888999999999999999999999776432110 00000 01111111112
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 275 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
...+...+.++.+++.+||+.||++|||+.++++.|+.+.
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2234556789999999999999999999999999998864
No 148
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=5e-43 Score=308.15 Aligned_cols=246 Identities=20% Similarity=0.271 Sum_probs=199.0
Q ss_pred cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
++.+.||+|+||+||++. ..+++.||+|.+...... ....+.+|+.+++.++|+|++.+.+.+.+.+..++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 344556999999999998 557889999998754322 2345678999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---Cc
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---SY 212 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~ 212 (329)
++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....... ..
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCC
Confidence 999999988654445689999999999999999999999 99999999999999999999999999987654332 23
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
.++..|+|||++.+..++.++||||||+++|+|++|..||......... ......... .....+...++++.+++.+|
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKE-VQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhh-hhhhcCccCCHHHHHHHHHH
Confidence 6789999999999888999999999999999999999888643211000 011111111 11123445677899999999
Q ss_pred cccCCCCCCC-----HHHHHH
Q 020221 293 LQYEPRERPN-----PRSLVT 308 (329)
Q Consensus 293 l~~dp~~Rps-----~~~~l~ 308 (329)
|+.||++||| +.++++
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCHHHccCCCCCchHHHHc
Confidence 9999999999 888887
No 149
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=2.3e-42 Score=303.04 Aligned_cols=252 Identities=18% Similarity=0.247 Sum_probs=200.0
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCC----EEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
++++++.||+|+||+||+|.+ .++. .+++|.+...... ...++..|+..++.+.||||+++++++. +...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence 456677889999999999984 3443 4788887654322 2356778888999999999999999875 4567899
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 210 (329)
+||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 87 TQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 999999999999964 345789999999999999999999999 99999999999999999999999999997653321
Q ss_pred -----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 211 -----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 211 -----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
...++..|+|||.+.+..++.++||||||+++||+++ |..|+......... ...........+..++.+
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 239 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-----DLLEKGERLAQPQICTID 239 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----HHHHCCCcCCCCCCCCHH
Confidence 2235678999999998889999999999999999998 88776543222111 111111111223335567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
+.+++..||..||++|||+.++++.|..+....
T Consensus 240 ~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 240 VYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 899999999999999999999999999987644
No 150
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=7.9e-43 Score=313.22 Aligned_cols=249 Identities=18% Similarity=0.137 Sum_probs=195.9
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|++++.||+|+||+||++. ..+++.||+|++.... ....+.+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 46778888999999999999 5568899999986421 1224457889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+++|+|.+++.+ ....+++..+..++.||+.||+|||++ +++||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred cCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 9999999999864 345689999999999999999999999 99999999999999999999999999986544322
Q ss_pred --CccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 211 --SYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 211 --~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
...|++.|+|||++.+ ..++.++||||||+++|+|++|..||................ ............++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~ 238 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-EHFQFPPDVTDVSE 238 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC-CcccCCCccCCCCH
Confidence 2357899999999863 347889999999999999999999886543322211111100 00000111123577
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHHHH
Q 020221 284 ELVRLASRCLQYEPRE--RPNPRSLVTA 309 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~--Rps~~~~l~~ 309 (329)
++.+++.+|+..++++ ||++.+++++
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 239 EAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 8999999988654443 7899999883
No 151
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=8.4e-43 Score=305.79 Aligned_cols=249 Identities=16% Similarity=0.225 Sum_probs=203.4
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
..+.|.+++.||.|+||.||++.. .+++.+|+|.+........+.+.+|+++++.++|||++++++.+..+...++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 445678888899999999999995 5688999999987665556778899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---- 209 (329)
|+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 83 FCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999999998864 345689999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 210 RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
....++..|+|||.+. +..++.++|+||||+++|+|++|..|+................ . .....+...+.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~ 237 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-P--PTLDQPSKWSSS 237 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC-C--CCcCCcccCCHH
Confidence 2235688899999875 3447789999999999999999998875432211111111100 0 011123456778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+.+++..||+.||++||++.++++
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhc
Confidence 999999999999999999999987
No 152
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=7.5e-43 Score=310.53 Aligned_cols=250 Identities=18% Similarity=0.257 Sum_probs=197.3
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
...|.+++.||+|+||.||+|. ..++..||+|.+...... ....+.+|+++++.++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 4567888899999999999998 446788999998754322 23457789999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---- 209 (329)
|+++ +|.+++.. ....+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 85 YLDK-DLKQYMDD-CGNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CCCC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 9976 88888754 334578999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------hccc----------
Q 020221 210 RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------LTDS---------- 271 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-------~~~~---------- 271 (329)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||............... ....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 23356789999998865 45888999999999999999999888654322111110000 0000
Q ss_pred cccC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 272 CLEG-------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 272 ~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.... ......++++.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000 011235678999999999999999999999997
No 153
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=4.5e-43 Score=313.63 Aligned_cols=232 Identities=19% Similarity=0.233 Sum_probs=188.9
Q ss_pred cCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHH-HHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEAR-AVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||++.. .+++.||+|++..... .....+.+|.. +++.++||||+++++++.+.+..++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 469999999999994 5688999999875321 12234555554 578889999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~ 214 (329)
+|...+. ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++...... ....+
T Consensus 82 ~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 82 ELFFHLQ--RERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccC
Confidence 9998885 345688899999999999999999999 9999999999999999999999999998753221 23457
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
++.|+|||++.+..++.++||||||+++|||++|..||............... ....+...+.++.+++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK------PLQLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred CcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHcc
Confidence 89999999999888999999999999999999999988665433322221111 112344567789999999999
Q ss_pred cCCCCCCCHH
Q 020221 295 YEPRERPNPR 304 (329)
Q Consensus 295 ~dp~~Rps~~ 304 (329)
.||.+||++.
T Consensus 233 ~~p~~R~~~~ 242 (321)
T cd05603 233 KDQRRRLGAK 242 (321)
T ss_pred CCHhhcCCCC
Confidence 9999999864
No 154
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=2e-42 Score=300.25 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=201.4
Q ss_pred cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
.+++.+.||+|++|.||++...++..+|+|.+..... ..+.+.+|+++++.++|+|++++++++. ....+++|||+.+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 3566777899999999999977767899999875442 3456889999999999999999998874 4678999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----Cc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SY 212 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~ 212 (329)
++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++....... ..
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 9999999754445689999999999999999999999 99999999999999999999999999987654322 12
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
.++..|+|||...+..++.++||||||+++|+|++ |..|+.............. ......+...+..+.+++.+
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-----GYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCcccCHHHHHHHHH
Confidence 34567999999988889999999999999999999 7766654332222211111 11122345567889999999
Q ss_pred hcccCCCCCCCHHHHHHHHHh
Q 020221 292 CLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L~~ 312 (329)
||+.||++||++.++++.|+.
T Consensus 239 ~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 239 CWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999875
No 155
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=7.8e-43 Score=308.70 Aligned_cols=252 Identities=17% Similarity=0.242 Sum_probs=207.5
Q ss_pred HHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCee
Q 020221 50 RTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDER 128 (329)
Q Consensus 50 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 128 (329)
....+....|.+++.||+|+||.||++. ..+++.||+|.+........+.+.+|+.+++.++|+|++++++++..+...
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 3344555778888999999999999999 467889999999876655566788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 208 (329)
++||||+++++|.+++. ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 92 WVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred EEeecccCCCCHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999999999984 35688999999999999999999999 999999999999999999999999999875443
Q ss_pred CC----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 209 GR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 209 ~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
.. ...+++.|+|||.+.+..++.++|+||||+++|++++|..||......... .............+...+..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 244 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIATNGTPELQNPERLSAV 244 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe---eeeccCCCCCCCCccccCHH
Confidence 32 235678899999999888999999999999999999999887543211110 00000011111223456678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+.+++.+||..||++||++.++++
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999999999999999998
No 156
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=2e-42 Score=300.46 Aligned_cols=243 Identities=18% Similarity=0.225 Sum_probs=199.0
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-----hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-----DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+.+.+.+|+|++|.||++. ..+++.+|+|.+...... ..+.+.+|+++++.++||||+++++++......++++
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 3445566999999999998 456889999998754311 2346788999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--- 209 (329)
||+++++|.+.+. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 84 e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 84 EYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EECCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999999886 345688999999999999999999999 9999999999999999999999999998754322
Q ss_pred ----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221 210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (329)
Q Consensus 210 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
....++..|+|||++.+..++.++||||||+++|+|++|+.||........... ..........+...+..+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 236 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSPDA 236 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCHHH
Confidence 223467889999999988899999999999999999999988754322111111 111111223455667889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 020221 286 VRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.+++.+||..+|++|||+.++++
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 237 RNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HHHHHHHhhcCcccCCCHHHHhh
Confidence 99999999999999999999998
No 157
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=1.9e-42 Score=307.74 Aligned_cols=250 Identities=18% Similarity=0.242 Sum_probs=199.5
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
.+++++.||+|+||.||++. ..++..+|+|.+...... ...++.+|+++++.++||||+++++++..++..++++||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 35677788999999999998 456888999998765332 2456889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCcc
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~ 213 (329)
++++|.+++.. ...+++..+..++.|++.||.|||+..+++|+||||+||++++++.++|+|||++...... ....
T Consensus 82 ~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (308)
T cd06615 82 DGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159 (308)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCC
Confidence 99999999863 3668999999999999999999997438999999999999999999999999998754332 3346
Q ss_pred CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc---hhhh----------------------
Q 020221 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---IQTL---------------------- 268 (329)
Q Consensus 214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~---~~~~---------------------- 268 (329)
++..|+|||.+.+..++.++|+||||+++|+|++|..|+............ ....
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (308)
T cd06615 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239 (308)
T ss_pred CCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhH
Confidence 788999999998888999999999999999999999887543221111000 0000
Q ss_pred ---cccc---ccCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221 269 ---TDSC---LEGQFS-SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 269 ---~~~~---~~~~~~-~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~ 309 (329)
.+.. .....+ ...+.++.+++.+||..||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred HHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 000111 1256789999999999999999999999983
No 158
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=1.6e-42 Score=314.69 Aligned_cols=246 Identities=15% Similarity=0.192 Sum_probs=192.3
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCC------e
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 127 (329)
..|.+++.||+|+||.||++. ..+++.||+|++.... ......+.+|+.+++.++||||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 457778888999999999998 4568899999997542 233456789999999999999999999885443 4
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.++||||+.+ +|...+. ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++....
T Consensus 101 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred eEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 7999999976 5766653 3478899999999999999999999 99999999999999999999999999987543
Q ss_pred CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc------------------hh
Q 020221 208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN------------------IQ 266 (329)
Q Consensus 208 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~------------------~~ 266 (329)
.. ....+|+.|+|||++.+..++.++||||||+++|+|++|..||............ ..
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 32 2346788999999999889999999999999999999999888643211000000 00
Q ss_pred hhccc--ccc----------------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 267 TLTDS--CLE----------------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 267 ~~~~~--~~~----------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..... ... .......++++.+|+.+||..||++|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 000 0011123567899999999999999999999998
No 159
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=2.3e-42 Score=299.05 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=205.7
Q ss_pred cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
.+++.+.+|.|+||.||++... ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++......++||||+++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 3556677899999999999874 67899999987654 466789999999999999999999999888999999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-ccCcc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-YSTNL 216 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~ 216 (329)
++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+........ ...+.
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 163 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV 163 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCCCEEEcccccccccccccccCCCcc
Confidence 9999999754444789999999999999999999999 999999999999999999999999999886643322 23356
Q ss_pred cccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhccc
Q 020221 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (329)
Q Consensus 217 ~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 295 (329)
.|+|||.+.+..++.++||||||++++++++ |..|+.............. ......+...++++.+++.+||..
T Consensus 164 ~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~ 238 (256)
T cd05039 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-----GYRMEAPEGCPPEVYKVMKDCWEL 238 (256)
T ss_pred cccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-----CCCCCCccCCCHHHHHHHHHHhcc
Confidence 7999999988889999999999999999997 8777654433222211111 112223445678899999999999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 020221 296 EPRERPNPRSLVTALVTL 313 (329)
Q Consensus 296 dp~~Rps~~~~l~~L~~~ 313 (329)
+|++|||+.++++.|+++
T Consensus 239 ~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 239 DPAKRPTFKQLREQLALI 256 (256)
T ss_pred ChhhCcCHHHHHHHHhcC
Confidence 999999999999999764
No 160
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=2.5e-42 Score=299.58 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=205.5
Q ss_pred cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
.+.+.+.||.|+||.||++..++++.+|+|.+..... ....+.+|+.+++.++|+||+++++++......+++|||+++
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence 4567778899999999999977778899999886543 356789999999999999999999999888899999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----Cc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SY 212 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~ 212 (329)
++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||++....... ..
T Consensus 86 ~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (261)
T cd05034 86 GSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164 (261)
T ss_pred CCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence 9999999764456789999999999999999999999 99999999999999999999999999987654321 12
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
..+..|+|||.+.+..++.++|+||||++++++++ |+.|+.............. ......+...+.++.+++.+
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-----GYRMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----CCCCCCCCCCCHHHHHHHHH
Confidence 23467999999998889999999999999999999 8877754332222211111 11122334457789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHh
Q 020221 292 CLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L~~ 312 (329)
||+.+|++||++.++.+.|+.
T Consensus 240 ~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 240 CWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HcccCcccCCCHHHHHHHHhc
Confidence 999999999999999998875
No 161
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.3e-42 Score=302.38 Aligned_cols=246 Identities=15% Similarity=0.165 Sum_probs=199.0
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
.|.+.+.||+|+||.||++. ..+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 46677778999999999998 55688999999987654555668889999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY 212 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~ 212 (329)
+++|.+++. ....+++.++..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++...... ...
T Consensus 90 ~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 90 GGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred CCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence 999999886 345789999999999999999999999 9999999999999999999999999998654322 234
Q ss_pred cCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc-hhhhccccccCCCChHHHHHHHHH
Q 020221 213 STNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-IQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 213 ~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
.++..|+|||++. ...++.++|+||||+++|+|++|..|+............ ......+... .....+..+.++
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 244 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLK--DKMKWSNSFHHF 244 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCccc--ccCCCCHHHHHH
Confidence 6788999999874 445888999999999999999999877543211111000 0001111100 112346789999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 020221 289 ASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~ 308 (329)
+.+||+.||++||++.++++
T Consensus 245 i~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 245 VKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHccCCchhCcCHHHHhc
Confidence 99999999999999999987
No 162
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=1.5e-42 Score=302.84 Aligned_cols=244 Identities=14% Similarity=0.210 Sum_probs=194.9
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeC------CeeEE
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEG------DERLL 130 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~~~l 130 (329)
|++.+.+|+|+||.||+|. ..+++.||+|.+.... .....+.+|+.+++.+ +|+|++++++++... ...++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 4455667999999999998 4568899999987654 3345688999999998 699999999998653 46899
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 209 (329)
+|||+.+++|.+++.......+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165 (272)
T ss_pred EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence 99999999999998754455789999999999999999999999 9999999999999999999999999998754322
Q ss_pred ---CCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221 210 ---RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (329)
Q Consensus 210 ---~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (329)
....++..|+|||++. +..++.++||||||+++|+|++|..|+........... ..............
T Consensus 166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 241 (272)
T cd06637 166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSKKW 241 (272)
T ss_pred ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCCCCCCc
Confidence 2345788999999986 33588899999999999999999987753321111111 01111111122345
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 282 GTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 282 ~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+.++.+++.+||..||++|||+.+++.
T Consensus 242 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 242 SKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 678999999999999999999999998
No 163
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=8.3e-43 Score=312.59 Aligned_cols=236 Identities=18% Similarity=0.225 Sum_probs=190.6
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||++. ..+++.||+|++..... ...+.+.+|+.++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 46999999999998 55678999999986432 2344578899998888 6999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----CCCccC
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD----GRSYST 214 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~----~~~~~~ 214 (329)
+|..++. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..... .....|
T Consensus 82 ~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 82 DLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred cHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccC
Confidence 9998885 345799999999999999999999999 999999999999999999999999999875321 123468
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH---HhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---IRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
++.|+|||++.+..++.++||||||+++|+|++|..||....... ............ ....+...+..+.+++.+
T Consensus 159 t~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHH
Confidence 899999999998899999999999999999999998884211000 000001111111 122455567889999999
Q ss_pred hcccCCCCCCCHH
Q 020221 292 CLQYEPRERPNPR 304 (329)
Q Consensus 292 cl~~dp~~Rps~~ 304 (329)
||..||++|+++.
T Consensus 237 ~L~~dP~~R~~~~ 249 (327)
T cd05617 237 FLNKDPKERLGCQ 249 (327)
T ss_pred HhccCHHHcCCCC
Confidence 9999999999853
No 164
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=1.7e-42 Score=301.91 Aligned_cols=250 Identities=18% Similarity=0.252 Sum_probs=200.3
Q ss_pred HHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221 51 TATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 51 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (329)
.+++++.....+ |+|+||.||+|. ..++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..+
T Consensus 5 ~~~~~~~~~~~l---g~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVL---GKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEE---ecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 345555555544 999999999998 5567889999988776666778999999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCcccC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPM--KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNS 206 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~ 206 (329)
+++||+++++|.+++... ...+ ++..+..++.|++.||.|||++ +++|+||||+||+++. ++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 82 IFMEQVPGGSLSALLRSK-WGPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEecCCCCCHHHHHHHh-cccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999998642 2344 7888999999999999999999 9999999999999986 678999999998654
Q ss_pred CCC----CCccCcccccCcccccCCC--CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221 207 RDG----RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (329)
Q Consensus 207 ~~~----~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (329)
... ....++..|+|||++.+.. ++.++|+||||+++|+|++|..|+............ ..........+..
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~ 236 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK---VGMFKIHPEIPES 236 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh---hhhhccCCCCCcc
Confidence 322 2235688999999987544 788999999999999999999877532111110000 0000112234556
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 281 EGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.++++.+++.+||+.+|++|||+.+++.
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 7788999999999999999999999998
No 165
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=9.2e-43 Score=317.17 Aligned_cols=251 Identities=17% Similarity=0.140 Sum_probs=198.3
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (329)
-....|++++.||+|+||.||++. ..+++.+|+|++.... ......+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 344567788888999999999999 4568899999986422 122345778999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+||||+++|+|.+++. ...++...+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMS---NYDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999985 34588899999999999999999999 9999999999999999999999999998765432
Q ss_pred -----CCccCcccccCcccccCCC----CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221 210 -----RSYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (329)
Q Consensus 210 -----~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (329)
....||+.|+|||++.+.. ++.++|||||||++|||++|..||................ .. ........
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~-~~~~~~~~ 273 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK-NS-LTFPDDND 273 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-Cc-ccCCCcCC
Confidence 2346899999999987543 7889999999999999999999887554322221111110 00 11111235
Q ss_pred HHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 020221 281 EGTELVRLASRCLQYEPRE--RPNPRSLVTAL 310 (329)
Q Consensus 281 ~~~~~~~li~~cl~~dp~~--Rps~~~~l~~L 310 (329)
.+.++.+++..||..++.+ |+++.+++++.
T Consensus 274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 6788999999999844433 67888888743
No 166
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=1.5e-42 Score=305.10 Aligned_cols=247 Identities=19% Similarity=0.233 Sum_probs=199.4
Q ss_pred cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
+..+.||.|+||+||++. ..+++.+|+|.+...... ....+.+|+++++.++|+|++.+.+.+..++..+++|||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 344556999999999998 457889999998654321 2345778999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCc
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSY 212 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~ 212 (329)
++++|.+.+.......+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++...... ...
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 999999888654455799999999999999999999999 9999999999999999999999999998654332 234
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
.++..|+|||++.+..++.++|+||||+++|+|++|..||................... ...++...+.++.+|+..|
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHHHHHHH
Confidence 67899999999998889999999999999999999998886543221111111111111 1123445677899999999
Q ss_pred cccCCCCCCC-----HHHHHHH
Q 020221 293 LQYEPRERPN-----PRSLVTA 309 (329)
Q Consensus 293 l~~dp~~Rps-----~~~~l~~ 309 (329)
|+.||++||+ +.+++++
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcC
Confidence 9999999999 7777763
No 167
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=1e-42 Score=315.63 Aligned_cols=247 Identities=15% Similarity=0.212 Sum_probs=193.8
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC------C
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------D 126 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 126 (329)
...|.+++.||+|+||.||++. ...++.||+|++..... .....+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 3457778888999999999998 45688999999976432 2345678899999999999999999988543 3
Q ss_pred eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (329)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 206 (329)
..+++|||+++ +|...+. ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 57999999976 6777663 3588899999999999999999999 9999999999999999999999999999765
Q ss_pred CCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-----------------
Q 020221 207 RDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----------------- 266 (329)
Q Consensus 207 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~----------------- 266 (329)
... ....++..|+|||++.+..++.++||||||+++|+|++|..||..............
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 443 234678999999999988899999999999999999999998865422111000000
Q ss_pred -hhcccc---------------c---cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 267 -TLTDSC---------------L---EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 267 -~~~~~~---------------~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...... . ....+...+.++.+++.+||+.||++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000000 0 00011223567899999999999999999999998
No 168
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=1.3e-42 Score=311.31 Aligned_cols=247 Identities=15% Similarity=0.160 Sum_probs=192.1
Q ss_pred ccccCCCC--CCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 61 IVSEHGEK--APNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 61 ~~~~lg~G--~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
+++.||+| +|++||++. ..+|+.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45567888 778999998 56789999999976532 22345778999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC------
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------ 209 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~------ 209 (329)
++|+|.+++.......+++..+..++.|++.||.|||++ +++||||||+||+++.++.++++||+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999998654445689999999999999999999999 9999999999999999999999999864332111
Q ss_pred -----CCccCcccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc----cc-------
Q 020221 210 -----RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT----DS------- 271 (329)
Q Consensus 210 -----~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~----~~------- 271 (329)
....++..|+|||++.+ ..++.++||||||+++|+|++|..||................. +.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 11235677999999876 3588999999999999999999988754221111100000000 00
Q ss_pred -----------------------------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 272 -----------------------------CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 272 -----------------------------~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..........++++.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000112234678999999999999999999999997
No 169
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=1.6e-42 Score=303.61 Aligned_cols=248 Identities=21% Similarity=0.343 Sum_probs=197.3
Q ss_pred ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
+++.+.+|+|+||.||+|... .+..||+|++..... .....+.+|+.+++.++||||+++++++..+...++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 556677799999999998742 246799999865432 2345688999999999999999999999988999999
Q ss_pred EecCCCCCHHhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221 132 AEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 203 (329)
|||+++++|.+++.+.. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCCCEEECCCCCc
Confidence 99999999999986421 12357888999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCC
Q 020221 204 KNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (329)
Q Consensus 204 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (329)
....... ...++..|+|||.+.+..++.++||||||+++|||++ |..|+............. .. ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~----~~-~~~~ 241 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM----EG-GLLD 241 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----cC-CcCC
Confidence 7543321 1234678999999998889999999999999999999 566665432222211111 11 1112
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
.+...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 334566789999999999999999999999998863
No 170
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=2e-42 Score=299.25 Aligned_cols=245 Identities=16% Similarity=0.205 Sum_probs=203.6
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
|.+.+.+|+|+||.||++. ..+++.+|+|.++... ....+.+.+|+.+++.++|+|++++++.+.+.+..++++||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 4567788999999999998 4568899999986543 2345668889999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----Cc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SY 212 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~ 212 (329)
+++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++.++++|||.+....... ..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCCcEEEcccCcceeecccccccccc
Confidence 99999988654556689999999999999999999999 99999999999999999999999999987554322 34
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
.++..|+|||++.+..++.++|+||||+++|+|++|..||............... .....+...+..+.+++.+|
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG-----SYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC-----CCCCCCcccCHHHHHHHHHH
Confidence 5778899999998888999999999999999999999888654332222111111 11123445677899999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 020221 293 LQYEPRERPNPRSLVTA 309 (329)
Q Consensus 293 l~~dp~~Rps~~~~l~~ 309 (329)
|+.||++||++.+++..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
No 171
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=4.4e-42 Score=301.15 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=201.2
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCC----EEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQF----RIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
.+++++.||+|+||+||+|. ..++. .||+|.+...... ....+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence 35566778999999999998 44444 4899998765432 34568899999999999999999998865 467899
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS 211 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 211 (329)
+||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +++|+||||+||++++++.+||+|||+++.......
T Consensus 87 ~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 87 TQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999999864 335689999999999999999999999 999999999999999999999999999876543221
Q ss_pred ------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 212 ------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 212 ------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
..++..|+|||.+.+..++.++||||||+++|||++ |..|+.......... .+........+...+.+
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 239 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-----LLEKGERLPQPPICTID 239 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-----HHHCCCcCCCCccCCHH
Confidence 223567999999988889999999999999999998 776654332221111 11111112233456778
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
+.+++.+||..||++||++.++++.|+++....
T Consensus 240 ~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 240 VYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 999999999999999999999999999887655
No 172
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=2.4e-42 Score=304.87 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=202.6
Q ss_pred ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 130 (329)
+++.+.||+|+||.||++... +...+|+|.+..... .....+.+|++++..+ +|+||+++++++...+..++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 556677899999999999843 236799999876432 2345688999999999 79999999999999999999
Q ss_pred EEecCCCCCHHhhhccC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCee
Q 020221 131 VAEYMPNDTLAKHLFHW--------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPR 196 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~k 196 (329)
+|||+++|+|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Nil~~~~~~~k 172 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVLVTEDHVMK 172 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeEEEcCCCeEE
Confidence 99999999999998542 234688999999999999999999999 999999999999999999999
Q ss_pred eecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhc
Q 020221 197 LSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLT 269 (329)
Q Consensus 197 l~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~ 269 (329)
|+|||++....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|++.............
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--- 249 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE--- 249 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc---
Confidence 99999987654322 1223567999999988889999999999999999998 7777665433222221111
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
......+...+..+.+++.+||..||++|||+.++++.|+.+.
T Consensus 250 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 250 --GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1112234456778999999999999999999999999998763
No 173
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=3.1e-42 Score=302.19 Aligned_cols=243 Identities=18% Similarity=0.255 Sum_probs=195.5
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
+++++.||+|+||.||++. ..+++.||+|.+..... ...+.+.+|+++++.++||||+++++++......++|+||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 4566778999999999998 56788999999876532 234568899999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCccC
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYST 214 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~ 214 (329)
+++|..+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ....+
T Consensus 83 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (279)
T cd06619 83 GGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVG 155 (279)
T ss_pred CCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCC
Confidence 99986543 468888999999999999999999 9999999999999999999999999998754432 33467
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH---HhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---IRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
+..|+|||++.+..++.++|+||||+++|+|++|..||....... ......................++++.+++.+
T Consensus 156 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 235 (279)
T cd06619 156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQ 235 (279)
T ss_pred ChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHH
Confidence 889999999998889999999999999999999998875321100 00000111111111111123356789999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 020221 292 CLQYEPRERPNPRSLVT 308 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~ 308 (329)
||+.||++||+++++++
T Consensus 236 ~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 236 CMRKQPKERPAPENLMD 252 (279)
T ss_pred HhhCChhhCCCHHHHhc
Confidence 99999999999999998
No 174
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=2.8e-42 Score=306.62 Aligned_cols=254 Identities=21% Similarity=0.302 Sum_probs=205.0
Q ss_pred cccccccCCCCCCcEEEEEEeC--------CCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCe
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 127 (329)
.+.+.+.||+|+||.||++... +...+|+|.+.... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 98 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 4677888999999999999742 23569999998653 23355688899999999 79999999999999999
Q ss_pred eEEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~ 193 (329)
.++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+. |++|+||||+||+++.++
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDN 177 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHHheEEcCCC
Confidence 999999999999999996432 13478999999999999999999999 999999999999999999
Q ss_pred CeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchh
Q 020221 194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (329)
Q Consensus 194 ~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~ 266 (329)
.++|+|||++....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+............
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~-- 255 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-- 255 (307)
T ss_pred cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH--
Confidence 99999999987654321 1123467999999998889999999999999999998 66666543332222111
Q ss_pred hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
........+...+.++.+++.+||..+|++|||+.++++.|+++.+..
T Consensus 256 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 256 ---KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ---HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 111122334556789999999999999999999999999999987653
No 175
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-44 Score=300.56 Aligned_cols=244 Identities=17% Similarity=0.237 Sum_probs=208.1
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
+.++++||+|+||.||++. ..+|+.+|+|.+.... +.+++.+|+.++++.+.|++|+++|.|.....+|+|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 3466788999999999998 5679999999987643 688999999999999999999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCcc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYS 213 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~ 213 (329)
||+.+.++- ++++++++.+..+++..+.||+|||.. .-+|||||..|||++-+|.+||+|||.|....+. .+..
T Consensus 113 GSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T KOG0574|consen 113 GSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVI 190 (502)
T ss_pred CcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccc
Confidence 999998865 678999999999999999999999998 8899999999999999999999999999876654 4668
Q ss_pred CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (329)
Q Consensus 214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 293 (329)
||+-|||||++..-.|+.++||||||++..||.-|++|+.+- ..++. .......+...-.-|..++.++.+++++||
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI--HPMRA-IFMIPT~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI--HPMRA-IFMIPTKPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc--cccce-eEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence 999999999999999999999999999999999999766432 11111 111111111122345678999999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 020221 294 QYEPRERPNPRSLVTA 309 (329)
Q Consensus 294 ~~dp~~Rps~~~~l~~ 309 (329)
-.+|++|-|+.+++++
T Consensus 268 iK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEH 283 (502)
T ss_pred cCCHHHHHHHHHHhhh
Confidence 9999999999999873
No 176
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=3.9e-42 Score=297.99 Aligned_cols=242 Identities=20% Similarity=0.284 Sum_probs=195.6
Q ss_pred cCCCCCCcEEEEEEeC---CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221 64 EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
.||+|+||.||+|.+. ++..||+|.+...... ..+.+.+|+.+++.++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3699999999999743 4557999998765432 2456889999999999999999999875 457899999999999
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-------c
Q 020221 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-------Y 212 (329)
Q Consensus 140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-------~ 212 (329)
|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++........ .
T Consensus 81 L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 9999864 345789999999999999999999999 999999999999999999999999999875433221 1
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
.++..|+|||.+.+..++.++||||||+++|++++ |..|+.......... ..........+...++++.+++.+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-----FIEQGKRLDCPAECPPEMYALMKD 233 (257)
T ss_pred CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-----HHHCCCCCCCCCCCCHHHHHHHHH
Confidence 22467999999988889999999999999999996 887765432221111 111112223445567899999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 020221 292 CLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
||..||++||++.++.+.|+.+
T Consensus 234 c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 234 CWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HcCCChhhCcCHHHHHHHHhhh
Confidence 9999999999999999998864
No 177
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=3.9e-42 Score=297.64 Aligned_cols=244 Identities=16% Similarity=0.184 Sum_probs=200.7
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee-CCeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 134 (329)
|++++.+|.|++|.||++. ..+++.+|+|.+..... ...+.+.+|+++++.++|+|++++.+.+.. ....++++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 6677888999999999998 45678999999875432 234568889999999999999999988764 3467899999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~ 210 (329)
+++++|.+++.......+++.++..++.|++.||.+||+. +++|+||||+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 9999999998754455689999999999999999999999 9999999999999999999999999998755332 2
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
...+++.|+|||++.+..++.++|+||||+++++|++|+.|+............... .....+...++++.+++.
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG-----KLPPMPKDYSPELGELIA 235 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-----CCCCCccccCHHHHHHHH
Confidence 335678999999999888999999999999999999999887654332222111111 112234556789999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~ 308 (329)
+||+.||++|||+.++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 236 TMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHhccCcccCCCHHHHhc
Confidence 999999999999999998
No 178
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=3.6e-44 Score=329.63 Aligned_cols=251 Identities=21% Similarity=0.310 Sum_probs=214.9
Q ss_pred cccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 60 NIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
++-+.||.|.||.|++|.++ ....||||.++....+. ..+|+.|..+|.+++||||++|.|+........||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 34456799999999999853 24679999999876543 45699999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc--
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY-- 212 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-- 212 (329)
|++|+|+.+|++.. ..+++-++..+.+.|+.|++||-+. |+|||||..+|||++.+..+|++|||+++...++...
T Consensus 712 MENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm-~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 712 MENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred hhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhc-CchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 99999999998744 5599999999999999999999999 9999999999999999999999999999987665422
Q ss_pred ---cC--cccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 213 ---ST--NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 213 ---~~--~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
.| .++|.|||.+...+++.++||||||+++||.++ |.+|+.+.....+.+ -++...+-+.|.++|..+.
T Consensus 790 tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk-----aIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK-----AIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH-----HHHhccCCCCCCCCcHHHH
Confidence 11 378999999999999999999999999999887 667776543333332 3333455566889999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
+|+..||++|-.+||.+.+|+..|+++...+
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 9999999999999999999999999997653
No 179
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=2.4e-42 Score=302.14 Aligned_cols=238 Identities=24% Similarity=0.382 Sum_probs=189.7
Q ss_pred cCCCCCCcEEEEEEeC-------------------------CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccccc
Q 020221 64 EHGEKAPNVVYKGKLE-------------------------NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANL 118 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 118 (329)
.||+|+||.||+|... ....|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5799999999999731 124589999876554445568889999999999999999
Q ss_pred ceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-----
Q 020221 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV----- 193 (329)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~----- 193 (329)
++++.+....++||||+++|+|..++.+ ....+++..+..++.|++.||+|||++ +++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEeccCcccCc
Confidence 9999999999999999999999998864 345689999999999999999999999 999999999999997644
Q ss_pred --CeeeecccCcccCCCCCCccCcccccCcccccC-CCCCCcccchhhhHHHHHHH-hCCCCCCchhhHHHhhhchhhhc
Q 020221 194 --NPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLL-SGKHIPPSHALDLIRDRNIQTLT 269 (329)
Q Consensus 194 --~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~-tg~~~~~~~~~~~~~~~~~~~~~ 269 (329)
.++++|||++..........++..|+|||.+.+ ..++.++||||||+++||++ +|..|+.......... ..
T Consensus 160 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-----~~ 234 (274)
T cd05076 160 SPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-----FY 234 (274)
T ss_pred cceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-----HH
Confidence 379999999876554445567788999998875 45889999999999999995 6776664332211111 11
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221 270 DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L 310 (329)
.. ....+...++.+.+++.+||+.+|++|||+.++++.|
T Consensus 235 ~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 235 EK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred Hh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11 0112233346799999999999999999999999876
No 180
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=6.1e-42 Score=298.94 Aligned_cols=248 Identities=22% Similarity=0.349 Sum_probs=197.7
Q ss_pred cccccCCCCCCcEEEEEEeC-C---CCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCe------
Q 020221 60 NIVSEHGEKAPNVVYKGKLE-N---QFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDE------ 127 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 127 (329)
.+.+.+|+|+||.||+|... + +..||+|.++.... .....+.+|++.++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 45567799999999999843 2 36799999886532 234568899999999999999999998865543
Q ss_pred eEEEEecCCCCCHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221 128 RLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 203 (329)
.++++||+++++|..++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCCeEEECCccce
Confidence 78999999999999888532 224689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCC------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCC
Q 020221 204 KNSRDGRS------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (329)
Q Consensus 204 ~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (329)
+....... ...+..|+|||.+.+..++.++||||||+++|||++ |..|+........... +... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~----~~~~-~~~~ 235 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY----LRHG-NRLK 235 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcC-CCCC
Confidence 76543321 223568999999988889999999999999999999 6666544322211111 1111 1122
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
.+...+.++.+++.+||+.||++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3455678999999999999999999999999999875
No 181
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=3.5e-42 Score=305.54 Aligned_cols=252 Identities=19% Similarity=0.306 Sum_probs=203.0
Q ss_pred cccccccCCCCCCcEEEEEEe--------CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCe
Q 020221 58 MENIVSEHGEKAPNVVYKGKL--------ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 127 (329)
.+.+.+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (304)
T cd05101 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 95 (304)
T ss_pred HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence 355667789999999999973 124579999987543 23356788999999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~ 193 (329)
.+++|||+++++|.+++.+.. ...+++.++..++.|++.||.|||++ |++|+||||+||++++++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nili~~~~ 174 (304)
T cd05101 96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAARNVLVTENN 174 (304)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-CeeecccccceEEEcCCC
Confidence 999999999999999986531 23578889999999999999999999 999999999999999999
Q ss_pred CeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchh
Q 020221 194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (329)
Q Consensus 194 ~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~ 266 (329)
.++|+|||++....... ...++..|+|||++.+..++.++||||||+++|+|++ |..|+..............
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 254 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254 (304)
T ss_pred cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 99999999987654322 1234567999999988889999999999999999998 6666654333322221111
Q ss_pred hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (329)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~ 315 (329)
......+...+.++.+++.+||..+|++|||+.++++.|+++..
T Consensus 255 -----~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 255 -----GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -----CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 11112344567889999999999999999999999999999865
No 182
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=3.9e-42 Score=302.25 Aligned_cols=253 Identities=18% Similarity=0.314 Sum_probs=199.5
Q ss_pred ccccccCCCCCCcEEEEEEe-----CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-----ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 130 (329)
+.+++.||+|+||.||++.. .++..||+|.+.... ......+.+|+++++.++|||++++.+++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 46778889999999999973 357889999987553 22345688999999999999999999988765 56899
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
+|||+++++|.+++.+ ....+++..+..++.|++.||+|||++ |++|+||||+||++++++.++|+|||++.......
T Consensus 86 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 86 IMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEccCCCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999854 234689999999999999999999999 99999999999999999999999999987654322
Q ss_pred -------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh-------h---hchhhhccccc
Q 020221 211 -------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR-------D---RNIQTLTDSCL 273 (329)
Q Consensus 211 -------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~-------~---~~~~~~~~~~~ 273 (329)
...++..|+|||++.+..++.++||||||+++|+|+++..|.......... . ...........
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence 234566799999998888999999999999999999987543221100000 0 00000011111
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 274 EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 274 ~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
....+..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1122345678999999999999999999999999999875
No 183
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=3.5e-42 Score=302.77 Aligned_cols=249 Identities=17% Similarity=0.258 Sum_probs=201.2
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
++++++.||+|+||.||++.. .+++.||+|.+.... ......+.+|+++++.++|+||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 467888899999999999995 478899999887543 223457889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCc
Q 020221 136 PNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (329)
Q Consensus 136 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~ 212 (329)
++++|..++.... ...+++..+..++.|++.||.|||+..+++|+||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN 161 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccC
Confidence 9999998885421 2378999999999999999999997439999999999999999999999999998764332 233
Q ss_pred cCcccccCcccccCCC------CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGR------VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
.++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........... ....... .....+..++.++.
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~ 239 (286)
T cd06622 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-LSAIVDG-DPPTLPSGYSDDAQ 239 (286)
T ss_pred CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-HHHHhhc-CCCCCCcccCHHHH
Confidence 5678899999986443 57899999999999999999998865432222111 1111111 12234556788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 020221 287 RLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+++.+||..+|++||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 240 DFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHcccCcccCCCHHHHhc
Confidence 9999999999999999999997
No 184
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=2.5e-42 Score=314.01 Aligned_cols=246 Identities=15% Similarity=0.202 Sum_probs=193.4
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC------Ce
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE 127 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 127 (329)
..|.+++.||+|+||.||++. ...++.||||++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 457777888999999999998 4568889999997542 23345678899999999999999999987543 35
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.++||||+++ +|...+. ..+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 104 ~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred EEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 7999999976 6777763 3478899999999999999999999 99999999999999999999999999997654
Q ss_pred CC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc---------------
Q 020221 208 DG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT--------------- 269 (329)
Q Consensus 208 ~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~--------------- 269 (329)
.. ....++..|+|||++.+..++.++||||||+++|+|++|+.||.................
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 43 234678999999999998999999999999999999999988865322111111000000
Q ss_pred ---ccc-----------c-------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 270 ---DSC-----------L-------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 270 ---~~~-----------~-------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
... . ........+.++.+++.+||..||++|||+.++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0 00011123467899999999999999999999998
No 185
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=6.6e-42 Score=296.42 Aligned_cols=242 Identities=29% Similarity=0.415 Sum_probs=201.8
Q ss_pred cCCCCCCcEEEEEEeC-C---CCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKLE-N---QFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||++... . +..+++|.+....... .+.+.+|++.++.++|+|++++++++......+++|||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 4699999999999954 3 7889999998765443 567899999999999999999999999989999999999999
Q ss_pred CHHhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221 139 TLAKHLFHWE-------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (329)
Q Consensus 139 sL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-- 209 (329)
+|.+++.... ...+++..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999997531 36789999999999999999999999 9999999999999999999999999999876543
Q ss_pred ----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhC-CCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 210 ----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSG-KHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 210 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
....++..|+|||.+.+..++.++||||||+++++|+++ ..|+.............. ......+...+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 235 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-----GYRLPKPEYCPDE 235 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----CCCCCCCccCChH
Confidence 233467889999999888899999999999999999994 766654422222211111 1222344556889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
+.+++.+||..||++|||+.++++.|+
T Consensus 236 ~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 236 LYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 999999999999999999999998873
No 186
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=7.3e-42 Score=294.80 Aligned_cols=241 Identities=25% Similarity=0.397 Sum_probs=198.6
Q ss_pred cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHh
Q 020221 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 142 (329)
.||+|+||.||+|...++..+|+|.+....... ...+.+|+++++.++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 469999999999997788899999987664332 3468899999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----CccCccc
Q 020221 143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----SYSTNLA 217 (329)
Q Consensus 143 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~ 217 (329)
++.. ....+++..+..++.|++.+|.|+|+. +++|+||||+||+++.++.++|+|||++....... ...++..
T Consensus 82 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 82 FLRK-KKDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 8864 334678999999999999999999999 99999999999999999999999999986543321 1233567
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 296 (329)
|+|||++.+..++.++||||||+++|++++ |..||............. .......+...+..+.+++.+||+.+
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-----KGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-----cCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 999999998889999999999999999998 777775443322221111 11122334456788999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 020221 297 PRERPNPRSLVTALV 311 (329)
Q Consensus 297 p~~Rps~~~~l~~L~ 311 (329)
|++||++.++++.|.
T Consensus 235 p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 235 PENRPKFSELQKELA 249 (250)
T ss_pred cccCCCHHHHHHHhc
Confidence 999999999998874
No 187
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=7.6e-42 Score=297.36 Aligned_cols=253 Identities=19% Similarity=0.235 Sum_probs=205.4
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|++.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+++++.++|+|++++++++...+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 4566777899999999999954 78899999886432 2224568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221 134 YMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-- 209 (329)
|+++++|.+++.+. ....+++.++..++.+++.||.|||+. |++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999988642 235589999999999999999999999 9999999999999999999999999998754332
Q ss_pred --CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh-HHHHHHH
Q 020221 210 --RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS-DEGTELV 286 (329)
Q Consensus 210 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 286 (329)
....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.......... ............+. ..+..+.
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH---HhhhhcCCCCCCChhhcCHHHH
Confidence 22356788999999998889999999999999999999998875432211100 00011111112222 5667899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221 287 RLASRCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
+++.+||..+|++|||+.++++.|+++.
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999999999874
No 188
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=4.2e-42 Score=304.72 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=201.2
Q ss_pred ccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 130 (329)
+.+.+.||+|+||.||++.. ..+..||+|.+..... ...+.+.+|+.+++.+ +|+||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 45666779999999999973 1345799999876532 2345688999999999 79999999999999999999
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
+|||+.+|+|.+++.......+++.++..++.|++.||.|||++ +++|+||||+||+++.++.++++|||++.......
T Consensus 117 v~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 195 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195 (302)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCCeEEECCCcccccccCCC
Confidence 99999999999999653444589999999999999999999999 99999999999999999999999999987554322
Q ss_pred ------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 211 ------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 211 ------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
...++..|+|||.+.+..++.++||||||+++|+|++ |..|+........... ..........+...++
T Consensus 196 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 271 (302)
T cd05055 196 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK----LIKEGYRMAQPEHAPA 271 (302)
T ss_pred ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH----HHHcCCcCCCCCCCCH
Confidence 1234578999999998889999999999999999998 8877654322211111 1111111122334567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 284 ELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
++.+++.+||..+|++|||+.++++.|+++
T Consensus 272 ~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 272 EIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 899999999999999999999999999874
No 189
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=6.1e-42 Score=297.84 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=201.5
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
.|++.+.+|.|+||+||+|. ..++..+++|++..... ...+.+.+|++.++.++|+|++++++.+..+...++++|++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 35677778999999999999 45688999999876432 24567899999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221 136 PNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (329)
Q Consensus 136 ~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---- 210 (329)
++++|.+++..... ..+++..+..++.|++.||+|||+. |++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999999965322 5689999999999999999999999 99999999999999999999999999986554432
Q ss_pred ----CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221 211 ----SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (329)
Q Consensus 211 ----~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
...++..|+|||.+... .++.++|+||||+++|+|++|..|+.............................++++
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSF 240 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHH
Confidence 22467889999998877 6889999999999999999999887543222111111111111110111113567889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 020221 286 VRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.+++.+||..||++||++.+++.
T Consensus 241 ~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 241 RKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHcCCChhhCcCHHHHhh
Confidence 99999999999999999999998
No 190
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=1.1e-41 Score=295.54 Aligned_cols=248 Identities=15% Similarity=0.163 Sum_probs=202.8
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
.+++.+.+|.|+||.||++.. .+++.+++|.+........+.+.+|+++++.++||||+++++++......+++|||+.
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 456777789999999999984 5678899999987665566789999999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY 212 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~ 212 (329)
+++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 84 ~~~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 161 (262)
T cd06613 84 GGSLQDIYQV-TRGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161 (262)
T ss_pred CCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence 9999998864 335789999999999999999999999 9999999999999999999999999998765432 233
Q ss_pred cCcccccCcccccCC---CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
.++..|+|||.+.+. .++.++|+||||+++|+|++|..|+................... .....+...+.++.+++
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 240 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-PKLKDKEKWSPVFHDFI 240 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC-ccccchhhhhHHHHHHH
Confidence 567889999998876 78899999999999999999998875432111111111110011 01112345678899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 020221 290 SRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 290 ~~cl~~dp~~Rps~~~~l~ 308 (329)
.+||..||++|||+.+++.
T Consensus 241 ~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 241 KKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHcCCChhhCCCHHHHhc
Confidence 9999999999999999987
No 191
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=5e-42 Score=296.64 Aligned_cols=244 Identities=16% Similarity=0.205 Sum_probs=200.8
Q ss_pred cccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
.|++.+.+|.|+||.||++... +++.+++|.+..... .+.+.+|+++++.++|+||+++++.+......++++||++
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 3556677799999999999954 478999999876532 6679999999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----Cc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SY 212 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~ 212 (329)
+++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (256)
T cd06612 82 AGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV 159 (256)
T ss_pred CCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence 9999999854 346789999999999999999999999 99999999999999999999999999987654432 23
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
.++..|+|||.+.+..++.++||||||+++|+|++|..|+.............. ........+...+.++.+++.+|
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCCCCCCchhhcCHHHHHHHHHH
Confidence 467899999999988899999999999999999999988754321111100000 00001112334567899999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020221 293 LQYEPRERPNPRSLVT 308 (329)
Q Consensus 293 l~~dp~~Rps~~~~l~ 308 (329)
|+.||++|||+.++++
T Consensus 237 l~~~P~~Rps~~~il~ 252 (256)
T cd06612 237 LVKDPEERPSAIQLLQ 252 (256)
T ss_pred HhcChhhCcCHHHHhc
Confidence 9999999999999998
No 192
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=4.2e-43 Score=304.00 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=199.0
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHH--HHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDAR--QFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|++++.||+|+||+||++. ..+++.+|+|.+......... ...+|+.+++.++||||+++++++......+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677888999999999999 455678999999887644332 2456999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC----CCCCC
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS----RDGRS 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~----~~~~~ 211 (329)
.+++|.+++. ....+++..+..++.|++.||.+||+. +++|+||||+||++++++.++|+|||.+... .....
T Consensus 81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 157 (260)
T PF00069_consen 81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNP 157 (260)
T ss_dssp TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSS
T ss_pred cccccccccc--ccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence 9999999996 456789999999999999999999999 9999999999999999999999999998742 22234
Q ss_pred ccCcccccCccccc-CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccc-ccCCCChHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLR-TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC-LEGQFSSDEGTELVRLA 289 (329)
Q Consensus 212 ~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li 289 (329)
..++..|+|||++. +..++.++||||+|+++++|++|..|+.................... .........++++.+++
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 56788999999998 77899999999999999999999988765411111111100000000 00011112248999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 020221 290 SRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 290 ~~cl~~dp~~Rps~~~~l~ 308 (329)
.+||+.||++|||+.++++
T Consensus 238 ~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHT
T ss_pred HHHccCChhHCcCHHHHhc
Confidence 9999999999999999998
No 193
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=5.2e-42 Score=299.02 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=201.3
Q ss_pred cccccccCCCCCCcEEEEEEeC-CC---CEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE-NQ---FRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
.+++.+.||+|+||.||+|... ++ ..||+|.+.... ......+..|+.+++.++||||+++++++..+...+++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4567778899999999999843 33 369999987653 223567899999999999999999999999889999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS- 211 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~- 211 (329)
||+++++|.+++.. ....+++.++..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 85 EFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred ecCCCCcHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999999864 345689999999999999999999999 999999999999999999999999999875433221
Q ss_pred ------ccC--cccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221 212 ------YST--NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (329)
Q Consensus 212 ------~~~--~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (329)
..+ +..|+|||.+.+..++.++||||||+++||+++ |..|+............. .......+.+++
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-----~~~~~~~~~~~~ 237 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-----QDYRLPPPMDCP 237 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-----cCCcCCCcccCC
Confidence 111 347999999998889999999999999999886 887775433222221111 111122334567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 283 TELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
..+.+++.+||..+|++||++.+++..|+.+
T Consensus 238 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 238 TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 7899999999999999999999999998864
No 194
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=3.1e-42 Score=311.01 Aligned_cols=247 Identities=18% Similarity=0.255 Sum_probs=193.0
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeC------Ce
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG------DE 127 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 127 (329)
..|.+++.||+|+||+||++. ..+++.||+|++...... ..+.+.+|+++++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 457778888999999999998 567889999998764322 245577899999999999999999887543 35
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.+++++++ +++|.+++ ....+++..+..++.||+.||.|||+. +++||||||+||++++++.+||+|||++....
T Consensus 95 ~~~~~~~~-~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 95 VYLVTNLM-GADLNNIV---KCQKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEEeecC-CCCHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 68999988 67898887 345799999999999999999999999 99999999999999999999999999998654
Q ss_pred CC-CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-------hhhccccc-----
Q 020221 208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------QTLTDSCL----- 273 (329)
Q Consensus 208 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-------~~~~~~~~----- 273 (329)
.. ....++..|+|||++.+ ..++.++||||||+++|+|++|..||+............ ........
T Consensus 170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07878 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR 249 (343)
T ss_pred CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence 43 34567899999999876 458899999999999999999998886532211110000 00000000
Q ss_pred -----cCCCC--------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 274 -----EGQFS--------SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 274 -----~~~~~--------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
....+ ...++.+.+++.+||..||++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 250 KYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 123456889999999999999999999997
No 195
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=8.5e-42 Score=298.04 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=194.4
Q ss_pred ccccCCCCCCcEEEEEEeCC-CC--EEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC------CeeE
Q 020221 61 IVSEHGEKAPNVVYKGKLEN-QF--RIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERL 129 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~ 129 (329)
+.+.||+|+||.||+|...+ +. .+|+|.++... ....+.+.+|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 34567999999999998544 32 58999887643 23356788999999999999999999987432 2568
Q ss_pred EEEecCCCCCHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221 130 LVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
+++||+.+|+|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||++..
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCCCEEECCCCcccc
Confidence 999999999999877421 234578999999999999999999999 999999999999999999999999999886
Q ss_pred CCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221 206 SRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (329)
Q Consensus 206 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (329)
..... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+............. .......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~ 236 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-----QGNRLKQP 236 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----cCCCCCCC
Confidence 54322 2234568999999998889999999999999999999 666665432221111111 11111223
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 45667899999999999999999999999999875
No 196
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=6e-42 Score=299.43 Aligned_cols=242 Identities=15% Similarity=0.229 Sum_probs=200.3
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
.|++++.+|.|++|.||++. ..+++.||+|.+.... ......+.+|+++++.++|+|++++.+++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 35667778999999999999 4568899999987653 333556889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~ 211 (329)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 82 GGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred CCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 99999999853 3789999999999999999999999 9999999999999999999999999998765543 23
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH-HHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD-EGTELVRLAS 290 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~ 290 (329)
..++..|+|||.+.+..++.++||||||+++|+|++|..|+............. .......+.. .++++.+++.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~ 232 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-----KNNPPSLEGNKFSKPFKDFVS 232 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-----hcCCCCCcccccCHHHHHHHH
Confidence 456778999999998889999999999999999999998875432111111111 1111122222 6778999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~ 308 (329)
+||..||++|||++++++
T Consensus 233 ~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 233 LCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHhhCChhhCcCHHHHhh
Confidence 999999999999999987
No 197
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=5.3e-42 Score=296.68 Aligned_cols=244 Identities=18% Similarity=0.195 Sum_probs=203.3
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|.+++.+|+|+||.||++. ..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 5667788999999999998 5578899999986532 233457889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~ 211 (329)
.+++|.+++.......+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....... .
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 999999988653445688999999999999999999999 99999999999999999999999999987654432 2
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
..+++.|+|||++.+..++.++|+||||+++++|++|..|+............... .....+...+.++.+++.+
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-----SYPPVSSHYSYDLRNLVSQ 235 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC-----CCCCCcccCCHHHHHHHHH
Confidence 34678899999999888999999999999999999999887654333222111111 1122345567889999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 020221 292 CLQYEPRERPNPRSLVT 308 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~ 308 (329)
||+.+|++||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 236 LFKRNPRDRPSVNSILE 252 (256)
T ss_pred HhhCChhhCcCHHHHhh
Confidence 99999999999999998
No 198
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=7.5e-42 Score=301.37 Aligned_cols=251 Identities=20% Similarity=0.285 Sum_probs=202.4
Q ss_pred ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
+.+.+.||+|+||.||+|... +...+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..+++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI 81 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence 345667799999999999842 235688998876543 2345688999999999999999999999999999999
Q ss_pred EecCCCCCHHhhhccCC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee
Q 020221 132 AEYMPNDTLAKHLFHWE----------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~ 189 (329)
+||+.+++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dikp~nill 160 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLAARNVLV 160 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-CeehhhhhhheEEE
Confidence 99999999999875321 13578899999999999999999999 99999999999999
Q ss_pred CCCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhh
Q 020221 190 DDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRD 262 (329)
Q Consensus 190 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~ 262 (329)
++++.++|+|||++....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+.......+..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999987543322 1234568999999988889999999999999999998 887765443222221
Q ss_pred hchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221 263 RNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (329)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~ 315 (329)
. .........+...+.++.+++.+||+.||++||++.++++.|+++-.
T Consensus 241 ~-----~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 241 L-----LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H-----HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 11111222345567889999999999999999999999999998764
No 199
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.5e-41 Score=307.87 Aligned_cols=242 Identities=13% Similarity=0.176 Sum_probs=188.8
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
.|++++.||+|+||.||+|.. .++..||+|+..... ...|+.+++.++|+||+++++++......++|+|++.
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 477888889999999999994 456789999854322 3468999999999999999999999999999999995
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCcc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYS 213 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~ 213 (329)
++|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+||+++.++.++|+|||++...... ....
T Consensus 141 -~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 141 -SDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred -CcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence 588888854 446789999999999999999999999 9999999999999999999999999998753322 2346
Q ss_pred CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh----HHH--hhhchhhhc------ccccc-------
Q 020221 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLI--RDRNIQTLT------DSCLE------- 274 (329)
Q Consensus 214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~----~~~--~~~~~~~~~------~~~~~------- 274 (329)
||..|+|||++.+..++.++||||||+++|||+++..++..... ... ....+...+ .....
T Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 297 (357)
T PHA03209 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRL 297 (357)
T ss_pred ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHH
Confidence 78999999999988999999999999999999997655432100 000 000000000 00000
Q ss_pred ------------CCC-------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 275 ------------GQF-------SSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 275 ------------~~~-------~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
... ....+.++.++|.+||+.||++|||+.++++
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 298 VRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 000 0123456778999999999999999999998
No 200
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=8.4e-43 Score=313.04 Aligned_cols=235 Identities=17% Similarity=0.181 Sum_probs=186.8
Q ss_pred CCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcC---CCccccccceeeeeCCeeEEEEecCCC
Q 020221 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQL---RNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
||+|+||+||++. ..+++.||+|++...... .......|..++... .||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 5999999999998 456889999998653211 223345566666655 699999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCcc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYS 213 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~ 213 (329)
|+|..++. ....+++..+..++.||+.||+|||++ +++||||||+|||++.++.++|+|||++...... ....
T Consensus 81 g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence 99999886 446789999999999999999999999 9999999999999999999999999998753222 2346
Q ss_pred CcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC-hHHHHHHHHHHHH
Q 020221 214 TNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS-SDEGTELVRLASR 291 (329)
Q Consensus 214 ~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ 291 (329)
||..|+|||++.+.. ++.++||||||+++|+|++|..||................ ..++ ...++++.+++.+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~~li~~ 231 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK------VRFPKNVLSDEGRQFVKG 231 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC------CCCCCccCCHHHHHHHHH
Confidence 889999999987654 8899999999999999999999886654332222111110 0111 2356789999999
Q ss_pred hcccCCCCCCC----HHHHHH
Q 020221 292 CLQYEPRERPN----PRSLVT 308 (329)
Q Consensus 292 cl~~dp~~Rps----~~~~l~ 308 (329)
||+.||++||+ +.++++
T Consensus 232 ~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 232 LLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HcCCCHHHCCCCCCCHHHHhc
Confidence 99999999994 555554
No 201
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=1e-41 Score=297.22 Aligned_cols=246 Identities=21% Similarity=0.254 Sum_probs=189.8
Q ss_pred cCCCCCCcEEEEEEeCC---CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221 64 EHGEKAPNVVYKGKLEN---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
.||+|+||.||+|...+ +..+|+|.++..... ....+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 57999999999998533 457999998765432 23468889999999999999999999998889999999999999
Q ss_pred HHhhhccCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------
Q 020221 140 LAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------ 210 (329)
Q Consensus 140 L~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------ 210 (329)
|.+++.... ....++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCC
Confidence 999986422 22456778889999999999999999 99999999999999999999999999986543221
Q ss_pred CccCcccccCcccccCC-------CCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221 211 SYSTNLAFTPPEYLRTG-------RVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (329)
...++..|+|||++.+. .++.++||||||+++|||++ |..||......................+......+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLS 240 (269)
T ss_pred CcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCC
Confidence 23456789999988642 35789999999999999996 88777543222211111111111111122223456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 283 TELVRLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
..+.+++..|| .+|++|||+.+|+..|+
T Consensus 241 ~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 241 DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 77899999999 68999999999998764
No 202
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=9.2e-42 Score=294.34 Aligned_cols=241 Identities=27% Similarity=0.421 Sum_probs=198.6
Q ss_pred cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHh
Q 020221 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 142 (329)
.||+|+||.||++...+++.|++|.+...... ....+.+|+++++.++|+||+++++++......++++||+.+++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 56999999999999766889999998876544 45678999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC------ccCcc
Q 020221 143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS------YSTNL 216 (329)
Q Consensus 143 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~------~~~~~ 216 (329)
++.. ....+++..+..++.+++.||.|||++ +++|+||+|+||+++.++.++|+|||++........ ...+.
T Consensus 82 ~l~~-~~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 82 FLRK-KKNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 9864 334688999999999999999999999 999999999999999999999999999876542221 12245
Q ss_pred cccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhccc
Q 020221 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQY 295 (329)
Q Consensus 217 ~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 295 (329)
.|+|||.+.++.++.++|+||||+++|+|++ |..|+............ ........+...+.++.+++.+||..
T Consensus 160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-----ESGYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-----hcCCCCCCCccCCHHHHHHHHHHhcc
Confidence 6999999988889999999999999999999 66555443222211111 11112223455678999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 020221 296 EPRERPNPRSLVTALV 311 (329)
Q Consensus 296 dp~~Rps~~~~l~~L~ 311 (329)
+|++|||+.++++.|+
T Consensus 235 ~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 235 DPENRPSFSEIYNELQ 250 (251)
T ss_pred ChhhCcCHHHHHHHhh
Confidence 9999999999999886
No 203
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=8.1e-42 Score=297.35 Aligned_cols=241 Identities=18% Similarity=0.291 Sum_probs=198.1
Q ss_pred cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---------HHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (329)
.+.+.||.|++|.||+|. ..+++.+|+|.+....... .+.+.+|+.+++.++||||+++++++......+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 344567999999999998 4567899999887643221 245788999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+++||+++++|.+++.+ ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.++.....
T Consensus 83 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 83 IFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred EEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 99999999999999963 35688999999999999999999999 9999999999999999999999999998765421
Q ss_pred ----------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh
Q 020221 210 ----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (329)
Q Consensus 210 ----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (329)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..... ......+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~ 234 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI----FKIGE-NASPEIPS 234 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH----HHHhc-cCCCcCCc
Confidence 1234678899999999888999999999999999999999888643221111 11111 12223445
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 280 DEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 280 ~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..+..+.+++.+||+.||++||++.++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 235 NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 56788999999999999999999999998
No 204
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=2e-42 Score=311.32 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=212.9
Q ss_pred ccCCCCCCcEEEEEEeCC-----CCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 63 SEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
+.||.|.||.||+|.+.+ .-.||||..+.+. ..+.+.|++|..+|+.++||||++++|+|.+ ...|||||+++
T Consensus 395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~ 473 (974)
T KOG4257|consen 395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAP 473 (974)
T ss_pred HhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEeccc
Confidence 567999999999998533 2458999998864 3456779999999999999999999999954 68999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCcc---
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYS--- 213 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~--- 213 (329)
.|.|..||.. +...++......++.||+.||+|||++ +.|||||..+|||+.....+||+|||+++...+..-+.
T Consensus 474 ~GELr~yLq~-nk~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~ 551 (974)
T KOG4257|consen 474 LGELREYLQQ-NKDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASR 551 (974)
T ss_pred chhHHHHHHh-ccccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcceeeecccchhhhccccchhhccc
Confidence 9999999976 556789999999999999999999999 99999999999999999999999999999877765433
Q ss_pred --CcccccCcccccCCCCCCcccchhhhHHHHHHHhCC-CCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 214 --TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 214 --~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
-.+.|||||.++...++.++|||-|||.+||+++-+ .||.+ +.+.+....++..-+.+.|+.+|+.+..++.
T Consensus 552 ~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg-----vkNsDVI~~iEnGeRlP~P~nCPp~LYslms 626 (974)
T KOG4257|consen 552 GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG-----VKNSDVIGHIENGERLPCPPNCPPALYSLMS 626 (974)
T ss_pred cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc-----ccccceEEEecCCCCCCCCCCCChHHHHHHH
Confidence 246799999999999999999999999999998744 55543 4445555566666777889999999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhhh
Q 020221 291 RCLQYEPRERPNPRSLVTALVTLQK 315 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~~L~~~~~ 315 (329)
+||++||.+||.+.++...|..+..
T Consensus 627 kcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 627 KCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999999999999988865
No 205
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=4.1e-42 Score=314.72 Aligned_cols=250 Identities=20% Similarity=0.303 Sum_probs=200.1
Q ss_pred ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 130 (329)
+.+.+.||+|+||.||+|.+. .+..||+|++...... ..+.+.+|+.++..+. ||||+++++++......++
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i 118 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI 118 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence 456677899999999999853 3467999999865433 2446889999999997 9999999999999899999
Q ss_pred EEecCCCCCHHhhhccCC--------------------------------------------------------------
Q 020221 131 VAEYMPNDTLAKHLFHWE-------------------------------------------------------------- 148 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~-------------------------------------------------------------- 148 (329)
|+||+++|+|.+++....
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 999999999999886421
Q ss_pred ----------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC
Q 020221 149 ----------------------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (329)
Q Consensus 149 ----------------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~ 194 (329)
...+++..+..++.|++.||.|||+. +++||||||+|||+++++.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~NiLl~~~~~ 277 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAARNVLICEGKL 277 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCcceEEEeCCCE
Confidence 12357778899999999999999999 9999999999999999999
Q ss_pred eeeecccCcccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhh
Q 020221 195 PRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT 267 (329)
Q Consensus 195 ~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~ 267 (329)
++|+|||+++..... ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......... ..
T Consensus 278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~----~~ 353 (401)
T cd05107 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF----YN 353 (401)
T ss_pred EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH----HH
Confidence 999999998754322 12345678999999998889999999999999999998 77666432211111 11
Q ss_pred hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
......+...+...+.++.+++.+||..+|++||+++++++.|+.+
T Consensus 354 ~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 354 AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111112233445678999999999999999999999999999875
No 206
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=9.9e-42 Score=295.16 Aligned_cols=242 Identities=22% Similarity=0.297 Sum_probs=197.8
Q ss_pred cCCCCCCcEEEEEEeCC--C--CEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKLEN--Q--FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|++|.||++.+.+ + ..||+|.+..... ...+.+.+|+..++.++||||+++++.+.. ...++++||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 46999999999998533 3 3699999988765 456678999999999999999999999987 8899999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-------C
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-------S 211 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-------~ 211 (329)
+|.+++.+.....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 159 (257)
T cd05040 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159 (257)
T ss_pred cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCCEEEeccccccccccccccceecccC
Confidence 999999753335689999999999999999999999 99999999999999999999999999987654421 2
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
..++..|+|||.+.+..++.++||||||+++|+|++ |..|+.............. .......+...+..+.+++.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd05040 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK----EGERLERPEACPQDIYNVML 235 (257)
T ss_pred CCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCcCCCCccCCHHHHHHHH
Confidence 345678999999998889999999999999999998 8877643322221111111 11111223445778999999
Q ss_pred HhcccCCCCCCCHHHHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~~L~ 311 (329)
+||+.+|++|||+.++++.|.
T Consensus 236 ~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 236 QCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHCCCCcccCCCHHHHHHHhc
Confidence 999999999999999999874
No 207
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=4.7e-42 Score=301.36 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=203.9
Q ss_pred CcccccccCCCCCCcEEEEEEeC-----CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeee--CCee
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLE-----NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCE--GDER 128 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 128 (329)
..+++++.||+|+||.||++.+. +++.+|+|.+...... ..+.+.+|++.++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34567788899999999999843 3678999999876543 45678999999999999999999998876 5578
Q ss_pred EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 208 (329)
+++|||+++++|.+++.. ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred EEEEecCCCCCHHHHHHh-CccccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 999999999999999964 233589999999999999999999999 999999999999999999999999999887653
Q ss_pred CCC-------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh----------hhchhhhccc
Q 020221 209 GRS-------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR----------DRNIQTLTDS 271 (329)
Q Consensus 209 ~~~-------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~----------~~~~~~~~~~ 271 (329)
... ...+..|+|||.+.+..++.++||||||+++++|++|..|+......... .......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 221 22345699999998888999999999999999999999876443211110 0011111111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
......+..++.++.+++.+||..+|++|||+.++++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 112222345567899999999999999999999999999876
No 208
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=8.4e-42 Score=297.74 Aligned_cols=245 Identities=20% Similarity=0.277 Sum_probs=187.8
Q ss_pred cCCCCCCcEEEEEEeCC---CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221 64 EHGEKAPNVVYKGKLEN---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
.||+|+||.||+|...+ ...+++|.+...... ....+.+|+..++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 57999999999997432 356888887654322 23467899999999999999999999999999999999999999
Q ss_pred HHhhhccCCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC------C
Q 020221 140 LAKHLFHWET---QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------R 210 (329)
Q Consensus 140 L~~~l~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~------~ 210 (329)
|.+++..... ...++.....++.||+.||+|||+. +++||||||+||++++++.+||+|||++...... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 9999865321 2346788899999999999999999 9999999999999999999999999998653222 1
Q ss_pred CccCcccccCcccccC-------CCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221 211 SYSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (329)
...++..|+|||++.. ..++.++||||||+++|||++ |..|+.........................+...+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS 240 (269)
T ss_pred CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence 2234567999998743 346789999999999999999 55555433222111111111111112223344567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221 283 TELVRLASRCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L 310 (329)
..+.+++..|| .||++|||+.+|++.|
T Consensus 241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 241 DRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred HHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 88899999999 5999999999999876
No 209
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=5.4e-42 Score=303.88 Aligned_cols=251 Identities=17% Similarity=0.249 Sum_probs=198.5
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
.++.|.+++.||.|+||.||++.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++..+...++|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 456788889999999999999984 4678999999875432 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--- 209 (329)
||+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 84 e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLDK-DLKQYLDD-CGNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred ecccc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 99974 89888864 345688999999999999999999999 9999999999999999999999999998754322
Q ss_pred -CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-------hhhcccc--------
Q 020221 210 -RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------QTLTDSC-------- 272 (329)
Q Consensus 210 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-------~~~~~~~-------- 272 (329)
....++..|+|||.+.+. .++.++||||||+++|+|++|..||............. .......
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 223457899999988754 47889999999999999999998886543221111000 0000000
Q ss_pred -----ccC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 273 -----LEG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 273 -----~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
... ......++++.+++.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 011235678899999999999999999999998
No 210
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=9.5e-42 Score=299.12 Aligned_cols=252 Identities=19% Similarity=0.241 Sum_probs=203.1
Q ss_pred ccccccCCCCCCcEEEEEEeCC-----CCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeee-CCeeEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLV 131 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 131 (329)
+.+.+.||+|+||.||+|...+ +..|++|.+..... .....+.+|+.+++.++|+||+++++++.. +...+++
T Consensus 8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 87 (280)
T cd05043 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVL 87 (280)
T ss_pred eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEE
Confidence 4556677999999999999654 68899999875532 234568899999999999999999998765 4678999
Q ss_pred EecCCCCCHHhhhccCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221 132 AEYMPNDTLAKHLFHWET------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
++|+++++|.+++..... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.
T Consensus 88 ~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 88 YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred EEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 999999999999864322 4689999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221 206 SRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (329)
Q Consensus 206 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (329)
..... ...++..|+|||++.+..++.++||||||+++||+++ |..|+............. .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~ 241 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-----DGYRLAQP 241 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-----cCCCCCCC
Confidence 54322 2234677999999988889999999999999999999 887765432222211111 11111223
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~ 316 (329)
..+++++.+++.+||..||++|||+.++++.|+.+.+.
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 44577899999999999999999999999999998764
No 211
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=3.1e-42 Score=304.13 Aligned_cols=239 Identities=18% Similarity=0.243 Sum_probs=196.8
Q ss_pred ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (329)
..||+|+||.||++. ..++..||+|.+........+.+.+|+..++.++|+|++++++.+..++..+++|||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 456999999999998 4568899999987665555667889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCccc
Q 020221 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLA 217 (329)
Q Consensus 142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~ 217 (329)
+++. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++...... ....++..
T Consensus 108 ~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~ 183 (292)
T cd06658 108 DIVT---HTRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183 (292)
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCcc
Confidence 9884 34689999999999999999999999 9999999999999999999999999998654322 22356789
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 297 (329)
|+|||.+.+..++.++||||||+++|||++|..|+........... .......... .....+..+.+++.+||..||
T Consensus 184 y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P 260 (292)
T cd06658 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDNLPPRVK--DSHKVSSVLRGFLDLMLVREP 260 (292)
T ss_pred ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcCCCccc--cccccCHHHHHHHHHHccCCh
Confidence 9999999888899999999999999999999988764332211111 1111111111 122356789999999999999
Q ss_pred CCCCCHHHHHH
Q 020221 298 RERPNPRSLVT 308 (329)
Q Consensus 298 ~~Rps~~~~l~ 308 (329)
++|||+.++++
T Consensus 261 ~~Rpt~~~il~ 271 (292)
T cd06658 261 SQRATAQELLQ 271 (292)
T ss_pred hHCcCHHHHhh
Confidence 99999999997
No 212
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=3.9e-42 Score=308.92 Aligned_cols=249 Identities=17% Similarity=0.139 Sum_probs=196.2
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|++++.||+|+||.||++.. .+++.+|+|++.... ......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 466778889999999999994 457889999986422 1223447789999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---- 209 (329)
|+++|+|.+++.+ ....+++..+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 82 y~~~g~L~~~l~~-~~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 82 YYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred ccCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999999999964 235689999999999999999999999 9999999999999999999999999998654322
Q ss_pred -CCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 210 -RSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 210 -~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
....||+.|+|||++. ...++.++||||||+++|||++|+.||................. ...........++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~s~ 238 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-RFQFPAQVTDVSE 238 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-cccCCCccccCCH
Confidence 1246889999999986 34588899999999999999999998876543222222111110 0001111234678
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHHHH
Q 020221 284 ELVRLASRCLQYEPRE--RPNPRSLVTA 309 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~--Rps~~~~l~~ 309 (329)
++.+++.+|+..++++ |+++.+++++
T Consensus 239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 239 DAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 8999999999765554 6889999874
No 213
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=1.3e-41 Score=295.04 Aligned_cols=248 Identities=20% Similarity=0.310 Sum_probs=202.4
Q ss_pred cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
.+++.+.+|+|+||.||++...++..+|+|.+.... .....+.+|+++++.++|+||+++.+.+.. ...+++|||+++
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 456777889999999999997777789999887643 235678899999999999999999999877 778999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-----c
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-----Y 212 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-----~ 212 (329)
++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+........ .
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 163 (260)
T cd05073 85 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 163 (260)
T ss_pred CcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence 9999999754455678899999999999999999999 999999999999999999999999999876543221 1
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
.++..|+|||++.+..++.++|+||||+++|++++ |..|+............... .....+...+.++.+++.+
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~ 238 (260)
T cd05073 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-----YRMPRPENCPEELYNIMMR 238 (260)
T ss_pred cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-----CCCCCcccCCHHHHHHHHH
Confidence 23467999999988889999999999999999999 77776544322222111111 1112234556789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhh
Q 020221 292 CLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
||+.+|++||++.+++..|+.+
T Consensus 239 ~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 239 CWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred HcccCcccCcCHHHHHHHHhcC
Confidence 9999999999999999998753
No 214
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=1.5e-41 Score=293.94 Aligned_cols=245 Identities=18% Similarity=0.190 Sum_probs=203.2
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|+.++.+|+|+||.||.+. ..+++.+++|.+.... ....+.+.+|+++++.++|+||+++++++.+....+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 5667778999999999998 5668899999987543 233556889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~ 211 (329)
++++|.+++.+.....+++.++..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 999999999754445689999999999999999999999 99999999999999999999999999987654332 3
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
..+++.|.|||.+.+..++.++|+||||+++|+|++|..|+.............. .. ....+...+.++.+++.+
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~i~~ 235 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ----GN-YTPVVSVYSSELISLVHS 235 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----CC-CCCCccccCHHHHHHHHH
Confidence 4578899999999888889999999999999999999988765432222211111 11 112234557789999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 020221 292 CLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~ 309 (329)
||..+|++||++.++++.
T Consensus 236 ~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 236 LLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HcccCcccCCCHHHHhhC
Confidence 999999999999999983
No 215
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=7.6e-42 Score=299.37 Aligned_cols=248 Identities=20% Similarity=0.303 Sum_probs=198.9
Q ss_pred ccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
+.+++.||+|++|.||+|... .+..|++|.+...... ....+.+|+.+++.++|+||+++++++.+....+++
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 456677799999999999854 4578999988755433 244688999999999999999999999888899999
Q ss_pred EecCCCCCHHhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC---CeeeecccCc
Q 020221 132 AEYMPNDTLAKHLFHWET-----QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLM 203 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a 203 (329)
|||+++++|.+++.+... ..+++..+..++.||+.||.|||++ +++|+||||+||+++.++ .++|+|||++
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcceEeccCccc
Confidence 999999999999864321 2588999999999999999999999 999999999999998655 5999999998
Q ss_pred ccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCC
Q 020221 204 KNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (329)
Q Consensus 204 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (329)
+...... ....+..|+|||++.+..++.++||||||+++|+|++ |..||........... ........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~-----~~~~~~~~ 241 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF-----VTGGGRLD 241 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----HHcCCcCC
Confidence 7653221 1122467999999998889999999999999999997 7777655433222111 11112223
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
.+...+..+.+++.+||+.+|++|||+.+++++|+.
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 345567889999999999999999999999998863
No 216
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-42 Score=305.70 Aligned_cols=251 Identities=17% Similarity=0.241 Sum_probs=211.4
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|.+-+.||+|.|+.|-+++ .-+|+.||||++.+..... ...+.+|++.|+.++|||||+++++......+|||+|+-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 4455667999999999998 6689999999998875443 345889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecccCcccCCCCC---C
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDGR---S 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~---~ 211 (329)
++|+|.+||-. ....+.+..+.+++.||+.|+.|+|.. .+|||||||+||++. .-|-+||.|||++-.+.++. +
T Consensus 100 D~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqL-HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~T 177 (864)
T KOG4717|consen 100 DGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQL-HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTT 177 (864)
T ss_pred CCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhh-hhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhc
Confidence 99999999975 456799999999999999999999999 999999999999886 46789999999998888774 5
Q ss_pred ccCcccccCcccccCCCCCC-cccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTP-ESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
.+|.+.|.|||.+.|..|+. .+||||||||||.|++|+.||........... ++ .+ ....|...+.++++||.
T Consensus 178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm----Im-DC-KYtvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM----IM-DC-KYTVPSHVSKECRDLIQ 251 (864)
T ss_pred ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh----hh-cc-cccCchhhhHHHHHHHH
Confidence 57899999999999998775 79999999999999999988865433222211 11 11 23467889999999999
Q ss_pred HhcccCCCCCCCHHHHHH--HHHhhhhcc
Q 020221 291 RCLQYEPRERPNPRSLVT--ALVTLQKDT 317 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~--~L~~~~~~~ 317 (329)
.||..||.+|-+.++|.. +|+.+.+..
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHhcCchhhccHHHHhccccccCCCCCc
Confidence 999999999999999985 444444433
No 217
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=1.1e-41 Score=296.82 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=199.7
Q ss_pred cccccCCCCCCcEEEEEEeC-CC---CEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 60 NIVSEHGEKAPNVVYKGKLE-NQ---FRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
+..+.+|+|+||.||+|... ++ ..+|+|.+.... ....+.+.+|+++++.++|+|++++.+++...+..+++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence 34455699999999999853 33 379999987653 23355688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC---
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS--- 211 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--- 211 (329)
+++++|.+++.. ....+++.++..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 165 (268)
T cd05063 88 MENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY 165 (268)
T ss_pred CCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCCcEEECCCccceecccccccce
Confidence 999999999864 345689999999999999999999999 999999999999999999999999999875543221
Q ss_pred ----ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 212 ----YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 212 ----~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
...+..|+|||++.+..++.++||||||+++|+|++ |..|+.............. ......+.+.+.++.
T Consensus 166 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~~ 240 (268)
T cd05063 166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-----GFRLPAPMDCPSAVY 240 (268)
T ss_pred eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-----CCCCCCCCCCCHHHH
Confidence 112356999999988889999999999999999997 8887754332222211111 112223345678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 287 RLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
+++.+||+.+|++||++.++++.|+++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 999999999999999999999999875
No 218
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=1.1e-41 Score=295.64 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=191.9
Q ss_pred cCCCCCCcEEEEEEeC----CCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeee-eCCeeEEEEecCCC
Q 020221 64 EHGEKAPNVVYKGKLE----NQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCC-EGDERLLVAEYMPN 137 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~ 137 (329)
.||+|+||.||+|... +...+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++++||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 4699999999999842 23579999986433 234567889999999999999999999775 35568899999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--------
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-------- 209 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-------- 209 (329)
++|.+++.+ .....++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 82 ~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 82 GDLRNFIRS-ETHNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 999999864 234567888899999999999999999 9999999999999999999999999998754321
Q ss_pred CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCch-hhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSH-ALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+... ........ +. .......+...+..+.++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~l 234 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY----LL-QGRRLLQPEYCPDPLYEV 234 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----Hh-cCCCCCCCCcCCHHHHHH
Confidence 1223456899999998888999999999999999999976544322 11111111 11 111112233456789999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221 289 ASRCLQYEPRERPNPRSLVTALVTLQK 315 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~~L~~~~~ 315 (329)
+.+||..+|++||++.++++.|+++..
T Consensus 235 i~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 235 MLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 999999999999999999999998753
No 219
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=6.6e-42 Score=300.75 Aligned_cols=248 Identities=19% Similarity=0.226 Sum_probs=194.4
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|++++.||+|++|.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|||++++++++..+...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 56777889999999999994 5688999999875432 22456788999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221 136 PNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (329)
Q Consensus 136 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~ 210 (329)
. ++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... .
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 7 58888875433 25689999999999999999999999 9999999999999999999999999998754322 1
Q ss_pred CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh--------------------hhc
Q 020221 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------------------TLT 269 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~--------------------~~~ 269 (329)
...+++.|+|||.+.+. .++.++||||||+++++|++|+.||.............. ...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 23457889999988754 478899999999999999999987754321111000000 000
Q ss_pred ccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 270 DSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 270 ~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..... .......++++.+++.+||..||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 0011235678899999999999999999999998
No 220
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=9.1e-42 Score=298.64 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=200.7
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
.+.+.+.||+|+||.||++... .+..||+|.+..... .....+.+|+++++.++|+||+++++++......++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 86 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV 86 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence 4567778899999999999853 236899999876542 234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccC
Q 020221 131 VAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 202 (329)
+|||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCCCEEECCccc
Confidence 999999999999986422 22468889999999999999999999 999999999999999999999999999
Q ss_pred cccCCCC------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccC
Q 020221 203 MKNSRDG------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (329)
Q Consensus 203 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (329)
++..... ....++..|+|||.+.+..++.++||||||+++||+++ |..|+............. .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-----~~~~~ 240 (277)
T cd05032 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-----DGGHL 240 (277)
T ss_pred chhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-----cCCCC
Confidence 8754332 12234678999999988889999999999999999998 777765433222221111 11112
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
..+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 234456789999999999999999999999999876
No 221
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.6e-43 Score=313.65 Aligned_cols=249 Identities=21% Similarity=0.336 Sum_probs=215.2
Q ss_pred ccccCCCCCCcEEEEEEeCC-CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221 61 IVSEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
...+||-|.||.||.|.|+. ...||||.++.+.. ..++|+.|..+|+.++|||+|+++|+|.....+|||+|||..|+
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 34567999999999999654 67899999988763 47789999999999999999999999999999999999999999
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--CccC---
Q 020221 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--SYST--- 214 (329)
Q Consensus 140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~--- 214 (329)
|.+||++.+...++.-..+.++.||.+|++||..+ ++|||||..+|+|+.++..+|++|||++++...+. .+.|
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKF 428 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKF 428 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccC
Confidence 99999987777788888999999999999999999 99999999999999999999999999998765442 2223
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCC-CCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 293 (329)
.+.|.|||.+..+.++.++|||+|||+||||.|-+ .|++.-... ....+++...+-.-|..|++.+.+|+.+||
T Consensus 429 PIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~LLEkgyRM~~PeGCPpkVYeLMraCW 503 (1157)
T KOG4278|consen 429 PIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYGLLEKGYRMDGPEGCPPKVYELMRACW 503 (1157)
T ss_pred cccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHHHHhccccccCCCCCCHHHHHHHHHHh
Confidence 47899999999999999999999999999998854 566654332 233444555555667889999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhc
Q 020221 294 QYEPRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 294 ~~dp~~Rps~~~~l~~L~~~~~~ 316 (329)
+.+|.+||++.++-+.++.+-.+
T Consensus 504 ~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 504 NWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cCCcccCccHHHHHHHHHHHhcc
Confidence 99999999999999999987544
No 222
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=9.2e-42 Score=296.76 Aligned_cols=244 Identities=17% Similarity=0.226 Sum_probs=198.5
Q ss_pred ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh------hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+.+.+.||.|+||.||+|...++..+|+|.+...... ....+.+|+++++.++|+||+++++++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 4455667999999999999778889999998754321 1345788999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC----
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---- 208 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~---- 208 (329)
||+++++|.+++.+ ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 99999999999863 35688999999999999999999999 999999999999999999999999998865321
Q ss_pred ------CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221 209 ------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (329)
Q Consensus 209 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (329)
.....++..|+|||++.+..++.++||||||+++|+|++|..||............ . .........+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~ 235 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-G--AHRGLMPRLPDSFS 235 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-h--hccCCCCCCCCCCC
Confidence 12335678999999999888999999999999999999999887542211111000 0 00011122344567
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 283 TELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.++.+++.+||..+|++||++.++++
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 88999999999999999999999998
No 223
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-42 Score=310.56 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=208.8
Q ss_pred cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhH-HHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA-RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.+.++||+|.||.|..+...++..||||+++....... .+|.+|+++|.+++||||+.++|+|..++.+++|+||+++|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 45678999999999999988889999999998765544 78999999999999999999999999999999999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc------
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY------ 212 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~------ 212 (329)
+|.+++.........-....+|+.||+.|++||.+. ++|||||.++|+|+|.++++||+|||+++....+..+
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~-nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~ 699 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL-NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRA 699 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh-chhhccccccceeecCcccEEecCcccccccccCCceeeecce
Confidence 999999764434445566778999999999999999 9999999999999999999999999999976655433
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHh--CCCCCCchhhHHHhhhchhhhccccc---cCCCChHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS--GKHIPPSHALDLIRDRNIQTLTDSCL---EGQFSSDEGTELVR 287 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 287 (329)
.-.++|||+|.+..++++.++|+|+||+++||+++ ...|+.....+.+.+. ...+.+... -...|.-++..+.+
T Consensus 700 vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-~~~~~~~~~~~~~l~~P~~cp~~lye 778 (807)
T KOG1094|consen 700 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-AGEFFRDQGRQVVLSRPPACPQGLYE 778 (807)
T ss_pred eeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-hhhhcCCCCcceeccCCCcCcHHHHH
Confidence 33589999999999999999999999999999966 4456654433333222 222222111 11235567888999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 288 LASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 288 li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
++..||..|-++||+++++...|++.
T Consensus 779 lml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 779 LMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 99999999999999999999888764
No 224
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.5e-41 Score=302.91 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=202.7
Q ss_pred cccccccCCCCCCcEEEEEEeC--------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCe
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDE 127 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 127 (329)
.+.+.+.||+|+||.||++... ....+|+|.+..... .....+.+|+.+++.+ +||||+++++++.....
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 3556778899999999999731 245799999876432 2345688999999999 69999999999988889
Q ss_pred eEEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~ 193 (329)
.++++||+++|+|.+++.... ...+++.++..++.|++.||.|||++ |++|+||||+||+++.++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLAARNVLVTEDN 171 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-CeeeccccceeEEEcCCC
Confidence 999999999999999986422 23578999999999999999999999 999999999999999999
Q ss_pred CeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchh
Q 020221 194 NPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQ 266 (329)
Q Consensus 194 ~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~ 266 (329)
.+||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|+|++ |..|+..............
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 251 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 99999999997654321 1123457999999998889999999999999999999 7766654332222211111
Q ss_pred hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221 267 TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~ 316 (329)
......+..++.++.+++.+||+.||++|||+.++++.|+++...
T Consensus 252 -----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 252 -----GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 111123445667899999999999999999999999999999763
No 225
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=4.2e-42 Score=308.55 Aligned_cols=248 Identities=17% Similarity=0.127 Sum_probs=195.3
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|++++.||+|+||.||++. ..+++.||+|.+.... ......+.+|..++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 46778888999999999999 4567889999986532 1223447788999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+++|+|.+++.+ ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 82 y~~gg~L~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 82 YYVGGDLLTLLSK-FEDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 9999999999964 235689999999999999999999999 99999999999999999999999999987654322
Q ss_pred --CccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 211 --SYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 211 --~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
...|++.|+|||++.+ +.++.++||||||+++|+|++|+.||................. ...........++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~~~ 238 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE-RFQFPSHITDVSE 238 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC-cccCCCccccCCH
Confidence 2458899999999875 4578899999999999999999998865433222211111000 0000111234578
Q ss_pred HHHHHHHHhcccCCCC--CCCHHHHHH
Q 020221 284 ELVRLASRCLQYEPRE--RPNPRSLVT 308 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~--Rps~~~~l~ 308 (329)
++.+++.+|+..++++ |+++.++++
T Consensus 239 ~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 239 EAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 8999999999876554 457888776
No 226
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=5.9e-42 Score=317.57 Aligned_cols=242 Identities=18% Similarity=0.204 Sum_probs=189.6
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
.|.+.+.||+|+||.||++.. ..++.||+|.... ..+.+|+++++.++|+||+++++++..++..+++||++.
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 366778889999999999994 4578899996432 235689999999999999999999999999999999995
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------ 210 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------ 210 (329)
++|..++.. ....+++.++..++.|++.||.|||++ ||+||||||+|||++.++.++|+|||+++......
T Consensus 244 -~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 244 -SDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred -CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 588888854 334799999999999999999999999 99999999999999999999999999987643321
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchh------------hHHHhhhchh-hhcccc-----
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA------------LDLIRDRNIQ-TLTDSC----- 272 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~------------~~~~~~~~~~-~~~~~~----- 272 (329)
...||..|+|||++.+..++.++|||||||++|||++|..++.... ...+...... ......
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 2358999999999999889999999999999999999875443211 1111110000 000000
Q ss_pred -----------ccC-----CCC--hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 273 -----------LEG-----QFS--SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 273 -----------~~~-----~~~--~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
... .+. ...+..+.+|+.+||+.||.+|||+.|+|+
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 000 023457899999999999999999999999
No 227
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=1.2e-41 Score=300.83 Aligned_cols=255 Identities=19% Similarity=0.273 Sum_probs=199.4
Q ss_pred CcccccccCCCCCCcEEEEEEeCC-----------------CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCcccccc
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLEN-----------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANL 118 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~ 118 (329)
..+++++.||+|+||.||++...+ +..||+|.+...... ..+.+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 356788889999999999987432 245899998865433 35578899999999999999999
Q ss_pred ceeeeeCCeeEEEEecCCCCCHHhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee
Q 020221 119 LGCCCEGDERLLVAEYMPNDTLAKHLFHWE---------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (329)
Q Consensus 119 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~ 189 (329)
++++...+..++++||+++++|.+++.+.. ...+++..++.++.|++.||+|||+. +++|+||||+||++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlkp~Nili 163 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLATRNCLV 163 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccchhceee
Confidence 999998899999999999999999986432 12689999999999999999999999 99999999999999
Q ss_pred CCCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh--CCCCCCchhhHHHh
Q 020221 190 DDDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS--GKHIPPSHALDLIR 261 (329)
Q Consensus 190 ~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~~~~~~~~~~~~ 261 (329)
+.++.++|+|||++....... ...++..|+|||.+.+..++.++||||||+++|+|++ +..|+.........
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHH
Confidence 999999999999987543321 2234678999999988889999999999999999998 44444332211111
Q ss_pred hhchhhhc--cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 262 DRNIQTLT--DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 262 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
........ ........+...+.++.+++.+||+.||++|||+.++++.|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 244 ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111000 0001111233456789999999999999999999999998863
No 228
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=1.6e-41 Score=293.58 Aligned_cols=244 Identities=18% Similarity=0.207 Sum_probs=201.8
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|.+++.||+|+||.||++. ..+++.+|+|.+..... ...+.+.+|+++++.++|||++++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 5667778999999999998 45688999999876432 23556889999999999999999999998889999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcccCCCCC---C
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDGR---S 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~---~ 211 (329)
++++|.+++.......+++..+..++.+++.||.|||++ +++|+||+|+||++++++ .++|+|||++....... .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 999999999754455689999999999999999999999 999999999999998554 58999999987655432 2
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
..++..|+|||.+.+..++.++||||||+++|+|++|+.|+............... .....+...+.++.+++.+
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG-----TFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc-----CCCCCCCCcCHHHHHHHHH
Confidence 45678999999999888999999999999999999999887654332222111111 1122344567889999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 020221 292 CLQYEPRERPNPRSLVT 308 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~ 308 (329)
||..||++|||+.++++
T Consensus 236 ~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 236 MLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HccCChhhCCCHHHHhh
Confidence 99999999999999998
No 229
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=1.4e-41 Score=294.02 Aligned_cols=246 Identities=22% Similarity=0.336 Sum_probs=200.3
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
+.+.+.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+++++.++|||++++++++......++++||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 34667788899999999999976677899999875543 34578899999999999999999999988899999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----C
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-----S 211 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~ 211 (329)
+++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....... .
T Consensus 83 ~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 83 HGCLSDYLRA-QRGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9999999864 334688999999999999999999999 99999999999999999999999999987543321 1
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+.............. ......+...+.++.+++.
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-----GFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-----CCCCCCCCCCCHHHHHHHH
Confidence 223568999999998889999999999999999998 7776654332222211111 0111122334678999999
Q ss_pred HhcccCCCCCCCHHHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~~L 310 (329)
+||+.+|++|||+.++++.|
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHcccChhhCCCHHHHHHhh
Confidence 99999999999999999876
No 230
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=1.2e-41 Score=300.79 Aligned_cols=254 Identities=20% Similarity=0.270 Sum_probs=197.2
Q ss_pred cccccccCCCCCCcEEEEEEeCC---------------CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCcccccccee
Q 020221 58 MENIVSEHGEKAPNVVYKGKLEN---------------QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGC 121 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~ 121 (329)
.+++.+.||+|+||.||++...+ ...||+|.++..... ....+.+|+++++.++|+|+++++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 85 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV 85 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 56778889999999999987422 235899999765333 24568899999999999999999999
Q ss_pred eeeCCeeEEEEecCCCCCHHhhhccCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC
Q 020221 122 CCEGDERLLVAEYMPNDTLAKHLFHWE----------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD 191 (329)
Q Consensus 122 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~ 191 (329)
+......++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nill~~ 164 (295)
T cd05097 86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATRNCLVGN 164 (295)
T ss_pred EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChhhEEEcC
Confidence 999999999999999999999885421 12468889999999999999999999 9999999999999999
Q ss_pred CCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCC--CCCCchhhHHHhhh
Q 020221 192 DVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK--HIPPSHALDLIRDR 263 (329)
Q Consensus 192 ~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~--~~~~~~~~~~~~~~ 263 (329)
++.+||+|||++....... ...++..|+|||.+.+..++.++||||||+++++|+++. .|+...........
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~ 244 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244 (295)
T ss_pred CCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHH
Confidence 9999999999987543322 123356899999998888999999999999999999843 34433222211111
Q ss_pred chhhhc--cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 264 NIQTLT--DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 264 ~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
...... ........+...++.+.+++.+||+.||++|||+.++++.|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 245 TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 110000 0001111233456789999999999999999999999998863
No 231
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=1.7e-41 Score=293.76 Aligned_cols=242 Identities=23% Similarity=0.344 Sum_probs=196.2
Q ss_pred cCCCCCCcEEEEEEe-CC---CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKL-EN---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~-~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||+|.+ .. +..+|+|.+...... ..+.+.+|+++++.++|+|++++++++. ....+++|||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 80 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG 80 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence 579999999999973 22 268999999876542 3556889999999999999999999875 56789999999999
Q ss_pred CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc------
Q 020221 139 TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY------ 212 (329)
Q Consensus 139 sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~------ 212 (329)
+|.+++.+ ...+++..+..++.|++.||+|||.. +++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 81 PLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999973 34789999999999999999999999 9999999999999999999999999998765433221
Q ss_pred -cCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 213 -STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 213 -~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
.++..|+|||.+.+..++.++||||||+++|++++ |..|+........... .........+...+..+.+++.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-----LESGERLPRPEECPQEIYSIML 232 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-----HHcCCcCCCCCCCCHHHHHHHH
Confidence 12357999999998889999999999999999998 7776644322111111 1111122334556788999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhhh
Q 020221 291 RCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
+||..+|++||++.++++.|+.+.
T Consensus 233 ~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 233 SCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHhcCChhhCcCHHHHHHHHHhcc
Confidence 999999999999999999998763
No 232
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=1.1e-41 Score=307.32 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=198.9
Q ss_pred cccccccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeC-Cee
Q 020221 58 MENIVSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEG-DER 128 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~~ 128 (329)
.+++.+.||+|+||.||+|.. .+++.||||.++..... ....+.+|+.++..+ +|+||+++++++... ...
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 467788889999999999973 34678999999765432 345688999999999 689999999988654 567
Q ss_pred EEEEecCCCCCHHhhhccCC------------------------------------------------------------
Q 020221 129 LLVAEYMPNDTLAKHLFHWE------------------------------------------------------------ 148 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~------------------------------------------------------------ 148 (329)
+++|||+++|+|.+++....
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 89999999999999886421
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC------CccCccc
Q 020221 149 -----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR------SYSTNLA 217 (329)
Q Consensus 149 -----~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~ 217 (329)
...+++.++..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++....... ...++..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 12367888899999999999999999 99999999999999999999999999987643221 1234567
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 296 (329)
|+|||.+.+..++.++||||||+++|+|++ |..|++........ ............+...++++.+++..||+.|
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH----HHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 999999988889999999999999999997 77666542211110 0111111111223334678999999999999
Q ss_pred CCCCCCHHHHHHHHHhhhhc
Q 020221 297 PRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 297 p~~Rps~~~~l~~L~~~~~~ 316 (329)
|++|||+.+++++|+.+.+.
T Consensus 323 p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 323 PSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred hhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999988653
No 233
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=1.7e-41 Score=302.82 Aligned_cols=242 Identities=16% Similarity=0.226 Sum_probs=182.5
Q ss_pred ccCCCCCCcEEEEEEeC---CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEEEEecCCC
Q 020221 63 SEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAEYMPN 137 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~ 137 (329)
++||+|+||+||+|... +++.+|+|.+..... ...+.+|+++++.++||||+++++++.. ....++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 45799999999999853 467899999876542 3457789999999999999999998854 4568999999865
Q ss_pred CCHHhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee----CCCCCeeeecccCcccC
Q 020221 138 DTLAKHLFHW-------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNS 206 (329)
Q Consensus 138 gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~a~~~ 206 (329)
+|.+++... ....+++..+..++.||+.||.|||++ |++||||||+|||+ +.++.+||+|||++...
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 788876421 123588999999999999999999999 99999999999999 45678999999999765
Q ss_pred CCC-------CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhH-------------HHhhh--
Q 020221 207 RDG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-------------LIRDR-- 263 (329)
Q Consensus 207 ~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~-------------~~~~~-- 263 (329)
... ....+|+.|+|||++.+. .++.++||||+||++|+|++|..||.....+ .+...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 432 234568899999998774 4888999999999999999999887432110 00000
Q ss_pred --------chh------hhccccccCC------------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 264 --------NIQ------TLTDSCLEGQ------------FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 264 --------~~~------~~~~~~~~~~------------~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
... .......... .....+.++.+++.+||+.||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0000000000 00012346889999999999999999999998
No 234
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=2.1e-41 Score=301.01 Aligned_cols=246 Identities=19% Similarity=0.225 Sum_probs=199.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
..|.+++.+|+|+||.||++.. .+++.||+|.+..... ...+.+.+|+++++.++|||++++.+++.+....++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4466777889999999999984 5688999999865432 22356889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY 212 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 212 (329)
||+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 95 e~~~g-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~ 171 (307)
T cd06607 95 EYCLG-SASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF 171 (307)
T ss_pred HhhCC-CHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCCCEEEeecCcceecCCCCCc
Confidence 99974 77777643 345689999999999999999999999 9999999999999999999999999999877666666
Q ss_pred cCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 213 ~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
.++..|+|||++. ...++.++||||||+++|+|++|..|+.............. .......+...+..+.+++
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li 247 (307)
T cd06607 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPTLSSNDWSDYFRNFV 247 (307)
T ss_pred cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc----CCCCCCCchhhCHHHHHHH
Confidence 7888999999874 35588899999999999999999987754322111111100 0011111234677899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 020221 290 SRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 290 ~~cl~~dp~~Rps~~~~l~~ 309 (329)
.+||..||++||++.+++.+
T Consensus 248 ~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 248 DSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999873
No 235
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=9.2e-42 Score=299.92 Aligned_cols=255 Identities=20% Similarity=0.284 Sum_probs=204.4
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
..+++++.||+|+||+||++. ..+++.||+|++..... ...+.+.+|+++++.++||||+++++++......++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 456778888999999999998 55688999998875432 3356788999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCc
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSY 212 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~ 212 (329)
+++++|.+++. ....+++..+..++.+++.||.|||+..+++|+||+|+||++++++.++|+|||++...... ...
T Consensus 85 ~~~~~L~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~ 162 (284)
T cd06620 85 MDCGSLDRIYK--KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF 162 (284)
T ss_pred CCCCCHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCcc
Confidence 99999999886 34568999999999999999999997448999999999999999999999999998654322 234
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH----Hh---hhchhhhccccccCCCC-hHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL----IR---DRNIQTLTDSCLEGQFS-SDEGTE 284 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~----~~---~~~~~~~~~~~~~~~~~-~~~~~~ 284 (329)
.++..|+|||++.+..++.++|+||||+++|++++|..||....... .. ........... ....+ ...+.+
T Consensus 163 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (284)
T cd06620 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-PPRLPSSDFPED 241 (284)
T ss_pred ccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-CCCCCchhcCHH
Confidence 67899999999988889999999999999999999998876432210 00 00111111111 11112 236678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
+.+++.+||..||++|||+.+++++..-++
T Consensus 242 ~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 242 LRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 999999999999999999999998654443
No 236
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=1.6e-41 Score=295.66 Aligned_cols=249 Identities=22% Similarity=0.298 Sum_probs=201.4
Q ss_pred cccccccCCCCCCcEEEEEEeC-C---CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE-N---QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
.+++.+.||+|+||.||+|... + +..+|+|.+...... ..+.+.+|+.+++.++||||+++++++...+..+++|
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 4566778899999999999842 2 347999998764422 3456889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS- 211 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~- 211 (329)
||+++++|.+++.. ....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 85 EYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999999864 335689999999999999999999999 999999999999999999999999999876543321
Q ss_pred ------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 212 ------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 212 ------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
...+..|+|||.+.+..++.++|+||||+++|++++ |..|+............... .....+...++.
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 237 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-----YRLPAPMDCPAA 237 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-----CcCCCCCCCCHH
Confidence 112457999999998889999999999999999886 88776543222111111111 112233456788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
+.+++.+||+.+|++||++.++++.|+++
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 238 LHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 99999999999999999999999999875
No 237
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=1.3e-41 Score=299.50 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=199.6
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
++++++.||+|+||.||++... ++..||+|.+...... ....+.+|+.+++.++||||+++++++..+...++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 4567778899999999999853 4678999998765432 24568899999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC
Q 020221 131 VAEYMPNDTLAKHLFHWE--------------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~ 190 (329)
++||+++++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~p~nil~~ 164 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLATRNCLVG 164 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CeecccccHhheEec
Confidence 999999999999986321 12468889999999999999999999 999999999999999
Q ss_pred CCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhh
Q 020221 191 DDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDR 263 (329)
Q Consensus 191 ~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~ 263 (329)
+++.++|+|||++....... ....+..|+|||.+.+..++.++||||||+++|+|++ |..|+...........
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~ 244 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244 (288)
T ss_pred CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999987543221 2233567999999988889999999999999999998 6666643322221111
Q ss_pred chhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 264 NIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
+.... ....+...+.++.+++.+||+.||++|||+.++++.|++
T Consensus 245 ----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 245 ----VRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 112234567889999999999999999999999998874
No 238
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=1e-41 Score=295.26 Aligned_cols=237 Identities=25% Similarity=0.384 Sum_probs=189.6
Q ss_pred cCCCCCCcEEEEEEeCC-C----------CEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 64 EHGEKAPNVVYKGKLEN-Q----------FRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
.||+|+||.||+|...+ + ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|+
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999543 3 25788887665433 5678899999999999999999999987 7889999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-------CeeeecccCccc
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-------NPRLSCFGLMKN 205 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-------~~kl~Dfg~a~~ 205 (329)
||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++ .++|+|||++..
T Consensus 80 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~ 157 (259)
T cd05037 80 EYVKFGPLDVFLHR-EKNNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPIT 157 (259)
T ss_pred EcCCCCcHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeCCCCcccc
Confidence 99999999999864 223689999999999999999999999 999999999999999887 799999999987
Q ss_pred CCCCCCccCcccccCcccccCC--CCCCcccchhhhHHHHHHHhCCC-CCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221 206 SRDGRSYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (329)
Q Consensus 206 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (329)
........++..|+|||++.+. .++.++||||||+++|+|++|.. |+........... .. . ....+....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-~~---~---~~~~~~~~~ 230 (259)
T cd05037 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQ---D---QHRLPMPDC 230 (259)
T ss_pred cccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-Hh---c---CCCCCCCCc
Confidence 6655555677889999999876 68899999999999999999643 3322211111100 00 0 111122223
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 283 TELVRLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
..+.+++.+||..+|++|||+.++++.|+
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 231 AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 78999999999999999999999998763
No 239
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=1.6e-41 Score=302.81 Aligned_cols=246 Identities=18% Similarity=0.177 Sum_probs=200.5
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|++.+.||+|++|.||++.. .+++.+|+|.+...... ..+.+..|++.++.++|+||+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 356677789999999999994 45889999999765433 34568889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+.+++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999998754456789999999999999999999999 99999999999999999999999999876432211
Q ss_pred ------------------------------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHH
Q 020221 211 ------------------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI 260 (329)
Q Consensus 211 ------------------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 260 (329)
...|+..|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 22467789999999988899999999999999999999998865432221
Q ss_pred hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 020221 261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN----PRSLVT 308 (329)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps----~~~~l~ 308 (329)
... ..............+.++.+++.+||..||++||| +.++++
T Consensus 241 ~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 241 FSN----ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH----HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 111 11111111111225789999999999999999999 777776
No 240
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=1.3e-41 Score=294.12 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=200.5
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
..+++.+.+|+|+||.||++.. +++.+|+|.+.... ..+.+.+|+.+++.++|||++++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 4467778889999999999975 56689999987543 34568899999999999999999998865 45799999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-CccCc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-SYSTN 215 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~ 215 (329)
+++|.+++.......+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++....... ....+
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence 99999999754445689999999999999999999999 99999999999999999999999999987654332 22345
Q ss_pred ccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 216 LAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 216 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
..|+|||.+.+..++.++|+||||+++|+|++ |..|+.............. ......+...+.++.+++.+||+
T Consensus 161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~ 235 (254)
T cd05083 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-----GYRMEPPEGCPADVYVLMTSCWE 235 (254)
T ss_pred ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-----CCCCCCCCcCCHHHHHHHHHHcC
Confidence 67999999988889999999999999999998 7777654433322221111 11222334567889999999999
Q ss_pred cCCCCCCCHHHHHHHHHh
Q 020221 295 YEPRERPNPRSLVTALVT 312 (329)
Q Consensus 295 ~dp~~Rps~~~~l~~L~~ 312 (329)
.+|++||++.++++.|++
T Consensus 236 ~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 236 TEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CChhhCcCHHHHHHHHcc
Confidence 999999999999998763
No 241
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=1.2e-41 Score=329.78 Aligned_cols=256 Identities=19% Similarity=0.189 Sum_probs=203.4
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
..|++++.||+|+||.||+|. ..+++.||+|++...... ..+.+.+|+++++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 457788888999999999998 456889999999764322 2456889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221 133 EYMPNDTLAKHLFHWE---------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 203 (329)
||+++++|.+++.+.. ....++..+..++.||+.||+|||++ |++||||||+||+++.++.++|+|||++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999885321 12456778899999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC----------------------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh
Q 020221 204 KNSRDG----------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR 261 (329)
Q Consensus 204 ~~~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~ 261 (329)
...... ....||+.|+|||.+.+..++.++||||||+++|||+||..||.........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 755110 1235789999999999989999999999999999999999887653222111
Q ss_pred hhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhc
Q 020221 262 DRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP-NPRSLVTALVTLQKD 316 (329)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp-s~~~~l~~L~~~~~~ 316 (329)
.. .....+. ........++.+.+++.+||+.||++|| +++++++.|+...+.
T Consensus 241 ~~--~~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 241 YR--DVILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh--hhccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 0011110 0001124567899999999999999996 677788888877553
No 242
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=1.2e-41 Score=298.88 Aligned_cols=245 Identities=14% Similarity=0.208 Sum_probs=195.0
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeee------CCeeE
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE------GDERL 129 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~~~ 129 (329)
.+++.+.+|+|+||.||+|. ..+++.+|+|.+.... .....+..|+.+++.+ +|+|++++++++.. ....+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 34556667999999999999 4668899999986644 2345678899999998 69999999998853 45789
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC-
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD- 208 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~- 208 (329)
++|||+.+|+|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence 999999999999998764556688999999999999999999999 999999999999999999999999999875432
Q ss_pred ---CCCccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221 209 ---GRSYSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (329)
Q Consensus 209 ---~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (329)
.....++..|+|||.+. +..++.++|+||||+++|+|++|..||......... ...............
T Consensus 175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~ 250 (282)
T cd06636 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRNPPPKLKSKK 250 (282)
T ss_pred ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----hhHhhCCCCCCcccc
Confidence 22345788999999875 345888999999999999999999877543211111 111111111112234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 281 EGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.+.++.+++.+||..||++|||+.++++
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 6778999999999999999999999998
No 243
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=1.6e-41 Score=296.38 Aligned_cols=247 Identities=19% Similarity=0.222 Sum_probs=195.6
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh----------hHHHHHHHHHHHhcCCCccccccceeeeeCCe
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP----------DARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (329)
|.+.+.||.|+||.||+|. ..+++.+|+|.+...... ..+.+.+|+.+++.++|+|++++++++.....
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 4455677999999999998 456889999988642111 12357789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.++|+||+++++|.+++.+ ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++++|||++....
T Consensus 83 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred eEEEEecCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 9999999999999999864 35789999999999999999999999 99999999999999999999999999987544
Q ss_pred CC------CCccCcccccCcccccCCC--CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh
Q 020221 208 DG------RSYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (329)
Q Consensus 208 ~~------~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (329)
.. ....++..|+|||.+.... ++.++|+||||+++|++++|..|+...........................
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM 239 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence 32 1235678899999987654 788999999999999999999887543221111100000011111111223
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 280 DEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 280 ~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..+.++.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 240 NLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 45789999999999999999999999998
No 244
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=1.7e-41 Score=298.82 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=198.7
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
.+++++.||+|+||.||+|... .+..||+|.+...... ....+.+|+..++.++||||+++++++......++
T Consensus 7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 86 (288)
T cd05061 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV 86 (288)
T ss_pred HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 4667788899999999999742 2457999998755422 23457889999999999999999999998899999
Q ss_pred EEecCCCCCHHhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccC
Q 020221 131 VAEYMPNDTLAKHLFHWE--------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGL 202 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 202 (329)
+|||+++|+|.+++.... ....++..+..++.|++.||.|||++ +++|+||||+||++++++.++|+|||+
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~~~~L~Dfg~ 165 (288)
T cd05061 87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDFTVKIGDFGM 165 (288)
T ss_pred EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCCcEEECcCCc
Confidence 999999999999996421 13346778899999999999999999 999999999999999999999999999
Q ss_pred cccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccC
Q 020221 203 MKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (329)
Q Consensus 203 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (329)
++...... ...++..|+|||.+.+..++.++|+||||+++|||++ |..|+............ ... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~----~~~-~~~ 240 (288)
T cd05061 166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV----MDG-GYL 240 (288)
T ss_pred cccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcC-CCC
Confidence 87543221 1233567999999998889999999999999999999 56555433222221111 111 111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221 276 QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
..+...++.+.+++.+||+.||++|||+.++++.|+...
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 223445678999999999999999999999999888764
No 245
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=1e-41 Score=319.58 Aligned_cols=248 Identities=18% Similarity=0.175 Sum_probs=185.9
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC------ccccccceeeeeC-Cee
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN------RRLANLLGCCCEG-DER 128 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~-~~~ 128 (329)
..|++++.||+|+||+||++. ..+++.||||+++... ........|++++..++| .+++++++++... ...
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 346778888999999999998 4567889999997532 223345667777776654 4588888888654 578
Q ss_pred EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC---------------
Q 020221 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV--------------- 193 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~--------------- 193 (329)
++|||++ +++|.+++. ....+++..+..++.||+.||.|||++.||+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIM--KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEEecc-CCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 8999988 668888886 3457899999999999999999999733999999999999998665
Q ss_pred -CeeeecccCcccCCCC-CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc---h---
Q 020221 194 -NPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---I--- 265 (329)
Q Consensus 194 -~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~---~--- 265 (329)
.+||+|||.+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||............ .
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 4999999987654332 3457899999999999999999999999999999999999888643211100000 0
Q ss_pred -------------hhhcccc--ccCCC---------------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 266 -------------QTLTDSC--LEGQF---------------SSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 266 -------------~~~~~~~--~~~~~---------------~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..+.... +.... .....+.+.+||.+||..||++|||+.++++
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0000000 00000 0012456889999999999999999999998
No 246
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=1.1e-41 Score=298.24 Aligned_cols=241 Identities=17% Similarity=0.273 Sum_probs=198.5
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
|..++.||+|+||.||+|. ..++..||+|.+.... ....+.+.+|+++++.++||||+++++++......++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 4455667999999999998 4567889999987543 2334568899999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----Cc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SY 212 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~ 212 (329)
+++|.+++. ...+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++++|||++....... ..
T Consensus 86 ~~~L~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 86 GGSALDLLK---PGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 999999884 45789999999999999999999999 99999999999999999999999999987654332 23
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
.++..|+|||.+.+..++.++|+||||+++|||++|..|+.......... ..............+.++.+++.+|
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----LIPKNSPPTLEGQYSKPFKEFVEAC 236 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----hhhcCCCCCCCcccCHHHHHHHHHH
Confidence 46788999999998889999999999999999999998765332111111 1111112223345677899999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020221 293 LQYEPRERPNPRSLVT 308 (329)
Q Consensus 293 l~~dp~~Rps~~~~l~ 308 (329)
|+.+|++||++.++++
T Consensus 237 l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 237 LNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999998
No 247
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=3e-41 Score=295.83 Aligned_cols=253 Identities=19% Similarity=0.263 Sum_probs=204.6
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCC----EEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
.+++++.||+|+||.||+|.. .++. .+|+|.+...... ....+.+|+..++.++||||+++++++.. ...+++
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 356777889999999999984 3332 5899988766432 34568899999999999999999999876 789999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS 211 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 211 (329)
+||+++|+|.+++.+ ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 87 ~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 87 TQLMPLGCLLDYVRN-HKDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred EecCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 999999999999864 344689999999999999999999998 999999999999999999999999999976543322
Q ss_pred ------ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 212 ------YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 212 ------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
..++..|+|||.+....++.++|+||||+++||+++ |..|+.............. ......+..++..
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 239 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-----GERLPQPPICTID 239 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-----CCCCCCCCCCCHH
Confidence 112467999999988889999999999999999998 8877755433322221111 1111223345678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVTALVTLQKDTE 318 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~ 318 (329)
+.+++.+||..||++||++.++++.|.++.++..
T Consensus 240 ~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 240 VYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 9999999999999999999999999999877553
No 248
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=1.1e-41 Score=301.28 Aligned_cols=240 Identities=17% Similarity=0.228 Sum_probs=197.0
Q ss_pred ccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221 63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (329)
..||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|||++++++.+..+...++++||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 4569999999999984 568899999987655455567889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCccc
Q 020221 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLA 217 (329)
Q Consensus 142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~ 217 (329)
.++. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ....++..
T Consensus 107 ~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~ 182 (297)
T cd06659 107 DIVS---QTRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY 182 (297)
T ss_pred HHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCcc
Confidence 9873 35689999999999999999999999 9999999999999999999999999998654332 23457889
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 297 (329)
|+|||++.+..++.++||||||+++++|++|..|+............ ...... ........+..+.+++.+||+.+|
T Consensus 183 y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~P 259 (297)
T cd06659 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RDSPPP--KLKNAHKISPVLRDFLERMLTREP 259 (297)
T ss_pred ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hccCCC--CccccCCCCHHHHHHHHHHhcCCc
Confidence 99999999888999999999999999999999887543221111111 000000 011123456789999999999999
Q ss_pred CCCCCHHHHHHH
Q 020221 298 RERPNPRSLVTA 309 (329)
Q Consensus 298 ~~Rps~~~~l~~ 309 (329)
++||++.+++++
T Consensus 260 ~~Rps~~~ll~~ 271 (297)
T cd06659 260 QERATAQELLDH 271 (297)
T ss_pred ccCcCHHHHhhC
Confidence 999999999983
No 249
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=2.9e-41 Score=295.72 Aligned_cols=243 Identities=16% Similarity=0.258 Sum_probs=202.0
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
.|..++.||.|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.+.|+||+++++.+.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 355667789999999999984 467899999987543 233566889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~ 211 (329)
++++|.+++. ...+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....... .
T Consensus 85 ~~~~L~~~i~---~~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 85 GGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 9999999884 35688999999999999999999999 99999999999999999999999999986654322 2
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
..++..|+|||++.+..++.++|+||||+++|+|++|..|+.......... ..........+...+..+.+++.+
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~ 235 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-----LIPKNNPPTLTGEFSKPFKEFIDA 235 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-----hhhcCCCCCCchhhhHHHHHHHHH
Confidence 346788999999988889999999999999999999998775432211111 111112233445678899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 020221 292 CLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~ 309 (329)
||..+|++||++.+++++
T Consensus 236 ~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 236 CLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HcccCcccCcCHHHHHhC
Confidence 999999999999999874
No 250
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=2.8e-41 Score=294.67 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=195.0
Q ss_pred cCCCCCCcEEEEEEeC-CCC--EEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKLE-NQF--RIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
.||+|+||.||+|... ++. .+++|.+.... ....+.+.+|+++++.+ +||||+++++++...+..+++|||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 4699999999999853 443 47888887543 23355788999999999 7999999999999989999999999999
Q ss_pred CHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221 139 TLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 139 sL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 204 (329)
+|.+++.... ...+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCCeEEECCCCCcc
Confidence 9999986421 12478999999999999999999999 99999999999999999999999999985
Q ss_pred cCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221 205 NSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (329)
Q Consensus 205 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (329)
..... .....+..|+|||++.+..++.++||||||+++|||++ |..||............ ........+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-----~~~~~~~~~~~ 235 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-----PQGYRLEKPLN 235 (270)
T ss_pred ccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-----hCCCCCCCCCc
Confidence 33211 11223567999999988889999999999999999997 88777543322221111 11111123344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221 281 EGTELVRLASRCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
.+.++.+++.+||..||.+|||+.++++.|+++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 236 CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 5678999999999999999999999999998864
No 251
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=1.6e-41 Score=298.36 Aligned_cols=248 Identities=20% Similarity=0.254 Sum_probs=195.9
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
.|++++.+|+|++|.||++.. .+++.||+|++..... ...+.+.+|+++++.++|+|++++++++..+...++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 356777889999999999995 4688999999865432 2234578899999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---- 210 (329)
+++++|..++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 82 CDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred cCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 99988877764 344689999999999999999999999 99999999999999999999999999987654433
Q ss_pred CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc---hhhh-------c----------
Q 020221 211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN---IQTL-------T---------- 269 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~---~~~~-------~---------- 269 (329)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..||............ .... .
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 3456788999999876 44788999999999999999999887643211110000 0000 0
Q ss_pred cccccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 270 DSCLEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 270 ~~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.+..... .....+..+.+++.+||+.||++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000 01234678999999999999999999999998
No 252
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=8.5e-42 Score=313.24 Aligned_cols=242 Identities=16% Similarity=0.182 Sum_probs=193.3
Q ss_pred cccccccCCCCCCcEEEEEEeC---CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
.|++++.||+|+||.||++... .+..||+|.+.... ...+|+++++.++||||+++++++......+++||+
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 4788899999999999999742 35789999886532 346799999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---- 210 (329)
+. ++|.+++. ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.++|+|||++.......
T Consensus 168 ~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 168 YK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred cC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 86 58888884 456789999999999999999999999 99999999999999999999999999987544322
Q ss_pred --CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-------Hhhhc---hhh-----------
Q 020221 211 --SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-------IRDRN---IQT----------- 267 (329)
Q Consensus 211 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-------~~~~~---~~~----------- 267 (329)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.... ...
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 3468899999999998889999999999999999999999886432110 00000 000
Q ss_pred ---hccccccCCC--C-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 268 ---LTDSCLEGQF--S-----SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 268 ---~~~~~~~~~~--~-----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
......+..+ + ...+.++.+++.+||..||++|||+.+++.
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 0 123567899999999999999999999998
No 253
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=6.2e-42 Score=300.82 Aligned_cols=247 Identities=18% Similarity=0.199 Sum_probs=193.2
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|++++.||+|+||.||++.. .+|+.+|+|.++..... ....+.+|+++++.++|+||+++++++.+....++++||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 55667789999999999994 57889999998754321 2345778999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~ 211 (329)
.+ +|.+++.. ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++....... .
T Consensus 82 ~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 82 DQ-DLKKYFDS-CNGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred CC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 75 78887754 345689999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred ccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhch--------------hhhcccc---
Q 020221 212 YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNI--------------QTLTDSC--- 272 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~--------------~~~~~~~--- 272 (329)
..++..|+|||++.+.. ++.++||||||+++|+|++|+.|+..... ........ .......
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 34578899999987654 78899999999999999999987543211 11000000 0000000
Q ss_pred -cc-----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 273 -LE-----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 273 -~~-----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.. .......++++.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0111235688999999999999999999999998
No 254
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=2.9e-41 Score=298.49 Aligned_cols=254 Identities=20% Similarity=0.290 Sum_probs=197.3
Q ss_pred cccccccCCCCCCcEEEEEEeC-----------------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccc
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE-----------------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLL 119 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~ 119 (329)
.+++.+.||+|+||.||++... ++..+|+|.+...... ..+.+.+|+.+++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 3567778899999999998532 2446999999765332 346789999999999999999999
Q ss_pred eeeeeCCeeEEEEecCCCCCHHhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC
Q 020221 120 GCCCEGDERLLVAEYMPNDTLAKHLFHWE---------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (329)
Q Consensus 120 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~ 190 (329)
+++...+..+++|||+++++|.+++.... ...+++.++..++.|++.||+|||+. +++|+||||+||+++
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp~Nili~ 164 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLATRNCLVG 164 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCChheEEEc
Confidence 99999999999999999999999986422 12467889999999999999999999 999999999999999
Q ss_pred CCCCeeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh--CCCCCCchhhHHHhh
Q 020221 191 DDVNPRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS--GKHIPPSHALDLIRD 262 (329)
Q Consensus 191 ~~~~~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t--g~~~~~~~~~~~~~~ 262 (329)
.++.++|+|||++....... ...++..|+|||...++.++.++||||||+++|||++ |..|+..........
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIE 244 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 99999999999987643322 1223568999999888889999999999999999998 555554322211111
Q ss_pred hchhhhcc--ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 263 RNIQTLTD--SCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 263 ~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
........ .......+..+++.+.+++.+||+.||++||++.++++.|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 245 NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11000000 000111234456889999999999999999999999998863
No 255
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.9e-43 Score=305.02 Aligned_cols=244 Identities=18% Similarity=0.230 Sum_probs=207.7
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (329)
+.|..++++ |+|+||.||-++ ..+|+.+|+|++.+.... .....++|-++|..++.+.||.+..+|.+.+.++
T Consensus 185 n~F~~~Rvl---GkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 185 NTFRVYRVL---GKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred cceeeeEEE---ecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 667777777 999999999998 678999999988654311 2234678999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+|+..|.||+|.-.|.+..+..++++.+..++.+|+.||++||.. +||+||+||+|||+|++|+++|+|.|+|..+..+
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999999999887778999999999999999999999999 9999999999999999999999999999988877
Q ss_pred CCc---cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhh-hchhhhccccccCCCChHHHHHH
Q 020221 210 RSY---STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-RNIQTLTDSCLEGQFSSDEGTEL 285 (329)
Q Consensus 210 ~~~---~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
... .||.+|||||++.++.|+.+.|+|||||+||||+.|+.||..... .++. .....+.. ....+++.+|+++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-Kvk~eEvdrr~~~--~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-KVKREEVDRRTLE--DPEEYSDKFSEEA 417 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-hhhHHHHHHHHhc--chhhcccccCHHH
Confidence 543 689999999999999999999999999999999999998865321 1111 11111111 2235678899999
Q ss_pred HHHHHHhcccCCCCCCCHH
Q 020221 286 VRLASRCLQYEPRERPNPR 304 (329)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~ 304 (329)
.++....|+.||++|...+
T Consensus 418 kslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHHccCHHHhccCC
Confidence 9999999999999997554
No 256
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=3.2e-41 Score=294.24 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=201.1
Q ss_pred ccccccCCCCCCcEEEEEEeCC----CCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 59 ENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
+.+.+.+|+|+||.||+|...+ ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ ...+++||
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e 86 (270)
T cd05056 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME 86 (270)
T ss_pred ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence 4566677999999999998432 3468999887654 3345578999999999999999999998865 56789999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC--
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-- 211 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-- 211 (329)
|+++++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 87 LAPLGELRSYLQV-NKYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred cCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence 9999999999964 334689999999999999999999999 999999999999999999999999999876543321
Q ss_pred ---ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221 212 ---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (329)
Q Consensus 212 ---~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
..++..|+|||.+....++.++||||||++++++++ |..||............. .......+..++.++.+
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 165 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-----NGERLPMPPNCPPTLYS 239 (270)
T ss_pred cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-----cCCcCCCCCCCCHHHHH
Confidence 123457999999988889999999999999999996 887775443222111111 11111234556788999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221 288 LASRCLQYEPRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 288 li~~cl~~dp~~Rps~~~~l~~L~~~~~~ 316 (329)
++.+||..+|++|||+.++++.|+.+..+
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998754
No 257
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-42 Score=315.84 Aligned_cols=240 Identities=18% Similarity=0.308 Sum_probs=204.0
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHh
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 142 (329)
.+|+|.||+||-|+ .++...+|||.+........+.+..|+..-+.++|.|||+++|.+..++.+-|.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 36999999999999 66778899999998887778889999999999999999999999999999999999999999999
Q ss_pred hhccCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecccCcccCCC----CCCccCc
Q 020221 143 HLFHWETQPM--KWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRD----GRSYSTN 215 (329)
Q Consensus 143 ~l~~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~----~~~~~~~ 215 (329)
+|+. +=+++ .+.+...+.+||+.||.|||++ .|||||||-+|||++ -.|.+||+|||.++.... ..++.||
T Consensus 662 LLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 662 LLRS-KWGPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 9964 33445 7889999999999999999999 999999999999997 568899999998876443 3467899
Q ss_pred ccccCcccccCCC--CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhc
Q 020221 216 LAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCL 293 (329)
Q Consensus 216 ~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 293 (329)
..|||||++..++ |...+|||||||++.||.||++||..-..... .+-.+-.-...+++|.+.+++.+.+|.+|+
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 9999999998765 99999999999999999999988743211100 011111112456788999999999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 020221 294 QYEPRERPNPRSLVT 308 (329)
Q Consensus 294 ~~dp~~Rps~~~~l~ 308 (329)
..||.+||+|.+++.
T Consensus 817 epd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcccCccHHHhcc
Confidence 999999999999986
No 258
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=3.5e-41 Score=303.05 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=203.4
Q ss_pred ccccccCCCCCCcEEEEEEeC--------CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCee
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDER 128 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 128 (329)
+++.+.||+|+||.||++... ....||+|.+..... ...+.+.+|+++++.+ +||||+++++++......
T Consensus 14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (334)
T cd05100 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 93 (334)
T ss_pred eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCce
Confidence 567788899999999999731 123689998875432 2356788999999999 799999999999998999
Q ss_pred EEEEecCCCCCHHhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC
Q 020221 129 LLVAEYMPNDTLAKHLFHWE--------------TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~ 194 (329)
++++||+++|+|.+++.... ...+++.++..++.|++.||.|||++ +++|+||||+||++++++.
T Consensus 94 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~Nill~~~~~ 172 (334)
T cd05100 94 YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAARNVLVTEDNV 172 (334)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCCc
Confidence 99999999999999986421 23478889999999999999999999 9999999999999999999
Q ss_pred eeeecccCcccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhh
Q 020221 195 PRLSCFGLMKNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQT 267 (329)
Q Consensus 195 ~kl~Dfg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~ 267 (329)
++|+|||+++...... ...++..|+|||++.+..++.++||||||+++|||++ |..|+..............
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~- 251 (334)
T cd05100 173 MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE- 251 (334)
T ss_pred EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-
Confidence 9999999987654322 1123467999999998889999999999999999998 6666654433322221111
Q ss_pred hccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 268 LTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
......+...+.++.+++.+||+.+|++|||+.++++.|+.+....
T Consensus 252 ----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 252 ----GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1112234455778999999999999999999999999999987543
No 259
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=1.4e-41 Score=295.50 Aligned_cols=246 Identities=19% Similarity=0.282 Sum_probs=200.1
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
+++.+.||.|++|.||++.. .+++.+++|.+..... .....+.+|++.++.++||||+++++.+......++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 45666779999999999995 4688999999877643 334568899999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCcc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYS 213 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~ 213 (329)
+++|.+++... ...+++..+..++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.+...... ....
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (265)
T cd06605 83 GGSLDKILKEV-QGRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV 160 (265)
T ss_pred CCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhccc
Confidence 99999998642 2678999999999999999999999 7 9999999999999999999999999998654322 1256
Q ss_pred CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh--HHHhhhchhhhccccccCCCChH-HHHHHHHHHH
Q 020221 214 TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRDRNIQTLTDSCLEGQFSSD-EGTELVRLAS 290 (329)
Q Consensus 214 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~ 290 (329)
++..|+|||.+.+..++.++||||||+++++|++|..|+..... .... ......... .....+.. .+.++.+++.
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 238 (265)
T cd06605 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-ELLQYIVNE-PPPRLPSGKFSPDFQDFVN 238 (265)
T ss_pred CChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH-HHHHHHhcC-CCCCCChhhcCHHHHHHHH
Confidence 77899999999988899999999999999999999988754310 0000 001111111 11122222 6788999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~ 308 (329)
+||..||++|||+.+++.
T Consensus 239 ~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 239 LCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHcCCCchhCcCHHHHhh
Confidence 999999999999999997
No 260
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=2.8e-41 Score=296.78 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=197.0
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|++.+.+|+|++|.||+|.. .++..||+|++..... .....+.+|+.+++.++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 56778889999999999994 5688999999876542 23457889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----- 210 (329)
+++|.+++.. ....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 82 -~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 82 -PSDLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred -CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 9999998864 336789999999999999999999999 99999999999999999999999999987654432
Q ss_pred CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc----------------ccc-
Q 020221 211 SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT----------------DSC- 272 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~----------------~~~- 272 (329)
...++..|+|||.+.+.. ++.++||||+|+++++|++|.+++................. ...
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 345688999999987554 68899999999999999999766543321111000000000 000
Q ss_pred cc-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 273 LE-------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 273 ~~-------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.. .......+.++.+++.+||..||++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 0011234688999999999999999999999998
No 261
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-41 Score=298.11 Aligned_cols=248 Identities=18% Similarity=0.279 Sum_probs=196.3
Q ss_pred ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhc--CCCccccccceeeeeCC----eeEEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQ--LRNRRLANLLGCCCEGD----ERLLVA 132 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~ 132 (329)
..+++.+|+|+||.||+|.+.+ +.||||++... ..+.|.+|-.+... ++|+||++++++-..+. .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 3445566999999999999855 69999999863 35567777666555 58999999999887666 899999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------CCccccccCCCceeeCCCCCeeeecccCcc
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK--------ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 204 (329)
+|.++|||.++| +...++|....+++..|++||+|||+. ..|+|||||.+|||+.+|++..|+|||+|.
T Consensus 288 ~fh~kGsL~dyL---~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYL---KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHH---HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999 567899999999999999999999973 569999999999999999999999999998
Q ss_pred cCCCCC------CccCcccccCcccccCCC-CC-----CcccchhhhHHHHHHHhCCCCC-------Cch----------
Q 020221 205 NSRDGR------SYSTNLAFTPPEYLRTGR-VT-----PESVMYSFGTLLLDLLSGKHIP-------PSH---------- 255 (329)
Q Consensus 205 ~~~~~~------~~~~~~~y~aPE~~~~~~-~~-----~~~DvwslG~il~el~tg~~~~-------~~~---------- 255 (329)
.+.++. ..+||.+|||||++.+.. +. .+.||||+|.+||||+++..-. +..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 776553 357899999999998654 33 3689999999999999975321 111
Q ss_pred hhHHHhhhchhhhccccccCCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 256 ALDLIRDRNIQTLTDSCLEGQFSS-----DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
..+.++.-... ...++.++. ....-+++.+..||+.||+.|.|+.-+.+++..+..-.
T Consensus 445 t~e~mq~~VV~----kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 445 TLEEMQELVVR----KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CHHHHHHHHHh----hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 11122211111 112223332 23567899999999999999999999999999887644
No 262
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=2.8e-41 Score=297.71 Aligned_cols=242 Identities=19% Similarity=0.236 Sum_probs=200.6
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|.+++.||+|+||.||++. ..+++.+|+|.+..... ...+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 35677788999999999999 45688999999875432 234568889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCc
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSY 212 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~ 212 (329)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 158 (290)
T cd05580 82 YVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL 158 (290)
T ss_pred cCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence 9999999999863 46789999999999999999999999 9999999999999999999999999998765544 234
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
.+++.|+|||.+.+...+.++||||||+++|+|++|..|+............. . .....+...+..+.+++.+|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~--~~~~~~~~~~~~l~~li~~~ 232 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL----E--GKVRFPSFFSPDAKDLIRNL 232 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----c--CCccCCccCCHHHHHHHHHH
Confidence 57889999999988888999999999999999999998876543222211111 1 11223445578899999999
Q ss_pred cccCCCCCC-----CHHHHHH
Q 020221 293 LQYEPRERP-----NPRSLVT 308 (329)
Q Consensus 293 l~~dp~~Rp-----s~~~~l~ 308 (329)
|..||++|+ ++.++++
T Consensus 233 l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 233 LQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCHHHccCcccCCHHHHHc
Confidence 999999999 6777765
No 263
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=5.5e-41 Score=292.56 Aligned_cols=246 Identities=18% Similarity=0.225 Sum_probs=186.9
Q ss_pred cCCCCCCcEEEEEEeCCC---CEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221 64 EHGEKAPNVVYKGKLENQ---FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
.||+|+||.||++...++ ..+++|.+..... ...+.+.+|+..++.++||||+++++.+......+++|||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 479999999999974332 3466777765432 335678999999999999999999999999899999999999999
Q ss_pred HHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC------CCC
Q 020221 140 LAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------GRS 211 (329)
Q Consensus 140 L~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~------~~~ 211 (329)
|.+++.+.. ....++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++..... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 999986432 23456778889999999999999999 999999999999999999999999998754221 123
Q ss_pred ccCcccccCcccccC-------CCCCCcccchhhhHHHHHHHhCCC-CCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 212 YSTNLAFTPPEYLRT-------GRVTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~el~tg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
..++..|+|||++.. ..++.++||||||+++|||+++.. |+.....................++..+...++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE 240 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence 456788999998753 235779999999999999998654 443222111111111111111122333444677
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 284 ELVRLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
.+.+++..|| .+|++||+++++++.|.
T Consensus 241 ~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 241 RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 8999999999 78999999999998774
No 264
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=3.3e-41 Score=293.58 Aligned_cols=244 Identities=18% Similarity=0.289 Sum_probs=198.1
Q ss_pred ccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC------hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
..+.||+|++|.||++. ..+++.+|+|.+..... ...+.+.+|++.++.++|+||+++++++.+++..++|+|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 34556999999999998 56788999999875431 124568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcccCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~--- 209 (329)
|+++++|.+++. ....+++..+..++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||.+......
T Consensus 84 ~~~~~~L~~~l~--~~~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 84 WMAGGSVSHLLS--KYGAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred ccCCCcHHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999986 345788999999999999999999999 999999999999998776 5999999998765432
Q ss_pred -----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 210 -----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 210 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
....++..|+|||.+.+..++.++|+||+|+++++|++|..|+........... .............+...+++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-IFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-HHHHhccCCCCCCchhhCHH
Confidence 123467889999999888899999999999999999999988754321111111 11111111223455667889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+.+++.+||..+|++||++.++++
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhc
Confidence 999999999999999999999998
No 265
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=3.8e-41 Score=293.42 Aligned_cols=251 Identities=15% Similarity=0.146 Sum_probs=196.9
Q ss_pred HHHHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeee
Q 020221 47 ETLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE 124 (329)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 124 (329)
.++....+++...+.++ +|+|+||.||++. ..++..+|+|.+........ |+.....+ +|||++++++.+..
T Consensus 7 ~~~~~~~~~~~~~~~~~-lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLK-LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHhhcccccee-ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34444445555544444 6999999999998 56788899999875432211 22222222 79999999999999
Q ss_pred CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCc
Q 020221 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLM 203 (329)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a 203 (329)
.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999999863 34889999999999999999999999 999999999999999988 9999999998
Q ss_pred ccCCCCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 204 KNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 204 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
..........++..|+|||++.+..++.++||||||+++|+|++|..|+.................. .....+...++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T PHA03390 158 KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ--KKLPFIKNVSK 235 (267)
T ss_pred eecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc--ccCCcccccCH
Confidence 8776666667889999999999888999999999999999999999887643222111111111111 11123345788
Q ss_pred HHHHHHHHhcccCCCCCCC-HHHHHH
Q 020221 284 ELVRLASRCLQYEPRERPN-PRSLVT 308 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps-~~~~l~ 308 (329)
.+.+++.+||+.||++||+ ++++++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhc
Confidence 9999999999999999996 699997
No 266
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=1.9e-41 Score=299.22 Aligned_cols=247 Identities=18% Similarity=0.250 Sum_probs=202.0
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
....|.+++.+|+|+||.||++. ..++..|++|.+........+.+.+|+.+++.++|||++++++.+......++|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 34567778888999999999998 45678999999876554556678899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+++++|.+++. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~---~~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 97 YLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred cCCCCcHHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence 999999999984 34688999999999999999999999 99999999999999999999999999876544332
Q ss_pred -CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 211 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
...+++.|+|||.+.+..++.++|+||||+++|++++|..||........... . ..........+...+..+.+++
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~l~~li 249 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-I--ATNGTPELQNPEKLSAIFRDFL 249 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-h--hcCCCCCCCCccccCHHHHHHH
Confidence 23567889999999888899999999999999999999988764322111000 0 0001111112334567899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 020221 290 SRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 290 ~~cl~~dp~~Rps~~~~l~ 308 (329)
.+||+.+|++||++.+++.
T Consensus 250 ~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 250 NRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred HHHccCChhhCcCHHHHhc
Confidence 9999999999999999997
No 267
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=4.8e-41 Score=293.31 Aligned_cols=247 Identities=15% Similarity=0.184 Sum_probs=196.7
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCC------ee
Q 020221 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGD------ER 128 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~~ 128 (329)
..|++++.+|+|++|.||+|.. .+++.+++|.+..... ..+.+.+|+.+++.+ .|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 4466777889999999999995 4678899999876553 346788999999999 6999999999986543 48
Q ss_pred EEEEecCCCCCHHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221 129 LLVAEYMPNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 206 (329)
+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 163 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCCeEEECCCccceec
Confidence 99999999999999886432 45789999999999999999999999 9999999999999999999999999998654
Q ss_pred CCC----CCccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCC
Q 020221 207 RDG----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (329)
Q Consensus 207 ~~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (329)
... ....++..|+|||++.. ..++.++||||||+++++|++|..|+.................. ....
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 240 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP---TLKS 240 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC---CCCc
Confidence 332 23456788999998753 23778999999999999999999887543211111111111111 1112
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+...+.++.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2346778999999999999999999999998
No 268
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=8.9e-41 Score=290.13 Aligned_cols=243 Identities=19% Similarity=0.276 Sum_probs=198.9
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|.+.+.||+|+||.||++. ..+++.|++|.++..... ..+.+.+|+++++.++|+||+++++.+...+..++++||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 5566778999999999998 457889999999876543 4667899999999999999999999998899999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-----
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----- 210 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----- 210 (329)
++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 99999999863 34578899999999999999999999 99999999999999999999999999987654332
Q ss_pred ---CccCcccccCcccccCCC---CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh--HHH
Q 020221 211 ---SYSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS--DEG 282 (329)
Q Consensus 211 ---~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 282 (329)
...++..|+|||++.+.. .+.++||||||++++++++|..||............... ......+. ..+
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 234 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA----GHKPPIPDSLQLS 234 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc----CCCCCCCcccccC
Confidence 134578999999998766 888999999999999999999887543211111000110 11112222 237
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 283 TELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+.+.+++.+||+.+|++||++.+++.
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhc
Confidence 78899999999999999999999998
No 269
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=5.2e-41 Score=297.90 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=198.5
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCC----EEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQF----RIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
++.++.||+|+||.||++.. .++. .+|+|.+....... ...+.+|+.+++.++||||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~v~ 87 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQLVT 87 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCceeee
Confidence 34566779999999999984 4443 57899887654322 3468899999999999999999999865 4567999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-- 210 (329)
||+++|+|.+++.. ....+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||++.......
T Consensus 88 e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 88 QLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred hhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 99999999999864 344688999999999999999999999 99999999999999999999999999997654322
Q ss_pred ----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (329)
Q Consensus 211 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
...++..|+|||.+.+..++.++||||||+++|||++ |+.|+........... .........+...+..+
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-----LEKGERLPQPPICTIDV 240 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHCCCCCCCCCCCCHHH
Confidence 1223568999999998889999999999999999997 7777654322221111 11111112233456789
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 286 VRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
.+++..||..+|++||++.++++.|+.+.++.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 99999999999999999999999999986553
No 270
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-42 Score=285.62 Aligned_cols=240 Identities=17% Similarity=0.146 Sum_probs=195.6
Q ss_pred ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeee----CCeeEEEEecCC
Q 020221 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE----GDERLLVAEYMP 136 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~~ 136 (329)
+.||-|-.|.|-.+. ..+++.+|+|++... +..++|++.-... .|||||+++++|.. ...+.+|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 456999999999998 667999999998753 3457888876666 69999999999854 245789999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC---CCCCeeeecccCcccCCCC---C
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD---DDVNPRLSCFGLMKNSRDG---R 210 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~~---~ 210 (329)
||.|.+.+.++..+.+++.++..|++||+.|+.|||+. +|.||||||+|+|.. .|..+||+|||+|+..... .
T Consensus 143 GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~ 221 (400)
T KOG0604|consen 143 GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLM 221 (400)
T ss_pred chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEecccccccccCCCcccc
Confidence 99999999987888899999999999999999999999 999999999999996 4567999999999876643 2
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccc--ccCCCChHHHHHHHHH
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSC--LEGQFSSDEGTELVRL 288 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 288 (329)
+.+-|+.|.|||++...+|+...|+||+||++|.|++|.+||+...-..+..+....+.... ...+.-...|++..++
T Consensus 222 TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdl 301 (400)
T KOG0604|consen 222 TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDL 301 (400)
T ss_pred CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHH
Confidence 34558999999999999999999999999999999999998865422111111111111111 1111224578999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 020221 289 ASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~ 308 (329)
|+.+|..+|.+|.|+.++++
T Consensus 302 IR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 302 IRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HHHHhcCCchhheeHHHhhc
Confidence 99999999999999999998
No 271
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=3.4e-41 Score=296.15 Aligned_cols=248 Identities=18% Similarity=0.250 Sum_probs=195.3
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|++++.||.|++|.||+|.. .+++.||+|.+...... ....+.+|+++++.++||||+++++++.+....+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 45677789999999999984 56889999998754322 2356889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~ 211 (329)
. ++|.+++.......+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 6 5899888654556789999999999999999999999 9999999999999999999999999998754332 12
Q ss_pred ccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh--------------------cc
Q 020221 212 YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL--------------------TD 270 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~--------------------~~ 270 (329)
..++..|+|||.+.+.. ++.++||||||+++|+|+||+.||................ ..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 34578899999887655 6788999999999999999998876543211110000000 00
Q ss_pred cccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 271 SCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 271 ~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.... .......++++.+++.+||+.||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000 0011234577899999999999999999999998
No 272
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=6.1e-41 Score=291.85 Aligned_cols=241 Identities=18% Similarity=0.232 Sum_probs=192.2
Q ss_pred cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-----hhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEEE
Q 020221 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLV 131 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 131 (329)
...+.+|+|+||.||++. ..++..|++|.+..... .....+.+|+.+++.++||||+++++++.. ....+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 344556999999999998 45688999999865421 123457889999999999999999998865 3578899
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-- 209 (329)
+||+++++|.+++.+ ...+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999863 34688999999999999999999999 9999999999999999999999999998754321
Q ss_pred -----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHH
Q 020221 210 -----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 210 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
....++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ...........+...++.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF----KIATQPTNPQLPSHISEH 237 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH----HHhcCCCCCCCchhcCHH
Confidence 12346788999999998889999999999999999999998875432111111 111111123344556677
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+.+++ +||..+|++||++.++++
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhc
Confidence 88888 688899999999999998
No 273
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=5.9e-41 Score=290.19 Aligned_cols=242 Identities=20% Similarity=0.223 Sum_probs=198.0
Q ss_pred cccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCC-----hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 60 NIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
...+.||+|++|.||+|... ++..|++|.+..... ...+.+.+|+++++.++|+||+++++++..+...++++|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 34456799999999999954 788999999865431 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---C
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---R 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~ 210 (329)
|+++++|.+++.+ ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++...... .
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 83 LVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred ecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 9999999999863 34688999999999999999999999 9999999999999999999999999998764433 2
Q ss_pred CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 211 SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
...++..|+|||.+.... ++.++|+||||+++|+|++|..||........... ..........+...++.+.+++
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHHHH
Confidence 345788899999988766 88999999999999999999988754321111100 0110111233455678899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 020221 290 SRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 290 ~~cl~~dp~~Rps~~~~l~ 308 (329)
.+||+.+|++||++.+++.
T Consensus 236 ~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 236 LKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHhhcCcccCcCHHHHhc
Confidence 9999999999999999998
No 274
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=2e-42 Score=283.89 Aligned_cols=245 Identities=19% Similarity=0.265 Sum_probs=197.6
Q ss_pred cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCC
Q 020221 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
+.++.+|.|+.|.|++++ ..+|..+|||.++... ....+.++..+.++..- ++|.||+.+|+|.....+++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 456778999999999999 5668899999998764 33345567777765554 58999999999999999999999985
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCcc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYS 213 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~ 213 (329)
- .+..++++ -.+++++.-+-++...++.||.||..+++|+|||+||+|||+|+.|++|++|||++.+.-+. ....
T Consensus 175 ~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsA 252 (391)
T KOG0983|consen 175 T-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSA 252 (391)
T ss_pred H-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccccccc
Confidence 4 45565544 45679999999999999999999999999999999999999999999999999998765544 3446
Q ss_pred CcccccCcccccCC---CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 214 TNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 214 ~~~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
|.+.|||||-+.-. .|+-++||||||++|+||.||..|+.....+...-..+..-.++.+++. ..+++.+++|+.
T Consensus 253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~--~gFSp~F~~fv~ 330 (391)
T KOG0983|consen 253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH--MGFSPDFQSFVK 330 (391)
T ss_pred CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc--cCcCHHHHHHHH
Confidence 78999999988643 4888999999999999999999998875444333222222222333322 237899999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~ 308 (329)
.||+.|+.+||.+.++++
T Consensus 331 ~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 331 DCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHhhcCcccCcchHHHhc
Confidence 999999999999999987
No 275
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=4.8e-41 Score=295.57 Aligned_cols=239 Identities=17% Similarity=0.236 Sum_probs=196.9
Q ss_pred ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (329)
+.||+|++|.||++. ..+++.+++|.+........+.+.+|+.+++.++|||++++++++...+..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 455999999999998 4578899999987655445566889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCccc
Q 020221 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLA 217 (329)
Q Consensus 142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~ 217 (329)
+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...... ....++..
T Consensus 105 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 180 (285)
T cd06648 105 DIVTH---TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 180 (285)
T ss_pred HHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCcc
Confidence 99853 5689999999999999999999999 9999999999999999999999999987654332 22357889
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 297 (329)
|+|||.+.+..++.++||||||+++|+|++|..|+............... .... ...+...+..+.+++.+||+.+|
T Consensus 181 y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~l~~li~~~l~~~p 257 (285)
T cd06648 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK--LKNLHKVSPRLRSFLDRMLVRDP 257 (285)
T ss_pred ccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC--CcccccCCHHHHHHHHHHcccCh
Confidence 99999998888999999999999999999999887543322111111111 1111 11122356789999999999999
Q ss_pred CCCCCHHHHHH
Q 020221 298 RERPNPRSLVT 308 (329)
Q Consensus 298 ~~Rps~~~~l~ 308 (329)
++||++.++++
T Consensus 258 ~~Rpt~~~il~ 268 (285)
T cd06648 258 AQRATAAELLN 268 (285)
T ss_pred hhCcCHHHHcc
Confidence 99999999997
No 276
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=6.6e-41 Score=289.82 Aligned_cols=244 Identities=17% Similarity=0.254 Sum_probs=199.9
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|.+.+.+|.|+||.||++.. .++..+|+|.+..... ...+.+.+|+++++.++|+|++++++.+......++++||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 45566779999999999994 4678899999876422 23456789999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC-eeeecccCcccCCCCC----
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN-PRLSCFGLMKNSRDGR---- 210 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~~~~~~~---- 210 (329)
++++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++. ++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 999999998754445689999999999999999999999 9999999999999998864 6999999987655432
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
...+++.|+|||++.+..++.++|+||||++++++++|..|+................. .......+.++.+++.
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-----APISPNFSRDLRSLIS 235 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-----CCCCCCCCHHHHHHHH
Confidence 23467889999999888899999999999999999999988764433222221111111 1223345678999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~ 308 (329)
+||..+|++|||+.++++
T Consensus 236 ~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 236 QLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHhccChhhCcCHHHHhh
Confidence 999999999999999998
No 277
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=3.2e-41 Score=292.24 Aligned_cols=244 Identities=20% Similarity=0.220 Sum_probs=201.3
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
|++.+.||.|+||.||++.. .+++.||+|.+..... ...+.+.+|++.++.++||||+++++.+..+...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 55677789999999999995 4688999999975432 2356788999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CC
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RS 211 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~ 211 (329)
+.+++|..++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 82 LLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence 999999999863 35789999999999999999999999 9999999999999999999999999998765543 23
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
..++..|+|||.+.+..++.++|+||||+++|+|++|..|+........ ......... .....+...+..+.+++.+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQET--ADVLYPATWSTEAIDAINK 235 (258)
T ss_pred cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHHHHhcc--ccccCcccCcHHHHHHHHH
Confidence 4567889999999888899999999999999999999988765432100 000111110 2223455567899999999
Q ss_pred hcccCCCCCCCH--HHHHH
Q 020221 292 CLQYEPRERPNP--RSLVT 308 (329)
Q Consensus 292 cl~~dp~~Rps~--~~~l~ 308 (329)
||..||++||++ +++++
T Consensus 236 ~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 236 LLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HccCChhHcCCccHHHHhc
Confidence 999999999999 77665
No 278
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=1.1e-40 Score=290.07 Aligned_cols=242 Identities=17% Similarity=0.184 Sum_probs=194.4
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-----hhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-----PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 130 (329)
+++.+.+|+|+||.||++. ..++..||+|.+..... ...+.+.+|+++++.++||||+++++++.+. ..+++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 4556667999999999998 45688999998864321 2245688899999999999999999988663 46789
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC--
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD-- 208 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~-- 208 (329)
++||+++++|.+++.+ ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 84 FMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 9999999999999863 34578889999999999999999999 999999999999999999999999999875432
Q ss_pred -----CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 209 -----GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 209 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......... ...........+...+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 236 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPVLPPHVSD 236 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCCCCCCCchhhCH
Confidence 123457789999999988889999999999999999999998875432111111 11111112334556678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 284 ELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.+.+++.+||. +|++||+++++++
T Consensus 237 ~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 237 HCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 89999999994 9999999999998
No 279
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=7.1e-41 Score=292.75 Aligned_cols=249 Identities=20% Similarity=0.307 Sum_probs=198.9
Q ss_pred cccccccCCCCCCcEEEEEEeC------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKLE------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
.+.+++.+|+|+||.||++... +.+.+++|.+...... ..+.+.+|+++++.++|+||+++++++.+....++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM 85 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence 4567778899999999999843 2467999998765433 34678999999999999999999999988889999
Q ss_pred EEecCCCCCHHhhhccCCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221 131 VAEYMPNDTLAKHLFHWET-------QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 203 (329)
||||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999999864331 1589999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCC-----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCC
Q 020221 204 KNSRDG-----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQF 277 (329)
Q Consensus 204 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (329)
...... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||............. ........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~----~~~~~~~~ 240 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ----AGKLELPV 240 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH----cCCcCCCC
Confidence 643321 22244677999999988888899999999999999999 555554322221111111 11111122
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
+..++..+.+++.+||..||++|||+.++++.|.
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 3456778999999999999999999999999875
No 280
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=8.9e-41 Score=296.66 Aligned_cols=248 Identities=17% Similarity=0.135 Sum_probs=197.6
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
.|++++.+|+|+||.||++. ..+++.|++|.+..... .....+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 35667778999999999999 45678999999876532 224567889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---- 209 (329)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999963 35689999999999999999999999 9999999999999999999999999987631100
Q ss_pred ---------------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccccc
Q 020221 210 ---------------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE 274 (329)
Q Consensus 210 ---------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (329)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||.................. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~---~ 235 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE---W 235 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC---C
Confidence 1124577899999998888999999999999999999999988654333222222111110 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 275 GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 275 ~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
.......+.++.+++.+||+.||++||++.++.+.|+
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 1111245778999999999999999999655554443
No 281
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=3.4e-41 Score=296.33 Aligned_cols=248 Identities=20% Similarity=0.265 Sum_probs=195.1
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
.|++++.||+|+||.||++.. .+++.||+|.+...... ..+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 356778889999999999995 46889999998654322 245678899999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---- 210 (329)
+++++|..+.. ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 82 VDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred CCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 99988887764 334589999999999999999999999 99999999999999999999999999987643322
Q ss_pred CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh----------------hhccccc
Q 020221 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----------------TLTDSCL 273 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~----------------~~~~~~~ 273 (329)
...++..|+|||++.+. .++.++||||||+++|+|++|..|++............. .......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 23467889999998754 477899999999999999999977754321110000000 0000000
Q ss_pred cC---------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 274 EG---------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 274 ~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.. ......+..+.+++.+||..+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 011235678999999999999999999999998
No 282
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=1e-40 Score=293.44 Aligned_cols=247 Identities=14% Similarity=0.145 Sum_probs=193.2
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeee-----eCCeeE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCC-----EGDERL 129 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~~~ 129 (329)
..+++++.||+|+||.||++. ..+++.+|+|.+..... ....+.+|+.+++.+ +||||+++++++. .+...+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 345677778999999999998 45678999998865432 235678899999999 6999999999874 345789
Q ss_pred EEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
++|||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999999887531 235688999999999999999999999 99999999999999999999999999987644
Q ss_pred CC----CCccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221 208 DG----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (329)
Q Consensus 208 ~~----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (329)
.. ....++..|+|||++.. ..++.++||||||+++|+|++|..|+............... .. .....+
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~ 252 (286)
T cd06638 176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-PP--PTLHQP 252 (286)
T ss_pred cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc-CC--CcccCC
Confidence 32 23357889999998753 34788999999999999999999887543211111110000 00 011122
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 279 SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...+.++.+++.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 334678999999999999999999999998
No 283
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=2.7e-41 Score=328.75 Aligned_cols=248 Identities=18% Similarity=0.217 Sum_probs=194.7
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEE
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLL 130 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 130 (329)
+..|.+++.||.|+||+||++. ..++..+|+|.+..... .....+..|+.+++.++||||+++++++.. ...++|
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 4568888999999999999999 45678899999875432 234568899999999999999999998854 356899
Q ss_pred EEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcC------CCccccccCCCceeeCC-----------
Q 020221 131 VAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSK------ERALYHDLNAYRIVFDD----------- 191 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~------~~ivH~dlkp~Nil~~~----------- 191 (329)
||||+++++|.++|... ....+++..++.|+.||+.||.|||.. .+|+|+||||+|||++.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999998642 235689999999999999999999984 15999999999999964
Q ss_pred ------CCCeeeecccCcccCCCC---CCccCcccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHH
Q 020221 192 ------DVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLI 260 (329)
Q Consensus 192 ------~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 260 (329)
.+.+||+|||++...... ....+|+.|+|||++.+ ..++.++|||||||+||+|++|..||........
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q 251 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251 (1021)
T ss_pred ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence 345899999998765433 23467999999999864 3488899999999999999999988854321111
Q ss_pred hhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 261 RDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
. ... +..... ......+.++.+||..||..+|++||++.+++.
T Consensus 252 l---i~~-lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 252 L---ISE-LKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred H---HHH-HhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 0 000 110000 111234678999999999999999999999994
No 284
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=6.5e-41 Score=299.00 Aligned_cols=241 Identities=15% Similarity=0.237 Sum_probs=181.6
Q ss_pred cCCCCCCcEEEEEEeC---CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEEEEecCCCC
Q 020221 64 EHGEKAPNVVYKGKLE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAEYMPND 138 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g 138 (329)
.||+|+||.||+|... ++..||+|.+..... ...+.+|+++++.++||||+++++++.. ....++++||+.+
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred EeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 5699999999999854 357899999876442 3457789999999999999999998853 4678999999875
Q ss_pred CHHhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee----CCCCCeeeecccCcccCC
Q 020221 139 TLAKHLFHW-------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF----DDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 139 sL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~a~~~~ 207 (329)
+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++ +.++.+||+|||+++...
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 787776421 123578899999999999999999999 99999999999999 566789999999997654
Q ss_pred CC-------CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh---------hh-------
Q 020221 208 DG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR---------DR------- 263 (329)
Q Consensus 208 ~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~---------~~------- 263 (329)
.. ....+|..|+|||++.+. .++.++||||||+++|||+||..||.....+... ..
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence 32 223568899999998764 4888999999999999999999877432110000 00
Q ss_pred ----chhh---------hccccccC------------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 264 ----NIQT---------LTDSCLEG------------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 264 ----~~~~---------~~~~~~~~------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.... ........ ......+..+.+++.+||..||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000000 001112356889999999999999999999998
No 285
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=6.8e-41 Score=291.84 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=195.6
Q ss_pred cCCCCCCcEEEEEEeCC-------CCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 64 EHGEKAPNVVYKGKLEN-------QFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
.||+|+||.||+|...+ ++.+|+|.+..... .....+.+|+.+++.++||||+++++++......+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 46999999999998532 25799998865432 33557889999999999999999999999888999999999
Q ss_pred CCCCHHhhhccCC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-----CeeeecccCccc
Q 020221 136 PNDTLAKHLFHWE-----TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-----NPRLSCFGLMKN 205 (329)
Q Consensus 136 ~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~a~~ 205 (329)
++++|.+++.+.. ...+++.++..++.|++.||.|||+. +++|+||||+||+++.++ .++++|||++..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999986421 23478899999999999999999999 999999999999999877 899999999875
Q ss_pred CCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221 206 SRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (329)
Q Consensus 206 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (329)
..... ....+..|+|||++.+..++.++||||||+++|+|++ |..|++.......... .........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~-----~~~~~~~~~~ 235 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-----VTAGGRLQKP 235 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH-----HhcCCccCCc
Confidence 43221 2234578999999998889999999999999999998 8877754322211111 1111112234
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
...+..+.+++.+||..+|++||++.++++.|++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 4567889999999999999999999999998863
No 286
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=1.3e-40 Score=288.92 Aligned_cols=244 Identities=18% Similarity=0.242 Sum_probs=201.1
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee--CCeeEEEEe
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE--GDERLLVAE 133 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 133 (329)
|++++.+|.|+||.||++. ..+++.+|+|.+..... ...+.+.+|+++++.++|+||+++++++.. +...++++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 5677788999999999998 55778999999875432 234568889999999999999999997754 456899999
Q ss_pred cCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221 134 YMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCT-----SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (329)
Q Consensus 134 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH-----~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 206 (329)
|+++++|.+++... ....+++..++.++.|++.||.||| +. +++|+||+|+||++++++.++|+|||++...
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999998642 2457899999999999999999999 87 9999999999999999999999999998876
Q ss_pred CCCC----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221 207 RDGR----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (329)
Q Consensus 207 ~~~~----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (329)
.... ...++..|+|||.+.+..++.++|+||||+++++|++|..|+............ ........+...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 235 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-----KEGKFRRIPYRYS 235 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH-----hcCCCCCCccccC
Confidence 5433 345788999999999888999999999999999999999887654322222111 1111223445667
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 283 TELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.++.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 236 SELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhh
Confidence 88999999999999999999999998
No 287
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=8.7e-41 Score=294.69 Aligned_cols=247 Identities=15% Similarity=0.118 Sum_probs=194.1
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeC-----CeeE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEG-----DERL 129 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~~ 129 (329)
..|.+++.+|+|+||.||++. ..+++.+|+|.+..... ....+.+|+.+++.+ +|||++++++++... +..+
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 345666777999999999999 46788999999875432 245677899999998 799999999998653 3589
Q ss_pred EEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 130 LVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
+|+||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 999999999999987532 345689999999999999999999999 99999999999999999999999999987544
Q ss_pred CC----CCccCcccccCcccccCC-----CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221 208 DG----RSYSTNLAFTPPEYLRTG-----RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (329)
Q Consensus 208 ~~----~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (329)
.. ....++..|+|||.+... .++.++||||||+++|+|++|..|+.................. ....+
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~ 256 (291)
T cd06639 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP---TLLHP 256 (291)
T ss_pred cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC---CCCcc
Confidence 32 233567889999987643 2678999999999999999999887543221111111111000 11123
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 279 SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...+..+.+++.+||+.||++||++.++++
T Consensus 257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 345678999999999999999999999998
No 288
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=1.4e-40 Score=287.71 Aligned_cols=244 Identities=28% Similarity=0.432 Sum_probs=198.2
Q ss_pred ccccCCCCCCcEEEEEEeCC-----CCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 61 IVSEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
+.+.+|.|+||.||++...+ +..||+|.+...... ..+.+.+|+..++.++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45667999999999999543 378999999766543 466789999999999999999999999998999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC---
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS--- 211 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--- 211 (329)
+++++|.+++.......+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK 161 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCCeEEEcccCCceeccccccccc
Confidence 9999999998643333389999999999999999999999 999999999999999999999999999876554321
Q ss_pred --ccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 212 --YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 212 --~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
..++..|+|||.+.+..++.++||||+|+++++|++ |..|+.............. ......+...+.++.++
T Consensus 162 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 162 KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-----GYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----CCCCCCCCcCCHHHHHH
Confidence 225678999999988889999999999999999998 5555543322222111111 11122334467889999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 020221 289 ASRCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~~L 310 (329)
+.+||..||++|||+.++++.|
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHCcCChhhCcCHHHHHhhC
Confidence 9999999999999999998764
No 289
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=1.2e-40 Score=293.75 Aligned_cols=250 Identities=18% Similarity=0.261 Sum_probs=193.2
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
...|++++.||+|++|.||++.. .+++.||+|.+...... ....+.+|+++++.++|+||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 34577888889999999999994 46889999998754322 22346789999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---- 209 (329)
|+.+ +|.+++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~-~L~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 9985 89998864 334789999999999999999999999 9999999999999999999999999998653321
Q ss_pred CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhh--HHHhhh--c----hhhhccc---------
Q 020221 210 RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHAL--DLIRDR--N----IQTLTDS--------- 271 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~--~~~~~~--~----~~~~~~~--------- 271 (329)
....++..|+|||++.+. .++.++||||+|+++|+|++|..||..... +..... . .......
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 122357789999998754 488899999999999999999988754321 100000 0 0000000
Q ss_pred -ccc----C---CCChHHH--HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 272 -CLE----G---QFSSDEG--TELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 272 -~~~----~---~~~~~~~--~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
... . ......+ .++.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0 0000122 67889999999999999999999998
No 290
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=5.3e-41 Score=295.59 Aligned_cols=249 Identities=18% Similarity=0.217 Sum_probs=192.5
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
+..++.||+|+||.||++. ..+++.+|+|.+..... .....+.+|+.++..+. |+||+++++++..+...+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 3345667999999999998 45688999999876432 33456889999999996 999999999999889999999998
Q ss_pred CCCCHHhhh---ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---
Q 020221 136 PNDTLAKHL---FHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 136 ~~gsL~~~l---~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--- 209 (329)
.. ++.++. .......+++..+..++.|++.||+|||+..+++||||||+||+++.++.++|+|||++......
T Consensus 86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 65 555533 22234678999999999999999999997448999999999999999999999999998754332
Q ss_pred CCccCcccccCcccccCC---CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 210 RSYSTNLAFTPPEYLRTG---RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||..................+......+...+.++.
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (288)
T cd06616 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFV 244 (288)
T ss_pred ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHH
Confidence 233567889999998866 58889999999999999999998875432100000000000111111122234678899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 020221 287 RLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+|+.+||+.||++|||+.+++.
T Consensus 245 ~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 245 NFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHHHccCChhhCcCHHHHhc
Confidence 9999999999999999999997
No 291
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=2.5e-40 Score=291.27 Aligned_cols=248 Identities=17% Similarity=0.239 Sum_probs=196.6
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 134 (329)
++.++.||.|++|.||++.. .+++.+|+|.+..... .....+.+|+++++.++||||+++++++.+. ..+++||||
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 45667779999999999995 5688999999876533 3355688999999999999999999988553 478999999
Q ss_pred CCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--C
Q 020221 135 MPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--R 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~ 210 (329)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...... .
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 161 (287)
T cd06621 83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG 161 (287)
T ss_pred cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCCeEEEeeccccccccccccc
Confidence 9999998876431 345688999999999999999999999 9999999999999999999999999998754332 2
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-----HHHhhhchhhhccccccCCCC--hHHHH
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-----DLIRDRNIQTLTDSCLEGQFS--SDEGT 283 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~~ 283 (329)
...++..|+|||.+.+..++.++||||||+++|+|++|..|+..... ...... .............. ...++
T Consensus 162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd06621 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNPELKDEPGNGIKWSE 240 (287)
T ss_pred cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCchhhccCCCCCCchHH
Confidence 34567889999999988899999999999999999999988764311 001110 00000011111111 23577
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 284 ELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
++.+++.+||..||++|||+.++++
T Consensus 241 ~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 241 EFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHh
Confidence 8999999999999999999999998
No 292
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=7.5e-41 Score=295.40 Aligned_cols=250 Identities=17% Similarity=0.223 Sum_probs=196.0
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 130 (329)
...|++++.||.|+||.||+|.. .+++.+++|.++...... ...+.+|+.+++.++||||+++.+++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 34567778889999999999995 468899999997553222 23567899999999999999999998777 88999
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 209 (329)
|+||+.+ +|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~-~L~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEH-DLKSLMET-MKQPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCc-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999975 89888864 234689999999999999999999999 9999999999999999999999999998765443
Q ss_pred ---CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------------------
Q 020221 210 ---RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------- 266 (329)
Q Consensus 210 ---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~------------------- 266 (329)
....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..............
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 2234578899999987654 68899999999999999999987754321111110000
Q ss_pred ------hhccccccCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 267 ------TLTDSCLEGQFSSD-EGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 267 ------~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..........++.. .++.+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000111122222 4778999999999999999999999998
No 293
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=9.1e-41 Score=293.86 Aligned_cols=248 Identities=20% Similarity=0.276 Sum_probs=196.8
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
.|++.+.||+|+||.||+|.. .+++.||+|.++... ....+.+.+|+++++.++|+||+++++++..++..++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 356777889999999999984 468899999987543 22345688999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---- 210 (329)
++++.+..+.. ....+++..+..++.|++.||.|||.. +++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 82 VERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred CCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99876665553 345689999999999999999999999 99999999999999999999999999987655432
Q ss_pred -CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch--------------------h--
Q 020221 211 -SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI--------------------Q-- 266 (329)
Q Consensus 211 -~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~--------------------~-- 266 (329)
...++..|+|||++.+. .++.++||||||+++|+|++|..|+............. .
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 34567889999999888 78899999999999999999998775432110000000 0
Q ss_pred hhccc----cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 267 TLTDS----CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 267 ~~~~~----~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...+. .....++..+++++.+++.+||..+|++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0000122334788999999999999999999999997
No 294
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=1.5e-40 Score=288.26 Aligned_cols=241 Identities=17% Similarity=0.164 Sum_probs=191.7
Q ss_pred ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHH-hcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAV-GQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
+.+|.|+||.||+|. ..+++.||+|.+...... ....+..|...+ ...+|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 457999999999998 456889999998754321 122344555444 445899999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCccc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 217 (329)
++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..........++..
T Consensus 82 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIK--TLGGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD 158 (260)
T ss_pred CCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcC
Confidence 99999986 335689999999999999999999999 999999999999999999999999999887665556678889
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 297 (329)
|+|||.+.+..++.++||||||+++|+|++|..|+.................. ........+++++.+++.+||+.||
T Consensus 159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p 236 (260)
T cd05611 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN--WPEEVKEFCSPEAVDLINRLLCMDP 236 (260)
T ss_pred ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--CCCcccccCCHHHHHHHHHHccCCH
Confidence 99999998888899999999999999999999887654333222111111110 1111223457889999999999999
Q ss_pred CCCCCHHHHHH
Q 020221 298 RERPNPRSLVT 308 (329)
Q Consensus 298 ~~Rps~~~~l~ 308 (329)
++||++.++.+
T Consensus 237 ~~R~~~~~~~~ 247 (260)
T cd05611 237 AKRLGANGYQE 247 (260)
T ss_pred HHccCCCcHHH
Confidence 99997765544
No 295
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=2.2e-40 Score=291.44 Aligned_cols=247 Identities=17% Similarity=0.233 Sum_probs=200.9
Q ss_pred CCcccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 56 FAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
...++....+|+|++|.||++... ++..+++|.+..... ..+.+.+|++.++.++|+|++++++.+......++++||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 344556667799999999999954 678999999986554 456788999999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~ 210 (329)
+++++|.+++.... ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++...... .
T Consensus 97 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 97 MDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence 99999999997422 3789999999999999999999998 9999999999999999999999999987654332 2
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
...++..|+|||.+.+..++.++|+||||+++|+|++|..|+.................. ....+..++.++.+++.
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~ 251 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP---PLKNPEKWSPEFKDFLN 251 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC---CCcchhhCCHHHHHHHH
Confidence 234678899999998888999999999999999999999877543221111111111111 11112235678999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 020221 291 RCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 291 ~cl~~dp~~Rps~~~~l~ 308 (329)
+||+.+|.+||++.+++.
T Consensus 252 ~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 252 KCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHhccChhhCcCHHHHhh
Confidence 999999999999999986
No 296
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=1.5e-40 Score=288.63 Aligned_cols=239 Identities=16% Similarity=0.188 Sum_probs=196.3
Q ss_pred CCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (329)
Q Consensus 65 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (329)
||.|++|.||++.. .+++.+|+|.+..... ...+.+.+|+++++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 59999999999995 4588999999876432 2345688999999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCccCccc
Q 020221 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLA 217 (329)
Q Consensus 141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~ 217 (329)
.+++.+ ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... ....++..
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRD--RGLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157 (262)
T ss_pred HHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcC
Confidence 999963 34689999999999999999999999 9999999999999999999999999998866543 23456788
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 297 (329)
|+|||.+.+..++.++|+||||+++|+|++|..|+.....+.. ...............+...++++.+++.+||..||
T Consensus 158 ~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 235 (262)
T cd05572 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM--EIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235 (262)
T ss_pred ccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH--HHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence 9999999888899999999999999999999988765431110 00111111112223444457899999999999999
Q ss_pred CCCCC-----HHHHHH
Q 020221 298 RERPN-----PRSLVT 308 (329)
Q Consensus 298 ~~Rps-----~~~~l~ 308 (329)
++||+ +.++++
T Consensus 236 ~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 236 EERLGNLKGGIKDIKK 251 (262)
T ss_pred hhCcCCcccCHHHHhc
Confidence 99999 778777
No 297
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=1.2e-40 Score=291.77 Aligned_cols=241 Identities=18% Similarity=0.242 Sum_probs=193.7
Q ss_pred CCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (329)
Q Consensus 65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (329)
||+|+||+||++. ..+++.+|+|.+..... .....+.+|+++++.++|||++++.+++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 5899999999998 45688999999865321 2234567899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCccCccc
Q 020221 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLA 217 (329)
Q Consensus 141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~ 217 (329)
.+++.+.....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+...... ....++..
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence 9998754445789999999999999999999999 9999999999999999999999999998754432 22356778
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 297 (329)
|+|||++.+..++.++||||||+++++|++|+.||.................. .....+...++.+.+++.+||+.||
T Consensus 160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p 237 (277)
T cd05577 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEALLQKDP 237 (277)
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHHccCCh
Confidence 99999998888999999999999999999999887543221111111111111 1122344567899999999999999
Q ss_pred CCCC-----CHHHHHH
Q 020221 298 RERP-----NPRSLVT 308 (329)
Q Consensus 298 ~~Rp-----s~~~~l~ 308 (329)
++|| ++.+++.
T Consensus 238 ~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 238 EKRLGCRGGSADEVRE 253 (277)
T ss_pred hHccCCCcccHHHHHh
Confidence 9999 6666765
No 298
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=2.4e-40 Score=287.35 Aligned_cols=242 Identities=19% Similarity=0.292 Sum_probs=202.0
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
+++.+.||.|++|.||++... +++.|++|++..... .....+.+|+..+..++|+|++++++++......++++||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 456677799999999999954 589999999887654 335678999999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~ 211 (329)
+++|.+++.. ...+++..+..++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 83 ~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 83 GGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 9999999963 3678999999999999999999999 8 99999999999999999999999999987654432 2
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchh---hHHHhhhchhhhccccccCCCChH-HHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA---LDLIRDRNIQTLTDSCLEGQFSSD-EGTELVR 287 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 287 (329)
..++..|+|||.+.+..++.++|+||||+++|+|++|..|+.... ....... +... .....+.. .+..+.+
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA----ICDG-PPPSLPAEEFSPEFRD 234 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH----HhcC-CCCCCCcccCCHHHHH
Confidence 346788999999998889999999999999999999998875442 1111111 1111 11122333 6788999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 020221 288 LASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 288 li~~cl~~dp~~Rps~~~~l~ 308 (329)
++.+||..+|++||++.++++
T Consensus 235 li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred HHHHHccCChhhCCCHHHHHh
Confidence 999999999999999999998
No 299
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=3.4e-41 Score=299.87 Aligned_cols=245 Identities=17% Similarity=0.200 Sum_probs=197.6
Q ss_pred CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEe
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 133 (329)
..|+++++||.|+-+.||++...+..-+|+|++.... .+...-|.+|+..|.+|+ |.+|+++++|-..++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 4578899999999999999997777788888875542 334667999999999995 9999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|-+. +|...|.+.......| .+..+.+||+.++.++|.. ||||.||||.|+|+- .|.+||+|||+|.......
T Consensus 441 ~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 441 CGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred cccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEE-eeeEEeeeechhcccCccccce
Confidence 9755 8999997643333334 8889999999999999999 999999999999997 6899999999998776653
Q ss_pred ---CccCcccccCcccccCC-----------CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCC
Q 020221 211 ---SYSTNLAFTPPEYLRTG-----------RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (329)
Q Consensus 211 ---~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (329)
++.||+.||+||.+... +..+++||||||||||+|+.|+.||..-. .....+..+.++...-+
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHAITDPNHEIE 593 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHhhcCCCcccc
Confidence 56899999999988532 26789999999999999999997764321 01123444555543333
Q ss_pred CChHHH-HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 277 FSSDEG-TELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 277 ~~~~~~-~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
++..-+ .++.++++.||+.||++||+..++|+
T Consensus 594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 443222 34999999999999999999999998
No 300
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=5e-41 Score=316.42 Aligned_cols=249 Identities=16% Similarity=0.179 Sum_probs=182.7
Q ss_pred CcccccccCCCCCCcEEEEEEeC--CCCEEEEE------------------EeCCCCChhHHHHHHHHHHHhcCCCcccc
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLE--NQFRIAVK------------------RFNRSAWPDARQFLEEARAVGQLRNRRLA 116 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~niv 116 (329)
..|++++.||+|+||+||++... ++...+.| .+.. .......+.+|+++++.++||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCcC
Confidence 46888899999999999998742 22222222 1111 112244578999999999999999
Q ss_pred ccceeeeeCCeeEEEEecCCCCCHHhhhccCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC
Q 020221 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV 193 (329)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~ 193 (329)
++++++...+..+++++++.+ +|..++.... ........+..++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC
Confidence 999999999999999999865 6777764321 12234567788999999999999999 999999999999999999
Q ss_pred CeeeecccCcccCCCCC-----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh----HHHhhhc
Q 020221 194 NPRLSCFGLMKNSRDGR-----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRN 264 (329)
Q Consensus 194 ~~kl~Dfg~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~----~~~~~~~ 264 (329)
.+||+|||++....... ...|+..|+|||++.+..++.++|||||||++|||++|..+|..... .......
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~ 384 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII 384 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence 99999999997654432 24689999999999998999999999999999999999865432211 0000000
Q ss_pred -h-----h----------hhcccc-c---cCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 265 -I-----Q----------TLTDSC-L---EGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 265 -~-----~----------~~~~~~-~---~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
. . ..+... . ....+ ...+.++.+++.+||+.||++|||+.+++.
T Consensus 385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 0 000000 0 00000 113456788899999999999999999997
No 301
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=2.3e-40 Score=292.12 Aligned_cols=239 Identities=17% Similarity=0.229 Sum_probs=196.3
Q ss_pred ccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221 63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (329)
..||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++|+|++++++.+..++..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 3569999999999984 578899999987655445567889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCccc
Q 020221 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNLA 217 (329)
Q Consensus 142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~~ 217 (329)
+++. ...+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||++...... ....++..
T Consensus 106 ~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 181 (292)
T cd06657 106 DIVT---HTRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181 (292)
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCcc
Confidence 9874 34689999999999999999999999 9999999999999999999999999987654332 22456788
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 297 (329)
|+|||.+.+..++.++|+||||+++|+|++|..|+............... ..... ......++.+.+++.+||+.||
T Consensus 182 y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~li~~~l~~~P 258 (292)
T cd06657 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPKL--KNLHKVSPSLKGFLDRLLVRDP 258 (292)
T ss_pred ccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCccc--CCcccCCHHHHHHHHHHHhCCc
Confidence 99999998888899999999999999999999887654322211111111 11111 0123356788999999999999
Q ss_pred CCCCCHHHHHH
Q 020221 298 RERPNPRSLVT 308 (329)
Q Consensus 298 ~~Rps~~~~l~ 308 (329)
.+||++.+++.
T Consensus 259 ~~R~~~~~ll~ 269 (292)
T cd06657 259 AQRATAAELLK 269 (292)
T ss_pred ccCcCHHHHhc
Confidence 99999999997
No 302
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=3.7e-40 Score=283.65 Aligned_cols=245 Identities=18% Similarity=0.239 Sum_probs=202.5
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
|.+.+.+|+|++|.||++.. .+++.+++|++..........+.+|++.++.++|+|++++++.+......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 45566779999999999995 46889999999876654567789999999999999999999999988999999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCccC
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYST 214 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~ 214 (329)
++|.+++... ...+++..+..++.|++.||.+||.. +++|+||+|+||++++++.++|+|||.+...... ....+
T Consensus 82 ~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 159 (253)
T cd05122 82 GSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG 159 (253)
T ss_pred CcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence 9999998642 25789999999999999999999998 9999999999999999999999999998776654 34567
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
+..|+|||.+.+..++.++|+||||+++++|++|..|+................... ...+...+..+.+++.+||+
T Consensus 160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG---LRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC---cCcccccCHHHHHHHHHHcc
Confidence 889999999988889999999999999999999998876542111111111100110 01112236789999999999
Q ss_pred cCCCCCCCHHHHHH
Q 020221 295 YEPRERPNPRSLVT 308 (329)
Q Consensus 295 ~dp~~Rps~~~~l~ 308 (329)
.||++|||+.+++.
T Consensus 237 ~~p~~R~t~~~~l~ 250 (253)
T cd05122 237 KNPEKRPTAEQLLK 250 (253)
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999998
No 303
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=1.8e-40 Score=293.67 Aligned_cols=247 Identities=20% Similarity=0.189 Sum_probs=193.5
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-----hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-----DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
|++++.||.|++|.||+|.. .+++.||+|.+...... ....+..|+++++.++|+||+++++++.+....++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 45566789999999999994 56889999999765432 2345678999999999999999999999989999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-- 210 (329)
||+ +++|.+++.+. ...+++..+..++.||+.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~-~~~L~~~i~~~-~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 82 EFM-ETDLEKVIKDK-SIVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred ccc-CCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 999 88999999642 23689999999999999999999999 99999999999999999999999999987654432
Q ss_pred --CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-----------------hcc
Q 020221 211 --SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-----------------LTD 270 (329)
Q Consensus 211 --~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-----------------~~~ 270 (329)
...++..|+|||.+.+ ..++.++|+||||+++++|++|..++............... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence 2245678999998865 35788999999999999999997655432211110000000 000
Q ss_pred ccccC-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 271 SCLEG-----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 271 ~~~~~-----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..... ......+..+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000 011234678999999999999999999999998
No 304
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=3.1e-40 Score=285.31 Aligned_cols=244 Identities=20% Similarity=0.244 Sum_probs=204.9
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|.+.+.+|.|+||.||++.. .+++.+++|++..... ...+.+.+|++.++.++|+|++++.+.+......++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 45667789999999999994 4688999999986543 34567889999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 136 PNDTLAKHLFHWE--TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 136 ~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
++++|.+++.+.. ...+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999987532 46789999999999999999999999 99999999999999999999999999987654442
Q ss_pred -CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 211 -SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 211 -~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
...+++.|+|||.+.+..++.++|+||+|+++++|++|..|+................ ....+...+.++.+++
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i 235 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-----YPPIPSQYSSELRNLV 235 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----CCCCCCCCCHHHHHHH
Confidence 2356788999999988889999999999999999999998875543332222221111 2233446678899999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 020221 290 SRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 290 ~~cl~~dp~~Rps~~~~l~ 308 (329)
.+||..+|++|||+.++++
T Consensus 236 ~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 236 SSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHcCCChhhCcCHHHHhc
Confidence 9999999999999999998
No 305
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=2.9e-40 Score=289.17 Aligned_cols=241 Identities=18% Similarity=0.247 Sum_probs=196.1
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEEEEe
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e 133 (329)
|++++.+|+|+||.||+|. ..+++.+|+|.+.... ......+.+|+.+++.++ |||++++++++..+...+++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 4566778999999999999 4678899999987643 233556888999999986 9999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 83 YAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred cCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 9999999999843 4789999999999999999999999 99999999999999999999999999987654432
Q ss_pred -CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCCh-HHHHHHHH
Q 020221 211 -SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSS-DEGTELVR 287 (329)
Q Consensus 211 -~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 287 (329)
...++..|+|||.+.++ .++.++|+||||+++|+|++|..|+............ ........+. ..+.++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-----PKSKPPRLEDNGYSKLLRE 233 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-----ccCCCCCCCcccCCHHHHH
Confidence 23577889999988754 4788999999999999999999887543222111110 0001111222 25678999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 020221 288 LASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 288 li~~cl~~dp~~Rps~~~~l~ 308 (329)
++..||..||++||++.+++.
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhh
Confidence 999999999999999999986
No 306
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=3e-40 Score=289.23 Aligned_cols=242 Identities=16% Similarity=0.247 Sum_probs=199.3
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
+.+++.||.|+||.||+|.. .++..+|+|.+..... .....+.+|+..++.++||||+++++++..+...++|+||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 45667789999999999984 5688999999865432 234568899999999999999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----Cc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SY 212 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~ 212 (329)
+++|.+++. ...+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 86 ~~~l~~~i~---~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 86 GGSALDLLE---PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 999999884 45689999999999999999999999 99999999999999999999999999987544322 23
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
.++..|+|||.+.+..++.++|+||||+++|+|++|..|+........... .........+...+.++.+++.+|
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~i~~~ 236 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-----IPKNNPPTLEGNYSKPLKEFVEAC 236 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-----HhcCCCCCCCcccCHHHHHHHHHH
Confidence 567889999999888889999999999999999999987754322111111 111112223445678899999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 020221 293 LQYEPRERPNPRSLVTA 309 (329)
Q Consensus 293 l~~dp~~Rps~~~~l~~ 309 (329)
|..+|++||++.+++++
T Consensus 237 l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 237 LNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccCChhhCcCHHHHHhC
Confidence 99999999999999984
No 307
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=6e-40 Score=292.89 Aligned_cols=250 Identities=17% Similarity=0.227 Sum_probs=201.4
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
+..++.||+|+||.||++. ..++..+|+|.+..... .....+.+|+++++.++|+|++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 4456677999999999999 45688999999875432 2245688899999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccC
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST 214 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 214 (329)
+.+ +|.+.+.. ....+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..........+
T Consensus 107 ~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 183 (317)
T cd06635 107 CLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVG 183 (317)
T ss_pred CCC-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCCCEEEecCCCccccCCcccccC
Confidence 975 78777643 345689999999999999999999999 999999999999999999999999999887766666778
Q ss_pred cccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 215 NLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 215 ~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
+..|+|||++. ++.++.++||||||+++|+|++|..|+............. ............++.+.+++.+
T Consensus 184 ~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~ 259 (317)
T cd06635 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPTLQSNEWSDYFRNFVDS 259 (317)
T ss_pred CccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH----hccCCCCCCccccHHHHHHHHH
Confidence 89999999874 4568889999999999999999998875432211111111 1111111233456789999999
Q ss_pred hcccCCCCCCCHHHHHHHHHhhhh
Q 020221 292 CLQYEPRERPNPRSLVTALVTLQK 315 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~L~~~~~ 315 (329)
||+.+|++||++.++++++-.+..
T Consensus 260 ~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 260 CLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HccCCcccCcCHHHHHhChhhhcc
Confidence 999999999999999986554443
No 308
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=3.7e-40 Score=287.28 Aligned_cols=249 Identities=17% Similarity=0.262 Sum_probs=198.5
Q ss_pred ccccccCCCCCCcEEEEEEeCC--CCEEEEEEeCCCC----------ChhHHHHHHHHHHHhc-CCCccccccceeeeeC
Q 020221 59 ENIVSEHGEKAPNVVYKGKLEN--QFRIAVKRFNRSA----------WPDARQFLEEARAVGQ-LRNRRLANLLGCCCEG 125 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~ 125 (329)
|.+.+.||+|+||.||++.... ++.+|+|.+.... .....++.+|+.++.. ++||||+++++++...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4566778999999999999543 6889999886432 1223456778888765 6999999999999999
Q ss_pred CeeEEEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221 126 DERLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (329)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 203 (329)
+..+++|||+++++|.+++... ....+++..++.++.|++.||.|||+..+++|+||+|+||+++.++.++|+|||.+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 9999999999999999887432 34568999999999999999999996338999999999999999999999999998
Q ss_pred ccCCCC---CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221 204 KNSRDG---RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (329)
Q Consensus 204 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (329)
...... ....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.................. ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~ 237 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE----PLPEGM 237 (269)
T ss_pred eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC----cCCccc
Confidence 765543 2345678899999999888999999999999999999999877544332222221111111 111223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 020221 281 EGTELVRLASRCLQYEPRERPNPRSLVTALV 311 (329)
Q Consensus 281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~ 311 (329)
.++.+.+++.+||+.||++||++.++..++.
T Consensus 238 ~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 238 YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 5678999999999999999999999998875
No 309
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=2.4e-40 Score=290.57 Aligned_cols=244 Identities=19% Similarity=0.268 Sum_probs=191.0
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC-hhHHHHHHHHHH-HhcCCCccccccceeeeeCCeeEEEEec
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW-PDARQFLEEARA-VGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
++.+++.||+|+||.||++.. .+|+.||+|.+..... .....+..|+.. ++.++|||++++++++......++++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 356677789999999999994 5689999999876532 223445566665 6667899999999999999999999999
Q ss_pred CCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221 135 MPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-- 210 (329)
++ ++|.+++... ....+++..++.++.|++.||.|||++.+++|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (283)
T cd06617 82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK 160 (283)
T ss_pred hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 97 5888877542 235689999999999999999999985489999999999999999999999999987654322
Q ss_pred -CccCcccccCcccccC----CCCCCcccchhhhHHHHHHHhCCCCCCchh--hHHHhhhchhhhccccccCCC-ChHHH
Q 020221 211 -SYSTNLAFTPPEYLRT----GRVTPESVMYSFGTLLLDLLSGKHIPPSHA--LDLIRDRNIQTLTDSCLEGQF-SSDEG 282 (329)
Q Consensus 211 -~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~el~tg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~ 282 (329)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+.... .+... ..... ..... ....+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~ 234 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-----QVVEE-PSPQLPAEKFS 234 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH-----HHHhc-CCCCCCccccC
Confidence 2356788999998865 346889999999999999999998875321 11111 11111 11111 12357
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 283 TELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.++.+++.+||..+|++||++.++++
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 78999999999999999999999997
No 310
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=2.4e-40 Score=290.19 Aligned_cols=238 Identities=18% Similarity=0.186 Sum_probs=186.8
Q ss_pred CCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh---hHHHHHHHHHHHh---cCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVG---QLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 65 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
||+|+||.||++.. .+++.+|+|.+...... ....+.+|..+++ ...|||++.+.+++...+..++||||+++
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 59999999999984 56889999998654321 1222344444333 34799999999999888999999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCccCc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN 215 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~ 215 (329)
++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++...... ....++
T Consensus 82 ~~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 158 (279)
T cd05633 82 GDLHYHLS--QHGVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (279)
T ss_pred CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence 99999886 345689999999999999999999999 9999999999999999999999999998654332 234578
Q ss_pred ccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 216 LAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 216 ~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ..... .......+...+.++.+++.+||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMT-LTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--HHHHh-hcCCcCCccccCHHHHHHHHHHhc
Confidence 99999998864 458899999999999999999998875432111100 00000 011223445677899999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 020221 295 YEPRERP-----NPRSLVT 308 (329)
Q Consensus 295 ~dp~~Rp-----s~~~~l~ 308 (329)
.||++|| |++++++
T Consensus 236 ~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CCHHHhcCCCCCCHHHHHh
Confidence 9999999 5998887
No 311
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=4.7e-40 Score=290.03 Aligned_cols=249 Identities=17% Similarity=0.190 Sum_probs=191.7
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
..|.+++.||+|+||.||+|. ..++..||+|.+....... ...+.+|+.+++.++|+||+++.+++..+...++|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 346777888999999999998 4568899999987653222 33567899999999999999999999998999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----C
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----R 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~ 210 (329)
+. ++|.+.+.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... .
T Consensus 85 ~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 85 MH-TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred cc-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 96 577777643 234578888999999999999999999 9999999999999999999999999998753322 2
Q ss_pred CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhH--HHhhh----------------chhhhccc
Q 020221 211 SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALD--LIRDR----------------NIQTLTDS 271 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~--~~~~~----------------~~~~~~~~ 271 (329)
...++..|+|||++.+. .++.++||||||+++|+|++|..||...... ..... ........
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence 23467889999998764 4788999999999999999999877532211 00000 00000000
Q ss_pred cccCCCC---------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 272 CLEGQFS---------SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 272 ~~~~~~~---------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
......+ ...+..+.+++.+|+..||++|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 012568899999999999999999999998
No 312
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=3.7e-40 Score=295.62 Aligned_cols=242 Identities=17% Similarity=0.203 Sum_probs=188.7
Q ss_pred CCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHh
Q 020221 66 GEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (329)
Q Consensus 66 g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 142 (329)
|.|+||+||++.. .+++.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++++||+.+++|.+
T Consensus 9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~ 88 (328)
T cd08226 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANS 88 (328)
T ss_pred cccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHH
Confidence 4449999999994 57899999998754322 24568889999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----------CC
Q 020221 143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----------RS 211 (329)
Q Consensus 143 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----------~~ 211 (329)
++.+.....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++||+.+...... ..
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (328)
T cd08226 89 LLKTYFPEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167 (328)
T ss_pred HHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccccc
Confidence 98764455689999999999999999999999 9999999999999999999999999754322111 01
Q ss_pred ccCcccccCcccccCC--CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-----------------------
Q 020221 212 YSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----------------------- 266 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~----------------------- 266 (329)
..++..|+|||++.+. .++.++||||||+++|+|++|..|+..............
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (328)
T cd08226 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQ 247 (328)
T ss_pred ccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccch
Confidence 1235679999998764 478899999999999999999988764321111100000
Q ss_pred ------------------hhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 267 ------------------TLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 267 ------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...........+..++..+.+|+.+||..||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 248 SGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000000111123446788999999999999999999999985
No 313
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=5.6e-40 Score=291.92 Aligned_cols=244 Identities=19% Similarity=0.218 Sum_probs=196.7
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
+..++.+|.|+||.||+|. ..+++.+|+|.+.... ....+.+.+|+++++.++|+|++++.+++......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 4456677999999999999 4567889999986432 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccC
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYST 214 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 214 (329)
+. |+|.+.+.. ....+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..........+
T Consensus 97 ~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (308)
T cd06634 97 CL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVG 173 (308)
T ss_pred cC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCCcEEECCcccceeecCcccccC
Confidence 96 578777653 345689999999999999999999999 999999999999999999999999999887766666678
Q ss_pred cccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 215 NLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 215 ~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
+..|+|||.+. ...++.++||||||+++|+|++|..|+................ .........+..+.+++.+
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~ 249 (308)
T cd06634 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----SPALQSGHWSEYFRNFVDS 249 (308)
T ss_pred CccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC----CCCcCcccccHHHHHHHHH
Confidence 89999999874 3457889999999999999999998875432211111111111 1111123467789999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 020221 292 CLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~~ 309 (329)
||+.+|++||++.+++..
T Consensus 250 cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 250 CLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HhhCCcccCCCHHHHhhC
Confidence 999999999999999983
No 314
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=4.1e-40 Score=289.13 Aligned_cols=247 Identities=18% Similarity=0.236 Sum_probs=193.8
Q ss_pred cccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 60 NIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
++++.+|.|++|.||+|.. .+|..||+|++...... ....+.+|++.++.++|||++++++++..++..++++||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 4567789999999999984 57889999998754322 23567889999999999999999999999999999999995
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSY 212 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~ 212 (329)
++|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 5899988643334689999999999999999999999 9999999999999999999999999998754322 122
Q ss_pred cCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-----------------hhcccc--
Q 020221 213 STNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-----------------TLTDSC-- 272 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-----------------~~~~~~-- 272 (329)
.++..|+|||++.+. .++.++||||||+++|+|++|..||.............. ......
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 457889999988764 478899999999999999999988754322111000000 000000
Q ss_pred ----ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 273 ----LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 273 ----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.........+.++.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000112234578999999999999999999999997
No 315
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=6.3e-40 Score=283.33 Aligned_cols=244 Identities=18% Similarity=0.227 Sum_probs=201.9
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEEEEe
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAE 133 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 133 (329)
+.+.+.||+|++|.||+|... ++..|++|.+..... ...+.+.+|+..++.++|+||+++++.+... ...++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 344566799999999999954 788999999876553 3356788999999999999999999999888 88999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+++++|.+++.+ ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 82 YVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred ecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 9999999999874 33889999999999999999999998 99999999999999999999999999987655442
Q ss_pred ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (329)
Q Consensus 211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
...++..|+|||.+.+...+.++||||||+++++|++|..|+........ ..............+...+..+.+
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEAKD 235 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCHHHHH
Confidence 24567899999999988899999999999999999999988755431100 011111111222345556789999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 020221 288 LASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 288 li~~cl~~dp~~Rps~~~~l~ 308 (329)
++.+||..||++||++.++++
T Consensus 236 ~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 236 FLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHhCcCChhhCCCHHHHhh
Confidence 999999999999999999998
No 316
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=6.2e-41 Score=302.40 Aligned_cols=247 Identities=19% Similarity=0.289 Sum_probs=212.2
Q ss_pred hcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221 53 TSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 53 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (329)
.+.+..|.+++.||.|.|+.|.+++ ..++..||+|.+.+..... .+.+.+|+++|..+.|||||+++.+......++
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3556678899999999999999999 5678899999998875332 355889999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+||||+.+|.+.+++. +...+.+..+..++.|+.+|++|||++ +|+|||||++|||++.+.++||+|||++..+..+
T Consensus 132 lV~eya~~ge~~~yl~--~~gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLV--KHGRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHH--hcccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999998 445566689999999999999999999 9999999999999999999999999999877654
Q ss_pred ---CCccCcccccCcccccCCCCC-CcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHH
Q 020221 210 ---RSYSTNLAFTPPEYLRTGRVT-PESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTEL 285 (329)
Q Consensus 210 ---~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
.+.+|++.|.|||++.+..++ +.+|+||+|++||.|+.|..||.+......+...+.. ...++.-.+.+.
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g------k~rIp~~ms~dc 282 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG------KYRIPFYMSCDC 282 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee------eecccceeechh
Confidence 467899999999999988854 6899999999999999999998766544443332221 113455567889
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 020221 286 VRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 286 ~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.++|+.+|-++|.+|++..++..
T Consensus 283 e~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 283 EDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred HHHHHHhhccCccccCCHHHhhh
Confidence 99999999999999999999986
No 317
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4e-41 Score=306.25 Aligned_cols=244 Identities=21% Similarity=0.298 Sum_probs=203.5
Q ss_pred ccccCCCCCCcEEEEEEeCC--C--CEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 61 IVSEHGEKAPNVVYKGKLEN--Q--FRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
+.+.||+|.||.|++|.|.. | -.||||+++.+... ...+|++|+.+|.+|+|+|+++++|+..+ ....+|+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 34556999999999998643 3 45999999987655 56789999999999999999999999876 7889999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc---
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY--- 212 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--- 212 (329)
+.|||.+.|+......|.......++.||+.||.||.++ ++|||||..+|+|+.....+||+|||+.+....+...
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm 271 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM 271 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence 999999999875667788899999999999999999999 9999999999999999999999999999876654322
Q ss_pred ----cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 213 ----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 213 ----~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
.....|.|||.+....|+.++|||+|||++|||+|++.-++.+.. ...+...++..-+-.-+..+++++.++
T Consensus 272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----g~qIL~~iD~~erLpRPk~csedIY~i 347 (1039)
T KOG0199|consen 272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----GIQILKNIDAGERLPRPKYCSEDIYQI 347 (1039)
T ss_pred cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC----HHHHHHhccccccCCCCCCChHHHHHH
Confidence 234679999999999999999999999999999997754333211 111222333333444577899999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 020221 289 ASRCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~~L 310 (329)
+..||+.+|++|||+..|.+.+
T Consensus 348 mk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 348 MKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHhccCCccccccHHHHHHhH
Confidence 9999999999999999997444
No 318
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=5.7e-40 Score=287.93 Aligned_cols=246 Identities=17% Similarity=0.206 Sum_probs=190.5
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCC-CccccccceeeeeC--CeeEEEEe
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEG--DERLLVAE 133 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 133 (329)
|++++.+|+|+||.||++. ..+++.||+|.+...... ......+|+..+..+. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 3567788999999999998 556889999998764322 2233457888888885 99999999999887 88999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+.+ +|.+.+.. ....+++..+..++.|++.||+|||+. +++|+||+|+||+++. +.++|+|||++.......
T Consensus 81 ~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 9975 88887754 235689999999999999999999999 9999999999999999 999999999987654332
Q ss_pred CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-------hh---hccc--cccCC-
Q 020221 211 SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------QT---LTDS--CLEGQ- 276 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-------~~---~~~~--~~~~~- 276 (329)
...++..|+|||.+.. ..++.++||||||+++|||++|..||+............ .. .... .....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 3346789999997654 457889999999999999999998886532211100000 00 0000 00000
Q ss_pred ----------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 277 ----------FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 277 ----------~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.....+.++.+++.+||..||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 11235789999999999999999999999998
No 319
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=7.6e-40 Score=285.87 Aligned_cols=248 Identities=20% Similarity=0.293 Sum_probs=193.9
Q ss_pred cccccCCCCCCcEEEEEEeC----CCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCC------e
Q 020221 60 NIVSEHGEKAPNVVYKGKLE----NQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 127 (329)
.+.+.||+|+||.||+|... +++.||+|.+.... ....+++.+|+++++.++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 34566799999999999842 36789999987653 223556889999999999999999999875532 2
Q ss_pred eEEEEecCCCCCHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221 128 RLLVAEYMPNDTLAKHLFHW----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 203 (329)
.+++++|+.+|+|..++... ....+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||++
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCCCEEECccccc
Confidence 47889999999998876421 123578899999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHh-CCCCCCchhhHHHhhhchhhhccccccCC
Q 020221 204 KNSRDGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLS-GKHIPPSHALDLIRDRNIQTLTDSCLEGQ 276 (329)
Q Consensus 204 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (329)
....... ...++..|++||.+.+..++.++||||||+++|+|++ |..|+.............. .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~ 235 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-----GNRLK 235 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-----CCcCC
Confidence 7654322 2234567999999988889999999999999999999 6665543322211111111 01111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
.+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2334567899999999999999999999999999875
No 320
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=1.4e-39 Score=289.97 Aligned_cols=242 Identities=19% Similarity=0.223 Sum_probs=195.0
Q ss_pred cccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 60 NIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
..+..+|+|+||+||+|. ..+++.|++|.+..... ...+.+.+|+++++.++|||++++++++.+....+++|||+
T Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 103 (313)
T cd06633 24 VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC 103 (313)
T ss_pred hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecC
Confidence 344567999999999998 45688999999875432 22456788999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCc
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTN 215 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 215 (329)
. ++|.+++.. ....+++.++..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++..........++
T Consensus 104 ~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 180 (313)
T cd06633 104 L-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT 180 (313)
T ss_pred C-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCcccc
Confidence 6 478877754 345689999999999999999999999 9999999999999999999999999998766655566788
Q ss_pred ccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHh
Q 020221 216 LAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRC 292 (329)
Q Consensus 216 ~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 292 (329)
..|+|||++. ...++.++||||||+++|+|++|..|+................ .........+..+.+++.+|
T Consensus 181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~ 256 (313)
T cd06633 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND----SPTLQSNEWTDSFRGFVDYC 256 (313)
T ss_pred ccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----CCCCCccccCHHHHHHHHHH
Confidence 8999999984 3568889999999999999999998875532211111111111 11111233456799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 020221 293 LQYEPRERPNPRSLVT 308 (329)
Q Consensus 293 l~~dp~~Rps~~~~l~ 308 (329)
|+.+|++||++.+++.
T Consensus 257 l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 257 LQKIPQERPASAELLR 272 (313)
T ss_pred ccCChhhCcCHHHHhc
Confidence 9999999999999997
No 321
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=7.3e-40 Score=296.64 Aligned_cols=246 Identities=15% Similarity=0.205 Sum_probs=192.7
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC------Ce
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE 127 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 127 (329)
..|++++.||+|+||.||++. ..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 346677788999999999999 5578899999986532 23345677899999999999999999987543 35
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.++||||+.+ +|.+.+.. .++...+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++....
T Consensus 96 ~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 96 VYLVMELMDA-NLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EEEEEeccCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 7999999965 88887742 288999999999999999999999 99999999999999999999999999997654
Q ss_pred CCC---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh------------------
Q 020221 208 DGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------ 266 (329)
Q Consensus 208 ~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~------------------ 266 (329)
... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||..............
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 432 23567889999999988899999999999999999999988764321110000000
Q ss_pred hhc---------------cccc----cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 267 TLT---------------DSCL----EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 267 ~~~---------------~~~~----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
... .... ....+...++++.+++.+||+.||++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0000 00001234677899999999999999999999997
No 322
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=5.5e-40 Score=288.06 Aligned_cols=247 Identities=19% Similarity=0.253 Sum_probs=197.3
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|++++.||+|++|.||++.. .+++.+++|.+...... ....+.+|+++++.++|+||+++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 34567789999999999984 57889999998765432 3456888999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----C
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----S 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~ 211 (329)
++ +|.+.+.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKD-RQRGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHh-hcccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccC
Confidence 76 88888764 335789999999999999999999999 99999999999999999999999999987655432 3
Q ss_pred ccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-------cccc-----------
Q 020221 212 YSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------TDSC----------- 272 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------~~~~----------- 272 (329)
..++..|+|||.+.+. .++.++|+||||+++|+|++|+.||+............... ....
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 4567789999998876 68899999999999999999998876543211110000000 0000
Q ss_pred ------ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 273 ------LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 273 ------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.........+.++.+++.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000111245788999999999999999999999998
No 323
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=1.4e-39 Score=280.77 Aligned_cols=242 Identities=19% Similarity=0.276 Sum_probs=202.0
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|.+.+.||+|++|.||++. ..+++.+++|.+..... ...+.+.+|+++++.++|+|++++++++.+....++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 4566777999999999998 44678999999987654 34567899999999999999999999999999999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC----
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS---- 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---- 211 (329)
++++|.+++.. ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 82 ENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCcHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence 99999999863 36789999999999999999999999 999999999999999999999999999886654432
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
..++..|+|||...+...+.++||||+|+++++|++|..|+............. .......+...+..+.+++.+
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~ 233 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-----QDDHPPLPEGISPELKDFLMQ 233 (254)
T ss_pred cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-----ccCCCCCCCCCCHHHHHHHHH
Confidence 456788999999887778899999999999999999998775432111111111 111223445567889999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 020221 292 CLQYEPRERPNPRSLVT 308 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~ 308 (329)
||..+|++|||+.+++.
T Consensus 234 ~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 234 CFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHhCChhhCcCHHHHhc
Confidence 99999999999999986
No 324
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=8.9e-40 Score=287.21 Aligned_cols=247 Identities=21% Similarity=0.246 Sum_probs=194.6
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEEEEe
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLLVAE 133 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 133 (329)
|++++.+|.|++|.||+|.. .+++.+|+|.+.... ......+.+|+++++.++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 35667789999999999995 458899999998763 22345688899999999999999999999887 78999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--- 210 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--- 210 (329)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDS-PEVKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 9975 89888864 235789999999999999999999999 99999999999999999999999999987655432
Q ss_pred --CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc------------------
Q 020221 211 --SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT------------------ 269 (329)
Q Consensus 211 --~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~------------------ 269 (329)
...++..|+|||.+.+. .++.++||||||+++|+|++|..|+.................
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 22456789999987654 478899999999999999999988754432211111100000
Q ss_pred -------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 270 -------DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 270 -------~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.......+...+++++.+++.+||..||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000011113778999999999999999999999998
No 325
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=7.6e-40 Score=284.10 Aligned_cols=235 Identities=20% Similarity=0.224 Sum_probs=193.0
Q ss_pred CCCCCCcEEEEEEeC-CCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221 65 HGEKAPNVVYKGKLE-NQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (329)
Q Consensus 65 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (329)
+|.|+||.||++... +++.+++|.+..... ...+.+.+|+++++.++|+||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 489999999999954 588999999876543 2345688899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----------
Q 020221 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----------- 209 (329)
Q Consensus 141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----------- 209 (329)
.+++.+ ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~l~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLEN--VGSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999864 34789999999999999999999999 9999999999999999999999999998754332
Q ss_pred -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH--HHHHHH
Q 020221 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD--EGTELV 286 (329)
Q Consensus 210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 286 (329)
....++..|+|||.+.+...+.++||||||+++++|++|..|+................ ...+.. .+..+.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 231 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK------IEWPEDVEVSDEAI 231 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------cCCCccccCCHHHH
Confidence 12345678999999988888999999999999999999998876544332222111111 112222 378899
Q ss_pred HHHHHhcccCCCCCCCH---HHHHH
Q 020221 287 RLASRCLQYEPRERPNP---RSLVT 308 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~---~~~l~ 308 (329)
+++.+||+.+|++|||+ .++++
T Consensus 232 ~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 232 DLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHHhcCCHhhcCCCccHHHHhc
Confidence 99999999999999999 55554
No 326
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=8.5e-40 Score=288.78 Aligned_cols=250 Identities=19% Similarity=0.207 Sum_probs=193.5
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
..|++.+.||+|++|.||+|.. .+++.||+|.+..... .....+.+|+++++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4567778889999999999994 4688999999865432 223567889999999999999999999999999999999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCcccCCCC---
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~--- 209 (329)
|+++ +|.+.+.......+++..+..++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9964 788877644444568889999999999999999999 9999999999999985 567999999998754322
Q ss_pred -CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------hhcc----------
Q 020221 210 -RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------TLTD---------- 270 (329)
Q Consensus 210 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-------~~~~---------- 270 (329)
....+++.|+|||++.+. .++.++||||||+++|+|+||..||.............. ....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 223457889999988764 478899999999999999999988754322111110000 0000
Q ss_pred --ccccC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 271 --SCLEG----QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 271 --~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+.... ......++++.+++.+||+.||++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 011234678999999999999999999999997
No 327
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=6.6e-40 Score=289.52 Aligned_cols=248 Identities=17% Similarity=0.183 Sum_probs=190.8
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCC-CccccccceeeeeCCe-----eE
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLR-NRRLANLLGCCCEGDE-----RL 129 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----~~ 129 (329)
|++.+.||+|+||.||+|. ..+++.||+|.+...... ....+.+|+.+++.+. |+||+++++++..... .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 5566777999999999999 456889999998754322 2356788999999995 6999999999876655 89
Q ss_pred EEEecCCCCCHHhhhccCC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCccc
Q 020221 130 LVAEYMPNDTLAKHLFHWE---TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKN 205 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~ 205 (329)
++|||+++ +|.+++.... ...+++..+..++.||+.||.|||++ +++|+||+|+||+++. ++.++|+|||++..
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 99999986 7888875422 34689999999999999999999999 9999999999999998 88999999999875
Q ss_pred CCCC----CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-------cc---
Q 020221 206 SRDG----RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------TD--- 270 (329)
Q Consensus 206 ~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------~~--- 270 (329)
.... ....+++.|+|||++.+. .++.++|+||||+++|+|++|..||................ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 4322 123457789999988654 47899999999999999999998876432211110000000 00
Q ss_pred --------cccc----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 271 --------SCLE----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 271 --------~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+... .......+.++.+++.+||..||++||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0011235678999999999999999999999998
No 328
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=8.2e-40 Score=290.97 Aligned_cols=251 Identities=21% Similarity=0.239 Sum_probs=194.0
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeC--CeeE
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEG--DERL 129 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 129 (329)
....|++++.||+|+||.||+|.. .+++.||+|.+....... ...+.+|+.+++.++|+|++++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 445677888889999999999994 568899999987543221 23456899999999999999999998654 5689
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+||||+.+ +|.+++.. ....+++.++..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 85 lv~e~~~~-~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQ-DLASLLDN-MPTPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999975 78888754 236789999999999999999999999 9999999999999999999999999998765433
Q ss_pred C----CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------hcc-------
Q 020221 210 R----SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------LTD------- 270 (329)
Q Consensus 210 ~----~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-------~~~------- 270 (329)
. ...++..|+|||.+.+ ..++.++||||||+++|+|++|..||............... ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 1 2234678999999875 44788999999999999999999887644322111110000 000
Q ss_pred --cc-cc-CCC------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 271 --SC-LE-GQF------SSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 271 --~~-~~-~~~------~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.. .. ... ....++++.+++.+||..||++|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00 000 0124678899999999999999999999997
No 329
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=1.1e-39 Score=289.84 Aligned_cols=250 Identities=18% Similarity=0.232 Sum_probs=190.3
Q ss_pred CCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCC-----
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD----- 126 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 126 (329)
....|++++.||+|+||.||++. ..+++.||+|.+...... ....+.+|+++++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 34557788889999999999999 456889999998654322 2334678999999999999999999886543
Q ss_pred ---eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221 127 ---ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (329)
Q Consensus 127 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 203 (329)
..++||||+.+ +|.+.+.. ....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999965 78887754 334689999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCC--------CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhc-----
Q 020221 204 KNSRDGR--------SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLT----- 269 (329)
Q Consensus 204 ~~~~~~~--------~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~----- 269 (329)
....... ...++..|+|||.+.+.. ++.++||||||+++|+|++|..|+........... ...+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~-~~~~~~~~~~ 245 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL-ISQLCGSITP 245 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCh
Confidence 7543321 223567899999887654 78899999999999999999977754322111000 00000
Q ss_pred ---ccc----------ccCC---------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 270 ---DSC----------LEGQ---------FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 270 ---~~~----------~~~~---------~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+.. .... .+...+..+.+++.+||..||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 0000 00112456789999999999999999999998
No 330
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=2.5e-39 Score=283.67 Aligned_cols=238 Identities=19% Similarity=0.191 Sum_probs=187.4
Q ss_pred CCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh---HHHHHHHH---HHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 65 HGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD---ARQFLEEA---RAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 65 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
||+|+||.||++. ..+++.||+|.+....... ...+..|. +.++...||||+++.+++.+.+..++||||+.+
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 5999999999998 4568899999987643221 11233343 344455799999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CCccCc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RSYSTN 215 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~ 215 (329)
++|..++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...... ....++
T Consensus 82 ~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (278)
T cd05606 82 GDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158 (278)
T ss_pred CcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCC
Confidence 99999886 345689999999999999999999999 9999999999999999999999999998754332 234678
Q ss_pred ccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcc
Q 020221 216 LAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQ 294 (329)
Q Consensus 216 ~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 294 (329)
..|+|||.+.++ .++.++||||+|+++|+|++|..||........... .... .......+...+.++.+++.+||.
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--~~~~-~~~~~~~~~~~s~~~~~li~~~l~ 235 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMT-LTMAVELPDSFSPELRSLLEGLLQ 235 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--HHHh-hccCCCCCCcCCHHHHHHHHHHhh
Confidence 999999998755 588999999999999999999988764411111000 0000 011223444567899999999999
Q ss_pred cCCCCCC-----CHHHHHH
Q 020221 295 YEPRERP-----NPRSLVT 308 (329)
Q Consensus 295 ~dp~~Rp-----s~~~~l~ 308 (329)
.||++|| ++.++++
T Consensus 236 ~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 236 RDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred cCHHhccCCCCCCHHHHHh
Confidence 9999999 9999986
No 331
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=1.8e-39 Score=289.31 Aligned_cols=239 Identities=18% Similarity=0.212 Sum_probs=186.2
Q ss_pred CCcEEEEEE-eCCCCEEEEEEeCCC--CChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhc
Q 020221 69 APNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLF 145 (329)
Q Consensus 69 ~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 145 (329)
++|.||.+. ..+++.||+|++... .....+.+.+|++.++.++|+||+++++++......+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 445555555 336889999998765 23345678999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----------CCccC
Q 020221 146 HWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----------RSYST 214 (329)
Q Consensus 146 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----------~~~~~ 214 (329)
+.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+...... ....+
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 54455689999999999999999999999 9999999999999999999999999987643221 12345
Q ss_pred cccccCcccccCC--CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh----hhc-------------------
Q 020221 215 NLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ----TLT------------------- 269 (329)
Q Consensus 215 ~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~----~~~------------------- 269 (329)
+..|+|||++.+. .++.++||||||+++|+|++|..||.............. ...
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 6789999998763 488899999999999999999988764321111000000 000
Q ss_pred -----cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 270 -----DSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 270 -----~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
............+.++.+++.+||..||++|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000011122345678999999999999999999999997
No 332
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=2.4e-39 Score=281.48 Aligned_cols=242 Identities=17% Similarity=0.195 Sum_probs=196.1
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-----ChhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 130 (329)
|++.+.||+|+||.||++. ..+++.||+|.+.... ......+.+|+++++.++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 5566677999999999998 4568899999875321 22345688999999999999999999998664 46889
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG- 209 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 209 (329)
++||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 84 FVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 9999999999999863 34588999999999999999999999 9999999999999999999999999998754321
Q ss_pred ------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHH
Q 020221 210 ------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 210 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
....++..|+|||.+.+..++.++|+||||+++++|++|..||......... ............+...++
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~p~~~~~ 236 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI----FKIATQPTKPMLPDGVSD 236 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH----HHHHcCCCCCCCCcccCH
Confidence 1235678899999999888999999999999999999999887543211111 111111122345667788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 284 ELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
++.+++.+||. +|..||++.+++.
T Consensus 237 ~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 237 ACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHHHHHhc-CcccCccHHHHhc
Confidence 99999999998 6799999999887
No 333
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.5e-40 Score=275.34 Aligned_cols=240 Identities=18% Similarity=0.215 Sum_probs=195.4
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (329)
.||+|+|+.|-.++ +.+|..+|||++.+........+.+|++++...+ |+||++++++|+++..+|||||-|.||+|.
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplL 164 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLL 164 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHH
Confidence 46999999999998 8899999999998887666778999999999995 999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC---CeeeecccCcccCCCC---------
Q 020221 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLMKNSRDG--------- 209 (329)
Q Consensus 142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~~~~~~--------- 209 (329)
+.|. +...+++.++.++.++|+.||.|||.+ ||.|||+||+|||-.... -+||+||.+.......
T Consensus 165 shI~--~~~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 165 SHIQ--KRKHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred HHHH--HhhhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 9997 567899999999999999999999999 999999999999997544 3899999887543221
Q ss_pred --CCccCcccccCccccc---CC--CCCCcccchhhhHHHHHHHhCCCCCCchhhH-----------HHhhhchhhhccc
Q 020221 210 --RSYSTNLAFTPPEYLR---TG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALD-----------LIRDRNIQTLTDS 271 (329)
Q Consensus 210 --~~~~~~~~y~aPE~~~---~~--~~~~~~DvwslG~il~el~tg~~~~~~~~~~-----------~~~~~~~~~~~~~ 271 (329)
.+.+|+-.|||||+.. +. .|+.+.|.||||||||-|++|.+||.+..-. .-.+.....+-+.
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG 321 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 321 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence 1234567899999763 32 3888999999999999999999998653110 0011111111111
Q ss_pred cccCCCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 272 CLEGQFS----SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 272 ~~~~~~~----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...+| ...|.+..+++..+|..|+.+|.++.++++
T Consensus 322 --kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 322 --KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred --CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11233 357889999999999999999999999998
No 334
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=9.9e-40 Score=286.75 Aligned_cols=248 Identities=17% Similarity=0.250 Sum_probs=195.0
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
|++++.||.|++|.||+|.. .+++.||+|.++..... ....+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 55677889999999999995 56889999998765432 24567789999999999999999999999999999999998
Q ss_pred CCCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221 137 NDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (329)
Q Consensus 137 ~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~ 211 (329)
+ +|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++...... ..
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 5 8888875422 24689999999999999999999999 9999999999999999999999999998654322 22
Q ss_pred ccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh-----------cc-ccccC---
Q 020221 212 YSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-----------TD-SCLEG--- 275 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-----------~~-~~~~~--- 275 (329)
..++..|+|||.+.+. .++.++||||||+++|+|++|..|+................ .. +....
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 3457889999988664 47889999999999999999998876443221111110000 00 00000
Q ss_pred --------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 276 --------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 276 --------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
......+..+.+++..||+.||++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011234678899999999999999999999997
No 335
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=7.2e-40 Score=294.72 Aligned_cols=252 Identities=17% Similarity=0.252 Sum_probs=193.2
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeC-----CeeEE
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERLL 130 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l 130 (329)
.|++.+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 46677788999999999998 5578899999986432 22345678899999999999999999886543 35799
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
++||+.+ +|...+ ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 v~e~~~~-~l~~~~---~~~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 86 VQELMET-DLYKLI---KTQHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred Eehhccc-CHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 9999975 888877 446799999999999999999999999 99999999999999999999999999987543321
Q ss_pred -------CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc-----------hhh----
Q 020221 211 -------SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN-----------IQT---- 267 (329)
Q Consensus 211 -------~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~-----------~~~---- 267 (329)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||+........... ...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 2356788999998754 45888999999999999999999887643211100000 000
Q ss_pred ----hccccc-cCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 020221 268 ----LTDSCL-EGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQ 314 (329)
Q Consensus 268 ----~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~--L~~~~ 314 (329)
...... ... .....++++.+++.+||+.||++|||+.+++++ ++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 000000 000 011246789999999999999999999999985 44443
No 336
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-40 Score=316.37 Aligned_cols=247 Identities=19% Similarity=0.172 Sum_probs=205.4
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC---CChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeE
Q 020221 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS---AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 129 (329)
-+-+++++++.||+|+||.|..++ ..+++.||+|++.+. ......-|..|-.+|..-..+-|+++..+|++..++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 344567788888999999999999 567889999999762 2223345888999999999999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC-C
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR-D 208 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~-~ 208 (329)
+|||||+||+|..++.+.. .+++..++.++.+|.-||..||+. |+|||||||+|||+|.+|++||+|||.+-... +
T Consensus 152 lVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999999999997433 799999999999999999999999 99999999999999999999999999876655 3
Q ss_pred C----CCccCcccccCccccc----C-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC-
Q 020221 209 G----RSYSTNLAFTPPEYLR----T-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS- 278 (329)
Q Consensus 209 ~----~~~~~~~~y~aPE~~~----~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 278 (329)
+ ...+|||.|++||++. + +.|....|+||+||++|||+.|.-||+.+..-.....++.. . ..+ .+|
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-k-~~l--~FP~ 304 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-K-ESL--SFPD 304 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-h-hhc--CCCc
Confidence 3 2457999999999985 3 45999999999999999999999999877554443332221 1 111 233
Q ss_pred -hHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 020221 279 -SDEGTELVRLASRCLQYEPRERPN---PRSLVT 308 (329)
Q Consensus 279 -~~~~~~~~~li~~cl~~dp~~Rps---~~~~l~ 308 (329)
.+.|+++.+||.+.+. +|+.|.. ++++.+
T Consensus 305 ~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 305 ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 4589999999999994 8999988 777776
No 337
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=1.4e-39 Score=290.24 Aligned_cols=248 Identities=17% Similarity=0.221 Sum_probs=190.9
Q ss_pred ccccccCCCCCCcEEEEEEe-C--CCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeC--CeeEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-E--NQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEG--DERLL 130 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 130 (329)
|.+++.||+|+||.||+|.. . ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 45677789999999999995 3 57899999998743 23345678899999999999999999999887 78999
Q ss_pred EEecCCCCCHHhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC----CCCeeeecccCc
Q 020221 131 VAEYMPNDTLAKHLFHW---ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD----DVNPRLSCFGLM 203 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~a 203 (329)
||||+++ +|.+.+... ....+++..++.++.|++.||.|||+. +++|+||||+||+++. ++.+||+|||++
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999976 677766422 123688999999999999999999999 9999999999999999 999999999998
Q ss_pred ccCCCC-------CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHH---------Hhhhch-
Q 020221 204 KNSRDG-------RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDL---------IRDRNI- 265 (329)
Q Consensus 204 ~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~---------~~~~~~- 265 (329)
...... ....++..|+|||++.+. .++.++||||||+++++|++|..|+....... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 764332 223457889999988764 48889999999999999999998775332111 000000
Q ss_pred -------------------hhhccccccCCCC-----------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 266 -------------------QTLTDSCLEGQFS-----------SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 266 -------------------~~~~~~~~~~~~~-----------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
....+......++ ...+.++.+++.+||+.||++|||+.++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000111 034567899999999999999999999998
No 338
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=1.2e-39 Score=292.60 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=200.5
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCC-----eeEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGD-----ERLL 130 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l 130 (329)
|.+.+.||+|++|.||++.. .+++.+|+|++.... ....+.+.+|+.+++.++|+||+++.+++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 55667789999999999994 458899999987653 233567889999999999999999999987765 7899
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
+|||+.+ +|.+++.+ ...+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~~-~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELMET-DLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchhh-hHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 9999975 89888863 34789999999999999999999999 99999999999999999999999999988655432
Q ss_pred -------CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh--------------
Q 020221 211 -------SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL-------------- 268 (329)
Q Consensus 211 -------~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~-------------- 268 (329)
...++..|+|||.+.+. .++.++|+||||+++|+|++|..||................
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 23467889999999887 78899999999999999999998886543221111110000
Q ss_pred -----cc---cc---ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhhc
Q 020221 269 -----TD---SC---LEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQKD 316 (329)
Q Consensus 269 -----~~---~~---~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~--L~~~~~~ 316 (329)
.. .. .........++++.+++.+||+.||++||++.+++.+ ++.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 00 00 0000112356789999999999999999999999983 5555443
No 339
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=1.5e-39 Score=292.50 Aligned_cols=247 Identities=17% Similarity=0.257 Sum_probs=191.7
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee----CCeeEE
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLL 130 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l 130 (329)
.|++.+.||+|+||.||++. ..+++.||+|++..... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 34566677999999999998 55689999999876432 234567889999999999999999988753 356899
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
|+||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 v~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 86 VMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred EEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 999996 58988885 345589999999999999999999999 99999999999999999999999999986543221
Q ss_pred --------CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhh-------------------
Q 020221 211 --------SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD------------------- 262 (329)
Q Consensus 211 --------~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~------------------- 262 (329)
...++..|+|||.+.+ ..++.++||||||+++|+|++|..||..........
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 2356788999998865 458899999999999999999998886532111000
Q ss_pred hchhhhccccc-cCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 263 RNIQTLTDSCL-EGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 263 ~~~~~~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
........... ... .....++++.+++.+||+.||++||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000000000 000 11234788999999999999999999999997
No 340
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=1.6e-39 Score=284.52 Aligned_cols=242 Identities=21% Similarity=0.248 Sum_probs=199.3
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 132 (329)
.|.+.+.||+|+||.||++. ..+++.||+|++.... ......+.+|.++++.++ |+||+++++++...+..+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 35667778999999999999 4578899999987632 122356788999999998 999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR-- 210 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-- 210 (329)
|++++++|.+++.+ ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 82 e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999963 34799999999999999999999999 99999999999999999999999999987544322
Q ss_pred ----------------------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh
Q 020221 211 ----------------------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268 (329)
Q Consensus 211 ----------------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~ 268 (329)
...++..|+|||.+.+..++.++|+||||++++++++|..|+........... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~ 234 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK----I 234 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----H
Confidence 12356889999999888899999999999999999999988764432111111 1
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 020221 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP----RSLVT 308 (329)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~----~~~l~ 308 (329)
.. .....+...++.+.+++.+||+.||++||++ .++++
T Consensus 235 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 LK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred Hh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11 1223445567889999999999999999999 88877
No 341
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=5e-39 Score=282.55 Aligned_cols=248 Identities=19% Similarity=0.217 Sum_probs=191.9
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCChh--HHHHHHHHHHHhcC---CCccccccceeeeeCCe-----
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPD--ARQFLEEARAVGQL---RNRRLANLLGCCCEGDE----- 127 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----- 127 (329)
|++++.+|+|+||.||++... +++.||+|.+....... ...+.+|+.+++.+ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 345677899999999999954 58899999997543221 23456677766655 69999999999987766
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.+++|||+.+ +|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 898888654444689999999999999999999999 99999999999999999999999999987654
Q ss_pred CCC---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh----------------
Q 020221 208 DGR---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL---------------- 268 (329)
Q Consensus 208 ~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~---------------- 268 (329)
... ...++..|+|||++.+..++.++|+||||+++|+|++|..|+................
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 332 2346788999999998889999999999999999999987765433221111111000
Q ss_pred --cccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 269 --TDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 269 --~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...... .......++.+.+++.+||+.||++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000 0111245678899999999999999999999997
No 342
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=1.9e-39 Score=292.11 Aligned_cols=254 Identities=17% Similarity=0.255 Sum_probs=196.2
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC-----CeeE
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERL 129 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 129 (329)
.|.+++.||+|+||+||++. ..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++... ...+
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 35667778999999999998 5578899999987542 22345677899999999999999999987543 3579
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+++||+. ++|.+++. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 86 IVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 9999996 58988886 345789999999999999999999999 9999999999999999999999999998765433
Q ss_pred ----CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhh-------------------hch
Q 020221 210 ----RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD-------------------RNI 265 (329)
Q Consensus 210 ----~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~-------------------~~~ 265 (329)
....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......... ...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 23356788999998765 458899999999999999999998875432110000 000
Q ss_pred hhhc---ccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhh
Q 020221 266 QTLT---DSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQK 315 (329)
Q Consensus 266 ~~~~---~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~--L~~~~~ 315 (329)
.... ..... .......++++.+++.+||+.||++|||+.+++++ +..+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0000 00000 00112457889999999999999999999999985 555443
No 343
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=2.4e-39 Score=285.96 Aligned_cols=250 Identities=12% Similarity=0.056 Sum_probs=181.9
Q ss_pred CcccccccCCCCCCcEEEEEEeCC----CCEEEEEEeCCCCChhHH-----------HHHHHHHHHhcCCCcccccccee
Q 020221 57 AMENIVSEHGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDAR-----------QFLEEARAVGQLRNRRLANLLGC 121 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~niv~~~~~ 121 (329)
..|++.+.||+|+||.||+|...+ +..+|+|........... ....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 357788888999999999998543 455667764433221110 12233445666789999999987
Q ss_pred eeeCC----eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221 122 CCEGD----ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (329)
Q Consensus 122 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl 197 (329)
+.... ..+++++++.. ++.+.+.. ....++..+..++.|++.||.|||+. +++||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCcEEE
Confidence 65443 34678887754 67666642 23467888999999999999999999 9999999999999999999999
Q ss_pred ecccCcccCCCC-----------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhch
Q 020221 198 SCFGLMKNSRDG-----------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNI 265 (329)
Q Consensus 198 ~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~ 265 (329)
+|||+++..... ....||+.|+|||++.+..++.++||||||++++||++|..||..... ........
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999998754211 123588999999999998999999999999999999999988754411 11111111
Q ss_pred hhhccccccC-CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221 266 QTLTDSCLEG-QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 266 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L 310 (329)
.+.......+ ......++++.+++..||..+|++||++.++++.|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 248 CDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111111111 11234468899999999999999999999999876
No 344
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-41 Score=326.45 Aligned_cols=239 Identities=17% Similarity=0.202 Sum_probs=199.9
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (329)
+||.|.||.||.+. .++|...|+|.+...... ..+.+.+|..++..++|||+|+++|+-.+.+..+|.||||++|+|
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsL 1321 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSL 1321 (1509)
T ss_pred ccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcH
Confidence 56999999999999 788999999988654322 244578899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC--------Cc
Q 020221 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR--------SY 212 (329)
Q Consensus 141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--------~~ 212 (329)
.+.+. .++..++.....+..|++.|++|||+. |||||||||.||+++.+|.+|++|||.|....... ..
T Consensus 1322 a~ll~--~gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~ 1398 (1509)
T KOG4645|consen 1322 ASLLE--HGRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSM 1398 (1509)
T ss_pred HHHHH--hcchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhh
Confidence 99986 445677888888999999999999999 99999999999999999999999999998765442 34
Q ss_pred cCcccccCcccccCCC---CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
.||+.|||||++.+.. -..++||||+||+++||+||+.|+..-..+.. +.-.+...-.+.+|...+.+..+|+
T Consensus 1399 ~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----IMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1399 MGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----IMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred cCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH----HHhHHhccCCCCCchhhhHhHHHHH
Confidence 6899999999998644 55689999999999999999998753321111 1111122233456777999999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 020221 290 SRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 290 ~~cl~~dp~~Rps~~~~l~~ 309 (329)
..||..||+.|.++.|++++
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHHhcCchhhhHHHHHHHh
Confidence 99999999999999988874
No 345
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=4.9e-39 Score=284.29 Aligned_cols=250 Identities=18% Similarity=0.262 Sum_probs=192.7
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEE
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 131 (329)
++..+.+.+.+|+|+||.||++... +++.||||.++..... ....+..|+..+... .|+||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 3455677888899999999999965 4889999999764322 334566777766666 599999999999999999999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 210 (329)
|||+.+ +|.+++.. ....+++..+..++.|++.||.|||+..+++|+||+|+||++++++.++|+|||++.......
T Consensus 93 ~e~~~~-~l~~l~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 93 MELMST-CLDKLLKR-IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eeccCc-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 999854 77776654 234789999999999999999999974399999999999999999999999999987654322
Q ss_pred --CccCcccccCcccccCCC----CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccc-cCCCChHHHH
Q 020221 211 --SYSTNLAFTPPEYLRTGR----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL-EGQFSSDEGT 283 (329)
Q Consensus 211 --~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 283 (329)
...++..|+|||.+.+.. ++.++||||||+++|+|++|+.||........ .......... ........+.
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---VLTKILQEEPPSLPPNEGFSP 247 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH---HHHHHhcCCCCCCCCCCCCCH
Confidence 224567899999987553 78899999999999999999988754211100 0011111110 0011123567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221 284 ELVRLASRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps~~~~l~~ 309 (329)
++.+++.+||..||++||++.+++.+
T Consensus 248 ~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 248 DFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 89999999999999999999999973
No 346
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=4e-39 Score=282.74 Aligned_cols=247 Identities=17% Similarity=0.277 Sum_probs=193.0
Q ss_pred cccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCC
Q 020221 60 NIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
.+.+.||+|++|+||+|.. .+++.|++|.+...... ......+|+..++.++ |+|++++++++..++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 4567789999999999995 45788999998765322 2233567899999998 999999999999999999999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---Ccc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---SYS 213 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~ 213 (329)
+++|.+++.......+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV 159 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCC
Confidence 77999988754445789999999999999999999999 99999999999999999999999999987655432 345
Q ss_pred CcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-----------------hhhcccccc-
Q 020221 214 TNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-----------------QTLTDSCLE- 274 (329)
Q Consensus 214 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~- 274 (329)
++..|+|||++.+ ..++.++|+||||+++++|++|..|++............ .........
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07830 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ 239 (283)
T ss_pred CcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccc
Confidence 6788999998854 447889999999999999999998775442211110000 000000000
Q ss_pred ------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 275 ------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 275 ------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.......+..+.+++.+||+.||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0001122578999999999999999999999987
No 347
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=5.7e-39 Score=277.42 Aligned_cols=244 Identities=16% Similarity=0.236 Sum_probs=202.0
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|++.+.+|.|+||.||++. ..+++.+++|.+..... .....+.+|+++++.++|+||+++.+++......++|+||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 4566778999999999998 55788999999876432 23456788999999999999999999999999999999999
Q ss_pred CCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--CC
Q 020221 136 PNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG--RS 211 (329)
Q Consensus 136 ~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~ 211 (329)
++++|.+++.+. ....+++..+..++.|++.||.|||+. |++|+||+|+||++++++.++|+|||++...... ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 160 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence 999999988642 235689999999999999999999999 9999999999999999999999999998765443 22
Q ss_pred ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
..++..|+|||.+.+..++.++|+||||+++++|++|..|+.............. ......+...+.++.+++.+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~ 235 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-----GKYPPIPPIYSQDLQNFIRS 235 (256)
T ss_pred ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----CCCCCCchhhCHHHHHHHHH
Confidence 3467899999999988899999999999999999999988765433222221111 11122344677889999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 020221 292 CLQYEPRERPNPRSLVT 308 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~ 308 (329)
||..+|++||++.++++
T Consensus 236 ~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 236 MLQVKPKLRPNCDKILA 252 (256)
T ss_pred HcCCCcccCCCHHHHhc
Confidence 99999999999999997
No 348
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=4.7e-39 Score=282.00 Aligned_cols=246 Identities=22% Similarity=0.264 Sum_probs=194.8
Q ss_pred cccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 60 NIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
++.+.||+|.+|.||+|.. .+++.+|+|.+.... ....+.+.+|+.+++.++|+|++++++++.+....++|+||+.
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 3456679999999999994 568999999998753 2234567889999999999999999999999999999999998
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----Cc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR----SY 212 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~ 212 (329)
+ +|.+++.+. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~-~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 82 M-DLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred c-CHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 4 899999642 24789999999999999999999999 99999999999999999999999999987654332 23
Q ss_pred cCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh--------------------hhccc
Q 020221 213 STNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ--------------------TLTDS 271 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~--------------------~~~~~ 271 (329)
..+..|+|||.+.+. .++.++||||||++++||++|..|+.............. .....
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 346789999998776 688899999999999999999887765432211111000 00000
Q ss_pred cccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 272 CLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 272 ~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.... ......+..+.+++.+||..||++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 001123678999999999999999999999998
No 349
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-40 Score=277.28 Aligned_cols=234 Identities=18% Similarity=0.225 Sum_probs=199.8
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHH---HHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQ---FLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
+..++.||+|.||.|.+++ ..+++.+|+|++++...-..++ -..|-++|+..+||.+..+...|+..+.+++||||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 3456666999999999998 6789999999998765333333 45688999999999999999999999999999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC----CCC
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----DGR 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~----~~~ 210 (329)
..||.|.-.|. ..+.+++...+.+..+|+.||.|||++ +||+||+|.+|.++|.+|++||+|||+++..- ...
T Consensus 250 anGGeLf~HLs--rer~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~k 326 (516)
T KOG0690|consen 250 ANGGELFFHLS--RERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTK 326 (516)
T ss_pred ccCceEeeehh--hhhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCCceEeeecccchhcccccceec
Confidence 99999988886 457799999999999999999999999 99999999999999999999999999987532 235
Q ss_pred CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHH
Q 020221 211 SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLAS 290 (329)
Q Consensus 211 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 290 (329)
+++||+.|.|||++.+..|...+|+|.+||++|||++|+.||.....+..-.-.... .-.+|...+++...|+.
T Consensus 327 TFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------d~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------DLKFPRTLSPEAKTLLS 400 (516)
T ss_pred cccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh------hccCCccCCHHHHHHHH
Confidence 678999999999999999999999999999999999999999865444333222221 11366778899999999
Q ss_pred HhcccCCCCCC
Q 020221 291 RCLQYEPRERP 301 (329)
Q Consensus 291 ~cl~~dp~~Rp 301 (329)
.+|..||.+|.
T Consensus 401 GLL~kdP~kRL 411 (516)
T KOG0690|consen 401 GLLKKDPKKRL 411 (516)
T ss_pred HHhhcChHhhc
Confidence 99999999996
No 350
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.8e-40 Score=299.87 Aligned_cols=237 Identities=16% Similarity=0.226 Sum_probs=191.2
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCC----CChhHHHHHHHHHHHhcCCCccccccceeeeeCCe--eEEEEecCC
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRS----AWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE--RLLVAEYMP 136 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~~~ 136 (329)
.||+|+|-+||+|. -.+|..||--.++.. .....+.|..|+.+|+.|+||||++++.+|.+..+ +.+|+|++.
T Consensus 47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 46999999999998 445766775444322 22335779999999999999999999999988765 789999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCccccccCCCceeeC-CCCCeeeecccCcccCCCC--CCc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSRDG--RSY 212 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~--~~~ 212 (329)
.|+|..|++ +.+.++...+..|++||+.||.|||++ ..|+|||||.+||+|+ ..|.|||+|+|+|...... ...
T Consensus 127 SGtLr~Y~k--k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksv 204 (632)
T KOG0584|consen 127 SGTLREYRK--KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSV 204 (632)
T ss_pred CCcHHHHHH--HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccccee
Confidence 999999997 566788899999999999999999986 5799999999999998 5688999999999865543 456
Q ss_pred cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhchhhhccccccCCCChHHHHHHHHHHHH
Q 020221 213 STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASR 291 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 291 (329)
.|||.|||||+.. ..|++.+||||||+.++||+|+..|+..... ..+.......+.+..+. .---+++++||.+
T Consensus 205 IGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~----kV~dPevr~fIek 279 (632)
T KOG0584|consen 205 IGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS----KVKDPEVREFIEK 279 (632)
T ss_pred ccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh----ccCCHHHHHHHHH
Confidence 8999999999987 7899999999999999999999988754321 22222222222222211 1124689999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 020221 292 CLQYEPRERPNPRSLVT 308 (329)
Q Consensus 292 cl~~dp~~Rps~~~~l~ 308 (329)
||.. ..+|||+.++|+
T Consensus 280 Cl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 280 CLAT-KSERLSAKELLK 295 (632)
T ss_pred HhcC-chhccCHHHHhh
Confidence 9999 999999999996
No 351
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=6.7e-39 Score=276.10 Aligned_cols=235 Identities=22% Similarity=0.246 Sum_probs=195.5
Q ss_pred CCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221 65 HGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (329)
Q Consensus 65 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (329)
||+|+||.||++.. .+++.+++|.+...... ....+..|+++++.++|+|++++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 59999999999995 45889999998765422 345688899999999999999999999999999999999999999
Q ss_pred HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CCccCcc
Q 020221 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RSYSTNL 216 (329)
Q Consensus 141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~ 216 (329)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...... ....++.
T Consensus 81 ~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 81 FSHLSK--EGRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCc
Confidence 999963 34689999999999999999999998 9999999999999999999999999998765442 2345678
Q ss_pred cccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 020221 217 AFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (329)
Q Consensus 217 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 296 (329)
.|+|||.+.+...+.++|+||||+++|++++|..|+.............. .....+...+..+.+++.+||..|
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK------DPLRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc------CCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999999888889999999999999999999988754432222111111 112344455788999999999999
Q ss_pred CCCCCCH---HHHHH
Q 020221 297 PRERPNP---RSLVT 308 (329)
Q Consensus 297 p~~Rps~---~~~l~ 308 (329)
|++||++ .++++
T Consensus 232 p~~R~~~~~~~~l~~ 246 (250)
T cd05123 232 PTKRLGSGGAEEIKA 246 (250)
T ss_pred HhhCCCcccHHHHHh
Confidence 9999999 56665
No 352
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=2.3e-39 Score=292.07 Aligned_cols=247 Identities=16% Similarity=0.223 Sum_probs=190.4
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeC----------
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEG---------- 125 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------- 125 (329)
..|.+.+.||.|+||.||+|. ..+++.||+|.+........+.+.+|+++++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 346677788999999999998 456889999998776655567788999999999999999999776543
Q ss_pred ----CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecc
Q 020221 126 ----DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCF 200 (329)
Q Consensus 126 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Df 200 (329)
...++++||+.+ +|.+++. ...+++..+..++.|++.||.|||+. |++|+||||+||+++ +++.++++||
T Consensus 85 ~~~~~~~~lv~e~~~~-~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 85 LTELNSVYIVQEYMET-DLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred ccccceEEEEeecccc-cHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEECCc
Confidence 357899999974 8988873 35689999999999999999999999 999999999999997 4567899999
Q ss_pred cCcccCCCC-------CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-----
Q 020221 201 GLMKNSRDG-------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT----- 267 (329)
Q Consensus 201 g~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~----- 267 (329)
|.+...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 998754322 12245778999998754 45888999999999999999999888543211110000000
Q ss_pred -------------hcc-ccccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 268 -------------LTD-SCLEGQ-----FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 268 -------------~~~-~~~~~~-----~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
... ...... .....+.++.+++.+||+.||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 000000 11234578999999999999999999999996
No 353
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=9.9e-39 Score=324.04 Aligned_cols=244 Identities=25% Similarity=0.426 Sum_probs=195.1
Q ss_pred ccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221 63 SEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (329)
..+|+|+||.||+|.. .++..||+|.+...... ...|++.++.++||||+++++++.+....++||||+++|+|.
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~ 771 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence 3459999999999994 67889999998754322 134688999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHhh---cCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCcccc
Q 020221 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCT---SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAF 218 (329)
Q Consensus 142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y 218 (329)
+++. .++|..+..++.|++.||+||| +. +++||||||+||+++.++..++. ||.+..........++..|
T Consensus 772 ~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y 844 (968)
T PLN00113 772 EVLR-----NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAY 844 (968)
T ss_pred HHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccc
Confidence 9994 3899999999999999999999 66 99999999999999998888775 6665544334445678999
Q ss_pred cCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchh------hHHHh----hhchhhhccccccC--CCChHHHHHHH
Q 020221 219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHA------LDLIR----DRNIQTLTDSCLEG--QFSSDEGTELV 286 (329)
Q Consensus 219 ~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~------~~~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~ 286 (329)
+|||++.+..++.++|||||||++|||+||+.|+.... ..... ........++.... ..+.....++.
T Consensus 845 ~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (968)
T PLN00113 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM 924 (968)
T ss_pred cCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHH
Confidence 99999998899999999999999999999998874321 00000 00111122222221 22345566888
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
+++.+||+.||++|||+.++++.|+.+.+..
T Consensus 925 ~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 925 NLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 9999999999999999999999999997744
No 354
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-39 Score=252.09 Aligned_cols=247 Identities=18% Similarity=0.237 Sum_probs=197.0
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
|...++||+|.||+||+++ +.+++.||+|.++.+... ......+|+.+++.++|.|||++++....+..+-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 4456678999999999999 778999999999865422 2445789999999999999999999998899999999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC----CC
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG----RS 211 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~----~~ 211 (329)
.. +|..++.. -+..++.+.+..++.|+++||.|+|+. +++|||+||.|.|++.+|.+|++|||+++-+.-. ..
T Consensus 84 dq-dlkkyfds-lng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 84 DQ-DLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred hH-HHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 76 78888854 456789999999999999999999999 9999999999999999999999999999865533 23
Q ss_pred ccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCC-CCCchhhHHHhhhchhhhc-------cc-------cccC
Q 020221 212 YSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKH-IPPSHALDLIRDRNIQTLT-------DS-------CLEG 275 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~-~~~~~~~~~~~~~~~~~~~-------~~-------~~~~ 275 (329)
...|.+|.+|.++.+.+ |+.+.|+||.|||+.|+...+. .|++...+....+.....- +. ..-+
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 35689999999999887 8999999999999999987554 4555443322222111110 00 0001
Q ss_pred CCC---------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 276 QFS---------SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 276 ~~~---------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.++ +..+..-++++...|.-+|.+|.+++.+++
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111 123456689999999999999999999988
No 355
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=5.9e-39 Score=282.85 Aligned_cols=245 Identities=17% Similarity=0.227 Sum_probs=193.9
Q ss_pred ccccccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCCC----hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221 59 ENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (329)
|++.+.||.|+||.||++.. .+|..||+|.+..... ...+.+.+|++++..+ +|+||+++.+.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 45667789999999999984 3688999999875321 2235578899999999 5999999999998888999
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+|+||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999863 45688999999999999999999999 9999999999999999999999999998765432
Q ss_pred C-----CccCcccccCcccccCC--CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221 210 R-----SYSTNLAFTPPEYLRTG--RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (329)
Q Consensus 210 ~-----~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (329)
. ...++..|+|||.+.+. .++.++||||||+++|+|++|..|+.................. ....++...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQEMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc--cCCCCCccCC
Confidence 1 23477899999998753 4778999999999999999999887532111000001111111 1122345567
Q ss_pred HHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 020221 283 TELVRLASRCLQYEPRERP-----NPRSLVT 308 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rp-----s~~~~l~ 308 (329)
+.+.+++.+||+.||++|| ++.+++.
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 8899999999999999997 6677765
No 356
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=5.5e-39 Score=284.59 Aligned_cols=248 Identities=21% Similarity=0.230 Sum_probs=190.5
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeCC--------
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEGD-------- 126 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 126 (329)
.|.+.+.+|+|+||.||+|.. .+++.||+|.++.... .....+.+|+++++.++|||++++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 355667779999999999995 4688999999975432 22345778999999999999999999886654
Q ss_pred --eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221 127 --ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 127 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 204 (329)
..++++||+++ ++...+.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLES-GLVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 78999999986 77777754 345789999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCC-----CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------hhccc
Q 020221 205 NSRDGR-----SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------TLTDS 271 (329)
Q Consensus 205 ~~~~~~-----~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-------~~~~~ 271 (329)
...... ...++..|+|||.+.+. .++.++||||||+++++|++|+.|+.............. .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T cd07864 165 LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPD 244 (302)
T ss_pred cccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 654332 12346789999988654 478899999999999999999977754321111000000 00000
Q ss_pred c----c----------c---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 272 C----L----------E---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 272 ~----~----------~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
. . . .......+..+.+++..||..||++||++.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 245 VIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0 0 0001124678999999999999999999999998
No 357
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=6.8e-39 Score=277.94 Aligned_cols=243 Identities=16% Similarity=0.192 Sum_probs=194.0
Q ss_pred ccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC-----ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
|.+.+.||+|+||.||++.. ..+..+++|.++... ......+..|+.+++.++||||+++++++.+....++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 55667889999999999984 334456666655321 122345677899999999999999999999889999999
Q ss_pred ecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221 133 EYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 133 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
||+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999888532 345789999999999999999999999 9999999999999975 569999999987654322
Q ss_pred ----CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 211 ----SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 211 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
...++..|+|||.+.+..++.++|+||||+++|+|++|..|+.............. ......+...+.++.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 234 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-----GPTPSLPETYSRQLN 234 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc-----CCCCCCcchhcHHHH
Confidence 33567889999999888889999999999999999999988764432222111111 112233456778999
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 020221 287 RLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+++.+||..||++||++.++++
T Consensus 235 ~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 235 SIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHhcCChhhCcCHHHHhh
Confidence 9999999999999999999998
No 358
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=5.3e-39 Score=289.22 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=192.6
Q ss_pred cccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcC-CCccccccceeeeeC--CeeEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQL-RNRRLANLLGCCCEG--DERLLV 131 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~~lv 131 (329)
.|.+.+.||+|+||.||+|.. .+++.+|+|++.... ......+.+|+.+++.+ +||||+++++++... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 355666779999999999995 468899999886532 22345577899999999 999999999988643 468999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC-
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR- 210 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 210 (329)
|||+.+ +|..++.. ..+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~e~~~~-~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 88 FEYMET-DLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred eccccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 999975 89998853 3788999999999999999999999 99999999999999999999999999987543322
Q ss_pred --------CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhc-----------------
Q 020221 211 --------SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRN----------------- 264 (329)
Q Consensus 211 --------~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~----------------- 264 (329)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 2346788999998765 45788999999999999999999887543211110000
Q ss_pred --hhhhcccccc------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 020221 265 --IQTLTDSCLE------GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQ 314 (329)
Q Consensus 265 --~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~--L~~~~ 314 (329)
.......... .......+.++.+++.+||+.||++|||+.+++++ ++.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0000000000 00111256789999999999999999999999975 55553
No 359
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-39 Score=281.24 Aligned_cols=249 Identities=17% Similarity=0.229 Sum_probs=194.9
Q ss_pred cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC--CCccccccceeeeeC----CeeEEEEe
Q 020221 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL--RNRRLANLLGCCCEG----DERLLVAE 133 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~----~~~~lv~e 133 (329)
.+++.+|+|.||.||+|.|. |+.||||++.... .+.+.+|.++.+.+ +|+||+.++++-..+ ..+|||++
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 45677899999999999995 5689999998765 34567888888775 999999999875433 36899999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-------CCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-------KERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 206 (329)
|.+.|||.||| ....++-...++++..+++||++||. ++.|.|||||..|||+..++.+.|+|+|+|...
T Consensus 290 YHe~GSL~DyL---~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 290 YHEHGSLYDYL---NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred cccCCcHHHHH---hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 99999999999 55789999999999999999999996 367999999999999999999999999999765
Q ss_pred CCC--------CCccCcccccCcccccCCC----C--CCcccchhhhHHHHHHHhCC----------CCCCc-----hhh
Q 020221 207 RDG--------RSYSTNLAFTPPEYLRTGR----V--TPESVMYSFGTLLLDLLSGK----------HIPPS-----HAL 257 (329)
Q Consensus 207 ~~~--------~~~~~~~~y~aPE~~~~~~----~--~~~~DvwslG~il~el~tg~----------~~~~~-----~~~ 257 (329)
... ...+||.+|||||++.... | -..+||||||+++||+.-+. .||.+ -..
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ 446 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF 446 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence 433 3457999999999987532 2 23699999999999997643 23221 122
Q ss_pred HHHhhhchhhhccccccCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221 258 DLIRDRNIQTLTDSCLEGQF-SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (329)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~ 315 (329)
+.++.-...+.+.+.....+ ..+.-..+.++|+.||..+|..|.|+-.+-..|.++.+
T Consensus 447 eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 447 EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 22322222222222222222 34566789999999999999999999999999988875
No 360
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=100.00 E-value=2.9e-40 Score=264.75 Aligned_cols=257 Identities=18% Similarity=0.253 Sum_probs=207.2
Q ss_pred ccCHHHHHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-Cccccccce
Q 020221 43 EYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLG 120 (329)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~ 120 (329)
-++++.......+-+.|++++++|+|.|+.||.|. ..+.+.++||+++... .+.+.+|+.+|+.|. ||||+++++
T Consensus 24 YWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 24 YWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred hcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhh
Confidence 35566655556777889999999999999999998 7788899999998643 567899999999997 999999999
Q ss_pred eeeeC--CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeee
Q 020221 121 CCCEG--DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRL 197 (329)
Q Consensus 121 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl 197 (329)
...++ ....||+||+.+.+...+. +.++..++..++.+++.||.|+|+. ||+|||+||.|+++| +...++|
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred hhcCccccCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc-CcccccCCcceeeechhhceeee
Confidence 99776 4578999999998877766 4688889999999999999999999 999999999999999 5567999
Q ss_pred ecccCcccCCCCCCcc---CcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhH--HH-----------
Q 020221 198 SCFGLMKNSRDGRSYS---TNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALD--LI----------- 260 (329)
Q Consensus 198 ~Dfg~a~~~~~~~~~~---~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~--~~----------- 260 (329)
+|||+|.+..++..+. .+..|..||.+.+-+ |+.+-|+|||||++..|+..+.||+.+... ..
T Consensus 175 IDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred eecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 9999999999887653 467899999987655 899999999999999999999998754111 00
Q ss_pred -----h------hhchhhh--------ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 261 -----R------DRNIQTL--------TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 261 -----~------~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
. ......+ +............++++.+|+...|.+|..+||||.|++.
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 0 0000111 1111111122235689999999999999999999999997
No 361
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=8.6e-39 Score=288.38 Aligned_cols=253 Identities=15% Similarity=0.234 Sum_probs=193.6
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC------Ce
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG------DE 127 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 127 (329)
..|.+.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 446667778999999999999 45788999999875421 2234578899999999999999999988654 34
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.++++||+.. +|..++ ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 6899999965 676654 23689999999999999999999999 99999999999999999999999999987654
Q ss_pred CC-CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------------------
Q 020221 208 DG-RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------------- 266 (329)
Q Consensus 208 ~~-~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~------------------- 266 (329)
.. ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 32 23456788999999876 4588899999999999999999998865432111110000
Q ss_pred hh---ccccccCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhh
Q 020221 267 TL---TDSCLEGQF---SSDEGTELVRLASRCLQYEPRERPNPRSLVTA--LVTLQK 315 (329)
Q Consensus 267 ~~---~~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~--L~~~~~ 315 (329)
.. .....+... ....++.+.+++.+||+.||++||++.+++.+ ++..++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 000000000 01245678999999999999999999999964 665554
No 362
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=8.9e-39 Score=287.52 Aligned_cols=242 Identities=19% Similarity=0.205 Sum_probs=188.8
Q ss_pred ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--------------HHHHHHHHHHHhcCCCccccccceeeeeCCe
Q 020221 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--------------ARQFLEEARAVGQLRNRRLANLLGCCCEGDE 127 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 127 (329)
+.||.|+||+||++. ..+++.||+|++....... ...+.+|+++++.++|+||+++++++...+.
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 94 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF 94 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCc
Confidence 457999999999999 4568899999987543221 1246789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.+++|||+. ++|.+++. ....+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 95 INLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKGICKIADFGLARRYG 170 (335)
T ss_pred EEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCCCEEECCccceeecc
Confidence 999999997 58999885 345689999999999999999999999 99999999999999999999999999986544
Q ss_pred CC------------------CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhh
Q 020221 208 DG------------------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTL 268 (329)
Q Consensus 208 ~~------------------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~ 268 (329)
.. ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..|+................
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~ 250 (335)
T PTZ00024 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250 (335)
T ss_pred cccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 10 1123467899999987654 7889999999999999999998876443211111000000
Q ss_pred c---cc----------------cccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 269 T---DS----------------CLEG---QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 269 ~---~~----------------~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
. .. .... ......+.++.+++..||+.||++|||+.+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 0 00 0000 001234678899999999999999999999997
No 363
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-39 Score=294.51 Aligned_cols=240 Identities=19% Similarity=0.210 Sum_probs=199.6
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEE
Q 020221 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 131 (329)
..+..|++...+|.|+|+.|..+. ..+++..++|++...... ..+|+.++... +||||+++.+.+.++.+.|+|
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeee
Confidence 446778888889999999999998 667889999999876322 23577666665 799999999999999999999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee-CCCCCeeeecccCcccCCCCC
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF-DDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~-~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
||.+.++-+.+.+.. .+.....+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++......
T Consensus 395 ~e~l~g~ell~ri~~---~~~~~~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRS---KPEFCSEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC 470 (612)
T ss_pred ehhccccHHHHHHHh---cchhHHHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCCcEEEEEechhhhCchhh
Confidence 999999988887753 2233377888999999999999998 99999999999999 689999999999998877662
Q ss_pred C-ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 211 S-YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 211 ~-~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
. ..-|..|.|||++....+++++|+||||++||+|++|+.|+...... .++......+.+....|.++++|+
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s~~vS~~AKdLl 543 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFSECVSDEAKDLL 543 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccccccCHHHHHHH
Confidence 2 24578899999999888999999999999999999999988654332 122222233445577899999999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 020221 290 SRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 290 ~~cl~~dp~~Rps~~~~l~ 308 (329)
.+||+.||.+||++.++..
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHhccCChhhCcChhhhcc
Confidence 9999999999999999997
No 364
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=1.1e-38 Score=283.57 Aligned_cols=250 Identities=18% Similarity=0.226 Sum_probs=189.4
Q ss_pred CCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeC-------
Q 020221 56 FAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEG------- 125 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------- 125 (329)
...|.+++.||+|+||.||++. ..+++.+|+|.+...... ....+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 3567788888999999999999 456889999998654322 234567899999999999999999887543
Q ss_pred -CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221 126 -DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 126 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 204 (329)
..+++++||+.+ +|...+.. ....+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 346999999976 67776643 345799999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCC---------------CccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh--
Q 020221 205 NSRDGR---------------SYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-- 266 (329)
Q Consensus 205 ~~~~~~---------------~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-- 266 (329)
...... ...++..|+|||.+.+. .++.++||||||+++|+|++|..|+..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 543221 11346779999988654 488899999999999999999987754322111110000
Q ss_pred ---------------hhccccccCCCC-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 267 ---------------TLTDSCLEGQFS-------SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 267 ---------------~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...........+ ...++.+.+++.+||..||++|||+.+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000000001 123467899999999999999999999998
No 365
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=5.2e-40 Score=274.05 Aligned_cols=254 Identities=15% Similarity=0.201 Sum_probs=195.3
Q ss_pred CCCcccccccCCCCCCcEEEEEEeC-C----CCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeee-CC
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGKLE-N----QFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCE-GD 126 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 126 (329)
....|+.++.||+|.||.||++... + .+.+|+|+++.... .-.....+|+..++.++|||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3456889999999999999999632 2 24699999986522 123457899999999999999999999877 78
Q ss_pred eeEEEEecCCCCCHHhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC----CCeeeec
Q 020221 127 ERLLVAEYMPNDTLAKHLFHW---ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD----VNPRLSC 199 (329)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~----~~~kl~D 199 (329)
.+++++||.+. +|++.|+-. +.+.++...+..|++||+.|+.|||++ =++||||||.||++..+ |.+||+|
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccCeeEeec
Confidence 89999999987 799888632 335688999999999999999999999 89999999999999877 8999999
Q ss_pred ccCcccCCCC-------CCccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhh--------h
Q 020221 200 FGLMKNSRDG-------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRD--------R 263 (329)
Q Consensus 200 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~--------~ 263 (329)
||+++.+.+. ...+.|.+|.|||.+.|.. |+.+.|||++|||..||+|-.+.|.....+.... .
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999876543 3456789999999999887 9999999999999999999887665431111000 0
Q ss_pred chhhhcc---------------------ccccCCCCh-----------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221 264 NIQTLTD---------------------SCLEGQFSS-----------DEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 264 ~~~~~~~---------------------~~~~~~~~~-----------~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L 310 (329)
.+..++. ......+.. .-++...+|+..+|.+||-+|.|+++++++.
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 0000000 000000000 0134578999999999999999999999853
No 366
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=1.3e-38 Score=280.35 Aligned_cols=249 Identities=18% Similarity=0.216 Sum_probs=195.7
Q ss_pred ccccccCCCCCCcEEEEEEe----CCCCEEEEEEeCCCCC----hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeE
Q 020221 59 ENIVSEHGEKAPNVVYKGKL----ENQFRIAVKRFNRSAW----PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERL 129 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 129 (329)
+.+.+.||.|++|.||++.. .++..||+|.++.... ...+.+.+|++++..+ +||||+++.+.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 45667789999999999873 3567899999875321 2234578899999999 5999999999999999999
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+||||+++++|.+++. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLY--QREHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHh--hcCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999886 345688999999999999999999999 9999999999999999999999999998754332
Q ss_pred C-----CccCcccccCcccccCCC--CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221 210 R-----SYSTNLAFTPPEYLRTGR--VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (329)
Q Consensus 210 ~-----~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (329)
. ...++..|+|||.+.+.. .+.++|+||||+++|+|++|..|+................... ....+...+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--KPPFPKTMS 236 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--CCCCCcccC
Confidence 2 234678999999987655 7789999999999999999998875321110000001111111 122344466
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 283 TELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 237 AEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 789999999999999999998877765543
No 367
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=2.1e-38 Score=285.98 Aligned_cols=253 Identities=15% Similarity=0.204 Sum_probs=195.1
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh--hHHHHHHHHHHHhcCCCccccccceeeeeCC------e
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP--DARQFLEEARAVGQLRNRRLANLLGCCCEGD------E 127 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~ 127 (329)
..|.+++.||+|+||.||++. ..++..||+|.+...... ....+.+|+++++.++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 346678888999999999998 567889999998654322 2345789999999999999999999886543 4
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.++|+||+ +++|.+++. ...+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999998 668988874 45789999999999999999999999 99999999999999999999999999987654
Q ss_pred CCC-CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhch-------------------h
Q 020221 208 DGR-SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNI-------------------Q 266 (329)
Q Consensus 208 ~~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~-------------------~ 266 (329)
... ...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||............. .
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 432 3456889999999876 358889999999999999999998876432111100000 0
Q ss_pred hhcccc---cc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 020221 267 TLTDSC---LE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT--ALVTLQ 314 (329)
Q Consensus 267 ~~~~~~---~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~--~L~~~~ 314 (329)
...... .. .......++++.+++.+|+..||++|||+.+++. .++...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 000000 00 0011235677999999999999999999999994 444443
No 368
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=9.2e-39 Score=288.30 Aligned_cols=247 Identities=19% Similarity=0.242 Sum_probs=193.2
Q ss_pred CcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeCCe------
Q 020221 57 AMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDE------ 127 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 127 (329)
..|.+++.||+|++|.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++|+|++++.+++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 3466778889999999999994 567899999987542 2234567789999999999999999998765544
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
.++|+||+ +++|.+++. ...+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~L~~~~~---~~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 95 VYLVTHLM-GADLNNIVK---CQKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999998 569999884 45799999999999999999999999 99999999999999999999999999987654
Q ss_pred CC-CCccCcccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhh-------h----------
Q 020221 208 DG-RSYSTNLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQT-------L---------- 268 (329)
Q Consensus 208 ~~-~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~-------~---------- 268 (329)
.. ....++..|+|||.+.+. .++.++||||||+++|++++|..||+.............. .
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 33 334567889999988653 5788999999999999999999888654322111110000 0
Q ss_pred --ccc---cccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 269 --TDS---CLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 269 --~~~---~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
... ..... .....++++.+++.+||+.||++|||+.+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 00000 01123678999999999999999999999987
No 369
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=7.4e-39 Score=306.92 Aligned_cols=242 Identities=19% Similarity=0.234 Sum_probs=182.5
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeC-----------
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEG----------- 125 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----------- 125 (329)
++.++.||+|+||.||+++ .-+|..||||++...... ....+.+|+..|++|+|||||+++..|.+.
T Consensus 481 FEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~ 560 (1351)
T KOG1035|consen 481 FEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVA 560 (1351)
T ss_pred hHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccc
Confidence 3444555999999999999 568999999999887522 234588999999999999999987644110
Q ss_pred --------------------------------------------------------------------------------
Q 020221 126 -------------------------------------------------------------------------------- 125 (329)
Q Consensus 126 -------------------------------------------------------------------------------- 125 (329)
T Consensus 561 ~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~ 640 (1351)
T KOG1035|consen 561 SDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSV 640 (1351)
T ss_pred cchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcc
Confidence
Q ss_pred ----------------------------CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCc
Q 020221 126 ----------------------------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA 177 (329)
Q Consensus 126 ----------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i 177 (329)
..+||-||||+..+|.+++.+ +...-.....++++++|+.||+|+|++ |+
T Consensus 641 ~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-N~~~~~~d~~wrLFreIlEGLaYIH~~-gi 718 (1351)
T KOG1035|consen 641 ILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-NHFNSQRDEAWRLFREILEGLAYIHDQ-GI 718 (1351)
T ss_pred ccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-cccchhhHHHHHHHHHHHHHHHHHHhC-ce
Confidence 014789999999777777753 222225678899999999999999999 99
Q ss_pred cccccCCCceeeCCCCCeeeecccCcccCC----------------------CCCCccCcccccCcccccCCC---CCCc
Q 020221 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----------------------DGRSYSTNLAFTPPEYLRTGR---VTPE 232 (329)
Q Consensus 178 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~~~y~aPE~~~~~~---~~~~ 232 (329)
|||||||.||++|+++.+||+|||+|+... +.....||.-|+|||++.+.. |+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999997611 112346788999999998654 9999
Q ss_pred ccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhcccccc--CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 233 SVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLE--GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 233 ~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+||||||++++||+.- |.-.. .+...+..+.+.... ..+..+.-+.-.++|.++++.||.+||||.++|+
T Consensus 799 iDmYSLGIVlFEM~yP---F~TsM---ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLYP---FGTSM---ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred hhhHHHHHHHHHHhcc---CCchH---HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 9999999999999953 33221 111112222222111 1123334456678999999999999999999986
No 370
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=2.3e-38 Score=285.84 Aligned_cols=254 Identities=18% Similarity=0.236 Sum_probs=193.3
Q ss_pred HHHHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeee
Q 020221 47 ETLRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCC 123 (329)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 123 (329)
.++...+++ |.+++.||+|+||.||++. ..+++.||+|++..... ...+.+.+|+.+++.++||||+++.+++.
T Consensus 10 ~~~~~~~~~---y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 10 KTIWEVPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred HHHhhccCc---eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 344444444 5566777999999999998 56788999999875432 22456788999999999999999999875
Q ss_pred eC------CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221 124 EG------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (329)
Q Consensus 124 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl 197 (329)
.. ...+++++++ +++|.+.+. ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCCCEEE
Confidence 43 3467888876 679988874 34689999999999999999999999 9999999999999999999999
Q ss_pred ecccCcccCCCCC-CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------hh
Q 020221 198 SCFGLMKNSRDGR-SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-------TL 268 (329)
Q Consensus 198 ~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-------~~ 268 (329)
+|||++....... ...++..|+|||.+.+ ..++.++||||||+++|+|++|..||+............. ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T cd07877 162 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241 (345)
T ss_pred ecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9999987654432 3456889999998866 4588899999999999999999988764321111000000 00
Q ss_pred c---------------cccccCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 269 T---------------DSCLEGQ---FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 269 ~---------------~~~~~~~---~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
. ....... .....++++.+++.+||..||++||++.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 242 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0 0000000 01124678899999999999999999999997
No 371
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=1.6e-38 Score=272.11 Aligned_cols=218 Identities=19% Similarity=0.206 Sum_probs=177.4
Q ss_pred CCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhcc
Q 020221 68 KAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH 146 (329)
Q Consensus 68 G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 146 (329)
|.+|.||++. ..+++.+|+|.+.... .+.+|...+....||||+++++++.+....+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8899999999 5678899999987643 223455555566799999999999999999999999999999998863
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCccCcccccCccccc
Q 020221 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYSTNLAFTPPEYLR 225 (329)
Q Consensus 147 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~y~aPE~~~ 225 (329)
...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+...... ....++..|+|||.+.
T Consensus 79 --~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 79 --FLNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG 155 (237)
T ss_pred --hcCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence 34689999999999999999999999 9999999999999999999999999987654433 2334567799999998
Q ss_pred CCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 020221 226 TGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303 (329)
Q Consensus 226 ~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 303 (329)
+..++.++|+||+|+++|+|++|..|+...... .........+...++.+.+++.+||+.||++||++
T Consensus 156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 156 ISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 888999999999999999999999664321100 00011112344567889999999999999999997
No 372
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=3.6e-38 Score=283.26 Aligned_cols=246 Identities=18% Similarity=0.239 Sum_probs=187.2
Q ss_pred ccccccCCCCCCcEEEEEEe-CC--CCEEEEEEeCCCC--ChhHHHHHHHHHHHhcC-CCccccccceeeeeC----Cee
Q 020221 59 ENIVSEHGEKAPNVVYKGKL-EN--QFRIAVKRFNRSA--WPDARQFLEEARAVGQL-RNRRLANLLGCCCEG----DER 128 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~-~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~~ 128 (329)
|++.+.||+|+||.||++.. .+ +..||+|.+.... ....+.+.+|+.+++.+ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 45667789999999999994 34 7789999987532 12245678899999999 599999999875332 457
Q ss_pred EEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221 129 LLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 208 (329)
+++++|+. ++|.+.+. ....+++..+..++.||+.||.|||+. |++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 88899986 58998885 456789999999999999999999999 999999999999999999999999999875432
Q ss_pred C--------CCccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-------------
Q 020221 209 G--------RSYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ------------- 266 (329)
Q Consensus 209 ~--------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~------------- 266 (329)
. ....++..|+|||++.+ ..++.++||||||+++|+|++|..||..............
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2 12357889999998765 4588999999999999999999987754321111100000
Q ss_pred ------hh---cccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 267 ------TL---TDSCLE---GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 267 ------~~---~~~~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.. ...... .......+..+.+++.+||+.||++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 000000 0011123578999999999999999999999985
No 373
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-40 Score=271.33 Aligned_cols=244 Identities=18% Similarity=0.229 Sum_probs=193.7
Q ss_pred cccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhc-CCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 62 VSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQ-LRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
++.||+|+||+|+|-. ..+|+.+|||.++.... .+.++++.|.+...+ -+.||||+++|++...+..|+.||+|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 4567999999999998 66799999999987764 334568888886554 4799999999999999999999999965
Q ss_pred CHHhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCc
Q 020221 139 TLAKHLFH---WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSY 212 (329)
Q Consensus 139 sL~~~l~~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~ 212 (329)
||..+... -....++++-+-.|..-...||.||.....|+|||+||+|||++..|.+||+|||++....+. ...
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~d 227 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVD 227 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhc
Confidence 77765432 234568888888999999999999998779999999999999999999999999998765433 334
Q ss_pred cCcccccCcccccC--CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc--ccc-CCCChHHHHHHHH
Q 020221 213 STNLAFTPPEYLRT--GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS--CLE-GQFSSDEGTELVR 287 (329)
Q Consensus 213 ~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~ 287 (329)
.|...|||||-+.. ..|+-++||||||++|+|+.||..|+. .|+.+.++....+... .+. .....+.+..+..
T Consensus 228 aGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr--~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~ 305 (361)
T KOG1006|consen 228 AGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR--KWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVR 305 (361)
T ss_pred cCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc--hHHHHHHHHHHHHcCCCCeecCcccccccCHHHHH
Confidence 67889999998863 348999999999999999999995554 4444444433333211 111 1112347889999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 020221 288 LASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 288 li~~cl~~dp~~Rps~~~~l~ 308 (329)
++..||.+|-..||++.+++.
T Consensus 306 fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 306 FINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHhhcccccCcchhhhhc
Confidence 999999999999999999875
No 374
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=4.1e-38 Score=282.25 Aligned_cols=246 Identities=17% Similarity=0.260 Sum_probs=191.1
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeee-CCeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 134 (329)
|.+++.||.|+||.||++. ..+++.||+|++.... ....+.+.+|+++++.++||||+++.+++.. ....++++||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 5566777999999999998 5578899999886532 2234567889999999999999999998865 4678999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-CCcc
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-RSYS 213 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~ 213 (329)
+ +++|..++. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+...... ....
T Consensus 92 ~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 166 (328)
T cd07856 92 L-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV 166 (328)
T ss_pred h-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCCc
Confidence 8 458988884 45688888999999999999999999 9999999999999999999999999998754433 2345
Q ss_pred CcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh---------------h----hchhhhcccc-
Q 020221 214 TNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR---------------D----RNIQTLTDSC- 272 (329)
Q Consensus 214 ~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~---------------~----~~~~~~~~~~- 272 (329)
++..|+|||.+.+ ..++.++||||||+++|+|++|..||+........ . ..........
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (328)
T cd07856 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP 246 (328)
T ss_pred ccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcc
Confidence 6788999998766 46889999999999999999999887643211000 0 0000000000
Q ss_pred ccCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221 273 LEGQFS-----SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 273 ~~~~~~-----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~ 309 (329)
.....+ ...++++.+++.+||+.+|++||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 247 KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000111 2346789999999999999999999999873
No 375
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-39 Score=288.61 Aligned_cols=238 Identities=21% Similarity=0.220 Sum_probs=198.5
Q ss_pred cCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCH
Q 020221 64 EHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTL 140 (329)
Q Consensus 64 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 140 (329)
.||.|.||+||-|. .++|+.||||++.+-.... ..++++|+.+|+.+.||.||.+--.|++++.+|+|||-+.| +.
T Consensus 571 vLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DM 649 (888)
T KOG4236|consen 571 VLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DM 649 (888)
T ss_pred hccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hH
Confidence 46999999999999 6789999999997654322 35689999999999999999999999999999999999955 67
Q ss_pred HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---CCCeeeecccCcccCCCC---CCccC
Q 020221 141 AKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---DVNPRLSCFGLMKNSRDG---RSYST 214 (329)
Q Consensus 141 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~~~~kl~Dfg~a~~~~~~---~~~~~ 214 (329)
..+|...+...+++.....++.||+.||.|||.+ ||+|+||||+|||+.. --.+||+|||+|+.+... .+..|
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 7777666778899999999999999999999999 9999999999999964 346999999999987764 46789
Q ss_pred cccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchh-hhccccccCCCChHHHHHHHHHHHHhc
Q 020221 215 NLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQ-TLTDSCLEGQFSSDEGTELVRLASRCL 293 (329)
Q Consensus 215 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl 293 (329)
|+.|.|||++....|+.+-||||+|||+|.-++|..||..+. .+.++... .++. ......+.+++..+||...|
T Consensus 729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMy---Pp~PW~eis~~AidlIn~LL 803 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMY---PPNPWSEISPEAIDLINNLL 803 (888)
T ss_pred CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhcccccc---CCCchhhcCHHHHHHHHHHH
Confidence 999999999999999999999999999999999998776442 22222111 1111 11223567889999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 020221 294 QYEPRERPNPRSLVT 308 (329)
Q Consensus 294 ~~dp~~Rps~~~~l~ 308 (329)
+..-.+|.|....+.
T Consensus 804 qVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 804 QVKMRKRYSVDKSLS 818 (888)
T ss_pred HHHHHHhcchHhhcc
Confidence 999999999887665
No 376
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.4e-38 Score=299.61 Aligned_cols=249 Identities=21% Similarity=0.309 Sum_probs=204.2
Q ss_pred ccCCCCCCcEEEEEEeC--------CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEE
Q 020221 63 SEHGEKAPNVVYKGKLE--------NQFRIAVKRFNRSAWP-DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+.+|.|.||.|++|... ....||||.++..... +.+.+..|+++|+.+ +|+||+.++|+|...+..++|+
T Consensus 302 ~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~ 381 (609)
T KOG0200|consen 302 KYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIV 381 (609)
T ss_pred ceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEE
Confidence 36799999999999732 1457999999876433 456789999999999 6999999999999989999999
Q ss_pred ecCCCCCHHhhhccCC------------C--CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeee
Q 020221 133 EYMPNDTLAKHLFHWE------------T--QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLS 198 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~------------~--~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~ 198 (329)
||+..|+|.++++..+ . ..++..+.+.++.||+.|++||+++ +++||||..+|||+..+..+||+
T Consensus 382 Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVLi~~~~~~kIa 460 (609)
T KOG0200|consen 382 EYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVLITKNKVIKIA 460 (609)
T ss_pred EeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEEecCCCEEEEc
Confidence 9999999999997533 0 2388899999999999999999999 99999999999999999999999
Q ss_pred cccCcccCCCCCCc-----c--CcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc
Q 020221 199 CFGLMKNSRDGRSY-----S--TNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS 271 (329)
Q Consensus 199 Dfg~a~~~~~~~~~-----~--~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
|||+|+...+...+ . -...|||||.+....|+.++||||||++||||+|.+.+|..+.. ....+...+..
T Consensus 461 DFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~---~~~~l~~~l~~ 537 (609)
T KOG0200|consen 461 DFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP---PTEELLEFLKE 537 (609)
T ss_pred cccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC---cHHHHHHHHhc
Confidence 99999865544322 1 23459999999998999999999999999999997765443311 00111123334
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (329)
Q Consensus 272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~ 315 (329)
..+...|..++.++.+++..||+.+|++||++.++.+.++....
T Consensus 538 G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 538 GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 44555677788999999999999999999999999999999643
No 377
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=1e-37 Score=302.70 Aligned_cols=146 Identities=21% Similarity=0.219 Sum_probs=129.4
Q ss_pred CCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCC---hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 56 FAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAW---PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
+..|.+++.||.|+||.||+|.. .+++.||+|+++.... .....+.+|+.+++.++|+||+++++.+......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 45677888899999999999995 4688999999975432 2235688899999999999999999999999999999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 204 (329)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||.. +|+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999863 35688999999999999999999999 99999999999999999999999999864
No 378
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.1e-38 Score=291.85 Aligned_cols=256 Identities=20% Similarity=0.271 Sum_probs=212.1
Q ss_pred cccccCCCCCCcEEEEEE-eCCC----CEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 60 NIVSEHGEKAPNVVYKGK-LENQ----FRIAVKRFNRSAW-PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~-~~~~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
+..+.||+|+||+||+|. ...| -+||+|++..... ...+++..|+-.|.+++|||+++++|+|.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 345678999999999998 4443 5689999876543 34567999999999999999999999997654 889999
Q ss_pred cCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc-
Q 020221 134 YMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY- 212 (329)
Q Consensus 134 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~- 212 (329)
|++.|+|.++++. ....+-.+..+.|..||++||.|||.+ +++||||..+|||+..-..+||.|||+++........
T Consensus 778 ~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred hcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999999976 566788899999999999999999999 9999999999999999999999999999987655322
Q ss_pred -----cCcccccCcccccCCCCCCcccchhhhHHHHHHHhCC-CCCCchhhHHHhhhchhhhccccccCCCChHHHHHHH
Q 020221 213 -----STNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELV 286 (329)
Q Consensus 213 -----~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
...+.|||-|.+....|+.++|||||||++||++|-+ .|+.....+. +...++...+-..|+.++-++-
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-----I~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-----IPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-----hhHHHhccccCCCCCCccHHHH
Confidence 2357799999999999999999999999999999944 4554433322 2333333344456777888999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhhhhccccccCc
Q 020221 287 RLASRCLQYEPRERPNPRSLVTALVTLQKDTELYLSL 323 (329)
Q Consensus 287 ~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~~~~~~~ 323 (329)
.++.+||..|++.||+++++...+.++.++..-+.+.
T Consensus 931 ~~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~i 967 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLVI 967 (1177)
T ss_pred HHHHHHhccCcccCccHHHHHHHHHHHhcCcceEeee
Confidence 9999999999999999999999999998776554443
No 379
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.7e-39 Score=262.63 Aligned_cols=251 Identities=16% Similarity=0.222 Sum_probs=191.7
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCCCccccccceeeeeC--------
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLRNRRLANLLGCCCEG-------- 125 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------- 125 (329)
+.|+.+.++|+|.||.||+++ .++|+.||+|++-... ..-.....+|+++|..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 446677788999999999999 6678889998764422 11234568999999999999999999988542
Q ss_pred CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
..+++|+++|+. +|.-+|.+ ....++..++..+++++..||.|+|+. .|+|||+|+.|+||+.+|.+||+|||+++.
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 358999999987 79988864 346789999999999999999999999 999999999999999999999999999975
Q ss_pred CCCCC--------CccCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchhhHH-------Hhhhchhhhc
Q 020221 206 SRDGR--------SYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHALDL-------IRDRNIQTLT 269 (329)
Q Consensus 206 ~~~~~--------~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~~~~-------~~~~~~~~~~ 269 (329)
+.... +...|.+|.+||.+.|.. |+++.|||+.|||+.||+||.+.+.+..... .-.....+++
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 44322 224489999999988765 9999999999999999999997665431110 0000011111
Q ss_pred cccc---------cCCCC-------------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221 270 DSCL---------EGQFS-------------SDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 270 ~~~~---------~~~~~-------------~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L 310 (329)
+... .++.+ -.-.++..+|+.+++..||.+|+++.+++++-
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 1000 00000 00124788999999999999999999999753
No 380
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-37 Score=284.28 Aligned_cols=251 Identities=20% Similarity=0.237 Sum_probs=192.3
Q ss_pred ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-ChhHHHHHHHHHHHhcCCCccccccceeeeeC------CeeEEEEec
Q 020221 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERLLVAEY 134 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e~ 134 (329)
+.+|+|+||.||+|+ ..+|..||||.++... ....+...+|+++|++++|+|||+++++-.+. ....++|||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy 98 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY 98 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence 445999999999999 7789999999998753 23456788999999999999999999986543 356899999
Q ss_pred CCCCCHHhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC--CCC--CeeeecccCcccCCCC
Q 020221 135 MPNDTLAKHLFHWE-TQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDV--NPRLSCFGLMKNSRDG 209 (329)
Q Consensus 135 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~--~~~--~~kl~Dfg~a~~~~~~ 209 (329)
|.+|||...+.+.+ ...+++.+.+.+..++..||.|||++ ||+||||||.||++- ++| ..||+|||.|+...++
T Consensus 99 C~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~ 177 (732)
T KOG4250|consen 99 CSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN 177 (732)
T ss_pred cCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence 99999999997653 35799999999999999999999998 999999999999994 334 4799999999988877
Q ss_pred C---CccCcccccCcccccC-CCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-----Hh---hhchhhhc---ccc--
Q 020221 210 R---SYSTNLAFTPPEYLRT-GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-----IR---DRNIQTLT---DSC-- 272 (329)
Q Consensus 210 ~---~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-----~~---~~~~~~~~---~~~-- 272 (329)
. +..||..|.+||+... +.|+..+|.|||||++|+++||..||-....+. +. .+....+. ...
T Consensus 178 s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eN 257 (732)
T KOG4250|consen 178 SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEEN 257 (732)
T ss_pred CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccC
Confidence 5 4579999999999985 779999999999999999999999884332111 00 00000000 000
Q ss_pred ----ccC--CCC----hHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhhh
Q 020221 273 ----LEG--QFS----SDEGTELVRLASRCLQYEPRERP--NPRSLVTALVTLQ 314 (329)
Q Consensus 273 ----~~~--~~~----~~~~~~~~~li~~cl~~dp~~Rp--s~~~~l~~L~~~~ 314 (329)
+.. +++ ......+...+..+|.-+|.+|. ...+.-..+..+.
T Consensus 258 gpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 258 GPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred CceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 001 112 22334566778888888999998 5555555554443
No 381
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.8e-37 Score=286.25 Aligned_cols=247 Identities=15% Similarity=0.216 Sum_probs=202.8
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeee-----CCeeE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCE-----GDERL 129 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~~~ 129 (329)
+..+++..+|.|.+|.||+++ .++++.+|+|++...... .+++..|..+++.. .|||++.++|++.- ++.+|
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 334556666999999999999 778889999998876533 45677889999998 59999999999853 57899
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
||||||.+||..+++.+..+..+.|..+..|+++++.|+.+||.. .++|||||-.|||++.++.+||+|||.+......
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 999999999999999887788899999999999999999999999 9999999999999999999999999998765433
Q ss_pred ----CCccCcccccCcccccC-----CCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChH
Q 020221 210 ----RSYSTNLAFTPPEYLRT-----GRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSD 280 (329)
Q Consensus 210 ----~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (329)
.+..||+.|||||++.- ..|+.++|+||||++..||.-|.+|+-+.. . ++ ........+.....-+..
T Consensus 177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-P-mr-aLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-P-MR-ALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-h-hh-hhccCCCCCCccccchhh
Confidence 45678999999999863 348889999999999999999996653221 1 11 011111122222234677
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 281 EGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 281 ~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.++++.++|..||..|-++||+..++++
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 8999999999999999999999999986
No 382
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1e-37 Score=266.92 Aligned_cols=249 Identities=16% Similarity=0.164 Sum_probs=195.0
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC--Cc----cccccceeeeeCCeeE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR--NR----RLANLLGCCCEGDERL 129 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~----niv~~~~~~~~~~~~~ 129 (329)
..|.+++.+|+|.||.|-.+. ...+..||+|+++.-.. -.+..+-|+++|+++. .| -+|++.+++.-.++.+
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 346788888999999999998 44578899999976431 1334567999999993 23 3788888898889999
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-------------------
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD------------------- 190 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~------------------- 190 (329)
||+|.+ |-|+.+++.+.+-.+++..++..+++|++.+++|||+. +++|-||||+|||+.
T Consensus 168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 999998 55999999876677899999999999999999999999 999999999999992
Q ss_pred -CCCCeeeecccCcccCCCCC-CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH-------Hh
Q 020221 191 -DDVNPRLSCFGLMKNSRDGR-SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL-------IR 261 (329)
Q Consensus 191 -~~~~~kl~Dfg~a~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~-------~~ 261 (329)
.+..++++|||.|+...... ..+.|..|.|||++.+..++...||||+||||+||.||...|+...... +.
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIl 325 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERIL 325 (415)
T ss_pred CCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhh
Confidence 12358999999998766554 4567999999999999999999999999999999999998776542111 00
Q ss_pred hhchhh-----------------------------hcccccc----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 262 DRNIQT-----------------------------LTDSCLE----GQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 262 ~~~~~~-----------------------------~~~~~~~----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+..... +.+.+.. ....+....++.+|+..||..||.+|+|+.|+++
T Consensus 326 Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 326 GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 000000 0000000 0011334568999999999999999999999998
No 383
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2e-37 Score=279.58 Aligned_cols=247 Identities=17% Similarity=0.175 Sum_probs=195.4
Q ss_pred HHHHhcCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHH---HHHHHHHHHhcCCCccccccceeeee
Q 020221 49 LRTATSGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDAR---QFLEEARAVGQLRNRRLANLLGCCCE 124 (329)
Q Consensus 49 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~ 124 (329)
|+++-=+-+.+..|+.||-|+||.|.++. .++...+|+|.+++.+.-... -+..|..||..-+.+-||+|+..|++
T Consensus 621 LkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 621 LKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred HHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 33333344556678899999999999998 667788999999875433222 35779999999999999999999999
Q ss_pred CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221 125 GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 125 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 204 (329)
.+++|+||||++||++-.+|. ...-|.+..++.++.++.+|+++.|.. |+|||||||+|||||.+|++||.|||++.
T Consensus 701 kdnLYFVMdYIPGGDmMSLLI--rmgIFeE~LARFYIAEltcAiesVHkm-GFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLI--RMGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred CCceEEEEeccCCccHHHHHH--HhccCHHHHHHHHHHHHHHHHHHHHhc-cceecccCccceEEccCCceeeeeccccc
Confidence 999999999999999999887 456789999999999999999999999 99999999999999999999999999975
Q ss_pred cCC---------CC-------------------------------------CCccCcccccCcccccCCCCCCcccchhh
Q 020221 205 NSR---------DG-------------------------------------RSYSTNLAFTPPEYLRTGRVTPESVMYSF 238 (329)
Q Consensus 205 ~~~---------~~-------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 238 (329)
-+. .+ ...+||+.|+|||++....++...|+||.
T Consensus 778 GfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSV 857 (1034)
T ss_pred cceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHh
Confidence 211 00 02357899999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC
Q 020221 239 GTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301 (329)
Q Consensus 239 G~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 301 (329)
|||||||+.|+.||....-..... ...-+...+.-.+...++++..++|.++. -+++.|.
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~--kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQY--KVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCccee--eeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 999999999999886543211111 11112233333445567788888887655 3677775
No 384
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-37 Score=267.64 Aligned_cols=236 Identities=19% Similarity=0.243 Sum_probs=197.3
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWP---DARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+.+++..||.|+||.|.++. ..+.+.+|||+++++..- +.+--+.|-++|..- +-|.++++..++++-+.+|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 45667777999999999998 556788999999876422 122234566777766 6789999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC----C
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----D 208 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~----~ 208 (329)
||+.||+|--.++ .-..+.+..+..++.+|+-||-|||++ ||++||||.+||++|.+|++||+|||+++..- .
T Consensus 430 EyvnGGDLMyhiQ--Q~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQ--QVGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred EEecCchhhhHHH--HhcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence 9999999998886 345688889999999999999999999 99999999999999999999999999987532 2
Q ss_pred CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 209 GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 209 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
..+.+||+.|+|||.+...+|..++|+|||||+||||+.|++||..+.-+.+-... .+.. -.+|...|.+...+
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI----~ehn--vsyPKslSkEAv~i 580 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI----MEHN--VSYPKSLSKEAVAI 580 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----HHcc--CcCcccccHHHHHH
Confidence 24678999999999999999999999999999999999999988876554443332 2222 24678889999999
Q ss_pred HHHhcccCCCCCCC
Q 020221 289 ASRCLQYEPRERPN 302 (329)
Q Consensus 289 i~~cl~~dp~~Rps 302 (329)
.+..|..+|.+|..
T Consensus 581 ckg~ltK~P~kRLG 594 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHhhcCCccccC
Confidence 99999999999964
No 385
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=100.00 E-value=7.3e-36 Score=255.15 Aligned_cols=234 Identities=21% Similarity=0.250 Sum_probs=192.5
Q ss_pred CCcEEEEEEeC-CCCEEEEEEeCCCCChh-HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhcc
Q 020221 69 APNVVYKGKLE-NQFRIAVKRFNRSAWPD-ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH 146 (329)
Q Consensus 69 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 146 (329)
+||.||++... +++.+++|++....... .+.+.+|++.++.++|+|++++++.+......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 47899999954 58899999998765444 67899999999999999999999999988999999999999999999863
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCccCcccccCccc
Q 020221 147 WETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLAFTPPEY 223 (329)
Q Consensus 147 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~ 223 (329)
...+++..+..++.+++.++.+||.. +++|+||+|+||++++++.++++|||.+...... ....++..|++||.
T Consensus 81 --~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 81 --RGRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEV 157 (244)
T ss_pred --ccCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHH
Confidence 22389999999999999999999999 9999999999999999999999999998876553 34557789999999
Q ss_pred ccCCCCCCcccchhhhHHHHHHHhCCCCCCc-hhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 020221 224 LRTGRVTPESVMYSFGTLLLDLLSGKHIPPS-HALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPN 302 (329)
Q Consensus 224 ~~~~~~~~~~DvwslG~il~el~tg~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps 302 (329)
+.+..++.++||||||++++++++|..|+.. ................. .......+.++.+++.+||..+|++||+
T Consensus 158 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 158 LLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---PPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC---ccccccCCHHHHHHHHHHccCCchhccC
Confidence 9888889999999999999999999987755 22222211111111100 0001115678999999999999999999
Q ss_pred HHHHHH
Q 020221 303 PRSLVT 308 (329)
Q Consensus 303 ~~~~l~ 308 (329)
+.++++
T Consensus 235 ~~~~~~ 240 (244)
T smart00220 235 AEEALQ 240 (244)
T ss_pred HHHHhh
Confidence 999998
No 386
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=100.00 E-value=1.7e-36 Score=287.63 Aligned_cols=249 Identities=18% Similarity=0.197 Sum_probs=165.0
Q ss_pred CCCcccccccCCCCCCcEEEEEEe-CC----CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccccccee------ee
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGKL-EN----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGC------CC 123 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~~-~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~ 123 (329)
....|.+.+.||+|+||.||+|.. .+ +..||+|++...... +....+ .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 345677788889999999999994 45 689999998654321 111111 1122222233322221 23
Q ss_pred eCCeeEEEEecCCCCCHHhhhccCCCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCC
Q 020221 124 EGDERLLVAEYMPNDTLAKHLFHWETQ------------------PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185 (329)
Q Consensus 124 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~ 185 (329)
.....++|+||+.+++|.+++...... ......+..++.|++.||.|||++ +|+||||||+
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~ 284 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQ 284 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHH
Confidence 456899999999999999988642110 012334668999999999999999 9999999999
Q ss_pred ceeeCC-CCCeeeecccCcccCCCC-----CCccCcccccCcccccCC----------------------CCCCcccchh
Q 020221 186 RIVFDD-DVNPRLSCFGLMKNSRDG-----RSYSTNLAFTPPEYLRTG----------------------RVTPESVMYS 237 (329)
Q Consensus 186 Nil~~~-~~~~kl~Dfg~a~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~~~Dvws 237 (329)
|||++. ++.+||+|||+++..... ....+++.|+|||.+... .++.++||||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999985 689999999999765432 344678999999965322 2345679999
Q ss_pred hhHHHHHHHhCCCCCCchhhHHHhhh---c--h---hhhccccccCC------CChHHHHHHHHHHHHhcccCCCCCCCH
Q 020221 238 FGTLLLDLLSGKHIPPSHALDLIRDR---N--I---QTLTDSCLEGQ------FSSDEGTELVRLASRCLQYEPRERPNP 303 (329)
Q Consensus 238 lG~il~el~tg~~~~~~~~~~~~~~~---~--~---~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~dp~~Rps~ 303 (329)
|||++|||+++..++........... . . ........... ..........+|+.+||+.||++|||+
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 99999999997754433211111000 0 0 00000000000 001112345689999999999999999
Q ss_pred HHHHH
Q 020221 304 RSLVT 308 (329)
Q Consensus 304 ~~~l~ 308 (329)
.++++
T Consensus 445 ~e~L~ 449 (566)
T PLN03225 445 KAALA 449 (566)
T ss_pred HHHhC
Confidence 99998
No 387
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-37 Score=274.54 Aligned_cols=241 Identities=17% Similarity=0.176 Sum_probs=203.9
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCC-EEEEEEeCCCCChh---HHHHHHHHHHHhcCCCccccccceeeeeCCeeEE
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGKLENQF-RIAVKRFNRSAWPD---ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 130 (329)
.+++.+++..||-|+||.|-++..++.. .+|+|++++...-+ .+-+..|-.+|...+.|.||+++..|.+...+|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 4455677889999999999999865543 38999988764333 3347789999999999999999999999999999
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
+||-|-||.|+..++ ..+.++..++..++.-++.|++|||++ |||+|||||+|.++|.+|-+||.|||+|+....+.
T Consensus 498 LmEaClGGElWTiLr--dRg~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 498 LMEACLGGELWTILR--DRGSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hHHhhcCchhhhhhh--hcCCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999999997 567899999999999999999999999 99999999999999999999999999999877664
Q ss_pred ---CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHH
Q 020221 211 ---SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVR 287 (329)
Q Consensus 211 ---~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
+++||+.|.|||.+.+...+.++|.||||+++|||++|.+||..-..-...+..+. ..-.-.+|...+....+
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk----Gid~i~~Pr~I~k~a~~ 650 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK----GIDKIEFPRRITKTATD 650 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh----hhhhhhcccccchhHHH
Confidence 57899999999999999999999999999999999999988865433222222222 22222456677888999
Q ss_pred HHHHhcccCCCCCCC
Q 020221 288 LASRCLQYEPRERPN 302 (329)
Q Consensus 288 li~~cl~~dp~~Rps 302 (329)
+++.+-..+|.+|..
T Consensus 651 Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 651 LIKKLCRDNPTERLG 665 (732)
T ss_pred HHHHHHhcCcHhhhc
Confidence 999999999999975
No 388
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=100.00 E-value=6.9e-35 Score=270.56 Aligned_cols=251 Identities=15% Similarity=0.180 Sum_probs=175.3
Q ss_pred CcccccccCCCCCCcEEEEEEe-----------------CCCCEEEEEEeCCCCChhHHHH--------------HHHHH
Q 020221 57 AMENIVSEHGEKAPNVVYKGKL-----------------ENQFRIAVKRFNRSAWPDARQF--------------LEEAR 105 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e~~ 105 (329)
+.+.+.++||+|+||+||+|.. .+++.||||++........++| ..|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 3455667779999999999963 2356799999876543322233 34666
Q ss_pred HHhcCCCccc-----cccceeeee--------CCeeEEEEecCCCCCHHhhhccCC----------------------CC
Q 020221 106 AVGQLRNRRL-----ANLLGCCCE--------GDERLLVAEYMPNDTLAKHLFHWE----------------------TQ 150 (329)
Q Consensus 106 ~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~ 150 (329)
++..++|.++ ++++++|.. .+..++||||+++++|.+++.... ..
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7777766543 667777643 356899999999999999885311 11
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC-----ccCcccccCccccc
Q 020221 151 PMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS-----YSTNLAFTPPEYLR 225 (329)
Q Consensus 151 ~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~y~aPE~~~ 225 (329)
.+++..+..++.|++.+|.|||+. +++||||||+||+++.++.+||+|||++........ ..+++.|+|||.+.
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 346778899999999999999999 999999999999999999999999999875433221 12368999999875
Q ss_pred CCC--------------------C--CCcccchhhhHHHHHHHhCCCCCCchh--hHH-Hhh--hch---hhhccccccC
Q 020221 226 TGR--------------------V--TPESVMYSFGTLLLDLLSGKHIPPSHA--LDL-IRD--RNI---QTLTDSCLEG 275 (329)
Q Consensus 226 ~~~--------------------~--~~~~DvwslG~il~el~tg~~~~~~~~--~~~-~~~--~~~---~~~~~~~~~~ 275 (329)
... + ..+.||||+||++++|+++...+.... ... ... ... .........-
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~ 463 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF 463 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence 322 1 124799999999999999885332211 000 000 000 0000011111
Q ss_pred CCChHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 020221 276 QFSSDEGTELVRLASRCLQYEP---RERPNPRSLVT 308 (329)
Q Consensus 276 ~~~~~~~~~~~~li~~cl~~dp---~~Rps~~~~l~ 308 (329)
...+..++...+|+.++|..+| .+|+|+.++++
T Consensus 464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1223457889999999999866 68999999998
No 389
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-35 Score=258.19 Aligned_cols=246 Identities=21% Similarity=0.267 Sum_probs=191.8
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC-Chh------HHHHHHHHHHHhcCCCccccccceeeeeC-CeeE
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA-WPD------ARQFLEEARAVGQLRNRRLANLLGCCCEG-DERL 129 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~ 129 (329)
|-++..||+|+|+.||++. +.....||||+-.... +.+ .+-..+|.++-+.|+||.||++++++.-+ +.++
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 4456778999999999998 6667789999865542 221 12356899999999999999999998654 6788
Q ss_pred EEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCccccccCCCceeeC---CCCCeeeecccCccc
Q 020221 130 LVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK-ERALYHDLNAYRIVFD---DDVNPRLSCFGLMKN 205 (329)
Q Consensus 130 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~~ 205 (329)
-|+|||+|.+|+-||. ..+.+++..++.|+.||+.||.||... ..|||-||||.|||+- ..|.+||.|||+++.
T Consensus 545 TVLEYceGNDLDFYLK--QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLK--QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeeecCCCchhHHHH--hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 9999999999999997 556789999999999999999999863 5799999999999994 567899999999986
Q ss_pred CCCCC-----------CccCcccccCcccccCC----CCCCcccchhhhHHHHHHHhCCCCCCchhhH--HHhhhchhhh
Q 020221 206 SRDGR-----------SYSTNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHALD--LIRDRNIQTL 268 (329)
Q Consensus 206 ~~~~~-----------~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~~~~~~~~~--~~~~~~~~~~ 268 (329)
..+.. ...||.+|.+||.+.-+ .++.++||||+|||+|.++.|+.||...... .+....+...
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 55432 23679999999987633 3888999999999999999999998644221 1111111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
.-+.-+..+.++.+...||..||++.-++|.+..++..
T Consensus 703 --tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 703 --TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111223456789999999999999999998888764
No 390
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-35 Score=234.16 Aligned_cols=197 Identities=17% Similarity=0.206 Sum_probs=165.7
Q ss_pred ccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCCC
Q 020221 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW-PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
-+..||+|++|.|-+.+ ..+|+..|+|.++..-. +...+.++|+.+.... .+|.+|.++|...+....|+.||.|+.
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 34567999999999988 67899999999987643 3344578888876554 799999999999999999999999976
Q ss_pred CCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC---Cc
Q 020221 138 DTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---SY 212 (329)
Q Consensus 138 gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~ 212 (329)
||..+.++. .+..+++..+-+|+..+..||.|||++..++|||+||+|||++.+|++|++|||.+....+.- ..
T Consensus 130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~d 208 (282)
T KOG0984|consen 130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMD 208 (282)
T ss_pred -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHh
Confidence 887766431 567889999999999999999999998899999999999999999999999999987655442 24
Q ss_pred cCcccccCcccccCC----CCCCcccchhhhHHHHHHHhCCCCCCchhhH
Q 020221 213 STNLAFTPPEYLRTG----RVTPESVMYSFGTLLLDLLSGKHIPPSHALD 258 (329)
Q Consensus 213 ~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 258 (329)
.|...|||||.+..+ .|+-++||||||+++.||.+++.|+.....+
T Consensus 209 aGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 209 AGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred cCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 677899999987633 5888999999999999999999887655443
No 391
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-35 Score=246.57 Aligned_cols=241 Identities=17% Similarity=0.242 Sum_probs=193.8
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 131 (329)
.++.+++.||+|+|+.|..++ .++.+.+|+|++++.- .++++....|-.+...- +||.+|.+..+|++...+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 445677888999999999999 6678899999987643 23345556666665555 699999999999999999999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC-CC--
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS-RD-- 208 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~-~~-- 208 (329)
.||++||+|--.+. ..+.++++.++.+..+|+-||.|||++ ||++||||.+|+|+|..|++||.|+|+++.. .+
T Consensus 330 ieyv~ggdlmfhmq--rqrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEecCcceeeehh--hhhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 99999999977665 567899999999999999999999999 9999999999999999999999999998752 22
Q ss_pred -CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh---HH-HhhhchhhhccccccCCCChHHHH
Q 020221 209 -GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL---DL-IRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 209 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
..+++||+.|+|||.+.+..|..++|+|+||++++||+.|+.||..-.. +. ......+.+++... .+|...+-
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--riprslsv 484 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIPRSLSV 484 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--cccceeeh
Confidence 3467899999999999999999999999999999999999998843111 00 11111222222222 24555566
Q ss_pred HHHHHHHHhcccCCCCCCC
Q 020221 284 ELVRLASRCLQYEPRERPN 302 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps 302 (329)
....+++..|++||.+|..
T Consensus 485 kas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hhHHHHHHhhcCCcHHhcC
Confidence 7788999999999999963
No 392
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.4e-36 Score=245.07 Aligned_cols=244 Identities=18% Similarity=0.269 Sum_probs=189.2
Q ss_pred ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcCCCccccccceeeeeC-----CeeEEEEec
Q 020221 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAW--PDARQFLEEARAVGQLRNRRLANLLGCCCEG-----DERLLVAEY 134 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~ 134 (329)
+-||.|+||.||..+ -.+|+.||+|++..-.. ...+.+.+|+++|..++|.|++..++..+-. .++|+++|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 456999999999998 56789999999876432 2345688999999999999999999887544 246788999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc--
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY-- 212 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-- 212 (329)
+.. +|...+. ..+.++...+..+.+||++||+|||+. +|+||||||.|.|++.|-.+||+|||+++........
T Consensus 139 mQS-DLHKIIV--SPQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 139 MQS-DLHKIIV--SPQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHh-hhhheec--cCCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 865 7888876 567899999999999999999999999 9999999999999999999999999999876655432
Q ss_pred ---cCcccccCcccccCCC-CCCcccchhhhHHHHHHHhCCCCCCchh----hH------------HHh---hhchhhhc
Q 020221 213 ---STNLAFTPPEYLRTGR-VTPESVMYSFGTLLLDLLSGKHIPPSHA----LD------------LIR---DRNIQTLT 269 (329)
Q Consensus 213 ---~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~~~~~~~----~~------------~~~---~~~~~~~~ 269 (329)
..|..|.|||.++|.. |+...||||+|||..||+.++..|.... .+ .++ ++....++
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 3578999999999876 9999999999999999999887664320 00 010 00000111
Q ss_pred cccccC---------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221 270 DSCLEG---------QFSSDEGTELVRLASRCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 270 ~~~~~~---------~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L 310 (329)
....+. ..+.....+...++.+++..||+.|.+..+++..+
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 100000 01123345778889999999999999999888754
No 393
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-34 Score=246.09 Aligned_cols=250 Identities=19% Similarity=0.215 Sum_probs=202.2
Q ss_pred cccCCCCCCcEEEEEEe------CCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeee-CCeeEEEEe
Q 020221 62 VSEHGEKAPNVVYKGKL------ENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCE-GDERLLVAE 133 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 133 (329)
...+-+|.||.||.|.| ++.+.|-+|.++....+ ....+.+|.-.+..+.|||+.++.+++.+ ....+.++.
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~ 368 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP 368 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence 34458999999999954 34566888888776543 24458889999999999999999999855 467889999
Q ss_pred cCCCCCHHhhhccC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 134 YMPNDTLAKHLFHW------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 134 ~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
++.-|+|..++... ..+.++-.+...++.|++.|++|||+. ++||.||..+|.++|+...+||+|-.+++...
T Consensus 369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLF 447 (563)
T KOG1024|consen 369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQLQVKLTDSALSRDLF 447 (563)
T ss_pred ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-CcccchhhhhcceehhheeEEeccchhccccC
Confidence 99999999999721 234567788999999999999999999 99999999999999999999999999998766
Q ss_pred CCC------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHH
Q 020221 208 DGR------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDE 281 (329)
Q Consensus 208 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (329)
+.+ .......||+||.+....|+..+|+||||++||||+|-+..|..+..+ ..+...+....+-..|.++
T Consensus 448 P~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP----fEm~~ylkdGyRlaQP~NC 523 (563)
T KOG1024|consen 448 PGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP----FEMEHYLKDGYRLAQPFNC 523 (563)
T ss_pred cccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH----HHHHHHHhccceecCCCCC
Confidence 543 334568899999999999999999999999999999865544333221 1122233333444567788
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 020221 282 GTELVRLASRCLQYEPRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 282 ~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~ 316 (329)
|.++..++.-||+.+|++||+++|+..-|.++.-.
T Consensus 524 PDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 524 PDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred cHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999887643
No 394
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=100.00 E-value=8.2e-35 Score=270.18 Aligned_cols=238 Identities=21% Similarity=0.227 Sum_probs=178.8
Q ss_pred CcccccccCCCCCCcE-EEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEec
Q 020221 57 AMENIVSEHGEKAPNV-VYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
...+++ |.|+.|+ ||+|... ++.||||.+-... ..-..+|++.|+.- .|||||++++.-.+....||..|.
T Consensus 512 ~~~eil---G~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 512 SPKEIL---GYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred ccHHHc---ccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 344444 7777754 6999984 5599999986533 33457899999988 699999999998889999999999
Q ss_pred CCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC---C--CCeeeecccCcccCC
Q 020221 135 MPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD---D--VNPRLSCFGLMKNSR 207 (329)
Q Consensus 135 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~---~--~~~kl~Dfg~a~~~~ 207 (329)
|.. +|.+++... +.....-...+....|+++||++||+. +||||||||.||||+- + ..++|+|||+++...
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 966 999999642 111111134578899999999999998 9999999999999975 3 468999999998765
Q ss_pred CCC-------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCC-CCCCchhhHHHhhhchhhhccccccCCCCh
Q 020221 208 DGR-------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGK-HIPPSHALDLIRDRNIQTLTDSCLEGQFSS 279 (329)
Q Consensus 208 ~~~-------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (329)
.+. ...||-+|+|||++....-+..+||||+||++|+.++|+ +||.+. .+... ........-..-.. ..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~-~~R~~-NIl~~~~~L~~L~~-~~ 739 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS-LERQA-NILTGNYTLVHLEP-LP 739 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch-HHhhh-hhhcCccceeeecc-Cc
Confidence 543 346899999999999988888999999999999999985 455332 22111 11111111000001 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 280 DEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 280 ~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
++ ++.+||.+|++.||..||+|.+|+.
T Consensus 740 d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 740 DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 22 8999999999999999999999986
No 395
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-33 Score=248.80 Aligned_cols=131 Identities=16% Similarity=0.195 Sum_probs=113.6
Q ss_pred CcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-----C---ccccccceeeee---
Q 020221 57 AMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-----N---RRLANLLGCCCE--- 124 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~--- 124 (329)
..|.++++||=|.|++||++. ..+.+.||+|+++... .-.+..+.||++|+.++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 368899999999999999999 5667789999987643 23456788999999983 3 369999999854
Q ss_pred -CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceee
Q 020221 125 -GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVF 189 (329)
Q Consensus 125 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~ 189 (329)
+.++++|+|++ |.+|..+|.....+.++...+..|++||+.||.|||.+.||||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 56899999999 56899999877788999999999999999999999998899999999999999
No 396
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=7e-35 Score=264.55 Aligned_cols=250 Identities=16% Similarity=0.175 Sum_probs=207.2
Q ss_pred cCCCcccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 54 SGFAMENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+.-++|+++..+|.|.||.|||++ ..+++..|+|+++.....+..-+.+|+-+++..+||||+-++|.+...+..|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 556778899999999999999999 6788999999999888777778889999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC----C
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR----D 208 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~----~ 208 (329)
|||.+|+|.+... -..++++.++....++.++||+|||++ |-+|||||-.||++++.|.+|++|||.+-.+. .
T Consensus 92 EycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 9999999999775 567899999999999999999999999 99999999999999999999999999876544 3
Q ss_pred CCCccCcccccCccccc---CCCCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhchhhhccccccCCCChHHHHH
Q 020221 209 GRSYSTNLAFTPPEYLR---TGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLEGQFSSDEGTE 284 (329)
Q Consensus 209 ~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
...+.||+.|||||+.. .+.|+...|||++|++..|+---++|-+.... ....-......-.+.+ .-+...++.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~l--kDk~kws~~ 246 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTL--KDKTKWSEF 246 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcc--cCCccchHH
Confidence 35778999999999764 45699999999999999999877754332110 0000000111111111 123456889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 020221 285 LVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 285 ~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
|.+|++.++..+|++||+++.+++
T Consensus 247 fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhhee
Confidence 999999999999999999998875
No 397
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=100.00 E-value=2.3e-34 Score=254.69 Aligned_cols=248 Identities=16% Similarity=0.168 Sum_probs=195.9
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC------ccccccceeeeeCCeeEE
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN------RRLANLLGCCCEGDERLL 130 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~~~~~~l 130 (329)
.|++....|+|-|++|-.|. ...|+.||||++..... -.+.=+.|+++|+.|.. -|+++++..|...++++|
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 46778888999999999998 44577999999987652 24455789999999952 389999999999999999
Q ss_pred EEecCCCCCHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCCC
Q 020221 131 VAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRD 208 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~ 208 (329)
|+|-+. .+|.++|... ..-.+....+..+++|+.-||..|... |++|.||||+|||+++. ..+||||||.|.....
T Consensus 512 VFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c-~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 512 VFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC-GVLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred Eehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc-CeeecccCccceEeccCcceeeeccCcccccccc
Confidence 999884 4899999753 345678889999999999999999998 99999999999999865 5689999999987665
Q ss_pred C--CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHh-------------------------
Q 020221 209 G--RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIR------------------------- 261 (329)
Q Consensus 209 ~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~------------------------- 261 (329)
. .++..+..|.|||.+.|.+|+...|+||+||+||||.||+..||+.....+.
T Consensus 590 neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHF 669 (752)
T KOG0670|consen 590 NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHF 669 (752)
T ss_pred ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhc
Confidence 4 3455667899999999999999999999999999999999988865221111
Q ss_pred ---------------hhchhhhc---cc------cc--cCCCCh---HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 262 ---------------DRNIQTLT---DS------CL--EGQFSS---DEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 262 ---------------~~~~~~~~---~~------~~--~~~~~~---~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
......++ .+ .+ ...++. ....+|.+|+..||.+||++|.|..++|.
T Consensus 670 D~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 670 DQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred ccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00000000 00 00 001222 24578999999999999999999999998
No 398
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=100.00 E-value=7e-32 Score=225.16 Aligned_cols=206 Identities=25% Similarity=0.372 Sum_probs=182.4
Q ss_pred CCCCCCcEEEEEEeC-CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHh
Q 020221 65 HGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAK 142 (329)
Q Consensus 65 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 142 (329)
||.|.+|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 589999999999964 4889999999876543 34678999999999999999999999998899999999999899999
Q ss_pred hhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-CCCeeeecccCcccCCCC----CCccCccc
Q 020221 143 HLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-DVNPRLSCFGLMKNSRDG----RSYSTNLA 217 (329)
Q Consensus 143 ~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~----~~~~~~~~ 217 (329)
++... ...+++..+..++.+++.++.+||+. +++|+||+|.||+++. ++.++|+|||.+...... ....+...
T Consensus 81 ~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKEN-EGKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 98642 14689999999999999999999999 9999999999999999 899999999998766543 23456788
Q ss_pred ccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccC
Q 020221 218 FTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYE 296 (329)
Q Consensus 218 y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 296 (329)
|++||.+... ..+.++|+|++|+++++| ..+.+++..|++.|
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD 201 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence 9999998877 788899999999999999 57889999999999
Q ss_pred CCCCCCHHHHHHH
Q 020221 297 PRERPNPRSLVTA 309 (329)
Q Consensus 297 p~~Rps~~~~l~~ 309 (329)
|++||++.++++.
T Consensus 202 p~~R~~~~~l~~~ 214 (215)
T cd00180 202 PEKRPSAKEILEH 214 (215)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999874
No 399
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-33 Score=234.95 Aligned_cols=241 Identities=18% Similarity=0.234 Sum_probs=184.8
Q ss_pred ccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC--CChhHHHHHHHHHHHhcCCCccccccceeeeeC------CeeEEE
Q 020221 61 IVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDARQFLEEARAVGQLRNRRLANLLGCCCEG------DERLLV 131 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~lv 131 (329)
-++.+|.|+- .|-.+- .-.+++||+|++... ....++...+|...+..+.|+||++++.++.-. ..+|+|
T Consensus 21 nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v 99 (369)
T KOG0665|consen 21 NLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV 99 (369)
T ss_pred eecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence 3455677876 454444 335779999998654 234466788999999999999999999988432 357999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC--
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-- 209 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-- 209 (329)
||+|.. +|...+. ..++=.++..+..|+++|++|||+. ||+||||||+||++..+..+||.|||+|......
T Consensus 100 ~e~m~~-nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~ 173 (369)
T KOG0665|consen 100 MELMDA-NLCQVIL----MELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFM 173 (369)
T ss_pred HHhhhh-HHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchhheeeccchhhcccCcccc
Confidence 999965 8888875 3466678899999999999999999 9999999999999999999999999999865544
Q ss_pred -CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-H---HHhh----------------------
Q 020221 210 -RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-D---LIRD---------------------- 262 (329)
Q Consensus 210 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~---~~~~---------------------- 262 (329)
..+..+..|.|||++-+-.+.+.+||||+||++.||++|...|++... + .+..
T Consensus 174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~ 253 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE 253 (369)
T ss_pred cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence 456788999999999888899999999999999999999988875411 0 0000
Q ss_pred -------hchhhhc-cccccC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 263 -------RNIQTLT-DSCLEG--QFSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 263 -------~~~~~~~-~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
....... +..+.. ..+...+..+++++.+||..||++|.|++++|.
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0000000 000000 011223567899999999999999999999998
No 400
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-33 Score=250.93 Aligned_cols=200 Identities=14% Similarity=0.143 Sum_probs=172.2
Q ss_pred HHhcCCCcccccccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCChh--------HHHHHHHHHHHhcCC---Ccccccc
Q 020221 51 TATSGFAMENIVSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWPD--------ARQFLEEARAVGQLR---NRRLANL 118 (329)
Q Consensus 51 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~---h~niv~~ 118 (329)
....+|+.|..++.+|.|+||.|+.|.+ .+...|++|.+.+...-. .-.+-.|+++|..++ |+||+++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 3456788899999999999999999994 456778999887643110 112456999999996 9999999
Q ss_pred ceeeeeCCeeEEEEecC-CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeee
Q 020221 119 LGCCCEGDERLLVAEYM-PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRL 197 (329)
Q Consensus 119 ~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl 197 (329)
+++|++.+++||+||-. ++-+|.+++. ....+++..+..|++|++.|+++||+. ||||||||-+|++++.+|-+||
T Consensus 635 LdfFEddd~yyl~te~hg~gIDLFd~IE--~kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 635 LDFFEDDDYYYLETEVHGEGIDLFDFIE--FKPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred hheeecCCeeEEEecCCCCCcchhhhhh--ccCccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecCCeEEE
Confidence 99999999999999974 6678999996 456789999999999999999999999 9999999999999999999999
Q ss_pred ecccCcccCCC--CCCccCcccccCcccccCCCCCC-cccchhhhHHHHHHHhCCCCCC
Q 020221 198 SCFGLMKNSRD--GRSYSTNLAFTPPEYLRTGRVTP-ESVMYSFGTLLLDLLSGKHIPP 253 (329)
Q Consensus 198 ~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~~~~ 253 (329)
+|||.+..... ...+.||..|.|||++.|.+|-- .-|||++|++||.++....|++
T Consensus 712 idfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999876554 46789999999999999988655 5899999999999999887764
No 401
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=99.97 E-value=4.2e-32 Score=235.34 Aligned_cols=243 Identities=21% Similarity=0.280 Sum_probs=189.9
Q ss_pred cccccccCCCCCCcEEEEEE-eC---CCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LE---NQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 132 (329)
.+..+.+||.|.|++||++. .. .+..||+|.+...... ..+.+|++.|..+ -+.||+++.+++...+...+|+
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl 114 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL 114 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence 35677788999999999998 33 4678999999876643 5688999999999 4899999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-CCCCeeeecccCcccCC----
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-DDVNPRLSCFGLMKNSR---- 207 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~---- 207 (329)
||++..+..+++. .++...+..+++.++.||+++|.+ |||||||||+|+|.+ ..+.-.|+|||+|....
T Consensus 115 p~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 115 PYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred cccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 9999999999884 477889999999999999999999 999999999999998 45678999999986100
Q ss_pred -------------C--C-----------------------------CCccCcccccCcccccCCC-CCCcccchhhhHHH
Q 020221 208 -------------D--G-----------------------------RSYSTNLAFTPPEYLRTGR-VTPESVMYSFGTLL 242 (329)
Q Consensus 208 -------------~--~-----------------------------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il 242 (329)
+ + .+..||++|.|||++...+ .+.++||||.|+|+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0 0124789999999988665 78899999999999
Q ss_pred HHHHhCCCCCCchhhH--------------HH-hhhchhh----------------------h-cccccc--------CC
Q 020221 243 LDLLSGKHIPPSHALD--------------LI-RDRNIQT----------------------L-TDSCLE--------GQ 276 (329)
Q Consensus 243 ~el~tg~~~~~~~~~~--------------~~-~~~~~~~----------------------~-~~~~~~--------~~ 276 (329)
+-+++++.||.....+ .+ +...... + ...+.. ..
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 9999999988643100 00 0000000 0 000101 11
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 277 FSSDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 277 ~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..+..+..+.+++.+|+..||.+|.|++++|.
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 11224568999999999999999999999997
No 402
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.97 E-value=3.2e-31 Score=217.74 Aligned_cols=247 Identities=19% Similarity=0.209 Sum_probs=185.7
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCcccccccee-eeeCCeeEEEEec
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGC-CCEGDERLLVAEY 134 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e~ 134 (329)
.|.+.+.+|+|.||.+-++. ..+.+.+++|-++.... ...+|.+|..---.| .|.||+.-++. |++.+..++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 46777888999999999999 55677899999887663 466899988766566 58999987764 6677888999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC--CCCCeeeecccCcccCCCCCCc
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD--DDVNPRLSCFGLMKNSRDGRSY 212 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~--~~~~~kl~Dfg~a~~~~~~~~~ 212 (329)
++.|+|.+-+ ....+-+.-..+++.|+++|+.|+|++ ++||||||.+||||- +.-.+||+|||..+........
T Consensus 104 aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 104 APRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred Cccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 9999999988 567788889999999999999999999 999999999999994 3457999999998765443322
Q ss_pred -cCcccccCcccccCC-----CCCCcccchhhhHHHHHHHhCCCCCCchhhH---HHhhhchhhhccccccCCCChHHHH
Q 020221 213 -STNLAFTPPEYLRTG-----RVTPESVMYSFGTLLLDLLSGKHIPPSHALD---LIRDRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 213 -~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
.-+..|.+||..... ..++.+|+|.||++++.++||..|+...... .+.-........+.++. .-..+++
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~-~F~~fs~ 258 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK-KFNPFSE 258 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch-hhcccCH
Confidence 235679999976532 2678999999999999999999877532111 11111111111111111 1134577
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 020221 284 ELVRLASRCLQYEPRERPNPRSLVTAL 310 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps~~~~l~~L 310 (329)
.+..+.++-|..+|++|-...++.+..
T Consensus 259 ~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 259 KALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred HHHHHHHHhcCCcccccchhHHHHHHH
Confidence 889999999999999996555555443
No 403
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.97 E-value=4.8e-30 Score=216.98 Aligned_cols=191 Identities=24% Similarity=0.267 Sum_probs=168.1
Q ss_pred ccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCC
Q 020221 61 IVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
+.+.+|.|++|+||++... +++.+++|.+...... ..+.+.+|++.++.++|+|++++++++......++++|+++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 4456799999999999954 4889999999876654 5678899999999999999999999998889999999999999
Q ss_pred CHHhhhccCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC-----CCc
Q 020221 139 TLAKHLFHWETQP-MKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG-----RSY 212 (329)
Q Consensus 139 sL~~~l~~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-----~~~ 212 (329)
+|.+++.. ... +++.....++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+...... ...
T Consensus 83 ~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 83 DLFDYLRK--KGGKLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 99999864 223 88999999999999999999999 9999999999999999999999999998876554 344
Q ss_pred cCcccccCcccc-cCCCCCCcccchhhhHHHHHHHhCCCCCCc
Q 020221 213 STNLAFTPPEYL-RTGRVTPESVMYSFGTLLLDLLSGKHIPPS 254 (329)
Q Consensus 213 ~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~el~tg~~~~~~ 254 (329)
.++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 567889999998 666688899999999999999999988865
No 404
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.97 E-value=5.3e-31 Score=261.48 Aligned_cols=190 Identities=17% Similarity=0.150 Sum_probs=138.6
Q ss_pred cCCC-ccccccceee-------eeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccc
Q 020221 109 QLRN-RRLANLLGCC-------CEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH 180 (329)
Q Consensus 109 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~ 180 (329)
.++| +||+.+++++ .....+++++|++ +++|.+++.. ....+++.++..++.||+.||.|||++ ||+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-gIvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQ-GIVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhC-Ceeec
Confidence 3344 5777788876 2234677888987 5599999964 345699999999999999999999999 99999
Q ss_pred ccCCCceeeCC-------------------CCCeeeecccCcccCCCC--------------------CCccCcccccCc
Q 020221 181 DLNAYRIVFDD-------------------DVNPRLSCFGLMKNSRDG--------------------RSYSTNLAFTPP 221 (329)
Q Consensus 181 dlkp~Nil~~~-------------------~~~~kl~Dfg~a~~~~~~--------------------~~~~~~~~y~aP 221 (329)
||||+|||++. ++.+|++|||+++..... ....+|+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 455677777776532110 012467889999
Q ss_pred ccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCC
Q 020221 222 EYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERP 301 (329)
Q Consensus 222 E~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp 301 (329)
|++.+..++.++|||||||+||||++|..|+.... ... ........++ . .....+...+++.+||..||.+||
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-~~~-~~~~~~~~~~----~-~~~~~~~~~~~~~~~L~~~P~~Rp 257 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-RTM-SSLRHRVLPP----Q-ILLNWPKEASFCLWLLHPEPSCRP 257 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-HHH-HHHHHhhcCh----h-hhhcCHHHHHHHHHhCCCChhhCc
Confidence 99999999999999999999999999886543221 111 0111111111 1 111234567889999999999999
Q ss_pred CHHHHHH
Q 020221 302 NPRSLVT 308 (329)
Q Consensus 302 s~~~~l~ 308 (329)
++.++++
T Consensus 258 s~~eil~ 264 (793)
T PLN00181 258 SMSELLQ 264 (793)
T ss_pred ChHHHhh
Confidence 9999987
No 405
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.96 E-value=1.9e-29 Score=205.92 Aligned_cols=168 Identities=15% Similarity=0.123 Sum_probs=129.1
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCccc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 217 (329)
|||.+++.. ....+++.+++.++.|++.||.|||+. + ||+||+++.++.+++ ||++....... ..+++.
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~~g~~~ 69 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-SRVDPY 69 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCccceee--ccceEeecccc-CCCccc
Confidence 689999864 345799999999999999999999999 6 999999999999999 99987655433 367899
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhh-HHHhhhchhhhcccccc-CCCChHHHH--HHHHHHHHhc
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHAL-DLIRDRNIQTLTDSCLE-GQFSSDEGT--ELVRLASRCL 293 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~li~~cl 293 (329)
|+|||++.+..++.++||||||+++|||++|..|+..... ................. ...+...+. ++.+++..||
T Consensus 70 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl 149 (176)
T smart00750 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCA 149 (176)
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHH
Confidence 9999999999999999999999999999999988754321 11111111111111000 011223344 6999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhc
Q 020221 294 QYEPRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 294 ~~dp~~Rps~~~~l~~L~~~~~~ 316 (329)
..||++||++.++++++..+...
T Consensus 150 ~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 150 SRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred hcccccccCHHHHHHHHHHHHHH
Confidence 99999999999999998877543
No 406
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.96 E-value=6.7e-30 Score=210.31 Aligned_cols=254 Identities=20% Similarity=0.303 Sum_probs=200.1
Q ss_pred CCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 55 GFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 55 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+++..+++-+|.+...|..|+|+++++ .+++|++....... .++|..|.-.|+.+.||||+.++|.|..+.++.+|.
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred chhhhhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 345556677778888999999999655 68888887654332 356888999999999999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccc-ccCCCceeeCCCCCeeeecccCcccCCCCCC
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYH-DLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS 211 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~-dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 211 (329)
.||+.|||...+.......++-.++.+++.+|++|++|||+...++-| -|....+++|++.+++|+- +-+++......
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kfsfqe~g 345 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEVG 345 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-ccceeeeeccc
Confidence 999999999999865555567789999999999999999997677766 7889999999999888753 22333222222
Q ss_pred ccCcccccCcccccCCC---CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 212 YSTNLAFTPPEYLRTGR---VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 212 ~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
..-.+.|++||.+...+ --..+|+|||.+++|||.|+..||..... +.-+ ..+--..++..+|+..++.+.+|
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp--mecg--mkialeglrv~ippgis~hm~kl 421 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP--MECG--MKIALEGLRVHIPPGISRHMNKL 421 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc--hhhh--hhhhhccccccCCCCccHHHHHH
Confidence 23358899999998765 33579999999999999999988754321 1111 11122335566788889999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhhh
Q 020221 289 ASRCLQYEPRERPNPRSLVTALVTLQ 314 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~~L~~~~ 314 (329)
+.-|+..||.+||.+..++-.|+++.
T Consensus 422 m~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 422 MNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999998864
No 407
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.95 E-value=4.1e-27 Score=210.10 Aligned_cols=257 Identities=16% Similarity=0.141 Sum_probs=197.4
Q ss_pred cccccccCCCCCCcEEEEEEeCCC--CEEEEEEeCCCCChhHHHHHHHHHHHhcCCC----ccccccceee-eeCCeeEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQ--FRIAVKRFNRSAWPDARQFLEEARAVGQLRN----RRLANLLGCC-CEGDERLL 130 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l 130 (329)
.+.+.+.||+|+||.||.+..... ..+|+|............+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 688889999999999999995443 4789998876533322267778888888863 6888888888 47778999
Q ss_pred EEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-----CCeeeecccCccc
Q 020221 131 VAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-----VNPRLSCFGLMKN 205 (329)
Q Consensus 131 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-----~~~kl~Dfg~a~~ 205 (329)
||+.+ |.+|.++......+.++..++..++.|++.+|+++|+. |++||||||+|+++... ..+.|.|||+++.
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 99998 66999988654567899999999999999999999999 99999999999999854 4699999999982
Q ss_pred CC--C--------C----CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccc
Q 020221 206 SR--D--------G----RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDS 271 (329)
Q Consensus 206 ~~--~--------~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 271 (329)
.. . . ....||..|+++....+...+++.|+||++.++.+++.|..|+........... .......
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~-~~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK-FEKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH-HHHHhhh
Confidence 21 1 1 123489999999999999999999999999999999999877643321111111 1111111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 272 CLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 272 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
..........+.++.++...+-..+...+|.+..+...|+......
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 256 LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111122334567888888888899999999999999988876654
No 408
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.95 E-value=1.8e-27 Score=192.64 Aligned_cols=254 Identities=16% Similarity=0.164 Sum_probs=203.3
Q ss_pred cccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecC
Q 020221 58 MENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
.|+++++||.|+||.+|.|. ..+|+.||+|.-..... ..++..|..+...++ ...|..+..+..+.....+||+.+
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 47899999999999999999 88899999999776543 345778999999997 467888888888889999999998
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC---CCeeeecccCcccCCCC---
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD---VNPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~---~~~kl~Dfg~a~~~~~~--- 209 (329)
|.||.+++. ...+.++..+++.++-||+.-++|+|.+ +++||||||+|+|+.-+ ..+.++|||+|+.+.+.
T Consensus 94 -GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 94 -GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred -CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 679999873 3667899999999999999999999999 99999999999999743 45889999999875543
Q ss_pred --------CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccC---CCC
Q 020221 210 --------RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG---QFS 278 (329)
Q Consensus 210 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 278 (329)
....||..|.+--...+...+.+.|+-|+|.+|.++.-|..|+.+-. ...+.+..+.+.+..... ...
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk-a~tk~QKyEkI~EkK~s~~ie~LC 249 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK-AATKKQKYEKISEKKMSTPIEVLC 249 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc-hhhHHHHHHHHHHhhcCCCHHHHh
Confidence 34568899999888887788899999999999999999998775432 222333333332222111 123
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 279 SDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
...|.++.-.+..|-...-++-|++.-+.+.+.-+-...
T Consensus 250 ~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 250 KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 456788999999999999999999998888777665543
No 409
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.94 E-value=9.5e-27 Score=196.54 Aligned_cols=253 Identities=16% Similarity=0.182 Sum_probs=205.5
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEEecCC
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
|++-++||+|+||.++.|+ +-+++.||||.-.... .+.++..|.+..+.| ..++|...+.+...+-+..||+|++
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 6677888999999999998 6788999999866543 456788899999998 5799999999888888999999998
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-----CeeeecccCcccCCCCC-
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-----NPRLSCFGLMKNSRDGR- 210 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-----~~kl~Dfg~a~~~~~~~- 210 (329)
|.||.+++ ++.++.++..++..++.||+.-++|+|++ .+|+|||||+|+||..-+ .+-++|||+|+.+.+..
T Consensus 107 GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 107 GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 67999977 55788999999999999999999999999 999999999999997443 48899999999766543
Q ss_pred ----------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccc---cCCC
Q 020221 211 ----------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL---EGQF 277 (329)
Q Consensus 211 ----------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 277 (329)
+..||-+||+--...|...+.+.|+-|+|-++++.+-|..|+.+-..+..+.. .+.+-+..- ....
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k-YeKIGe~Kr~T~i~~L 263 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK-YEKIGETKRSTPIEVL 263 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH-HHHhccccccCCHHHH
Confidence 45789999999988898999999999999999999999988765432222111 111111110 1112
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 278 SSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 278 ~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
...+|.++...+...-.++-++-|++.-+...+..+....
T Consensus 264 c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 264 CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 2446889999999999999999999999988888876643
No 410
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.93 E-value=1.6e-25 Score=199.90 Aligned_cols=156 Identities=15% Similarity=-0.000 Sum_probs=120.5
Q ss_pred ccccccCCCCCCcEEEEEEeC--CCCEEEEEEeCCCC-----ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEE
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE--NQFRIAVKRFNRSA-----WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 131 (329)
|.+.+.||+|+||+||+|... +++.+|||++.... ......+.+|+++|+.++|+|++..+.. .+..++|
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LV 96 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLV 96 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEE
Confidence 556666799999999999853 57778999875331 1124458999999999999999863322 2468999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccc-CCCceeeCCCCCeeeecccCcccCCCCC
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL-NAYRIVFDDDVNPRLSCFGLMKNSRDGR 210 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl-kp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 210 (329)
|||+++++|.. +. ... ...++.+++.+|.|||+. ||+|||| ||+|||++.++.++|+|||+++......
T Consensus 97 mE~~~G~~L~~-~~--~~~------~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~ 166 (365)
T PRK09188 97 RGWTEGVPLHL-AR--PHG------DPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG 166 (365)
T ss_pred EEccCCCCHHH-hC--ccc------hHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence 99999999963 21 111 146788999999999999 9999999 9999999999999999999998654432
Q ss_pred ------------CccCcccccCcccccCC
Q 020221 211 ------------SYSTNLAFTPPEYLRTG 227 (329)
Q Consensus 211 ------------~~~~~~~y~aPE~~~~~ 227 (329)
...++..|+|||.+...
T Consensus 167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 167 ALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred chhhhhhhhhhhhhhccCccCCcccCChh
Confidence 22356779999988643
No 411
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.93 E-value=2.2e-26 Score=218.25 Aligned_cols=242 Identities=15% Similarity=0.084 Sum_probs=180.2
Q ss_pred ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCC--CChhH----HHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRS--AWPDA----RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
..+|.|++|.|+... ....+..+.|.+... ..... ..+..|+.+-..+.|+|++..+..+.+.....-.||||
T Consensus 324 ~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~ 403 (601)
T KOG0590|consen 324 RVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYC 403 (601)
T ss_pred ceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcc
Confidence 445999999888776 444445555554321 11111 12566777888899999988888777666666669999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC------
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG------ 209 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~------ 209 (329)
++ +|..++.. ...+...++..+++|++.|+.|+|+. |+.|||+|++|++++.+|.+||+|||.+..+.-.
T Consensus 404 ~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 404 PY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred cH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99 99998852 24688889999999999999999999 9999999999999999999999999998754433
Q ss_pred --CCccCcccccCcccccCCCCCCc-ccchhhhHHHHHHHhCCCCCCchhhHHHh---hhchhhhccccccCCCChHHHH
Q 020221 210 --RSYSTNLAFTPPEYLRTGRVTPE-SVMYSFGTLLLDLLSGKHIPPSHALDLIR---DRNIQTLTDSCLEGQFSSDEGT 283 (329)
Q Consensus 210 --~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
....|+-+|+|||++.+..|++. .||||.|+++..|++|+.|+......... ....................+.
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~ 559 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR 559 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence 23467889999999999998885 89999999999999999776432211110 0000000000011112345788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 284 ELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 284 ~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
+.+.++..+|+.||.+|.|+.+|++
T Consensus 560 ~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 560 ETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hHHHHHHHHccCChhheecHHHHhh
Confidence 8999999999999999999999997
No 412
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.92 E-value=9.9e-24 Score=187.65 Aligned_cols=247 Identities=22% Similarity=0.262 Sum_probs=192.2
Q ss_pred ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCCc-cccccceeeeeCCeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRNR-RLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 134 (329)
+.+.+.+|.|+||.||++... ..+++|.+...... ....+.+|+..++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455667799999999999976 68999998876433 256789999999999888 799999999777778999999
Q ss_pred CCCCCHHhhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCC-CeeeecccCcccCCCC---
Q 020221 135 MPNDTLAKHLFHWET-QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRDG--- 209 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~--- 209 (329)
+.++++.+++..... ..++......++.|++.++.|+|.. +++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999977643111 2688999999999999999999999 999999999999999988 6999999998744332
Q ss_pred -------CCccCcccccCcccccC---CCCCCcccchhhhHHHHHHHhCCCCCCchhh----HHHhhhchhhhccccccC
Q 020221 210 -------RSYSTNLAFTPPEYLRT---GRVTPESVMYSFGTLLLDLLSGKHIPPSHAL----DLIRDRNIQTLTDSCLEG 275 (329)
Q Consensus 210 -------~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 275 (329)
....++..|+|||.+.+ .......|+||+|++++++++|..|+..... .......... ..+....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 237 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-PTPSLAS 237 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc-CCccccc
Confidence 34567899999999987 5788899999999999999999988544321 1111111111 1110011
Q ss_pred CCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 020221 276 QFS----SDEGTELVRLASRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 276 ~~~----~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~ 309 (329)
... ......+.+++..++..+|..|.+..+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111 1123678999999999999999998887764
No 413
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.91 E-value=5.8e-24 Score=174.90 Aligned_cols=140 Identities=15% Similarity=0.135 Sum_probs=109.1
Q ss_pred cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh---------H-----------------HHHHHHHHHHhcCCCccc
Q 020221 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD---------A-----------------RQFLEEARAVGQLRNRRL 115 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---------~-----------------~~~~~e~~~l~~l~h~ni 115 (329)
.+.||+|++|.||+|...+|+.||+|+++...... . ....+|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35679999999999997789999999997643210 0 112358999999988776
Q ss_pred cccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCccccccCCCceeeCCCCC
Q 020221 116 ANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYHDLNAYRIVFDDDVN 194 (329)
Q Consensus 116 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~ivH~dlkp~Nil~~~~~~ 194 (329)
........ ...+|||||++++++..... ....++..++..++.|++.+|.++ |+. |++||||||+||+++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEE-CCc
Confidence 44333222 23489999999877765432 345788999999999999999999 688 999999999999998 478
Q ss_pred eeeecccCcccCC
Q 020221 195 PRLSCFGLMKNSR 207 (329)
Q Consensus 195 ~kl~Dfg~a~~~~ 207 (329)
++|+|||++....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999987543
No 414
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.90 E-value=1.2e-23 Score=175.18 Aligned_cols=168 Identities=11% Similarity=0.038 Sum_probs=129.4
Q ss_pred cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHH---------HHHHHHHHhcCCCccccccceeeeeC---
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQ---------FLEEARAVGQLRNRRLANLLGCCCEG--- 125 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~~~--- 125 (329)
.|+.++.+|.|+||.||.... ++..+|+|.+.......... +.+|++.+.++.|++|..+..++...
T Consensus 32 ~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 32 NIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK 110 (232)
T ss_pred ceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence 466777889999999999766 46689999998654333222 57899999999999999998886533
Q ss_pred -----CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecc
Q 020221 126 -----DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (329)
Q Consensus 126 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Df 200 (329)
...+++|||++|.+|.++.. ++. ....+++.++..+|.. |++|+|+||+||+++.++ ++|+||
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC-EEEEEC
Confidence 35789999999999988642 232 2456999999999999 999999999999999888 999999
Q ss_pred cCcccCCCCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHH
Q 020221 201 GLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246 (329)
Q Consensus 201 g~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 246 (329)
|........... ..++....++.++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence 987655322111 11333445677999999999887554
No 415
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.89 E-value=1.2e-22 Score=167.61 Aligned_cols=141 Identities=15% Similarity=0.148 Sum_probs=111.2
Q ss_pred cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh---------------------h-----HHHHHHHHHHHhcCCCccc
Q 020221 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP---------------------D-----ARQFLEEARAVGQLRNRRL 115 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~ni 115 (329)
.+.||+|++|.||+|...+|+.||||+++..... . ...+.+|.+.+..+.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4567999999999999668999999998865311 0 1123578899999999987
Q ss_pred cccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCC
Q 020221 116 ANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVN 194 (329)
Q Consensus 116 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~ 194 (329)
.....+... ..++||||++++++..... ....++......++.|++.++.++|+ . |++||||||+||+++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhhEEEE-CCC
Confidence 554443322 3489999999876544322 33467788999999999999999999 8 999999999999999 889
Q ss_pred eeeecccCcccCCC
Q 020221 195 PRLSCFGLMKNSRD 208 (329)
Q Consensus 195 ~kl~Dfg~a~~~~~ 208 (329)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999976544
No 416
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.89 E-value=4e-24 Score=194.82 Aligned_cols=224 Identities=15% Similarity=0.170 Sum_probs=186.6
Q ss_pred CCCCCCcEEEEEE----eCCCCEEEEEEeCCCCChh--HHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCC
Q 020221 65 HGEKAPNVVYKGK----LENQFRIAVKRFNRSAWPD--ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 65 lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
+|+|.||.|+.+. .+.++.+|+|.+++..... ......|..++..++ ||.++++...++.+...++++++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 5999999999775 3457789999887643211 123456788888886 99999999999999999999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCccc
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLA 217 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 217 (329)
|.|...+. ....+.+.....+..+++-+++++|.. +++|||+|++||+++.+|++++.|||+++..-.....+||..
T Consensus 82 g~lft~l~--~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~e 158 (612)
T KOG0603|consen 82 GDLFTRLS--KEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYE 158 (612)
T ss_pred chhhhccc--cCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccCccccCCchhhhHhHhhhhcccchh
Confidence 99988775 456678888889999999999999999 999999999999999999999999999988776666699999
Q ss_pred ccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCC
Q 020221 218 FTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEP 297 (329)
Q Consensus 218 y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp 297 (329)
|||||++. .....+|.||||++.+||+||..||..+... .+.. .....|...+..+++++..++..+|
T Consensus 159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~--------~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMK--------RILK--AELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHH--------HHhh--hccCCchhhhHHHHHHHHHHHhhCH
Confidence 99999988 5677899999999999999999988752211 1111 1234678889999999999999999
Q ss_pred CCCCCH
Q 020221 298 RERPNP 303 (329)
Q Consensus 298 ~~Rps~ 303 (329)
..|.-.
T Consensus 227 ~nrLg~ 232 (612)
T KOG0603|consen 227 ENRLGA 232 (612)
T ss_pred HHHhcc
Confidence 999855
No 417
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.89 E-value=4.6e-23 Score=187.57 Aligned_cols=209 Identities=22% Similarity=0.331 Sum_probs=164.3
Q ss_pred HhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCc-cccccCCC
Q 020221 107 VGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA-LYHDLNAY 185 (329)
Q Consensus 107 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i-vH~dlkp~ 185 (329)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-....+++++.||.|||.. .| .|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNS-PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcC-cceeeeeeccc
Confidence 4578999999999999999999999999999999999975 567889999999999999999999998 55 89999999
Q ss_pred ceeeCCCCCeeeecccCcccCCCC------CCccCcccccCcccccCCC-------CCCcccchhhhHHHHHHHhCCCCC
Q 020221 186 RIVFDDDVNPRLSCFGLMKNSRDG------RSYSTNLAFTPPEYLRTGR-------VTPESVMYSFGTLLLDLLSGKHIP 252 (329)
Q Consensus 186 Nil~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~il~el~tg~~~~ 252 (329)
|.++|....+||+|||+....... .......-|.|||.+.+.. .+.+.|+||||++++|+++++.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998766431 1112235699999988642 456799999999999999999988
Q ss_pred CchhhHHHhhhchhhh---ccccccCCCC-h-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 020221 253 PSHALDLIRDRNIQTL---TDSCLEGQFS-S-DEGTELVRLASRCLQYEPRERPNPRSLVTALVTLQKDT 317 (329)
Q Consensus 253 ~~~~~~~~~~~~~~~~---~~~~~~~~~~-~-~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~~~ 317 (329)
...............+ ..+..++... . +.++++..++..||..+|+.||++.++-..++.+.+..
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 6532211111111111 1111222211 1 44568999999999999999999999999999998754
No 418
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.88 E-value=1.9e-23 Score=199.82 Aligned_cols=242 Identities=16% Similarity=0.175 Sum_probs=177.9
Q ss_pred cccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCC-ChhHHHHHHHHHH--HhcCCCccccccceeeeeCCeeEEEEec
Q 020221 58 MENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA-WPDARQFLEEARA--VGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
++...+.+|.+.|=.|.+|+.+.|. |+||++-+.. .-..+.+.++++. ...+++||.+.+.-+-......|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4556677899999999999988885 9999986654 2234444443333 4556899999998887777788999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCC----
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGR---- 210 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---- 210 (329)
..+ +|.|.+. .+.-+...+..-|+.|++.||..+|.. ||+|+|||.+|||++..+=+.|+||...+...-..
T Consensus 103 vkh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 866 8999884 334456778888999999999999999 99999999999999999999999998766432111
Q ss_pred -------CccCcccccCcccccCC----------C-CCCcccchhhhHHHHHHHhCCCCCCchh-hHHHhhh---chhhh
Q 020221 211 -------SYSTNLAFTPPEYLRTG----------R-VTPESVMYSFGTLLLDLLSGKHIPPSHA-LDLIRDR---NIQTL 268 (329)
Q Consensus 211 -------~~~~~~~y~aPE~~~~~----------~-~~~~~DvwslG~il~el~tg~~~~~~~~-~~~~~~~---~~~~~ 268 (329)
+...-..|.|||-+... . .+++.||||+||++.||++-+.|.+.-. .-..+.+ .....
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 11223579999977531 2 6678999999999999999765543221 1111111 11111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 269 TDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
++. ++ ...++.++..|++.||++|.+|++.|+.-..
T Consensus 259 Le~-----Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 259 LEK-----IE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HHh-----Cc---CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 111 11 2368899999999999999999999987443
No 419
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.87 E-value=5.2e-22 Score=171.78 Aligned_cols=194 Identities=15% Similarity=0.145 Sum_probs=145.5
Q ss_pred CCccccccceeeee---------------------------CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHH
Q 020221 111 RNRRLANLLGCCCE---------------------------GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALH 163 (329)
Q Consensus 111 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~ 163 (329)
+|||||++.++|.+ +..+|+||..++. +|..++ ..+..+......++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl---~~~~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYL---WTRHRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHH---hcCCCchHHHHHHHHH
Confidence 59999999988754 2347899998866 899999 4456677778889999
Q ss_pred HHHHHHHhhcCCCccccccCCCceeeC--CCC--CeeeecccCcccCCC----------CCCccCcccccCcccccCCC-
Q 020221 164 IAEALEYCTSKERALYHDLNAYRIVFD--DDV--NPRLSCFGLMKNSRD----------GRSYSTNLAFTPPEYLRTGR- 228 (329)
Q Consensus 164 i~~~l~~lH~~~~ivH~dlkp~Nil~~--~~~--~~kl~Dfg~a~~~~~----------~~~~~~~~~y~aPE~~~~~~- 228 (329)
+++|+.|||.. |+.|||+|.+|||+. +++ .+.++|||++--... .....|.-..||||+....+
T Consensus 350 lLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 350 LLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 99999999999 999999999999993 444 478999998643221 12334667789999886332
Q ss_pred -----CCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 020221 229 -----VTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNP 303 (329)
Q Consensus 229 -----~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~ 303 (329)
--.++|.|+.|.+.||+++...||+........... ....-.+..++.+++.+++++...|+.||.+|++.
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~----Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT----YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 234899999999999999999988752111111111 11112234567788999999999999999999998
Q ss_pred HHHHHHHHhh
Q 020221 304 RSLVTALVTL 313 (329)
Q Consensus 304 ~~~l~~L~~~ 313 (329)
.-+.+.|+-.
T Consensus 505 ~iAANvl~Ls 514 (598)
T KOG4158|consen 505 NIAANVLNLS 514 (598)
T ss_pred cHHHhHHHHH
Confidence 8777766543
No 420
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.87 E-value=1.4e-22 Score=173.92 Aligned_cols=227 Identities=20% Similarity=0.188 Sum_probs=144.9
Q ss_pred cccCCCCCCcEEEEEEe-CCCCEEEEEEeCCCCCh---hHHHHHHHHHHHhcCCC----------ccccccceeee----
Q 020221 62 VSEHGEKAPNVVYKGKL-ENQFRIAVKRFNRSAWP---DARQFLEEARAVGQLRN----------RRLANLLGCCC---- 123 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h----------~niv~~~~~~~---- 123 (329)
.+.||.|+++.||.++. .+++.+|+|++...... ..+++.+|......+.+ -.++.-++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 34579999999999994 56899999998654422 35566777665555432 12222222211
Q ss_pred -----eCC--------eeEEEEecCCCCCHHhhhcc---CCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCC
Q 020221 124 -----EGD--------ERLLVAEYMPNDTLAKHLFH---WET--QPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAY 185 (329)
Q Consensus 124 -----~~~--------~~~lv~e~~~~gsL~~~l~~---~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~ 185 (329)
... +.+++|+-+.+ +|.+++.- ... ..+....+..+..|+++.+++||+. |++|+||+|+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi~~~ 174 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGDIKPE 174 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGG
T ss_pred CcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEeccccee
Confidence 111 34678887744 88877531 111 1233455677779999999999999 9999999999
Q ss_pred ceeeCCCCCeeeecccCcccCCCCCC-ccCcccccCcccccC--------CCCCCcccchhhhHHHHHHHhCCCCCCchh
Q 020221 186 RIVFDDDVNPRLSCFGLMKNSRDGRS-YSTNLAFTPPEYLRT--------GRVTPESVMYSFGTLLLDLLSGKHIPPSHA 256 (329)
Q Consensus 186 Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~~~~~~~ 256 (329)
|++++.+|.+.|+||+.......... ...+..|.+||.... ..++.+.|.|+||+++|.|+++..|+....
T Consensus 175 nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~ 254 (288)
T PF14531_consen 175 NFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSS 254 (288)
T ss_dssp GEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCG
T ss_pred eEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCC
Confidence 99999999999999998765544333 344577999997643 237889999999999999999998875432
Q ss_pred hHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCC
Q 020221 257 LDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRER 300 (329)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 300 (329)
....... . . ..+. +.|+.++.||..+|+.||++|
T Consensus 255 ~~~~~~~----~----f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 255 PEADPEW----D----F-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GGSTSGG----G----G-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccccccc----c----c-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 1111111 1 1 1233 788999999999999999988
No 421
>PRK10345 hypothetical protein; Provisional
Probab=99.86 E-value=5.4e-21 Score=158.78 Aligned_cols=133 Identities=14% Similarity=0.104 Sum_probs=104.1
Q ss_pred ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-----CCccccccceeeeeCC---e-eEEEEe
Q 020221 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-----RNRRLANLLGCCCEGD---E-RLLVAE 133 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~-~~lv~e 133 (329)
..||+|+||.||. ...++. .+||++........+.+.+|++.++.+ +||||++++|++.+.. . +.+|+|
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 3459999999996 323343 479998776544567799999999999 5799999999998763 3 337899
Q ss_pred c--CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCccccccCCCceeeCC----CCCeeeecccCc
Q 020221 134 Y--MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEAL-EYCTSKERALYHDLNAYRIVFDD----DVNPRLSCFGLM 203 (329)
Q Consensus 134 ~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~ivH~dlkp~Nil~~~----~~~~kl~Dfg~a 203 (329)
| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+. +|+||||||+|||++. +..++|+||+.+
T Consensus 86 ~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 86 FDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9 557999999953 345555 35678888887 999999 9999999999999973 347999995543
No 422
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.85 E-value=7.4e-21 Score=155.35 Aligned_cols=177 Identities=15% Similarity=0.093 Sum_probs=133.1
Q ss_pred ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh----HHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCC
Q 020221 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD----ARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
..+++|+||+||.+.. .+.+++.+.+.....-. ...+.+|+++|+.+. |+++++++++ +..+++|||+.|
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 4569999999997776 56688888877655421 124789999999995 5889998886 346999999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcccccc-CCCceeeCCCCCeeeecccCcccCCCCCCc----
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDL-NAYRIVFDDDVNPRLSCFGLMKNSRDGRSY---- 212 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl-kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~---- 212 (329)
.+|...+. . ....++.|++.+|.++|+. |++|||| ||+|||++.++.++|+|||++.........
T Consensus 83 ~~L~~~~~---~------~~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 83 AAMYQRPP---R------GDLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred ccHHhhhh---h------hhHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 88865431 1 1135778999999999999 9999999 799999999999999999999865543311
Q ss_pred -------------cCcccccCcccccCC-CCC-CcccchhhhHHHHHHHhCCCCCCc
Q 020221 213 -------------STNLAFTPPEYLRTG-RVT-PESVMYSFGTLLLDLLSGKHIPPS 254 (329)
Q Consensus 213 -------------~~~~~y~aPE~~~~~-~~~-~~~DvwslG~il~el~tg~~~~~~ 254 (329)
..++.|+.|+...-. ..+ ...+.++-|..+|.++|++.+...
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 124556666533221 222 456888999999999999976543
No 423
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.85 E-value=4.7e-21 Score=186.08 Aligned_cols=240 Identities=17% Similarity=0.136 Sum_probs=173.0
Q ss_pred ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEEEEecC
Q 020221 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
+.+-+.+|+|+||+||.|...+|+.||+|+-+....-. |---.+++.+|+ -+.|..+..++.-.+.-++|+||.
T Consensus 700 ~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~ 776 (974)
T KOG1166|consen 700 FCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS 776 (974)
T ss_pred EEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence 44567789999999999997779999999987655322 111123333443 344555666666667789999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC-------CCCCeeeecccCccc---
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD-------DDVNPRLSCFGLMKN--- 205 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~-------~~~~~kl~Dfg~a~~--- 205 (329)
+.|||.+++. ..+.+++.....++.||+..++.||.. +|||+||||+|+++. +...++|+|||.+..
T Consensus 777 ~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 777 PYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred ccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 9999999995 667789999999999999999999999 999999999999993 345699999998854
Q ss_pred CCCCCC---ccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHH
Q 020221 206 SRDGRS---YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEG 282 (329)
Q Consensus 206 ~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (329)
+.++.. ..+|-.+-.+|+..|..++.++|.|+|+.+++.|+.|+..- ..++....+... ++..+..+
T Consensus 854 fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------~~~g~~~~~~~~-~~Ry~~~~-- 923 (974)
T KOG1166|consen 854 FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------VKNGSSWMVKTN-FPRYWKRD-- 923 (974)
T ss_pred cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------hcCCcceecccc-chhhhhHH--
Confidence 334422 34578899999999999999999999999999999998321 111111111111 11112222
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 020221 283 TELVRLASRCLQYEPRERPNPRSLVTALVTLQK 315 (329)
Q Consensus 283 ~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~~~ 315 (329)
-+-++...+|+.|-..=|...++...|+....
T Consensus 924 -~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 924 -MWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred -HHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 34455666666555555777777777776543
No 424
>smart00090 RIO RIO-like kinase.
Probab=99.83 E-value=8.9e-20 Score=155.08 Aligned_cols=142 Identities=15% Similarity=0.102 Sum_probs=109.7
Q ss_pred cccccccCCCCCCcEEEEEE--eCCCCEEEEEEeCCCCCh-------------------h-----HHHHHHHHHHHhcCC
Q 020221 58 MENIVSEHGEKAPNVVYKGK--LENQFRIAVKRFNRSAWP-------------------D-----ARQFLEEARAVGQLR 111 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~-------------------~-----~~~~~~e~~~l~~l~ 111 (329)
.+.+.+.||+|++|.||+|. ..+|+.||+|+++..... . ...+.+|++.+..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45667778999999999998 568999999998754311 0 122567999999997
Q ss_pred Ccc--ccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-ccccccCCCcee
Q 020221 112 NRR--LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKER-ALYHDLNAYRIV 188 (329)
Q Consensus 112 h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-ivH~dlkp~Nil 188 (329)
+.+ +.+.++. ...++||||+++++|..... ....+.......++.|++.++.+||.. | ++|+||||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCChhhEE
Confidence 533 3333332 23589999999988876543 233456667789999999999999999 8 999999999999
Q ss_pred eCCCCCeeeecccCcccCC
Q 020221 189 FDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 189 ~~~~~~~kl~Dfg~a~~~~ 207 (329)
++ ++.++|+|||.+....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999987543
No 425
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.82 E-value=2.6e-19 Score=150.37 Aligned_cols=134 Identities=16% Similarity=0.168 Sum_probs=111.9
Q ss_pred ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh--------HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD--------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
+.||+|++|.||+|.. ++..+++|+........ ...+.+|+.++..+.|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4579999999999987 55679999866432211 23467899999999999988877777777888999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
++|++|.+.+.. ..+ ....++.+++.+|.++|.. +++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~-----~~~-~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS-----NGM-EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh-----ccH-HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998853 112 7889999999999999999 999999999999999 78999999998764
No 426
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.81 E-value=1.8e-20 Score=168.00 Aligned_cols=168 Identities=23% Similarity=0.349 Sum_probs=126.6
Q ss_pred eeEEEEecCCCCCHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221 127 ERLLVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
.++|.|++|...+|.+++.++ .....++...+.++.|++.|+.| + +.+|+|+||.||++..+..+||+|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccchhhhhhhhhheee
Confidence 578999999999999999743 34556888999999999999999 7 899999999999999999999999999875
Q ss_pred CCCCC----------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccC
Q 020221 206 SRDGR----------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEG 275 (329)
Q Consensus 206 ~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (329)
..... ...||..||+||.+.+..|+.++||||||++|+||++-- .-. .........+.+..+.+
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f---~T~---~er~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQF---STQ---FERIATLTDIRDGIIPP 479 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHh---ccH---HHHHHhhhhhhcCCCCh
Confidence 54433 346899999999999999999999999999999999721 100 01111122222222111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 020221 276 QFSSDEGTELVRLASRCLQYEPRERPNPRS 305 (329)
Q Consensus 276 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~~ 305 (329)
.+..+ -+.-..|+.+++...|.+||++.+
T Consensus 480 ~~~~d-~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 480 EFLQD-YPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHhhc-CcHHHHHHHHhcCCCcccCchHHH
Confidence 11111 123457999999999999994433
No 427
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.81 E-value=4.7e-20 Score=176.57 Aligned_cols=201 Identities=18% Similarity=0.179 Sum_probs=144.4
Q ss_pred ccccccCCCCCCcEEEEEEeC-CCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCC
Q 020221 59 ENIVSEHGEKAPNVVYKGKLE-NQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPN 137 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 137 (329)
++.|+.+..|+||-||..+++ +.+++|+|+ ++.. -+.+. ++.....| +.|
T Consensus 85 f~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~np---------------fvv------ 135 (1205)
T KOG0606|consen 85 FNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNP---------------FVV------ 135 (1205)
T ss_pred cceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCc---------------cee------
Confidence 445666699999999999854 567899944 3221 11111 22222222 222
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCC----------
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR---------- 207 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~---------- 207 (329)
|+=...+. ....++. +++.+++|||+. ||+|||+||+|.+|+.-|++|++|||+.+..-
T Consensus 136 gDc~tllk--~~g~lPv--------dmvla~Eylh~y-givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg 204 (1205)
T KOG0606|consen 136 GDCATLLK--NIGPLPV--------DMVLAVEYLHSY-GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG 204 (1205)
T ss_pred chhhhhcc--cCCCCcc--------hhhHHhHhhccC-CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence 23333343 2233443 237899999999 99999999999999999999999999976321
Q ss_pred ---------CCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221 208 ---------DGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (329)
Q Consensus 208 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (329)
......||+.|+|||++....|...+|+|++|+|+||.+.|..||..+.-+.+....+...+.- .+-.
T Consensus 205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w---pE~d 281 (1205)
T KOG0606|consen 205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW---PEED 281 (1205)
T ss_pred chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc---cccC
Confidence 1123478999999999999999999999999999999999999999887666665555444321 1123
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCC
Q 020221 279 SDEGTELVRLASRCLQYEPRERPN 302 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps 302 (329)
...++++++++.++|..+|..|.-
T Consensus 282 ea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 282 EALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred cCCCHHHHHHHHHHHHhChHhhcc
Confidence 445789999999999999999963
No 428
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.79 E-value=3.9e-19 Score=147.92 Aligned_cols=129 Identities=18% Similarity=0.208 Sum_probs=105.3
Q ss_pred CCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh--------hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCC
Q 020221 65 HGEKAPNVVYKGKLENQFRIAVKRFNRSAWP--------DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 65 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 136 (329)
||+|+||.||++.+ ++..+++|........ ....+.+|++++..++|+++.....++......+++|||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 69999999999996 4568999986543211 12456789999999998876665555666677899999999
Q ss_pred CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221 137 NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 137 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
|++|.+.+... .. .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~---~~------~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEG---ND------ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhc---HH------HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999887421 11 7899999999999999 999999999999999 89999999999865
No 429
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.78 E-value=1.7e-18 Score=143.89 Aligned_cols=137 Identities=17% Similarity=0.127 Sum_probs=106.5
Q ss_pred ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh----------------------hHHHHHHHHHHHhcCCCcc--
Q 020221 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP----------------------DARQFLEEARAVGQLRNRR-- 114 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n-- 114 (329)
+.+.+.||.|+||.||++...+|+.||||+++..... .......|...+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 4556678999999999999878999999987653211 0112567888888887774
Q ss_pred ccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC
Q 020221 115 LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (329)
Q Consensus 115 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~ 194 (329)
+...++ ....+++|||+++++|..... ......++.+++.++.++|.. |++|+||||+||++++++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKH-GIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHC-CCCcCCCCcccEEEcCCCc
Confidence 333333 245689999999998876542 034567889999999999999 9999999999999999999
Q ss_pred eeeecccCcccCCC
Q 020221 195 PRLSCFGLMKNSRD 208 (329)
Q Consensus 195 ~kl~Dfg~a~~~~~ 208 (329)
++|+|||.+.....
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999865443
No 430
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.78 E-value=2e-18 Score=164.24 Aligned_cols=132 Identities=18% Similarity=0.162 Sum_probs=106.9
Q ss_pred ccccCCCCCCcEEEEEEeCCCCEEEEEE-eCCC-CC------hhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEE
Q 020221 61 IVSEHGEKAPNVVYKGKLENQFRIAVKR-FNRS-AW------PDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~-~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 132 (329)
..+.||+|+||+||++.+.+.. +++|+ +... .. ...+.+.+|+++++.++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3456799999999999875543 44443 2221 11 11245788999999999999988777777777889999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
||+++++|.+++. ....++.+++.+|.+||+. +++|||+||+||++ .++.++|+|||+++.
T Consensus 416 E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 416 EYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999873 4567899999999999999 99999999999999 678999999999865
No 431
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.75 E-value=2.5e-19 Score=170.37 Aligned_cols=248 Identities=13% Similarity=0.117 Sum_probs=187.7
Q ss_pred CcccccccCCCCCCcEEEEEEe--CCCCEEEEEEeCCCC--ChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEE
Q 020221 57 AMENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSA--WPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLV 131 (329)
Q Consensus 57 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 131 (329)
..+++++.+|+|+|+.|-.... +....+|+|.+.... .........|..+-..+. |+|++.+++....+...+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4466777789999999988874 334557777665543 222334455777777776 99999999999999999999
Q ss_pred EecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCccccccCCCceeeCCCC-CeeeecccCcccCCC-
Q 020221 132 AEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT-SKERALYHDLNAYRIVFDDDV-NPRLSCFGLMKNSRD- 208 (329)
Q Consensus 132 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~- 208 (329)
.+|..++++.+-+........+....-.++.|+..++.|+| .. ++.|+|+||+|.+++..+ .++++|||+|.....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999988773212225667778899999999999999 77 999999999999999999 999999999987666
Q ss_pred CC------CccC-cccccCcccccCC-CCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccc--cCCCC
Q 020221 209 GR------SYST-NLAFTPPEYLRTG-RVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCL--EGQFS 278 (329)
Q Consensus 209 ~~------~~~~-~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 278 (329)
.. ...| ++.|+|||...+. ......|+||.|+++..+++|..|+....... ........... .....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 255 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNKGRFTQLPW 255 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeecccccccccCcc
Confidence 21 2356 8999999999885 45668999999999999999998764432211 11111111111 11223
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 279 SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
...+....+++..++..+|+.|.+.+++..
T Consensus 256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 256 NSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccCChhhhhcccccccCCchhccccccccc
Confidence 455677889999999999999999888765
No 432
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.73 E-value=1.2e-17 Score=132.01 Aligned_cols=134 Identities=15% Similarity=0.041 Sum_probs=111.7
Q ss_pred cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC--ccccccceeeeeCCeeEEEEecCCCCC
Q 020221 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN--RRLANLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
++.+|.|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||+.+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4567999999999999755 6899999876543 4568889999999976 588888888877788999999998876
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC--CCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK--ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
+..+ +......++.+++.+++++|.. .+++|+|++|+||+++..+.++++|||.+....
T Consensus 80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 6442 5567778899999999999984 269999999999999998999999999886543
No 433
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.72 E-value=6.7e-17 Score=133.03 Aligned_cols=137 Identities=15% Similarity=0.141 Sum_probs=95.9
Q ss_pred ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhH--HHH----------------------HHHHHHHhcCCCcc--cc
Q 020221 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA--RQF----------------------LEEARAVGQLRNRR--LA 116 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~----------------------~~e~~~l~~l~h~n--iv 116 (329)
+.||+|+||.||++...+++.||||+++....... ..+ ..|.+.+..+.+.+ +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 45799999999999977889999999876432211 111 23444555543322 33
Q ss_pred ccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCccccccCCCceeeCCCCCe
Q 020221 117 NLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTS-KERALYHDLNAYRIVFDDDVNP 195 (329)
Q Consensus 117 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~Nil~~~~~~~ 195 (329)
+.++. ...+++|||++++++..... ...... ..+..++.+++.++.++|. . +++|+||||+||+++ ++.+
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l--~~~~~~-~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRL--KDVRLL-EDPEELYDQILELMRKLYREA-GLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhh--hhhhhc-ccHHHHHHHHHHHHHHHhhcc-CcCcCCCChhhEEEE-CCcE
Confidence 33322 34689999999854332111 000111 5678899999999999999 7 999999999999999 8999
Q ss_pred eeecccCcccCCC
Q 020221 196 RLSCFGLMKNSRD 208 (329)
Q Consensus 196 kl~Dfg~a~~~~~ 208 (329)
+++|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999999865443
No 434
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.71 E-value=1.7e-16 Score=135.21 Aligned_cols=133 Identities=17% Similarity=0.147 Sum_probs=101.1
Q ss_pred CC-CCCCcEEEEEEeCCCCEEEEEEeCCCCC-------------hhHHHHHHHHHHHhcCCCccc--cccceeeeeC-C-
Q 020221 65 HG-EKAPNVVYKGKLENQFRIAVKRFNRSAW-------------PDARQFLEEARAVGQLRNRRL--ANLLGCCCEG-D- 126 (329)
Q Consensus 65 lg-~G~~g~V~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~-~- 126 (329)
+| .|+.|+||.+... +..+++|.+..... .....+.+|++.+..++|+++ +..+++.... .
T Consensus 39 lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~ 117 (239)
T PRK01723 39 VGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGL 117 (239)
T ss_pred eecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCc
Confidence 35 6777889988875 55899998854221 112357889999999998875 5666654332 2
Q ss_pred --eeEEEEecCCC-CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221 127 --ERLLVAEYMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (329)
Q Consensus 127 --~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 203 (329)
..++|+|++++ .+|.+++.+ ..++.. .+.+++.+|.+||+. ||+|+||||.|||++.++.++|+|||.+
T Consensus 118 ~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 118 FYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA-GVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 23599999997 689888742 345543 357899999999999 9999999999999999899999999988
Q ss_pred ccC
Q 020221 204 KNS 206 (329)
Q Consensus 204 ~~~ 206 (329)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 754
No 435
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.58 E-value=8.1e-15 Score=135.44 Aligned_cols=140 Identities=17% Similarity=0.142 Sum_probs=97.2
Q ss_pred cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHH----------------------------------------HHHHH
Q 020221 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDAR----------------------------------------QFLEE 103 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~e 103 (329)
.+|.|++|.||+|+..+|+.||||+.+........ ++.+|
T Consensus 124 plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~E 203 (437)
T TIGR01982 124 PLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRRE 203 (437)
T ss_pred ceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHH
Confidence 46999999999999889999999998764211100 13334
Q ss_pred HHHHhcC----CCccccccceeee-eCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHH-HHHHhhcCCCc
Q 020221 104 ARAVGQL----RNRRLANLLGCCC-EGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE-ALEYCTSKERA 177 (329)
Q Consensus 104 ~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~-~l~~lH~~~~i 177 (329)
.+.+..+ +|.+-+.+-..+. ..+..++||||++|++|.+.... .....+ ...++..++. .+..+|.. |+
T Consensus 204 a~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~-~~~~~~---~~~ia~~~~~~~l~ql~~~-g~ 278 (437)
T TIGR01982 204 AANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAAL-DEAGLD---RKALAENLARSFLNQVLRD-GF 278 (437)
T ss_pred HHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHH-HhcCCC---HHHHHHHHHHHHHHHHHhC-Cc
Confidence 4444443 2333333333332 23457899999999999887642 111222 3456666665 46788998 99
Q ss_pred cccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (329)
Q Consensus 178 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 208 (329)
+|+|+||.||+++.++.++++|||++....+
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999876543
No 436
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.57 E-value=4.9e-15 Score=135.58 Aligned_cols=239 Identities=20% Similarity=0.242 Sum_probs=178.8
Q ss_pred ccccCCC--CCCcEEEEEEe---CCCCEEEEEEeCCCCC--hhHHHHHHHHHHHhcC-CCccccccceeeeeCCeeEEEE
Q 020221 61 IVSEHGE--KAPNVVYKGKL---ENQFRIAVKRFNRSAW--PDARQFLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 61 ~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+.+.+|. |.+|.||.+.. .++..+|+|+-+.... .....-.+|+...+.+ .|+|.++....+...+..++-+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 4456688 99999999975 4577899998554432 2222335677777777 5999999999999999999999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCC
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAE----ALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSR 207 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~----~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~ 207 (329)
|++. .+|..+... ....++...++.+..+... ||.++|.. +++|-|+||.||++..+ ...+++|||+...+.
T Consensus 198 E~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 198 ELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS 274 (524)
T ss_pred cccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccceeecCCcceeEEcc
Confidence 9996 578887753 3344677788888888888 99999999 99999999999999988 889999999988766
Q ss_pred CCC---------CccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCC
Q 020221 208 DGR---------SYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFS 278 (329)
Q Consensus 208 ~~~---------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (329)
++. ...+...|++||+.. +.++...|+|++|.+..+-.++..++..+....+ ..........++.
T Consensus 275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-----~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 275 DGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-----SQLRQGYIPLEFC 348 (524)
T ss_pred CCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCc-----cccccccCchhhh
Confidence 553 114567899999877 5678899999999999999998876644311111 1111111112223
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 020221 279 SDEGTELVRLASRCLQYEPRERPNPRSLVT 308 (329)
Q Consensus 279 ~~~~~~~~~li~~cl~~dp~~Rps~~~~l~ 308 (329)
..-+.++...+.++++.+|-.|++++.+.+
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 333556667999999999999999877664
No 437
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.53 E-value=2.4e-14 Score=121.87 Aligned_cols=201 Identities=18% Similarity=0.209 Sum_probs=140.4
Q ss_pred HHHHhcCCCccccccceeeeeC-----CeeEEEEecCCCCCHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcC-C
Q 020221 104 ARAVGQLRNRRLANLLGCCCEG-----DERLLVAEYMPNDTLAKHLFHW--ETQPMKWAMRLRVALHIAEALEYCTSK-E 175 (329)
Q Consensus 104 ~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ 175 (329)
+..|-.+-|.|||++..|+.+. ....++.||+..|+|..+|++. ....+......+|..||+.||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 3445556799999999998653 3578999999999999999753 345677888899999999999999985 4
Q ss_pred CccccccCCCceeeCCCCCeeeecccCcccCCC---------CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHH
Q 020221 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD---------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246 (329)
Q Consensus 176 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 246 (329)
.|+|+++..+.|++..+|-+|++---. ..... .....+.++|.|||.-.....+..+|||+||+..++|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 689999999999999888888764221 11111 01123458899999877667788999999999999998
Q ss_pred hCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 020221 247 SGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVTL 313 (329)
Q Consensus 247 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~~ 313 (329)
.+..-+................+-.. ....-+.++..|+.-.|..||+|++++-+.-.+
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~l--------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIGL--------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred HheeccCCCcceeehhhhhhhheeec--------cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 87743221111111111111111100 011123578999999999999999998754433
No 438
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.48 E-value=5.2e-14 Score=131.76 Aligned_cols=137 Identities=13% Similarity=0.088 Sum_probs=90.2
Q ss_pred ccCCCCCCcEEEEEEeCC-CCEEEEEEeCCCCChh----------------------------------HHH------HH
Q 020221 63 SEHGEKAPNVVYKGKLEN-QFRIAVKRFNRSAWPD----------------------------------ARQ------FL 101 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~------~~ 101 (329)
+.+|.|++|.||+|+..+ |+.||||+.+..-... .+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 467999999999999766 9999999998642110 011 23
Q ss_pred HHHHHHhcC----CCccccccceeeee-CCeeEEEEecCCCCCHHhhhccCCCCC-----CCHHHHHHHHHHHHHHHHHh
Q 020221 102 EEARAVGQL----RNRRLANLLGCCCE-GDERLLVAEYMPNDTLAKHLFHWETQP-----MKWAMRLRVALHIAEALEYC 171 (329)
Q Consensus 102 ~e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~i~~~i~~~l~~l 171 (329)
+|...+.++ .+.+.+.+-.++.+ .+..+|||||++|+.+.+...- .... +....+..++.|+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Qif------ 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQVF------ 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHHHH------
Confidence 333333333 23333443333332 3466799999999999874211 1122 33334444455544
Q ss_pred hcCCCccccccCCCceeeCCCC----CeeeecccCcccCCC
Q 020221 172 TSKERALYHDLNAYRIVFDDDV----NPRLSCFGLMKNSRD 208 (329)
Q Consensus 172 H~~~~ivH~dlkp~Nil~~~~~----~~kl~Dfg~a~~~~~ 208 (329)
.. |++|+|+||.||+++.++ .++++|||++.....
T Consensus 278 -~~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -RD-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -hC-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 45 999999999999999888 899999999876544
No 439
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.47 E-value=8.3e-14 Score=127.58 Aligned_cols=243 Identities=16% Similarity=0.110 Sum_probs=178.5
Q ss_pred cccccccCCCCCCcEEEEEEe--CCCCEEEEEEeCCCCChhHHH--HHHHHHHHhcC-CCccccccceeeeeCCeeEEEE
Q 020221 58 MENIVSEHGEKAPNVVYKGKL--ENQFRIAVKRFNRSAWPDARQ--FLEEARAVGQL-RNRRLANLLGCCCEGDERLLVA 132 (329)
Q Consensus 58 ~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 132 (329)
+...+..||.|.|+.|+.... .++..+++|.+.........+ -..|+.+...+ .|.+++.....+..-...++-.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 345677889999999999873 467889999887765443333 35677777776 5888898888777777888999
Q ss_pred ecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC-CCeeeecccCcccCCC--C
Q 020221 133 EYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD-VNPRLSCFGLMKNSRD--G 209 (329)
Q Consensus 133 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~--~ 209 (329)
|||.++++...+. ....+.+...+++..|++.++.++|++ .++|+|+||+||++..+ +..+++|||......- .
T Consensus 346 e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 346 EFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred hhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhccccccccccceecc
Confidence 9999998877653 445677888999999999999999999 99999999999999876 7889999999864221 1
Q ss_pred CCccCcccc-cCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHH
Q 020221 210 RSYSTNLAF-TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRL 288 (329)
Q Consensus 210 ~~~~~~~~y-~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (329)
.....+..| .++.......+..++|++|||..+.+.+++....+... ....+... ..... .....+++.+
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~~i~~~-~~p~~-~~~~~~~q~~ 493 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSLTIRSG-DTPNL-PGLKLQLQVL 493 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCcccc-------cceeeecc-cccCC-CchHHhhhhh
Confidence 122233334 35555556668899999999999999999996543321 11111111 11112 2233788889
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHh
Q 020221 289 ASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 289 i~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
.+-+...|+..||.+.++..+.+.
T Consensus 494 ~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 494 LKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhcCCccccchhhhhhcccchh
Confidence 999999999999999888765443
No 440
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.47 E-value=2.8e-13 Score=109.54 Aligned_cols=127 Identities=15% Similarity=0.061 Sum_probs=94.4
Q ss_pred ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccc-ccceeeeeCCeeEEEEecCCCCCHH
Q 020221 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLA-NLLGCCCEGDERLLVAEYMPNDTLA 141 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (329)
+.++.|.++.||++... +..+++|....... ....+.+|+.+++.+.+.+++ +++.. .....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence 45688999999999875 66899999765432 123467889999988655544 34433 234468999999998765
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCc-----cccccCCCceeeCCCCCeeeecccCccc
Q 020221 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERA-----LYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i-----vH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
... . ....++.+++.+|+.||.. ++ +|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~-------~---~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-------F---SDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-------c---cCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 420 1 1134568999999999998 64 9999999999999 67899999998753
No 441
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.46 E-value=1.4e-12 Score=121.01 Aligned_cols=163 Identities=15% Similarity=0.136 Sum_probs=128.0
Q ss_pred eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHH
Q 020221 78 LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMR 157 (329)
Q Consensus 78 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 157 (329)
..++.+|.|...............+.++.|+.++||||++++..+...+..|||+|-+. -|..++.+ +.....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHH
Confidence 56778899998887665334557788999999999999999999999999999999975 47777753 335667
Q ss_pred HHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCC----ccCcccccCcccccCCCCCCcc
Q 020221 158 LRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----YSTNLAFTPPEYLRTGRVTPES 233 (329)
Q Consensus 158 ~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~ 233 (329)
...+.||+.||.|||.+.+++|++|.-+-|++++.|..||++|-++........ ...-..|..|+.+.... -..
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cch
Confidence 778899999999999766999999999999999999999999988765443331 11123355665443222 246
Q ss_pred cchhhhHHHHHHHhCC
Q 020221 234 VMYSFGTLLLDLLSGK 249 (329)
Q Consensus 234 DvwslG~il~el~tg~ 249 (329)
|.|.||+++++++.|.
T Consensus 185 D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhhHHHHHHHHhCcc
Confidence 9999999999999994
No 442
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.42 E-value=4.7e-12 Score=103.55 Aligned_cols=136 Identities=10% Similarity=0.118 Sum_probs=98.1
Q ss_pred ccCCCCCCcEEEEEEeCC-------CCEEEEEEeCCCC---------------------Chh-HHH----HHHHHHHHhc
Q 020221 63 SEHGEKAPNVVYKGKLEN-------QFRIAVKRFNRSA---------------------WPD-ARQ----FLEEARAVGQ 109 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~---------------------~~~-~~~----~~~e~~~l~~ 109 (329)
..||.|--+.||.|...+ +..+|||+.+... ..+ .+. ..+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 456999999999998432 4789999874311 011 112 2379999998
Q ss_pred CC--CccccccceeeeeCCeeEEEEecCCCCCHHh-hhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCccccccCCC
Q 020221 110 LR--NRRLANLLGCCCEGDERLLVAEYMPNDTLAK-HLFHWETQPMKWAMRLRVALHIAEALEYC-TSKERALYHDLNAY 185 (329)
Q Consensus 110 l~--h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~ivH~dlkp~ 185 (329)
+. .-++.+.+++ ...+|||||+.+..+.. .+ ....++..+...+..+++.+|..+ |.. |++|+||++.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~-glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKEC-NLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHH
Confidence 84 3456666654 46789999997653322 22 223455566778889999999999 787 9999999999
Q ss_pred ceeeCCCCCeeeecccCcccCC
Q 020221 186 RIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 186 Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
||+++ ++.+.|+|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4789999999876554
No 443
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=99.33 E-value=3.3e-11 Score=108.82 Aligned_cols=215 Identities=17% Similarity=0.155 Sum_probs=150.6
Q ss_pred CCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeee----CCeeEEEEecCCC-CCHHh
Q 020221 69 APNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCE----GDERLLVAEYMPN-DTLAK 142 (329)
Q Consensus 69 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~~ 142 (329)
.-.+.|++. ..+|..|++|+++............-+++++++.|+|+|++.+++.. +..+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 446789998 56788999999955443433344556889999999999999998863 3578999999876 57776
Q ss_pred hhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 143 HLFHW-------------ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 143 ~l~~~-------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+.... .+...++..+|.++.|+..||.++|+. |+..+-|.+.+||++.+.+++|+..|+.......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 55321 123467899999999999999999999 9999999999999999999999988876544433
Q ss_pred CCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHH
Q 020221 210 RSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLA 289 (329)
Q Consensus 210 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 289 (329)
.. |-+. -..+-|.=.||.+++.|.||..-.... +.. ... ....+....+.++++++
T Consensus 447 ~~----------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~--d~~-----~~s----~~~~I~~~yS~D~rn~v 502 (655)
T KOG3741|consen 447 PT----------EPLE---SQQQNDLRDLGLLLLALATGTENSNRT--DST-----QSS----HLTRITTTYSTDLRNVV 502 (655)
T ss_pred CC----------cchh---HHhhhhHHHHHHHHHHHhhcccccccc--cch-----HHH----HHHHhhhhhhHHHHHHH
Confidence 20 1111 134678889999999999997421100 000 000 00112234566777777
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 020221 290 SRCLQYEPRERPNPRSLVTA 309 (329)
Q Consensus 290 ~~cl~~dp~~Rps~~~~l~~ 309 (329)
......++++ -+..+++.+
T Consensus 503 ~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 503 EYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHhcCccc-ccHHHHHHH
Confidence 7777777776 456666544
No 444
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=99.32 E-value=1.7e-11 Score=103.47 Aligned_cols=139 Identities=17% Similarity=0.182 Sum_probs=105.6
Q ss_pred cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC-hhHHHHHHHHHHHhcCCCc--cccccceeeeeC---CeeEEEEecCCC
Q 020221 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAW-PDARQFLEEARAVGQLRNR--RLANLLGCCCEG---DERLLVAEYMPN 137 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~~ 137 (329)
.++.|..+.||++...+|..+++|....... .....+.+|.++++.+.+. ++.+++.+.... +..+++|||++|
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G 84 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG 84 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence 4589999999999976667899999866432 1345678999999999653 456677766543 256899999999
Q ss_pred CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 020221 138 DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK------------------------------------------- 174 (329)
Q Consensus 138 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~------------------------------------------- 174 (329)
.++.+.+. ...++..+...++.+++.+|..||+.
T Consensus 85 ~~l~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 85 RVLRDRLL---RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred EecCCCCC---CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 88877552 13466777777788888888888741
Q ss_pred ------------CCccccccCCCceeeCC--CCCeeeecccCccc
Q 020221 175 ------------ERALYHDLNAYRIVFDD--DVNPRLSCFGLMKN 205 (329)
Q Consensus 175 ------------~~ivH~dlkp~Nil~~~--~~~~kl~Dfg~a~~ 205 (329)
..++|+|++|.||++++ ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23589999999999998 56689999998754
No 445
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.30 E-value=1.4e-12 Score=126.12 Aligned_cols=240 Identities=15% Similarity=0.119 Sum_probs=167.9
Q ss_pred ccccccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCC---ChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEec
Q 020221 59 ENIVSEHGEKAPNVVYKGK-LENQFRIAVKRFNRSA---WPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEY 134 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 134 (329)
..+++-+-+|.++.++.+. -..|...+.|...... ....+....+-.++-...+|-++.....+.-....+|+++|
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~ 885 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY 885 (1205)
T ss_pred ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence 3445556788888888776 3344444444433221 11222233333333334556666665555456788999999
Q ss_pred CCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC------
Q 020221 135 MPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD------ 208 (329)
Q Consensus 135 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~------ 208 (329)
..+++|...+++ ....+..-....+..+..++++||.. .+.|+|++|.|.+...+++.++.|||.......
T Consensus 886 ~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 886 LNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred hccCCchhhhhc--CCCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999998863 33466666777888899999999998 799999999999999999999999984321100
Q ss_pred -----------------------------CCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCchhhHH
Q 020221 209 -----------------------------GRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPSHALDL 259 (329)
Q Consensus 209 -----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 259 (329)
.....+|+.|.+||...+..-...+|+|++|++++|.++|..||....-..
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 001246789999999999999999999999999999999998887654443
Q ss_pred HhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 020221 260 IRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPR 304 (329)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ 304 (329)
+.......... ...-+...+++.++++...+..+|.+|..+.
T Consensus 1043 ~f~ni~~~~~~---~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 IFENILNRDIP---WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhccccCCCC---CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 33222221111 1123455678899999999999999998765
No 446
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.28 E-value=5.9e-11 Score=94.12 Aligned_cols=131 Identities=18% Similarity=0.180 Sum_probs=96.9
Q ss_pred cCCCCCCcEEEEEEeCCCCEEEEEEeCCCC--ChhH------HHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecC
Q 020221 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSA--WPDA------RQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYM 135 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 135 (329)
.+++|+-+.+|.+.+.+. .+++|.=.+.. .+.. ..-.+|+.++..++--.|..-.=+..+++...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 358999999999987544 45555432221 1111 22467889988886555544444556788889999999
Q ss_pred CCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221 136 PNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (329)
Q Consensus 136 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 206 (329)
+|-.|.+++... ...++..+-.-+.-||.. ||+|+||.++||++...+ +.++|||++...
T Consensus 82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA---------RPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc---------chHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 998888888531 256778888888999999 999999999999998665 999999998743
No 447
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.26 E-value=6e-11 Score=93.76 Aligned_cols=142 Identities=18% Similarity=0.175 Sum_probs=101.2
Q ss_pred cccCCCCCCcEEEEEEeCCCCEEEEEE-eCCCC-Chh------HHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEe
Q 020221 62 VSEHGEKAPNVVYKGKLENQFRIAVKR-FNRSA-WPD------ARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~vavK~-~~~~~-~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 133 (329)
+..+-+|+-+.|+++.+. |+...||. +.+.- -+. ...-.+|++.|.++.--.|.--.-++.+...-.|+||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 344588999999999985 44555554 33221 111 2345678998888764455444445667778899999
Q ss_pred cCCC-CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC---eeeecccCccc
Q 020221 134 YMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN---PRLSCFGLMKN 205 (329)
Q Consensus 134 ~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~a~~ 205 (329)
|+++ .++.+++...............+++.|-..+.-||.. +++|+||..+||++..++. +.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 4777877653333333344478899999999999999 9999999999999965543 58999999754
No 448
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=99.18 E-value=1.5e-09 Score=96.13 Aligned_cols=247 Identities=16% Similarity=0.167 Sum_probs=157.6
Q ss_pred ccCCCCCCcEEEEEE-eCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-CCcccccccee------eeeC-CeeEEEEe
Q 020221 63 SEHGEKAPNVVYKGK-LENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-RNRRLANLLGC------CCEG-DERLLVAE 133 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~-~~~~lv~e 133 (329)
+.||+|+-+.+|..- ..+ -+.|+.......... +-+..|... .||-+..-+.+ .-+. ....++|.
T Consensus 17 r~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 17 RPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred ccccCCccceeeecchhhc---hhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 456999999999765 322 234666554433222 223344444 56644331211 1112 23678888
Q ss_pred cCCCCCHHhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCC
Q 020221 134 YMPNDTLAKHLFHW-----ETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRD 208 (329)
Q Consensus 134 ~~~~gsL~~~l~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 208 (329)
.+.+..--..+.+. .-....|.-.++.++.++.+.+-||.. |.+-+|+.++|+|+++++.+.|.|-........
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n 169 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN 169 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCceEEEEcccceeeccC
Confidence 87764322223221 123468999999999999999999999 999999999999999999999999665444333
Q ss_pred CCC---ccCcccccCccccc-----CCCCCCcccchhhhHHHHHHHhC-CCCCCchh--------hH-HHhhhchhhhcc
Q 020221 209 GRS---YSTNLAFTPPEYLR-----TGRVTPESVMYSFGTLLLDLLSG-KHIPPSHA--------LD-LIRDRNIQTLTD 270 (329)
Q Consensus 209 ~~~---~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~el~tg-~~~~~~~~--------~~-~~~~~~~~~~~~ 270 (329)
+.. ..|...|.+||.-+ +-.-+...|.|.||+++++++.| ++||.+-- .+ .+.......-.+
T Consensus 170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~ 249 (637)
T COG4248 170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASD 249 (637)
T ss_pred CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechh
Confidence 332 35678899999754 33456689999999999999998 56654310 00 000000000000
Q ss_pred --cc---ccCCCC-hHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHhhhhc
Q 020221 271 --SC---LEGQFS-SDEGTELVRLASRCLQYE--PRERPNPRSLVTALVTLQKD 316 (329)
Q Consensus 271 --~~---~~~~~~-~~~~~~~~~li~~cl~~d--p~~Rps~~~~l~~L~~~~~~ 316 (329)
.. ....+| .-.+++++.+..+|+... +.-|||++..+..|..+...
T Consensus 250 ~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 250 QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 00 001111 235788999999999763 56899999999999888765
No 449
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=99.17 E-value=6e-10 Score=96.16 Aligned_cols=132 Identities=11% Similarity=0.090 Sum_probs=96.6
Q ss_pred EEEEEEeCCCCEEEEEEeCCCCChh-H----------HHHHHHHHHHhcCCCccc--cccceeeee-----CCeeEEEEe
Q 020221 72 VVYKGKLENQFRIAVKRFNRSAWPD-A----------RQFLEEARAVGQLRNRRL--ANLLGCCCE-----GDERLLVAE 133 (329)
Q Consensus 72 ~V~~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~e~~~l~~l~h~ni--v~~~~~~~~-----~~~~~lv~e 133 (329)
.|.+..+ +|+.+.||......... . ..+.+|...+..+..-+| +..+++... ...-+||+|
T Consensus 37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 4667766 56689999775433211 1 136788888888854333 344555533 234689999
Q ss_pred cCCCC-CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCC-------CCCeeeecccCccc
Q 020221 134 YMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDD-------DVNPRLSCFGLMKN 205 (329)
Q Consensus 134 ~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-------~~~~kl~Dfg~a~~ 205 (329)
++++. +|.+++.+......+......++.+++..+.-||.. |++|+|++++|||++. +..+.++||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99885 899888543334556677789999999999999999 9999999999999975 46799999998753
No 450
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=99.09 E-value=4.8e-10 Score=91.37 Aligned_cols=126 Identities=19% Similarity=0.188 Sum_probs=81.7
Q ss_pred EEEEEEeCCCCEEEEEEeCCCCCh---------------------h-----HHHHHHHHHHHhcCCCc--cccccceeee
Q 020221 72 VVYKGKLENQFRIAVKRFNRSAWP---------------------D-----ARQFLEEARAVGQLRNR--RLANLLGCCC 123 (329)
Q Consensus 72 ~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~--niv~~~~~~~ 123 (329)
.||.|...+|..+|+|+.+..... . .....+|.+.|..+..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999888889999998542100 0 12356899999999755 456665442
Q ss_pred eCCeeEEEEecCC--CCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCccccccCCCceeeCCCCCeeeecc
Q 020221 124 EGDERLLVAEYMP--NDTLAKHLFHWETQPMKWAMRLRVALHIAEALEY-CTSKERALYHDLNAYRIVFDDDVNPRLSCF 200 (329)
Q Consensus 124 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~-lH~~~~ivH~dlkp~Nil~~~~~~~kl~Df 200 (329)
...|||||++ |..+.. +.. ..++......++.+++..+.. +|.. |++|+|+.+.||+++++ .+.++||
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~---~~~~~~~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKD---VDLSPEEPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHH---CGGGGSTHHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT-CEEE--G
T ss_pred ---CCEEEEEecCCCccchhh-HHh---ccccchhHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc-eEEEEec
Confidence 4579999998 544433 321 112234456677888886655 4677 99999999999999987 9999999
Q ss_pred cCcccCC
Q 020221 201 GLMKNSR 207 (329)
Q Consensus 201 g~a~~~~ 207 (329)
|.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9886554
No 451
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.05 E-value=5.1e-11 Score=111.16 Aligned_cols=145 Identities=20% Similarity=0.278 Sum_probs=103.9
Q ss_pred HHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCc-------------cCcccccCcccccCCC
Q 020221 162 LHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSY-------------STNLAFTPPEYLRTGR 228 (329)
Q Consensus 162 ~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-------------~~~~~y~aPE~~~~~~ 228 (329)
.+++.|+.|+|...++||++|.|++|.++.++..||+.|+++........+ .....|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 344599999999889999999999999999999999999987655442221 1236799999999988
Q ss_pred CCCcccchhhhHHHHHHHhCCCC-CCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 020221 229 VTPESVMYSFGTLLLDLLSGKHI-PPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307 (329)
Q Consensus 229 ~~~~~DvwslG~il~el~tg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l 307 (329)
.+.++|+||+|+.+|.+..|+.+ +........ ..............+....+.++++=+.+++..++.-||++..+.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcch--hhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 89999999999999999955533 221110000 001111111112224466788999999999999999999776654
Q ss_pred H
Q 020221 308 T 308 (329)
Q Consensus 308 ~ 308 (329)
.
T Consensus 264 ~ 264 (700)
T KOG2137|consen 264 S 264 (700)
T ss_pred c
Confidence 3
No 452
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=98.92 E-value=3.2e-08 Score=83.45 Aligned_cols=137 Identities=15% Similarity=0.116 Sum_probs=97.2
Q ss_pred ccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh----------------------hHHHHHHHHHHHhcCCCc--c
Q 020221 59 ENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP----------------------DARQFLEEARAVGQLRNR--R 114 (329)
Q Consensus 59 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~--n 114 (329)
+.+-..||-|--+.||.|...+|..+|||.=+....+ ......+|.++|+.|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3344567999999999999989999999975432111 112356899999999654 6
Q ss_pred ccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC
Q 020221 115 LANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN 194 (329)
Q Consensus 115 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~ 194 (329)
+.+-+++ +...+||||++|-.|...- ++......++..|+.-+.-+-.. |+||+|+++-||+++++|.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~-GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR-GIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc-CccccCCchheEEEecCCC
Confidence 6666654 4568999999886554321 12333444555555555555566 9999999999999999999
Q ss_pred eeeecccCcccCC
Q 020221 195 PRLSCFGLMKNSR 207 (329)
Q Consensus 195 ~kl~Dfg~a~~~~ 207 (329)
+.++||--+....
T Consensus 241 ~~vIDwPQ~v~~~ 253 (304)
T COG0478 241 IVVIDWPQAVPIS 253 (304)
T ss_pred EEEEeCcccccCC
Confidence 9999998665433
No 453
>PRK09902 hypothetical protein; Provisional
Probab=98.89 E-value=6.4e-08 Score=79.55 Aligned_cols=137 Identities=13% Similarity=0.037 Sum_probs=101.4
Q ss_pred CCCCCcEEEEEEeCCCCEEEEEEeCCCC------ChhHHHHHHHHHHHhcCCC--ccccccceeeeeC----CeeEEEEe
Q 020221 66 GEKAPNVVYKGKLENQFRIAVKRFNRSA------WPDARQFLEEARAVGQLRN--RRLANLLGCCCEG----DERLLVAE 133 (329)
Q Consensus 66 g~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e 133 (329)
|+|+.+.|++....+. .+-+|.-...- +.....|.+|+..+..+.. -.+.+........ ..-+||+|
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 7799999999887544 68888765211 1234678999999999853 2344444222111 23679999
Q ss_pred cCCC-CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCC--eeeecccCcc
Q 020221 134 YMPN-DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVN--PRLSCFGLMK 204 (329)
Q Consensus 134 ~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~ 204 (329)
-+.+ -+|.+++.+......+......++.+++..+.-||+. |+.|+|+.+.||+++.++. ++++||--++
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 7653 5888888653344567788889999999999999999 9999999999999986667 9999997654
No 454
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=98.87 E-value=4.9e-08 Score=81.43 Aligned_cols=160 Identities=20% Similarity=0.202 Sum_probs=110.0
Q ss_pred cccccCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChh-------------------HH--
Q 020221 40 VFCEYSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPD-------------------AR-- 98 (329)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------~~-- 98 (329)
.+...+...+....+.-....+...|.+|--+.||+|...++..+|+|+++.....- .+
T Consensus 31 v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l 110 (268)
T COG1718 31 VFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL 110 (268)
T ss_pred hhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence 334455667777777666677778889999999999998788899999986532110 01
Q ss_pred ---HHHHHHHHHhcCC--CccccccceeeeeCCeeEEEEecCCCC-CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 020221 99 ---QFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEYCT 172 (329)
Q Consensus 99 ---~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH 172 (329)
...+|+..|+++. +-.+.+-+++. ...|||||+... .-.-.| ..-++...+...+..++++.+.-|-
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHHHHHH
Confidence 1234666666653 33333334332 457999998553 111122 2223334467788889999998887
Q ss_pred cCCCccccccCCCceeeCCCCCeeeecccCcccCC
Q 020221 173 SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSR 207 (329)
Q Consensus 173 ~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 207 (329)
...++||+||+.-|||+. ++.+.|+|||-|....
T Consensus 184 ~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 184 KEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 744999999999999999 8999999999876554
No 455
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=98.81 E-value=4e-08 Score=81.98 Aligned_cols=106 Identities=20% Similarity=0.197 Sum_probs=81.5
Q ss_pred HHHHHHHHHHhcCCCc--cccccceeeeeC----CeeEEEEecCCCC-CHHhhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 020221 98 RQFLEEARAVGQLRNR--RLANLLGCCCEG----DERLLVAEYMPND-TLAKHLFHWETQPMKWAMRLRVALHIAEALEY 170 (329)
Q Consensus 98 ~~~~~e~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~ 170 (329)
....+|...+..+..- ...+.+++.... ...++|+|++++. +|.+++.+.. ..+......++.+++..++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence 3467788877777433 344555555442 2458999999874 7999886322 26667788999999999999
Q ss_pred hhcCCCccccccCCCceeeCCCC---CeeeecccCcccC
Q 020221 171 CTSKERALYHDLNAYRIVFDDDV---NPRLSCFGLMKNS 206 (329)
Q Consensus 171 lH~~~~ivH~dlkp~Nil~~~~~---~~kl~Dfg~a~~~ 206 (329)
||.. |++|+|+++.|||++.+. .+.++||+.+...
T Consensus 134 lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 999999999999999877 7999999987643
No 456
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=98.74 E-value=5.7e-08 Score=90.85 Aligned_cols=141 Identities=13% Similarity=0.101 Sum_probs=90.6
Q ss_pred cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHH----------------------------------------HHHHH
Q 020221 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDAR----------------------------------------QFLEE 103 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~e 103 (329)
-++.++-|.||+|++.+|+.||||+.+.+-..... ++.+|
T Consensus 132 PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~E 211 (517)
T COG0661 132 PIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRRE 211 (517)
T ss_pred chhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHH
Confidence 45889999999999999999999998764322110 12233
Q ss_pred HHHHhcC----CCccccccceeeee-CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCc
Q 020221 104 ARAVGQL----RNRRLANLLGCCCE-GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEAL-EYCTSKERA 177 (329)
Q Consensus 104 ~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~i 177 (329)
...+..+ ++.--+++-.++++ .+...|+|||++|-.+.+...- +....+.. .++..++.+. ..+-.. |+
T Consensus 212 A~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l-~~~g~d~k---~ia~~~~~~f~~q~~~d-gf 286 (517)
T COG0661 212 AANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL-KSAGIDRK---ELAELLVRAFLRQLLRD-GF 286 (517)
T ss_pred HHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH-HhcCCCHH---HHHHHHHHHHHHHHHhc-Cc
Confidence 3333333 22222333333332 3567899999999888887432 23445532 2333333321 222234 99
Q ss_pred cccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 178 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
+|.|.+|.||+++.+|.+.+.|||+.....+.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 99999999999999999999999998765543
No 457
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=98.58 E-value=1.3e-06 Score=72.21 Aligned_cols=130 Identities=13% Similarity=0.067 Sum_probs=81.8
Q ss_pred ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHH---------HHHHHHHHhcCCCc---cccccceeeee-----C
Q 020221 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQ---------FLEEARAVGQLRNR---RLANLLGCCCE-----G 125 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~---niv~~~~~~~~-----~ 125 (329)
+.+-......|.+-.. +|+.+++|..+....-..+. ..+.+..+..++.. ....++.+... .
T Consensus 37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~ 115 (229)
T PF06176_consen 37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT 115 (229)
T ss_pred EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence 3334455556666666 45689999987654322222 22334444444322 22222222211 2
Q ss_pred CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221 126 DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 126 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
...+++|||++|..|.+... ++. .+...+..++.-||.. |++|+|.+|.|++++++ .++++||+..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc-CCccCCCCcCcEEEECC-cEEEEECccccc
Confidence 34578999999987766531 222 2456677889999999 99999999999999955 499999987653
No 458
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=98.52 E-value=1.9e-06 Score=72.91 Aligned_cols=135 Identities=11% Similarity=0.106 Sum_probs=81.7
Q ss_pred cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--ccccceeeeeCCeeEEEEecCCCCC-H
Q 020221 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLLGCCCEGDERLLVAEYMPNDT-L 140 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~gs-L 140 (329)
.+|.|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+.+++....+...++||+++|.+ +
T Consensus 8 ~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 8 QTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 3599999999984 23467888887533 3345788999998885433 4666777766777889999998863 2
Q ss_pred Hhhh---------------------ccCCCCCCCHHHH-HHHHH----------HHHHH-HHHhh---cCCCccccccCC
Q 020221 141 AKHL---------------------FHWETQPMKWAMR-LRVAL----------HIAEA-LEYCT---SKERALYHDLNA 184 (329)
Q Consensus 141 ~~~l---------------------~~~~~~~~~~~~~-~~i~~----------~i~~~-l~~lH---~~~~ivH~dlkp 184 (329)
...+ +............ ..+.. .+... ..+|. ....++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1111 0000011111100 00100 01111 11221 122468999999
Q ss_pred CceeeCCCCCeeeecccCcc
Q 020221 185 YRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 185 ~Nil~~~~~~~kl~Dfg~a~ 204 (329)
.||++++++ +.++||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999999865
No 459
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=98.51 E-value=9.8e-07 Score=82.48 Aligned_cols=141 Identities=14% Similarity=0.069 Sum_probs=88.6
Q ss_pred cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhH---------------------------H----------HHHHHHHH
Q 020221 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDA---------------------------R----------QFLEEARA 106 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---------------------------~----------~~~~e~~~ 106 (329)
.||..+.|.||+|+..+|+.||||+-++.-.... + +|.+|.+.
T Consensus 168 piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~N 247 (538)
T KOG1235|consen 168 PIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKN 247 (538)
T ss_pred hhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHh
Confidence 4689999999999998999999999876432210 0 12233332
Q ss_pred ----HhcCCCcc---ccccceeeee-CCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCcc
Q 020221 107 ----VGQLRNRR---LANLLGCCCE-GDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERAL 178 (329)
Q Consensus 107 ----l~~l~h~n---iv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~iv 178 (329)
...+.|-+ -|.+-.++++ .....|+||||+|..+.+...- ....++...+..-+-+...-+-+ .. |++
T Consensus 248 ae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~~qIf--~~-Gff 323 (538)
T KOG1235|consen 248 AERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYLEQIF--KT-GFF 323 (538)
T ss_pred HHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHHHHHH--hc-CCc
Confidence 22233444 1223333333 2467899999999877664321 34456655433333222221111 23 899
Q ss_pred ccccCCCceeeC----CCCCeeeecccCcccCCC
Q 020221 179 YHDLNAYRIVFD----DDVNPRLSCFGLMKNSRD 208 (329)
Q Consensus 179 H~dlkp~Nil~~----~~~~~kl~Dfg~a~~~~~ 208 (329)
|+|-+|.||++. .++.+.+-|||+.....+
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999998 367899999999765543
No 460
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=98.47 E-value=1.6e-06 Score=68.64 Aligned_cols=131 Identities=18% Similarity=0.180 Sum_probs=90.1
Q ss_pred cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCC
Q 020221 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
+..+.|+.|.+|.||++.+.++ .+|+|+-+.+. ....+..|.++|..++..++.+-+..+ +..++.|||+.|-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcc
Confidence 3456779999999999999665 88999876654 346788999999999877766544333 34456699999988
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccC-CCceeeCCCCCeeeecccCcccC
Q 020221 140 LAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLN-AYRIVFDDDVNPRLSCFGLMKNS 206 (329)
Q Consensus 140 L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk-p~Nil~~~~~~~kl~Dfg~a~~~ 206 (329)
|.+.-.. .+..+ ...++...--|-.. ||-|..+. |...++.+++.+.|+||..|+.-
T Consensus 99 L~~~~~~-----~~rk~----l~~vlE~a~~LD~~-GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIG-----GDRKH----LLRVLEKAYKLDRL-GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhc-----ccHHH----HHHHHHHHHHHHHh-ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 8775421 12233 33444443333444 99999876 44555555569999999998743
No 461
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=98.41 E-value=3.5e-06 Score=72.27 Aligned_cols=74 Identities=15% Similarity=0.138 Sum_probs=51.5
Q ss_pred CCCCC-cEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC-CccccccceeeeeCCeeEEEEecCCCCCHHhh
Q 020221 66 GEKAP-NVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR-NRRLANLLGCCCEGDERLLVAEYMPNDTLAKH 143 (329)
Q Consensus 66 g~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 143 (329)
..|.. +.||+....+ ..+.+|...... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|...
T Consensus 7 ~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 7 TEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred CCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 34444 7899998644 578888876543 335667888888874 33355667766655678999999999777643
No 462
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=98.39 E-value=1.2e-07 Score=88.31 Aligned_cols=176 Identities=10% Similarity=-0.025 Sum_probs=127.9
Q ss_pred cCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc-ccccceeeeeCCeeEEEEecCCCC-CHH
Q 020221 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR-LANLLGCCCEGDERLLVAEYMPND-TLA 141 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-sL~ 141 (329)
..++|+++.++|.+-...+....+.+... ....-+++.|.+++||| .+..++.+..++..++.++++.++ +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 34788999999987433334445555432 34456889999999999 777777777778899999999877 221
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccCCCC---CCccCcccc
Q 020221 142 KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG---RSYSTNLAF 218 (329)
Q Consensus 142 ~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y 218 (329)
... ......+...+...+.+.-.++++++|+. --+|+| ||+..+ +..+.+||+.+...... ....+++.|
T Consensus 324 ~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~ 396 (829)
T KOG0576|consen 324 LEM-TVSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEP 396 (829)
T ss_pred ccC-ChhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----cccccc-cccccccccCCcccCcccccccCCCCCCC
Confidence 111 00112233445556666777889999987 568888 777665 78899999988766554 456788999
Q ss_pred cCcccccCCCCCCcccchhhhHHHHHHHhCCCC
Q 020221 219 TPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHI 251 (329)
Q Consensus 219 ~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~ 251 (329)
+|||+...+.+....|.|++|.--.++--|.+|
T Consensus 397 ~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 397 LAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred CCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 999999999999999999999877777766654
No 463
>PLN02876 acyl-CoA dehydrogenase
Probab=98.29 E-value=1.1e-05 Score=81.03 Aligned_cols=80 Identities=15% Similarity=0.258 Sum_probs=57.3
Q ss_pred ccccCCCCCCcEEEEEEeCCC---CEEEEEEeCCCC-ChhHHHHHHHHHHHhcCC-Cccc--cccceeeeeC---CeeEE
Q 020221 61 IVSEHGEKAPNVVYKGKLENQ---FRIAVKRFNRSA-WPDARQFLEEARAVGQLR-NRRL--ANLLGCCCEG---DERLL 130 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~l 130 (329)
-+..++.|.++.+|+....++ ..+++|+..... ......+.+|.++++.+. |.++ .+++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 356678999999999886553 467888765433 123456889999999995 6665 6677776554 46789
Q ss_pred EEecCCCCCH
Q 020221 131 VAEYMPNDTL 140 (329)
Q Consensus 131 v~e~~~~gsL 140 (329)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999988643
No 464
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=98.23 E-value=1.2e-05 Score=67.97 Aligned_cols=77 Identities=21% Similarity=0.294 Sum_probs=54.6
Q ss_pred ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCc--cccccceeeee---CCeeEEEEecCCC
Q 020221 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR--RLANLLGCCCE---GDERLLVAEYMPN 137 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~~ 137 (329)
+.++.|..+.||+....++ .+++|..... .....+.+|..+++.+... .+.+++..... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~~-~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDG-RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETTS-EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECCc-EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 3458899999999998774 8999997664 3456677888888888533 24555553322 2357899999999
Q ss_pred CCHHh
Q 020221 138 DTLAK 142 (329)
Q Consensus 138 gsL~~ 142 (329)
.++..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 87776
No 465
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=98.22 E-value=4.5e-06 Score=68.36 Aligned_cols=100 Identities=22% Similarity=0.266 Sum_probs=77.3
Q ss_pred HHHHHHhcCCC-ccccccceeeeeCCeeEEEEecCCCCCHHhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcC--CCc
Q 020221 102 EEARAVGQLRN-RRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHW-ETQPMKWAMRLRVALHIAEALEYCTSK--ERA 177 (329)
Q Consensus 102 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~i 177 (329)
.|.-+++.+++ +++.+++|+|- .+++.||...+++....... .-...+|..+.+|+.++++.+.+++.. +.+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 47788888875 69999999993 37799999876664211000 112468999999999999999999873 144
Q ss_pred cccccCCCceeeCCCCCeeeecccCccc
Q 020221 178 LYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 178 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
.-.|++++|+.+++++.+|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 5559999999999999999999987643
No 466
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=98.21 E-value=6.4e-06 Score=81.94 Aligned_cols=195 Identities=18% Similarity=0.134 Sum_probs=138.5
Q ss_pred HHHHHHHHhcCCCccccccceeeeeCCe----eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 020221 100 FLEEARAVGQLRNRRLANLLGCCCEGDE----RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKE 175 (329)
Q Consensus 100 ~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 175 (329)
..-|...+..+.|+|++.++.+....-. ..+..+++..-++...+. .-..++..+.+.+..+...||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--~v~~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--SVGSIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--hccccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 4456777888899999999988754322 234567788878888775 445678889999999999999999998
Q ss_pred CccccccCCC---ceeeCCCCCeeee--cccCcccCCCCCC---ccCcccccCcccccCCCCCC--cccchhhhHHHHHH
Q 020221 176 RALYHDLNAY---RIVFDDDVNPRLS--CFGLMKNSRDGRS---YSTNLAFTPPEYLRTGRVTP--ESVMYSFGTLLLDL 245 (329)
Q Consensus 176 ~ivH~dlkp~---Nil~~~~~~~kl~--Dfg~a~~~~~~~~---~~~~~~y~aPE~~~~~~~~~--~~DvwslG~il~el 245 (329)
...|.-+..+ +...+..+.+.++ ||+......+... ......+.+||......+.. ..|+|.+|.....+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 6666655555 5566677777777 8888776655432 23356688888877666544 47999999999999
Q ss_pred HhCCCCCCchhhHHHhhhchhhhccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 020221 246 LSGKHIPPSHALDLIRDRNIQTLTDSCLEGQFSSDEGTELVRLASRCLQYEPRERPNPRSLVTALVT 312 (329)
Q Consensus 246 ~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l~~L~~ 312 (329)
..|..+.... ......+.... .....+...+|+..++++|+++.+++.+.-.
T Consensus 386 ~~~~~i~~~~-----------~~~~~~l~~~~----~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 386 SQGEDISEKS-----------AVPVSLLDVLS----TSELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred hhcCcccccc-----------cchhhhhcccc----chhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 9988644211 11111111111 1157788999999999999999999975433
No 467
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=98.20 E-value=2.9e-05 Score=63.91 Aligned_cols=126 Identities=18% Similarity=0.071 Sum_probs=87.5
Q ss_pred cCCCCCCcEEEEEEeCCCCEEEEEEeCCCC----------------ChhHHHHHHHHHHHhcCC------Ccccccccee
Q 020221 64 EHGEKAPNVVYKGKLENQFRIAVKRFNRSA----------------WPDARQFLEEARAVGQLR------NRRLANLLGC 121 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~~~~ 121 (329)
.+|+|+.-.||.--. .....||+..... ....++..+|+.....+. +.+|.+++|+
T Consensus 8 ~i~~G~~R~cy~HP~--dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 8 LIAQGGERDCYQHPD--DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred ccccCCCceEEECCC--CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 349999888887643 3457888887655 122455666766555554 7899999999
Q ss_pred eeeCCeeEEEEecCCC------CCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC--C
Q 020221 122 CCEGDERLLVAEYMPN------DTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD--V 193 (329)
Q Consensus 122 ~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~--~ 193 (329)
..+.--..+|+|.+.+ -||.+++. ...++. .....+. .-..||-+. +|+.+|++|.||++..+ +
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---~~~~~~-~~~~~L~---~f~~~l~~~-~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLK---EGGLTE-ELRQALD---EFKRYLLDH-HIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHH---cCCccH-HHHHHHH---HHHHHHHHc-CCeecCCCcccEEEEecCCC
Confidence 9998888999998632 36778873 344554 3333333 334566676 99999999999999532 2
Q ss_pred --Ceeeec
Q 020221 194 --NPRLSC 199 (329)
Q Consensus 194 --~~kl~D 199 (329)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 577887
No 468
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=98.04 E-value=7.4e-05 Score=61.19 Aligned_cols=125 Identities=20% Similarity=0.227 Sum_probs=86.6
Q ss_pred CcccccccCCCCCC-cEEEEEEeCCCCEEEEEEeCC---CCC------------------hhHHHHHHHHHHHhcCC---
Q 020221 57 AMENIVSEHGEKAP-NVVYKGKLENQFRIAVKRFNR---SAW------------------PDARQFLEEARAVGQLR--- 111 (329)
Q Consensus 57 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 111 (329)
...+.++.||.|.- |.||++.+. |+.+|+|.+.. ... .-...|..|.++..+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 45667788899999 999999984 55999999322 110 01124677888877774
Q ss_pred Cccc--cccceeeeeC------------------CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 020221 112 NRRL--ANLLGCCCEG------------------DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYC 171 (329)
Q Consensus 112 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~l 171 (329)
+.++ |+.+||..-. ....||.||++... .++. .-+.+|.+-+..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence 4455 8888886221 11356777765532 2222 3356777888899
Q ss_pred hcCCCccccccCCCceeeCCCCCeeeecccCc
Q 020221 172 TSKERALYHDLNAYRIVFDDDVNPRLSCFGLM 203 (329)
Q Consensus 172 H~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 203 (329)
|.. ||+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~-gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL-GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC-CeeeccCcccccc-----CCEEEecccC
Confidence 999 9999999999987 3389999865
No 469
>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members. The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista
Probab=97.93 E-value=8.3e-05 Score=63.33 Aligned_cols=71 Identities=15% Similarity=0.124 Sum_probs=42.3
Q ss_pred CCCCCCc-EEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCc---cccccceeeeeC---CeeEEEEecCCC
Q 020221 65 HGEKAPN-VVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNR---RLANLLGCCCEG---DERLLVAEYMPN 137 (329)
Q Consensus 65 lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~~~ 137 (329)
++.|+.. .||+.. ..+++|..+... ....+.+|.+.+..+... -+.+.++..... ...+++|++++|
T Consensus 5 ~~~gG~~n~vy~~~----~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G 78 (235)
T cd05155 5 VDSGGTDNATFRLG----DDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG 78 (235)
T ss_pred ccCCCcccceEEcC----CceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence 4555554 588752 247778765432 244688899998887532 233333333221 235889999998
Q ss_pred CCHH
Q 020221 138 DTLA 141 (329)
Q Consensus 138 gsL~ 141 (329)
.++.
T Consensus 79 ~~l~ 82 (235)
T cd05155 79 ETAT 82 (235)
T ss_pred CCCC
Confidence 7664
No 470
>TIGR02721 ycfN_thiK thiamine kinase. Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.
Probab=97.89 E-value=0.00011 Score=63.43 Aligned_cols=134 Identities=13% Similarity=0.096 Sum_probs=76.0
Q ss_pred CCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEEecCCCCCHHhh-
Q 020221 66 GEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMPNDTLAKH- 143 (329)
Q Consensus 66 g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL~~~- 143 (329)
..|-.+.+|+... ++..+++|........-.-...+|..+++.+...++ .+++... .-++|+||++|..+...
T Consensus 5 ~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~~ 79 (256)
T TIGR02721 5 SGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLDQ 79 (256)
T ss_pred CCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccccc
Confidence 5577788998874 456788987654332211135678888888854333 3333332 23789999998665321
Q ss_pred -------------hc---cCC--CCCCCHH-HHHHHHHHH---------HHHHHHhhc-------CCCccccccCCCcee
Q 020221 144 -------------LF---HWE--TQPMKWA-MRLRVALHI---------AEALEYCTS-------KERALYHDLNAYRIV 188 (329)
Q Consensus 144 -------------l~---~~~--~~~~~~~-~~~~i~~~i---------~~~l~~lH~-------~~~ivH~dlkp~Nil 188 (329)
+. ... ..+++.. ....+..++ ...+..+-. ...++|+|+.|.||+
T Consensus 80 ~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil 159 (256)
T TIGR02721 80 FVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLV 159 (256)
T ss_pred ccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEE
Confidence 11 111 1112211 111221111 111221211 124799999999999
Q ss_pred eCCCCCeeeecccCccc
Q 020221 189 FDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 189 ~~~~~~~kl~Dfg~a~~ 205 (329)
+++++ +.++||..+..
T Consensus 160 ~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 160 VTPQG-LKLIDWEYASD 175 (256)
T ss_pred EeCCC-CEEEeccccCc
Confidence 99877 78999998754
No 471
>PRK10593 hypothetical protein; Provisional
Probab=97.84 E-value=0.0003 Score=62.12 Aligned_cols=77 Identities=12% Similarity=0.036 Sum_probs=55.4
Q ss_pred ccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCC---ccccccceeeee---CCeeEEEEec
Q 020221 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRN---RRLANLLGCCCE---GDERLLVAEY 134 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~ 134 (329)
-++.||.|..+.||.....++ .+.+|..+... ....+..|...|+.+.. -.+.++++++.. .+..++|||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 345679999999999986566 46677754311 23578889999988843 357777777644 3568999999
Q ss_pred CCCCCH
Q 020221 135 MPNDTL 140 (329)
Q Consensus 135 ~~~gsL 140 (329)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998754
No 472
>TIGR00938 thrB_alt homoserine kinase, Neisseria type. Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.
Probab=97.82 E-value=0.00055 Score=60.80 Aligned_cols=158 Identities=13% Similarity=0.156 Sum_probs=87.8
Q ss_pred cCHHHHHHHhcCCCcc--cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--ccccc
Q 020221 44 YSIETLRTATSGFAME--NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLL 119 (329)
Q Consensus 44 ~~~~~~~~~~~~~~~~--~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~ 119 (329)
.+.+++...-..|+.. ..++.++.|....+|+....++ .+++|+...... ...+..|.+++..|...+ +.+.+
T Consensus 7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccc
Confidence 3445555544444332 2355667787789999876555 677888765321 234455666666663222 33433
Q ss_pred eee------eeCCeeEEEEecCCCCCHH-----------hhhccC----CC-----CC----CCHHHHH-----------
Q 020221 120 GCC------CEGDERLLVAEYMPNDTLA-----------KHLFHW----ET-----QP----MKWAMRL----------- 158 (329)
Q Consensus 120 ~~~------~~~~~~~lv~e~~~~gsL~-----------~~l~~~----~~-----~~----~~~~~~~----------- 158 (329)
... ...+..+++++|++|.++. ..+.+. .. .. -.|....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 321 1235678999999885432 111100 00 00 0111100
Q ss_pred -HHHHHHHHHHHHhhc------CCCccccccCCCceeeCCCCCeeeecccCcc
Q 020221 159 -RVALHIAEALEYCTS------KERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 159 -~i~~~i~~~l~~lH~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 204 (329)
.....+...+.++.. ..+++|+|+++.|+++++++...++||+.+.
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 001122334444432 1389999999999999988877899999864
No 473
>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo
Probab=97.77 E-value=0.00023 Score=60.48 Aligned_cols=72 Identities=19% Similarity=0.150 Sum_probs=46.2
Q ss_pred cCCCCCCcEEEEEEeCC--CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEEecCCCCCH
Q 020221 64 EHGEKAPNVVYKGKLEN--QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMPNDTL 140 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL 140 (329)
.+..|-...+|+....+ ++.|++|+....... .....+|+.+++.+...++ +++++... -.++|||++|.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCcC
Confidence 44677778999998654 668999987643221 1233578888888853333 34443322 2489999988765
No 474
>cd05153 HomoserineK_II Homoserine Kinase, type II. Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.
Probab=97.77 E-value=0.00061 Score=60.09 Aligned_cols=139 Identities=14% Similarity=0.181 Sum_probs=81.8
Q ss_pred cccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--cccccee------eeeCCeeEEEEe
Q 020221 62 VSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LANLLGC------CCEGDERLLVAE 133 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e 133 (329)
++.+..|....+|+....++ .+++|+.... ....+..|++++..+.+.+ +.+.+.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 44567787789999876554 7888987652 2345667777777774322 3444332 122345689999
Q ss_pred cCCCCCHHh-----------hhcc-------CCC-----CCCCHHHHH----------HHHHHHHHHHHHhhc------C
Q 020221 134 YMPNDTLAK-----------HLFH-------WET-----QPMKWAMRL----------RVALHIAEALEYCTS------K 174 (329)
Q Consensus 134 ~~~~gsL~~-----------~l~~-------~~~-----~~~~~~~~~----------~i~~~i~~~l~~lH~------~ 174 (329)
+++|.++.. .+.+ ... ....|.... .....+..++.++.. .
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998866432 1100 000 011121110 011112233444432 1
Q ss_pred CCccccccCCCceeeCCCCCeeeecccCcc
Q 020221 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 175 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 204 (329)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 368999999999999988778899999764
No 475
>PRK05231 homoserine kinase; Provisional
Probab=97.69 E-value=0.0017 Score=58.03 Aligned_cols=160 Identities=13% Similarity=0.110 Sum_probs=85.0
Q ss_pred cccCHHHHHHHhcCCCccc--ccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--ccc
Q 020221 42 CEYSIETLRTATSGFAMEN--IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LAN 117 (329)
Q Consensus 42 ~~~~~~~~~~~~~~~~~~~--~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~ 117 (329)
...+.+++......|...+ -++.++.|....+|.....+| .+++|++... ....+..|...+..|...+ +.+
T Consensus 5 t~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~ 80 (319)
T PRK05231 5 TDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPA 80 (319)
T ss_pred ccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCc
Confidence 4455666655555554322 234456777788999886566 6889987621 2233344555555542111 223
Q ss_pred ccee------eeeCCeeEEEEecCCCCCHH-----------hhhccC----CC--------CCCCH-HHHHH--------
Q 020221 118 LLGC------CCEGDERLLVAEYMPNDTLA-----------KHLFHW----ET--------QPMKW-AMRLR-------- 159 (329)
Q Consensus 118 ~~~~------~~~~~~~~lv~e~~~~gsL~-----------~~l~~~----~~--------~~~~~-~~~~~-------- 159 (329)
.+.. ....+..+++++|++|..+. ..+.+. .. ..+.| .....
T Consensus 81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (319)
T PRK05231 81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD 160 (319)
T ss_pred ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence 3321 12245678999999886431 111110 00 01111 11110
Q ss_pred ----HHHH-HHHHHHHhhc------CCCccccccCCCceeeCCCCCeeeecccCccc
Q 020221 160 ----VALH-IAEALEYCTS------KERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 160 ----i~~~-i~~~l~~lH~------~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
...+ +...+..+.. ..+++|+|+.|.||+++++...-++||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1111 1111222221 13799999999999999766668999998753
No 476
>PRK09550 mtnK methylthioribose kinase; Reviewed
Probab=97.63 E-value=0.0019 Score=59.03 Aligned_cols=76 Identities=14% Similarity=0.079 Sum_probs=52.9
Q ss_pred cccCCCCCCcEEEEEEeCCC-CEEEEEEeCCC------C-ChhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEE
Q 020221 62 VSEHGEKAPNVVYKGKLENQ-FRIAVKRFNRS------A-WPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l 130 (329)
.+.+|-|.++.||+....+| +.++||.-... . .-..+....|.+.|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35679999999999997766 58999985321 1 123456677888888762 2356666655 4466789
Q ss_pred EEecCCCCC
Q 020221 131 VAEYMPNDT 139 (329)
Q Consensus 131 v~e~~~~gs 139 (329)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998644
No 477
>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]
Probab=97.51 E-value=0.0013 Score=58.41 Aligned_cols=140 Identities=16% Similarity=0.148 Sum_probs=95.2
Q ss_pred cccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCC---------------------Chh-----HHHHHHHHHHHhcCCCc
Q 020221 60 NIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSA---------------------WPD-----ARQFLEEARAVGQLRNR 113 (329)
Q Consensus 60 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~~~-----~~~~~~e~~~l~~l~h~ 113 (329)
++-+.|..|--+.||.+.-.+|..+|||+++-+- ..+ .-....|++-|.++...
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3446778899999999998888899999874210 000 11245678888887655
Q ss_pred cccccceeeeeCCeeEEEEecCCCCCHH-hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCC
Q 020221 114 RLANLLGCCCEGDERLLVAEYMPNDTLA-KHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDD 192 (329)
Q Consensus 114 niv~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~ 192 (329)
.|..---+.. ....|||+|+....-. -.| +...++...+..+-.+++.-+.-|-...++||.||+--|+|+. +
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence 5442221111 2457899998532211 122 4456777777777788888887776555999999999999998 5
Q ss_pred CCeeeecccCccc
Q 020221 193 VNPRLSCFGLMKN 205 (329)
Q Consensus 193 ~~~kl~Dfg~a~~ 205 (329)
|.+.|+|.+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 7899999876543
No 478
>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer
Probab=97.33 E-value=0.0021 Score=56.94 Aligned_cols=72 Identities=22% Similarity=0.291 Sum_probs=46.0
Q ss_pred CCCCCCcEEEEEEeCC-------CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEEecCC
Q 020221 65 HGEKAPNVVYKGKLEN-------QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 65 lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~ 136 (329)
+..|--..+|+....+ ++.+++|+..... .......+|.+++..+...++ .++++++. -.+|+||++
T Consensus 6 l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~i~ 80 (302)
T cd05156 6 ISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEFIP 80 (302)
T ss_pred ecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhheeC
Confidence 3456666889888654 5789999976643 223345678888888753333 34444442 246899988
Q ss_pred CCCHH
Q 020221 137 NDTLA 141 (329)
Q Consensus 137 ~gsL~ 141 (329)
|.++.
T Consensus 81 G~~l~ 85 (302)
T cd05156 81 SRTLT 85 (302)
T ss_pred CCcCC
Confidence 87664
No 479
>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]
Probab=97.30 E-value=0.0063 Score=53.82 Aligned_cols=155 Identities=14% Similarity=0.118 Sum_probs=85.2
Q ss_pred cCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeC-CCCChhHHHHHHHHHHHhcCCC--ccccccceeeeeCC--ee
Q 020221 54 SGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFN-RSAWPDARQFLEEARAVGQLRN--RRLANLLGCCCEGD--ER 128 (329)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~ 128 (329)
..+....+++.+..|.-..+|..... +++++++... ...........+|...++.+.- --+...++.|.++. ..
T Consensus 22 p~~~~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 22 PGYAGLLIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred cCcCCCceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 34444555555544444444554443 7788888321 1223334556677777777632 22344566666655 67
Q ss_pred EEEEecCCCCCHHhhh------------------ccC------------CCCCCCHHHHHHHHHHH--------------
Q 020221 129 LLVAEYMPNDTLAKHL------------------FHW------------ETQPMKWAMRLRVALHI-------------- 164 (329)
Q Consensus 129 ~lv~e~~~~gsL~~~l------------------~~~------------~~~~~~~~~~~~i~~~i-------------- 164 (329)
|.||+|++|..+.+.+ ... ........+...+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 9999999873222211 100 00000011111111111
Q ss_pred HHHHHHhhcC-------CCccccccCCCceeeCCCCCeeeecccCcccCCCC
Q 020221 165 AEALEYCTSK-------ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDG 209 (329)
Q Consensus 165 ~~~l~~lH~~-------~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 209 (329)
..-..+|+.. ..++|+|+.+.|++++..+-+-+.||+++....+.
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 1122344332 34799999999999998888999999998765443
No 480
>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported
Probab=97.28 E-value=0.0045 Score=54.05 Aligned_cols=30 Identities=23% Similarity=0.215 Sum_probs=25.1
Q ss_pred CccccccCCCceeeCCCCC-eeeecccCccc
Q 020221 176 RALYHDLNAYRIVFDDDVN-PRLSCFGLMKN 205 (329)
Q Consensus 176 ~ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~~ 205 (329)
.++|+|++|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4799999999999997555 56999998754
No 481
>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]
Probab=97.22 E-value=0.00066 Score=59.35 Aligned_cols=148 Identities=14% Similarity=0.072 Sum_probs=97.0
Q ss_pred cCHHHHHHHhcCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCCh-----------------hH-----HHHH
Q 020221 44 YSIETLRTATSGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWP-----------------DA-----RQFL 101 (329)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------------~~-----~~~~ 101 (329)
+++..|....+.=.-+.+-.+||-|--+.||.+...+|.+.++|.-+....+ .+ -...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 3444454444444445566778999999999999988999999864322110 11 1234
Q ss_pred HHHHHHhcCC-Cc-cccccceeeeeCCeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccc
Q 020221 102 EEARAVGQLR-NR-RLANLLGCCCEGDERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALY 179 (329)
Q Consensus 102 ~e~~~l~~l~-h~-niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH 179 (329)
+|+..|+.+. |. -+.+.+++ +..++|||++.+-.|...-. -.+. ..+...+..-+.-|... |+||
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-----v~d~---~~ly~~lm~~Iv~la~~-GlIH 225 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH-----VEDP---PTLYDDLMGLIVRLANH-GLIH 225 (465)
T ss_pred HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee-----cCCh---HHHHHHHHHHHHHHHHc-Ccee
Confidence 6777777774 22 23444443 45688999998876655321 1122 23334444455566666 9999
Q ss_pred cccCCCceeeCCCCCeeeecccCcc
Q 020221 180 HDLNAYRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 180 ~dlkp~Nil~~~~~~~kl~Dfg~a~ 204 (329)
+|..-=||++++++.++++||--..
T Consensus 226 gDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cccchheeEEecCCCEEEeechHhh
Confidence 9999999999999999999997543
No 482
>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]
Probab=97.13 E-value=6.8e-05 Score=76.93 Aligned_cols=154 Identities=12% Similarity=-0.079 Sum_probs=109.9
Q ss_pred HHHHHHHHHhcCCCccccccceeee--eCCeeEEEEecCCCCCHHhhhccCCC--CCCCHHHHHHHHHHHHHHHHHhhcC
Q 020221 99 QFLEEARAVGQLRNRRLANLLGCCC--EGDERLLVAEYMPNDTLAKHLFHWET--QPMKWAMRLRVALHIAEALEYCTSK 174 (329)
Q Consensus 99 ~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~ 174 (329)
....|...++..+|+++.....-.. +....+..++|+.+|.+.+.+.+... ..+...-+....++......-+|+.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3455666666778988876554332 23467899999999999998875322 2333333333334435555555553
Q ss_pred C----CccccccCCCceeeCCCCCeeeecccCcccCCCCCC----ccCcccccCcccccCCCCCCcccchhhhHHHHHHH
Q 020221 175 E----RALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRS----YSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLL 246 (329)
Q Consensus 175 ~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 246 (329)
. -.+|+++|+.|.++..+-+++++++|+.+...+... ..+++.|++|+..+.-.++.++|+|..|+-+|+..
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2 248999999999999999999999999984444333 34567899999888888898899999999999998
Q ss_pred hCCCCC
Q 020221 247 SGKHIP 252 (329)
Q Consensus 247 tg~~~~ 252 (329)
-|..++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888544
No 483
>TIGR01767 MTRK 5-methylthioribose kinase. This enzyme is involved in the methionine salvage pathway in certain bacteria.
Probab=97.05 E-value=0.0081 Score=53.96 Aligned_cols=74 Identities=16% Similarity=0.013 Sum_probs=47.0
Q ss_pred cCCCCCCcEEEEEEeCCC-CEEEEEEeCC-------CCChhHHHHHHHHHHHhcCC--CccccccceeeeeCCeeEEEEe
Q 020221 64 EHGEKAPNVVYKGKLENQ-FRIAVKRFNR-------SAWPDARQFLEEARAVGQLR--NRRLANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 64 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e 133 (329)
.+|-|....||++...+| +.|+||.-.. +-.-.......|...|+... -|..++-+-+ .++....+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-EccccceehHh
Confidence 468999999999996554 5899997431 11223445556777777663 3433333322 35567779999
Q ss_pred cCCCC
Q 020221 134 YMPND 138 (329)
Q Consensus 134 ~~~~g 138 (329)
+++..
T Consensus 81 dL~~~ 85 (370)
T TIGR01767 81 DLSHH 85 (370)
T ss_pred hCccc
Confidence 98553
No 484
>PLN02756 S-methyl-5-thioribose kinase
Probab=97.04 E-value=0.014 Score=53.49 Aligned_cols=74 Identities=15% Similarity=0.068 Sum_probs=49.2
Q ss_pred ccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCC-------hhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEE
Q 020221 61 IVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAW-------PDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLL 130 (329)
Q Consensus 61 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l 130 (329)
..+.+|-|....||+.... +..++||.-..... -....-..|...|+.+. ..++.+++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 3456799999999998864 45799998652111 12333445666666653 246777887775 55788
Q ss_pred EEecCCC
Q 020221 131 VAEYMPN 137 (329)
Q Consensus 131 v~e~~~~ 137 (329)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
No 485
>PLN02236 choline kinase
Probab=97.03 E-value=0.0046 Score=55.79 Aligned_cols=138 Identities=13% Similarity=0.099 Sum_probs=79.1
Q ss_pred ccCCCCCCcEEEEEEeCC-----CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccc-ccceeeeeCCeeEEEEecCC
Q 020221 63 SEHGEKAPNVVYKGKLEN-----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLA-NLLGCCCEGDERLLVAEYMP 136 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~ 136 (329)
..+.-|-...+|+....+ ++.|++|+......... .-.+|..+++.+..-++. ++++.+.. ..|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC----ceEEEeeC
Confidence 344457778999987532 36799998876542222 236788888888544433 44555432 25899987
Q ss_pred CCCHHhh-----------------hccCC--CC--CCCHHHHHHHHHHH-----------------HHHHHH----hhc-
Q 020221 137 NDTLAKH-----------------LFHWE--TQ--PMKWAMRLRVALHI-----------------AEALEY----CTS- 173 (329)
Q Consensus 137 ~gsL~~~-----------------l~~~~--~~--~~~~~~~~~i~~~i-----------------~~~l~~----lH~- 173 (329)
+.+|... +++.. .. ...+.++..+..++ ...+.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 11101 00 11233333333221 111111 111
Q ss_pred --CCCccccccCCCceeeCC-CCCeeeecccCccc
Q 020221 174 --KERALYHDLNAYRIVFDD-DVNPRLSCFGLMKN 205 (329)
Q Consensus 174 --~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~ 205 (329)
...++|+|+++.||++++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 125799999999999986 57899999988753
No 486
>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]
Probab=96.83 E-value=0.0037 Score=57.98 Aligned_cols=160 Identities=20% Similarity=0.248 Sum_probs=89.1
Q ss_pred hHHHHHHHHHHHhcCCCccccccceeeeeC-CeeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 020221 96 DARQFLEEARAVGQLRNRRLANLLGCCCEG-DERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSK 174 (329)
Q Consensus 96 ~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 174 (329)
...++.-..+.++.++|+|....+.+.... ....+|+|++ +.||.+.+..+. +...... ..
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s~~--------------~~ 86 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDESLL--------------AH 86 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhhhc--------------cc
Confidence 345677778999999999999988776433 3467889998 458999885322 2111100 11
Q ss_pred CCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCcccccCcccccCCCCCCcccchhhhHHHHHHHhCCCCCCc
Q 020221 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLRTGRVTPESVMYSFGTLLLDLLSGKHIPPS 254 (329)
Q Consensus 175 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 254 (329)
++.|- |++ +++| -++... |- ...+|+||||+|.++.++..|...+..
T Consensus 87 -~~~~~-----~~~-------~~td-~~~t~~--------------~~-----~~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 87 -GVLHL-----NII-------YITD-HFLTKY--------------PS-----PIGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred -cccee-----hhh-------hccc-cccccC--------------CC-----CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 33332 122 2233 111000 00 111499999999999999998854332
Q ss_pred hhhHHHhhhchhhhc-cccc------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 020221 255 HALDLIRDRNIQTLT-DSCL------EGQFSSDEGTELVRLASRCLQYEPRERPNPRSLV 307 (329)
Q Consensus 255 ~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~~~l 307 (329)
......... +.... .+.. ...+.-.+...++++...|+...|..||...++.
T Consensus 134 ~~~s~~l~~-i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 134 LTESEYLEI-LLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHH-HHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 111100000 00000 0000 0011224567788999999999999998655443
No 487
>TIGR02906 spore_CotS spore coat protein, CotS family. Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.
Probab=96.64 E-value=0.024 Score=50.24 Aligned_cols=28 Identities=14% Similarity=0.070 Sum_probs=24.9
Q ss_pred CccccccCCCceeeCCCCCeeeecccCcc
Q 020221 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMK 204 (329)
Q Consensus 176 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 204 (329)
+++|+|+.+.||+++. +.+.++||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 7899999999999997 678999999754
No 488
>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []. Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.
Probab=96.63 E-value=0.0096 Score=52.15 Aligned_cols=72 Identities=18% Similarity=0.164 Sum_probs=45.1
Q ss_pred ccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEEEEecCCCC
Q 020221 63 SEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYMPND 138 (329)
Q Consensus 63 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g 138 (329)
+.++-|.-..+|+.. .+++.+-||.-... ....|..|..-|+.|. .-.+.+.+++....+..+|++||++.+
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 345778888998887 56678999987632 2345777888777773 445778888887777789999999765
No 489
>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]
Probab=96.46 E-value=0.011 Score=53.59 Aligned_cols=60 Identities=17% Similarity=0.102 Sum_probs=44.7
Q ss_pred eEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeC
Q 020221 128 RLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFD 190 (329)
Q Consensus 128 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~ 190 (329)
..++-+|..|-++..++ .....++.-...++.-...|+--+---.+.+|.|++|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v---~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFV---KWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhh---hcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 35666788888888888 4455666667777777777765554333899999999999994
No 490
>PRK11768 serine/threonine protein kinase; Provisional
Probab=96.34 E-value=0.24 Score=44.35 Aligned_cols=97 Identities=16% Similarity=0.110 Sum_probs=53.8
Q ss_pred ccccCHHHHHHHhcCC--CcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcc--cc
Q 020221 41 FCEYSIETLRTATSGF--AMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRR--LA 116 (329)
Q Consensus 41 ~~~~~~~~~~~~~~~~--~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv 116 (329)
+..++.+.+..+...+ .....+..++ +.-..||+....++..+++|+.+... ....++..|.+.+..+.... ++
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~-s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~ 85 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALN-SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVV 85 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeec-cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCC
Confidence 4445555555554333 2112222333 33467999987778789999886443 23456667777776663211 22
Q ss_pred ccc---e--eeeeCCeeEEEEecCCCCC
Q 020221 117 NLL---G--CCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 117 ~~~---~--~~~~~~~~~lv~e~~~~gs 139 (329)
... | ....++..+.++++++|..
T Consensus 86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 86 APLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 211 1 1122456778999987753
No 491
>PRK12396 5-methylribose kinase; Reviewed
Probab=96.29 E-value=0.031 Score=50.90 Aligned_cols=74 Identities=14% Similarity=0.085 Sum_probs=48.5
Q ss_pred cccCCCCCCcEEEEEEeC-CCCEEEEEEeCC------CCChhHHHHHHHHHHHhcCC--Ccc-ccccceeeeeCCeeEEE
Q 020221 62 VSEHGEKAPNVVYKGKLE-NQFRIAVKRFNR------SAWPDARQFLEEARAVGQLR--NRR-LANLLGCCCEGDERLLV 131 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv 131 (329)
++.||-|.-.-||++... ++..|+||.-.. +-.-..++..-|.++|+... -|. +.+++. + ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-CcHHhhHH
Confidence 567799999999999964 356899986321 11223555667888887763 344 444443 3 45667788
Q ss_pred EecCCC
Q 020221 132 AEYMPN 137 (329)
Q Consensus 132 ~e~~~~ 137 (329)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
No 492
>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length. The function of this family is unknown.
Probab=96.28 E-value=0.023 Score=47.28 Aligned_cols=151 Identities=13% Similarity=0.063 Sum_probs=89.8
Q ss_pred CCCcEEEEEEeCCCCEEEEEEeCCCCCh-hHHHHHHHHHHHhcCCCccccccceeeeeCCeeEEEEecCCCCCHHhhhcc
Q 020221 68 KAPNVVYKGKLENQFRIAVKRFNRSAWP-DARQFLEEARAVGQLRNRRLANLLGCCCEGDERLLVAEYMPNDTLAKHLFH 146 (329)
Q Consensus 68 G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 146 (329)
++.++.-.+.-+-| +..+|+++...-. ...-|..+.++++++. .|+++..- ......+|.|.|....
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------- 140 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence 44455555543334 4556666544333 2334677788888776 56666632 3446779999985421
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCccccccCCCceeeCCCCCeeeecccCcccCCCCCCccCcccccCccccc
Q 020221 147 WETQPMKWAMRLRVALHIAEALEYCT-SKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNSRDGRSYSTNLAFTPPEYLR 225 (329)
Q Consensus 147 ~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~ 225 (329)
-... -.+. .=+.+|.-.| +..+.+|+|..|+||+-|..|.+||.|-+.-- ..+..|.--|+
T Consensus 141 ----i~~~---N~i~-agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--------~~~V~~vN~~Y-- 202 (308)
T PF07387_consen 141 ----INFS---NFIT-AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--------ENQVNMVNIEY-- 202 (308)
T ss_pred ----cchh---HHHH-HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhh--------hheeeEEeeec--
Confidence 1111 1111 1135566678 34578999999999999999999999976421 11222333221
Q ss_pred CCCCCCcccchhhhHHHHHHHhCC
Q 020221 226 TGRVTPESVMYSFGTLLLDLLSGK 249 (329)
Q Consensus 226 ~~~~~~~~DvwslG~il~el~tg~ 249 (329)
...+.++.+-+|=..+++++...
T Consensus 203 -~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 203 -ESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred -cccChHHHHHHHHHHHHHHHHHH
Confidence 23456677777777777776654
No 493
>PLN02421 phosphotransferase, alcohol group as acceptor/kinase
Probab=96.25 E-value=0.028 Score=50.46 Aligned_cols=136 Identities=15% Similarity=0.162 Sum_probs=75.4
Q ss_pred CCCCCCcEEEEEEeCC----CCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCcccc-ccceeeeeCCeeEEEEecCCCCC
Q 020221 65 HGEKAPNVVYKGKLEN----QFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRLA-NLLGCCCEGDERLLVAEYMPNDT 139 (329)
Q Consensus 65 lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gs 139 (329)
+.-|=...+|+....+ +..|++|+....... .-.-.+|..+++.+..-++. ++++++.. .+|.+|+++.+
T Consensus 22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~----G~i~~fi~g~~ 96 (330)
T PLN02421 22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN----GMIQSFINART 96 (330)
T ss_pred eCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC----cEeehhhcCCC
Confidence 3446667788887433 247999988654322 22235788888888654443 45555422 25889987765
Q ss_pred HHh--------------hhccCCC------C-CCCHHHHHHHHHHH----------------------HHHHH---Hhh-
Q 020221 140 LAK--------------HLFHWET------Q-PMKWAMRLRVALHI----------------------AEALE---YCT- 172 (329)
Q Consensus 140 L~~--------------~l~~~~~------~-~~~~~~~~~i~~~i----------------------~~~l~---~lH- 172 (329)
|.. .+++... . .-.+..+..+..++ ..-+. .+.
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 421 1111000 0 11233333332222 11111 111
Q ss_pred cC---CCccccccCCCceeeCC-CCCeeeecccCccc
Q 020221 173 SK---ERALYHDLNAYRIVFDD-DVNPRLSCFGLMKN 205 (329)
Q Consensus 173 ~~---~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~ 205 (329)
.. .-.+|.|+.+.||++++ ++.++++||..|..
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 12689999999999974 57899999998754
No 494
>TIGR02904 spore_ysxE spore coat protein YsxE. Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.
Probab=96.21 E-value=0.066 Score=47.58 Aligned_cols=31 Identities=10% Similarity=0.076 Sum_probs=27.9
Q ss_pred CCccccccCCCceeeCCCCCeeeecccCccc
Q 020221 175 ERALYHDLNAYRIVFDDDVNPRLSCFGLMKN 205 (329)
Q Consensus 175 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 205 (329)
.+++|+|+.++|+++++++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3789999999999999999999999998754
No 495
>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]
Probab=96.09 E-value=0.11 Score=46.57 Aligned_cols=145 Identities=17% Similarity=0.297 Sum_probs=81.4
Q ss_pred CCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCCCccc------cccce----eeeeC
Q 020221 56 FAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQLRNRRL------ANLLG----CCCEG 125 (329)
Q Consensus 56 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni------v~~~~----~~~~~ 125 (329)
+....-...|.. .-..+|+....+|.. ++|+.... . ...++..|...+.-+.-.++ ..+=| ....+
T Consensus 25 ~g~~~~~~~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~-~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~ 100 (331)
T COG2334 25 YGLDGSLRGLNS-EENSNFRVQTEDGRY-ILKIYRPG-W-TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG 100 (331)
T ss_pred cCcccccccccc-ccCceEEEEecCCCe-EEEEecCC-C-CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC
Confidence 333333344455 456799999777755 88888776 2 34456667777776632111 11111 11112
Q ss_pred CeeEEEEecCCCCCHHh-h-----------h-------ccCC--CC----CCCHH-------------HHHHHHHHHHHH
Q 020221 126 DERLLVAEYMPNDTLAK-H-----------L-------FHWE--TQ----PMKWA-------------MRLRVALHIAEA 167 (329)
Q Consensus 126 ~~~~lv~e~~~~gsL~~-~-----------l-------~~~~--~~----~~~~~-------------~~~~i~~~i~~~ 167 (329)
...+-+++|++|..+.. . + ++.. .. ...|. .......++...
T Consensus 101 ~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~ 180 (331)
T COG2334 101 PRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAA 180 (331)
T ss_pred ceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHH
Confidence 36788999999877662 0 0 0001 00 11222 001122333333
Q ss_pred HHHhhc-------CCC--ccccccCCCceeeCCCCC-eeeecccCcc
Q 020221 168 LEYCTS-------KER--ALYHDLNAYRIVFDDDVN-PRLSCFGLMK 204 (329)
Q Consensus 168 l~~lH~-------~~~--ivH~dlkp~Nil~~~~~~-~kl~Dfg~a~ 204 (329)
+..+.+ ..+ +||+|+.|.||+++.+.. .-++||+.+.
T Consensus 181 ~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 181 LDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 333333 223 899999999999998875 8899999764
No 496
>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]
Probab=96.03 E-value=0.029 Score=50.17 Aligned_cols=75 Identities=16% Similarity=0.050 Sum_probs=57.7
Q ss_pred eeEEEEecCCCCCHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCccccccCCCceeeCCCCCeeeecccCcccC
Q 020221 127 ERLLVAEYMPNDTLAKHLFHWETQPMKWAMRLRVALHIAEALEYCTSKERALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (329)
Q Consensus 127 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 206 (329)
..|++|++- |++|. .+ ....+.+...++++-+..+.-+..+...-|||+.-.|||++ +|++-|+||-+++..
T Consensus 300 y~yl~~kdh-gt~is-~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 300 YLYLHFKDH-GTPIS-II-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred EEEEEEecC-Cceee-ee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 456677764 33332 22 23467889999999998888887776788999999999999 999999999999854
Q ss_pred CCC
Q 020221 207 RDG 209 (329)
Q Consensus 207 ~~~ 209 (329)
.++
T Consensus 372 ~~q 374 (488)
T COG5072 372 YSQ 374 (488)
T ss_pred cCC
Confidence 433
No 497
>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=95.64 E-value=0.16 Score=42.65 Aligned_cols=68 Identities=22% Similarity=0.290 Sum_probs=46.9
Q ss_pred cEEEEEE-e-CCCCEEEEEEeCCCCChhHHHHHHHHHHHhcCC---CccccccceeeeeCCeeEEEEecCCCCCHH
Q 020221 71 NVVYKGK-L-ENQFRIAVKRFNRSAWPDARQFLEEARAVGQLR---NRRLANLLGCCCEGDERLLVAEYMPNDTLA 141 (329)
Q Consensus 71 g~V~~~~-~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 141 (329)
|.|..|. . .+..++-||+-... ....|..|+.-|..+. .-++.+.+.+..+.++.|+|+||++-+.+.
T Consensus 27 G~inea~~v~dg~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 27 GDINEAWRLRDGTDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccccceeEeecCCcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 3565554 2 34567888885432 2455777877777664 345777787888889999999999876554
No 498
>PRK06148 hypothetical protein; Provisional
Probab=95.56 E-value=0.41 Score=49.66 Aligned_cols=148 Identities=17% Similarity=0.223 Sum_probs=80.1
Q ss_pred cCCCcccccccCCCCCCcEEEEEEeCCCCEEEEEEeCCCCChhHHHHHHHHHHHhcC-------CCccccccc-ee----
Q 020221 54 SGFAMENIVSEHGEKAPNVVYKGKLENQFRIAVKRFNRSAWPDARQFLEEARAVGQL-------RNRRLANLL-GC---- 121 (329)
Q Consensus 54 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~-~~---- 121 (329)
..|.....++.|+ |..-.+|+....++..+++|+.+.... ......|.+.|.-| .-|.+++-. |-
T Consensus 22 ~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~ 98 (1013)
T PRK06148 22 QHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLAS 98 (1013)
T ss_pred HHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEE
Confidence 3444333345564 456788999877788899999986532 22333444455433 223333322 11
Q ss_pred eee-CC--eeEEEEecCCCCCHHhhh---------------------ccCCC----CCCCHHH-----------------
Q 020221 122 CCE-GD--ERLLVAEYMPNDTLAKHL---------------------FHWET----QPMKWAM----------------- 156 (329)
Q Consensus 122 ~~~-~~--~~~lv~e~~~~gsL~~~l---------------------~~~~~----~~~~~~~----------------- 156 (329)
... .+ ..+-+++|++|..+.+.. ..... ..+.|..
T Consensus 99 v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~ 178 (1013)
T PRK06148 99 AQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPE 178 (1013)
T ss_pred eecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHH
Confidence 111 11 466789999987665411 00111 1122211
Q ss_pred HHHHHHHHHHHHH-----Hhh--cCCCccccccCCCceeeCCCC--Cee-eecccCccc
Q 020221 157 RLRVALHIAEALE-----YCT--SKERALYHDLNAYRIVFDDDV--NPR-LSCFGLMKN 205 (329)
Q Consensus 157 ~~~i~~~i~~~l~-----~lH--~~~~ivH~dlkp~Nil~~~~~--~~k-l~Dfg~a~~ 205 (329)
...++.++..... .+. .. ++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 179 ~r~~l~~~~~~~~~~v~p~l~~Lp~-~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 179 DRALVERFLARFERNVAPRLAALPA-QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHHHHHHhcCCc-ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 1122223322221 111 23 799999999999999775 454 999998754
No 499
>PTZ00384 choline kinase; Provisional
Probab=94.83 E-value=0.22 Score=45.62 Aligned_cols=75 Identities=13% Similarity=0.200 Sum_probs=43.7
Q ss_pred cccCCCCCCcEEEEEEeCCC--CE-----EEEEEeCCCCChhHHHHHHHHHHHhcCCCccc-cccceeeeeCCeeEEEEe
Q 020221 62 VSEHGEKAPNVVYKGKLENQ--FR-----IAVKRFNRSAWPDARQFLEEARAVGQLRNRRL-ANLLGCCCEGDERLLVAE 133 (329)
Q Consensus 62 ~~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 133 (329)
++.+.-|-.+.+|++...++ .. |.++.... .....-.-.+|.++++.+...++ .++++.+. -+++.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 34445577788999875432 12 44444322 11111223568889999865444 44555543 369999
Q ss_pred cCCCCCHH
Q 020221 134 YMPNDTLA 141 (329)
Q Consensus 134 ~~~~gsL~ 141 (329)
|++|-+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99887664
No 500
>PRK10271 thiK thiamine kinase; Provisional
Probab=94.03 E-value=0.04 Score=44.84 Aligned_cols=30 Identities=20% Similarity=0.170 Sum_probs=25.7
Q ss_pred CccccccCCCceeeCCCCCeeeecccCcccC
Q 020221 176 RALYHDLNAYRIVFDDDVNPRLSCFGLMKNS 206 (329)
Q Consensus 176 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 206 (329)
..+|+|+.|.|+++++++ ++++||+.+...
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 458999999999998877 899999987543
Done!